id	sid	tid	token	lemma	pos
cord-035016-ipv8npdy	1	1	key	key	NN
cord-035016-ipv8npdy	1	2	:	:	:
cord-035016-ipv8npdy	1	3	cord-035016-ipv8npdy	cord-035016-ipv8npdy	NNS
cord-035016-ipv8npdy	1	4	authors	author	NNS
cord-035016-ipv8npdy	1	5	:	:	:
cord-035016-ipv8npdy	1	6	Torreele	Torreele	NNP
cord-035016-ipv8npdy	1	7	,	,	,
cord-035016-ipv8npdy	1	8	Els	Els	NNP
cord-035016-ipv8npdy	1	9	title	title	NN
cord-035016-ipv8npdy	1	10	:	:	:
cord-035016-ipv8npdy	1	11	Business	business	NN
cord-035016-ipv8npdy	1	12	-	-	HYPH
cord-035016-ipv8npdy	1	13	as	as	IN
cord-035016-ipv8npdy	1	14	-	-	HYPH
cord-035016-ipv8npdy	1	15	Usual	Usual	NNP
cord-035016-ipv8npdy	1	16	will	will	MD
cord-035016-ipv8npdy	1	17	not	not	RB
cord-035016-ipv8npdy	1	18	Deliver	deliver	VB
cord-035016-ipv8npdy	1	19	the	the	DT
cord-035016-ipv8npdy	1	20	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	1	21	Vaccines	Vaccines	NNPS
cord-035016-ipv8npdy	1	22	We	-PRON-	PRP
cord-035016-ipv8npdy	1	23	Need	need	VBP
cord-035016-ipv8npdy	1	24	date	date	NN
cord-035016-ipv8npdy	1	25	:	:	:
cord-035016-ipv8npdy	1	26	2020	2020	CD
cord-035016-ipv8npdy	1	27	-	-	HYPH
cord-035016-ipv8npdy	1	28	11	11	CD
cord-035016-ipv8npdy	1	29	-	-	HYPH
cord-035016-ipv8npdy	1	30	09	09	CD
cord-035016-ipv8npdy	1	31	journal	journal	NN
cord-035016-ipv8npdy	1	32	:	:	:
cord-035016-ipv8npdy	1	33	Development	development	NN
cord-035016-ipv8npdy	1	34	(	(	-LRB-
cord-035016-ipv8npdy	1	35	Rome	Rome	NNP
cord-035016-ipv8npdy	1	36	)	)	-RRB-
cord-035016-ipv8npdy	1	37	DOI	DOI	NNP
cord-035016-ipv8npdy	1	38	:	:	:
cord-035016-ipv8npdy	2	1	10.1057	10.1057	CD
cord-035016-ipv8npdy	2	2	/	/	SYM
cord-035016-ipv8npdy	2	3	s41301	s41301	NN
cord-035016-ipv8npdy	2	4	-	-	HYPH
cord-035016-ipv8npdy	2	5	020	020	CD
cord-035016-ipv8npdy	2	6	-	-	HYPH
cord-035016-ipv8npdy	2	7	00261	00261	CD
cord-035016-ipv8npdy	2	8	-	-	SYM
cord-035016-ipv8npdy	2	9	1	1	CD
cord-035016-ipv8npdy	2	10	sha	sha	NNP
cord-035016-ipv8npdy	2	11	:	:	:
cord-035016-ipv8npdy	2	12	11c46bd2a3df50e5e102de009240952058efe571	11c46bd2a3df50e5e102de009240952058efe571	CD
cord-035016-ipv8npdy	2	13	doc_id	doc_id	CD
cord-035016-ipv8npdy	2	14	:	:	:
cord-035016-ipv8npdy	2	15	35016	35016	CD
cord-035016-ipv8npdy	2	16	cord_uid	cord_uid	NN
cord-035016-ipv8npdy	2	17	:	:	:
cord-035016-ipv8npdy	3	1	ipv8npdy	ipv8npdy	NNP
cord-035016-ipv8npdy	3	2	Governments	government	NNS
cord-035016-ipv8npdy	3	3	must	must	MD
cord-035016-ipv8npdy	3	4	become	become	VB
cord-035016-ipv8npdy	3	5	active	active	JJ
cord-035016-ipv8npdy	3	6	shapers	shaper	NNS
cord-035016-ipv8npdy	3	7	of	of	IN
cord-035016-ipv8npdy	3	8	medical	medical	JJ
cord-035016-ipv8npdy	3	9	innovation	innovation	NN
cord-035016-ipv8npdy	3	10	and	and	CC
cord-035016-ipv8npdy	3	11	drive	drive	VB
cord-035016-ipv8npdy	3	12	the	the	DT
cord-035016-ipv8npdy	3	13	development	development	NN
cord-035016-ipv8npdy	3	14	of	of	IN
cord-035016-ipv8npdy	3	15	critical	critical	JJ
cord-035016-ipv8npdy	3	16	health	health	NN
cord-035016-ipv8npdy	3	17	technologies	technology	NNS
cord-035016-ipv8npdy	3	18	as	as	IN
cord-035016-ipv8npdy	3	19	global	global	JJ
cord-035016-ipv8npdy	3	20	health	health	NN
cord-035016-ipv8npdy	3	21	commons	common	NNS
cord-035016-ipv8npdy	3	22	.	.	.
cord-035016-ipv8npdy	4	1	The	the	DT
cord-035016-ipv8npdy	4	2	‘	'	``
cord-035016-ipv8npdy	4	3	race	race	NN
cord-035016-ipv8npdy	4	4	’	'	''
cord-035016-ipv8npdy	4	5	for	for	IN
cord-035016-ipv8npdy	4	6	COVID-19	covid-19	JJ
cord-035016-ipv8npdy	4	7	vaccines	vaccine	NNS
cord-035016-ipv8npdy	4	8	is	be	VBZ
cord-035016-ipv8npdy	4	9	exposing	expose	VBG
cord-035016-ipv8npdy	4	10	the	the	DT
cord-035016-ipv8npdy	4	11	deficiencies	deficiency	NNS
cord-035016-ipv8npdy	4	12	of	of	IN
cord-035016-ipv8npdy	4	13	a	a	DT
cord-035016-ipv8npdy	4	14	business	business	NN
cord-035016-ipv8npdy	4	15	-	-	HYPH
cord-035016-ipv8npdy	4	16	as	as	IN
cord-035016-ipv8npdy	4	17	-	-	HYPH
cord-035016-ipv8npdy	4	18	usual	usual	JJ
cord-035016-ipv8npdy	4	19	medical	medical	JJ
cord-035016-ipv8npdy	4	20	innovation	innovation	NN
cord-035016-ipv8npdy	4	21	ecosystem	ecosystem	NN
cord-035016-ipv8npdy	4	22	driven	drive	VBN
cord-035016-ipv8npdy	4	23	by	by	IN
cord-035016-ipv8npdy	4	24	corporate	corporate	JJ
cord-035016-ipv8npdy	4	25	interests	interest	NNS
cord-035016-ipv8npdy	4	26	,	,	,
cord-035016-ipv8npdy	4	27	not	not	RB
cord-035016-ipv8npdy	4	28	health	health	NN
cord-035016-ipv8npdy	4	29	outcomes	outcome	NNS
cord-035016-ipv8npdy	4	30	.	.	.
cord-035016-ipv8npdy	5	1	Instead	instead	RB
cord-035016-ipv8npdy	5	2	of	of	IN
cord-035016-ipv8npdy	5	3	bolstering	bolster	VBG
cord-035016-ipv8npdy	5	4	collective	collective	JJ
cord-035016-ipv8npdy	5	5	intelligence	intelligence	NN
cord-035016-ipv8npdy	5	6	,	,	,
cord-035016-ipv8npdy	5	7	it	-PRON-	PRP
cord-035016-ipv8npdy	5	8	relies	rely	VBZ
cord-035016-ipv8npdy	5	9	on	on	IN
cord-035016-ipv8npdy	5	10	competition	competition	NN
cord-035016-ipv8npdy	5	11	between	between	IN
cord-035016-ipv8npdy	5	12	proprietary	proprietary	JJ
cord-035016-ipv8npdy	5	13	vaccines	vaccine	NNS
cord-035016-ipv8npdy	5	14	and	and	CC
cord-035016-ipv8npdy	5	15	allows	allow	VBZ
cord-035016-ipv8npdy	5	16	the	the	DT
cord-035016-ipv8npdy	5	17	bar	bar	NN
cord-035016-ipv8npdy	5	18	on	on	IN
cord-035016-ipv8npdy	5	19	safety	safety	NN
cord-035016-ipv8npdy	5	20	and	and	CC
cord-035016-ipv8npdy	5	21	efficacy	efficacy	NN
cord-035016-ipv8npdy	5	22	to	to	TO
cord-035016-ipv8npdy	5	23	be	be	VB
cord-035016-ipv8npdy	5	24	lowered	lower	VBN
cord-035016-ipv8npdy	5	25	,	,	,
cord-035016-ipv8npdy	5	26	risking	risk	VBG
cord-035016-ipv8npdy	5	27	people	people	NNS
cord-035016-ipv8npdy	5	28	’s	’s	POS
cord-035016-ipv8npdy	5	29	health	health	NN
cord-035016-ipv8npdy	5	30	and	and	CC
cord-035016-ipv8npdy	5	31	undermining	undermine	VBG
cord-035016-ipv8npdy	5	32	their	-PRON-	PRP$
cord-035016-ipv8npdy	5	33	trust	trust	NN
cord-035016-ipv8npdy	5	34	.	.	.
cord-035016-ipv8npdy	6	1	In	in	IN
cord-035016-ipv8npdy	6	2	the	the	DT
cord-035016-ipv8npdy	6	3	early	early	JJ
cord-035016-ipv8npdy	6	4	weeks	week	NNS
cord-035016-ipv8npdy	6	5	of	of	IN
cord-035016-ipv8npdy	6	6	2020	2020	CD
cord-035016-ipv8npdy	6	7	,	,	,
cord-035016-ipv8npdy	6	8	the	the	DT
cord-035016-ipv8npdy	6	9	world	world	NN
cord-035016-ipv8npdy	6	10	was	be	VBD
cord-035016-ipv8npdy	6	11	alerted	alert	VBN
cord-035016-ipv8npdy	6	12	to	to	IN
cord-035016-ipv8npdy	6	13	the	the	DT
cord-035016-ipv8npdy	6	14	emergence	emergence	NN
cord-035016-ipv8npdy	6	15	of	of	IN
cord-035016-ipv8npdy	6	16	a	a	DT
cord-035016-ipv8npdy	6	17	new	new	JJ
cord-035016-ipv8npdy	6	18	deadly	deadly	JJ
cord-035016-ipv8npdy	6	19	infectious	infectious	JJ
cord-035016-ipv8npdy	6	20	respiratory	respiratory	JJ
cord-035016-ipv8npdy	6	21	disease	disease	NN
cord-035016-ipv8npdy	6	22	,	,	,
cord-035016-ipv8npdy	6	23	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	6	24	,	,	,
cord-035016-ipv8npdy	6	25	caused	cause	VBN
cord-035016-ipv8npdy	6	26	by	by	IN
cord-035016-ipv8npdy	6	27	severe	severe	JJ
cord-035016-ipv8npdy	6	28	acute	acute	JJ
cord-035016-ipv8npdy	6	29	respiratory	respiratory	JJ
cord-035016-ipv8npdy	6	30	syndrome	syndrome	NN
cord-035016-ipv8npdy	6	31	coronavirus	coronavirus	NN
cord-035016-ipv8npdy	6	32	2	2	CD
cord-035016-ipv8npdy	7	1	(	(	-LRB-
cord-035016-ipv8npdy	7	2	SARS	SARS	NNP
cord-035016-ipv8npdy	7	3	-	-	HYPH
cord-035016-ipv8npdy	7	4	CoV-2	CoV-2	NNP
cord-035016-ipv8npdy	7	5	)	)	-RRB-
cord-035016-ipv8npdy	7	6	.	.	.
cord-035016-ipv8npdy	8	1	First	first	RB
cord-035016-ipv8npdy	8	2	reported	report	VBN
cord-035016-ipv8npdy	8	3	in	in	IN
cord-035016-ipv8npdy	8	4	China	China	NNP
cord-035016-ipv8npdy	8	5	,	,	,
cord-035016-ipv8npdy	8	6	it	-PRON-	PRP
cord-035016-ipv8npdy	8	7	rapidly	rapidly	RB
cord-035016-ipv8npdy	8	8	spread	spread	VBD
cord-035016-ipv8npdy	8	9	across	across	IN
cord-035016-ipv8npdy	8	10	the	the	DT
cord-035016-ipv8npdy	8	11	globe	globe	NN
cord-035016-ipv8npdy	8	12	.	.	.
cord-035016-ipv8npdy	9	1	Without	without	IN
cord-035016-ipv8npdy	9	2	effective	effective	JJ
cord-035016-ipv8npdy	9	3	treatments	treatment	NNS
cord-035016-ipv8npdy	9	4	or	or	CC
cord-035016-ipv8npdy	9	5	vaccines	vaccine	NNS
cord-035016-ipv8npdy	9	6	available	available	JJ
cord-035016-ipv8npdy	9	7	,	,	,
cord-035016-ipv8npdy	9	8	the	the	DT
cord-035016-ipv8npdy	9	9	response	response	NN
cord-035016-ipv8npdy	9	10	to	to	IN
cord-035016-ipv8npdy	9	11	the	the	DT
cord-035016-ipv8npdy	9	12	pandemic	pandemic	NN
cord-035016-ipv8npdy	9	13	has	have	VBZ
cord-035016-ipv8npdy	9	14	so	so	RB
cord-035016-ipv8npdy	9	15	far	far	RB
cord-035016-ipv8npdy	9	16	largely	largely	RB
cord-035016-ipv8npdy	9	17	relied	rely	VBN
cord-035016-ipv8npdy	9	18	on	on	IN
cord-035016-ipv8npdy	9	19	infection	infection	NN
cord-035016-ipv8npdy	9	20	control	control	NN
cord-035016-ipv8npdy	9	21	measures	measure	NNS
cord-035016-ipv8npdy	9	22	such	such	JJ
cord-035016-ipv8npdy	9	23	as	as	IN
cord-035016-ipv8npdy	9	24	hand	hand	NN
cord-035016-ipv8npdy	9	25	hygiene	hygiene	NN
cord-035016-ipv8npdy	9	26	,	,	,
cord-035016-ipv8npdy	9	27	personal	personal	JJ
cord-035016-ipv8npdy	9	28	protective	protective	JJ
cord-035016-ipv8npdy	9	29	equipment	equipment	NN
cord-035016-ipv8npdy	9	30	including	include	VBG
cord-035016-ipv8npdy	9	31	masks	mask	NNS
cord-035016-ipv8npdy	9	32	,	,	,
cord-035016-ipv8npdy	9	33	physical	physical	JJ
cord-035016-ipv8npdy	9	34	distancing	distancing	NN
cord-035016-ipv8npdy	9	35	and	and	CC
cord-035016-ipv8npdy	9	36	restrictions	restriction	NNS
cord-035016-ipv8npdy	9	37	on	on	IN
cord-035016-ipv8npdy	9	38	movement	movement	NN
cord-035016-ipv8npdy	9	39	which	which	WDT
cord-035016-ipv8npdy	9	40	have	have	VBP
cord-035016-ipv8npdy	9	41	included	include	VBN
cord-035016-ipv8npdy	9	42	variable	variable	JJ
cord-035016-ipv8npdy	9	43	periods	period	NNS
cord-035016-ipv8npdy	9	44	of	of	IN
cord-035016-ipv8npdy	9	45	lockdown	lockdown	NN
cord-035016-ipv8npdy	9	46	of	of	IN
cord-035016-ipv8npdy	9	47	cities	city	NNS
cord-035016-ipv8npdy	9	48	,	,	,
cord-035016-ipv8npdy	9	49	countries	country	NNS
cord-035016-ipv8npdy	9	50	or	or	CC
cord-035016-ipv8npdy	9	51	regions	region	NNS
cord-035016-ipv8npdy	9	52	.	.	.
cord-035016-ipv8npdy	10	1	By	by	IN
cord-035016-ipv8npdy	10	2	late	late	JJ
cord-035016-ipv8npdy	10	3	September	September	NNP
cord-035016-ipv8npdy	10	4	,	,	,
cord-035016-ipv8npdy	10	5	over	over	IN
cord-035016-ipv8npdy	10	6	one	one	CD
cord-035016-ipv8npdy	10	7	million	million	CD
cord-035016-ipv8npdy	10	8	people	people	NNS
cord-035016-ipv8npdy	10	9	had	have	VBD
cord-035016-ipv8npdy	10	10	died	die	VBN
cord-035016-ipv8npdy	10	11	from	from	IN
cord-035016-ipv8npdy	10	12	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	10	13	,	,	,
cord-035016-ipv8npdy	10	14	among	among	IN
cord-035016-ipv8npdy	10	15	over	over	IN
cord-035016-ipv8npdy	10	16	33	33	CD
cord-035016-ipv8npdy	10	17	million	million	CD
cord-035016-ipv8npdy	10	18	people	people	NNS
cord-035016-ipv8npdy	10	19	diagnosed	diagnose	VBN
cord-035016-ipv8npdy	10	20	.	.	.
cord-035016-ipv8npdy	11	1	Given	give	VBN
cord-035016-ipv8npdy	11	2	the	the	DT
cord-035016-ipv8npdy	11	3	enormous	enormous	JJ
cord-035016-ipv8npdy	11	4	health	health	NN
cord-035016-ipv8npdy	11	5	,	,	,
cord-035016-ipv8npdy	11	6	social	social	JJ
cord-035016-ipv8npdy	11	7	and	and	CC
cord-035016-ipv8npdy	11	8	economic	economic	JJ
cord-035016-ipv8npdy	11	9	impact	impact	NN
cord-035016-ipv8npdy	11	10	of	of	IN
cord-035016-ipv8npdy	11	11	the	the	DT
cord-035016-ipv8npdy	11	12	continued	continue	VBN
cord-035016-ipv8npdy	11	13	spread	spread	NN
cord-035016-ipv8npdy	11	14	of	of	IN
cord-035016-ipv8npdy	11	15	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	11	16	,	,	,
cord-035016-ipv8npdy	11	17	which	which	WDT
cord-035016-ipv8npdy	11	18	is	be	VBZ
cord-035016-ipv8npdy	11	19	nowhere	nowhere	RB
cord-035016-ipv8npdy	11	20	near	near	JJ
cord-035016-ipv8npdy	11	21	being	be	VBG
cord-035016-ipv8npdy	11	22	under	under	IN
cord-035016-ipv8npdy	11	23	control	control	NN
cord-035016-ipv8npdy	11	24	,	,	,
cord-035016-ipv8npdy	11	25	it	-PRON-	PRP
cord-035016-ipv8npdy	11	26	is	be	VBZ
cord-035016-ipv8npdy	11	27	no	no	DT
cord-035016-ipv8npdy	11	28	surprise	surprise	NN
cord-035016-ipv8npdy	11	29	that	that	IN
cord-035016-ipv8npdy	11	30	a	a	DT
cord-035016-ipv8npdy	11	31	lot	lot	NN
cord-035016-ipv8npdy	11	32	of	of	IN
cord-035016-ipv8npdy	11	33	hope	hope	NN
cord-035016-ipv8npdy	11	34	is	be	VBZ
cord-035016-ipv8npdy	11	35	set	set	VBN
cord-035016-ipv8npdy	11	36	on	on	IN
cord-035016-ipv8npdy	11	37	finding	find	VBG
cord-035016-ipv8npdy	11	38	a	a	DT
cord-035016-ipv8npdy	11	39	vaccine	vaccine	NN
cord-035016-ipv8npdy	11	40	.	.	.
cord-035016-ipv8npdy	12	1	With	with	IN
cord-035016-ipv8npdy	12	2	massive	massive	JJ
cord-035016-ipv8npdy	12	3	financial	financial	JJ
cord-035016-ipv8npdy	12	4	support	support	NN
cord-035016-ipv8npdy	12	5	from	from	IN
cord-035016-ipv8npdy	12	6	governments	government	NNS
cord-035016-ipv8npdy	12	7	,	,	,
cord-035016-ipv8npdy	12	8	in	in	IN
cord-035016-ipv8npdy	12	9	particular	particular	JJ
cord-035016-ipv8npdy	12	10	the	the	DT
cord-035016-ipv8npdy	12	11	US	US	NNP
cord-035016-ipv8npdy	12	12	,	,	,
cord-035016-ipv8npdy	12	13	the	the	DT
cord-035016-ipv8npdy	12	14	UK	UK	NNP
cord-035016-ipv8npdy	12	15	,	,	,
cord-035016-ipv8npdy	12	16	other	other	JJ
cord-035016-ipv8npdy	12	17	European	european	JJ
cord-035016-ipv8npdy	12	18	countries	country	NNS
cord-035016-ipv8npdy	12	19	,	,	,
cord-035016-ipv8npdy	12	20	as	as	RB
cord-035016-ipv8npdy	12	21	well	well	RB
cord-035016-ipv8npdy	12	22	as	as	IN
cord-035016-ipv8npdy	12	23	China	China	NNP
cord-035016-ipv8npdy	12	24	and	and	CC
cord-035016-ipv8npdy	12	25	Russia	Russia	NNP
cord-035016-ipv8npdy	12	26	,	,	,
cord-035016-ipv8npdy	12	27	researchers	researcher	NNS
cord-035016-ipv8npdy	12	28	and	and	CC
cord-035016-ipv8npdy	12	29	companies	company	NNS
cord-035016-ipv8npdy	12	30	engaged	engage	VBD
cord-035016-ipv8npdy	12	31	in	in	IN
cord-035016-ipv8npdy	12	32	what	what	WP
cord-035016-ipv8npdy	12	33	soon	soon	RB
cord-035016-ipv8npdy	12	34	became	become	VBD
cord-035016-ipv8npdy	12	35	a	a	DT
cord-035016-ipv8npdy	12	36	frantic	frantic	JJ
cord-035016-ipv8npdy	12	37	race	race	NN
cord-035016-ipv8npdy	12	38	to	to	TO
cord-035016-ipv8npdy	12	39	develop	develop	VB
cord-035016-ipv8npdy	12	40	vaccines	vaccine	NNS
cord-035016-ipv8npdy	12	41	against	against	IN
cord-035016-ipv8npdy	12	42	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	12	43	.	.	.
cord-035016-ipv8npdy	13	1	So	so	RB
cord-035016-ipv8npdy	13	2	far	far	RB
cord-035016-ipv8npdy	13	3	,	,	,
cord-035016-ipv8npdy	13	4	an	an	DT
cord-035016-ipv8npdy	13	5	unprecedented	unprecedented	JJ
cord-035016-ipv8npdy	13	6	amount	amount	NN
cord-035016-ipv8npdy	13	7	of	of	IN
cord-035016-ipv8npdy	13	8	public	public	JJ
cord-035016-ipv8npdy	13	9	funds	fund	NNS
cord-035016-ipv8npdy	13	10	(	(	-LRB-
cord-035016-ipv8npdy	13	11	estimated	estimate	VBN
cord-035016-ipv8npdy	13	12	at	at	IN
cord-035016-ipv8npdy	13	13	over	over	IN
cord-035016-ipv8npdy	13	14	5	5	CD
cord-035016-ipv8npdy	13	15	Bn	Bn	NNP
cord-035016-ipv8npdy	13	16	US$	us$	$
cord-035016-ipv8npdy	13	17	)	)	-RRB-
cord-035016-ipv8npdy	13	18	1	1	CD
cord-035016-ipv8npdy	13	19	has	have	VBZ
cord-035016-ipv8npdy	13	20	been	be	VBN
cord-035016-ipv8npdy	13	21	poured	pour	VBN
cord-035016-ipv8npdy	13	22	into	into	IN
cord-035016-ipv8npdy	13	23	vaccine	vaccine	NN
cord-035016-ipv8npdy	13	24	research	research	NN
cord-035016-ipv8npdy	13	25	and	and	CC
cord-035016-ipv8npdy	13	26	development	development	NN
cord-035016-ipv8npdy	13	27	(	(	-LRB-
cord-035016-ipv8npdy	13	28	R&D	r&d	NN
cord-035016-ipv8npdy	13	29	)	)	-RRB-
cord-035016-ipv8npdy	13	30	and	and	CC
cord-035016-ipv8npdy	13	31	manufacturing	manufacturing	NN
cord-035016-ipv8npdy	13	32	,	,	,
cord-035016-ipv8npdy	13	33	resulting	result	VBG
cord-035016-ipv8npdy	13	34	in	in	IN
cord-035016-ipv8npdy	13	35	over	over	IN
cord-035016-ipv8npdy	13	36	50	50	CD
cord-035016-ipv8npdy	13	37	vaccine	vaccine	NN
cord-035016-ipv8npdy	13	38	candidates	candidate	NNS
cord-035016-ipv8npdy	13	39	in	in	IN
cord-035016-ipv8npdy	13	40	clinical	clinical	JJ
cord-035016-ipv8npdy	13	41	trials	trial	NNS
cord-035016-ipv8npdy	13	42	2	2	CD
cord-035016-ipv8npdy	13	43	and	and	CC
cord-035016-ipv8npdy	13	44	many	many	JJ
cord-035016-ipv8npdy	13	45	more	more	JJR
cord-035016-ipv8npdy	13	46	in	in	IN
cord-035016-ipv8npdy	13	47	the	the	DT
cord-035016-ipv8npdy	13	48	pipeline	pipeline	NN
cord-035016-ipv8npdy	13	49	.	.	.
cord-035016-ipv8npdy	14	1	Touted	tout	VBN
cord-035016-ipv8npdy	14	2	by	by	IN
cord-035016-ipv8npdy	14	3	many	many	JJ
cord-035016-ipv8npdy	14	4	as	as	IN
cord-035016-ipv8npdy	14	5	a	a	DT
cord-035016-ipv8npdy	14	6	major	major	JJ
cord-035016-ipv8npdy	14	7	tour	tour	NN
cord-035016-ipv8npdy	14	8	de	de	IN
cord-035016-ipv8npdy	14	9	force	force	NN
cord-035016-ipv8npdy	14	10	,	,	,
cord-035016-ipv8npdy	14	11	the	the	DT
cord-035016-ipv8npdy	14	12	ongoing	ongoing	JJ
cord-035016-ipv8npdy	14	13	'	'	``
cord-035016-ipv8npdy	14	14	race	race	NN
cord-035016-ipv8npdy	14	15	'	'	''
cord-035016-ipv8npdy	14	16	towards	towards	IN
cord-035016-ipv8npdy	14	17	a	a	DT
cord-035016-ipv8npdy	14	18	vaccine	vaccine	NN
cord-035016-ipv8npdy	14	19	is	be	VBZ
cord-035016-ipv8npdy	14	20	also	also	RB
cord-035016-ipv8npdy	14	21	exposing	expose	VBG
cord-035016-ipv8npdy	14	22	the	the	DT
cord-035016-ipv8npdy	14	23	intrinsic	intrinsic	JJ
cord-035016-ipv8npdy	14	24	deficiencies	deficiency	NNS
cord-035016-ipv8npdy	14	25	of	of	IN
cord-035016-ipv8npdy	14	26	relying	rely	VBG
cord-035016-ipv8npdy	14	27	on	on	IN
cord-035016-ipv8npdy	14	28	for	for	IN
cord-035016-ipv8npdy	14	29	-	-	HYPH
cord-035016-ipv8npdy	14	30	profit	profit	NN
cord-035016-ipv8npdy	14	31	pharmaceutical	pharmaceutical	NN
cord-035016-ipv8npdy	14	32	companies	company	NNS
cord-035016-ipv8npdy	14	33	,	,	,
cord-035016-ipv8npdy	14	34	that	that	WDT
cord-035016-ipv8npdy	14	35	are	be	VBP
cord-035016-ipv8npdy	14	36	governed	govern	VBN
cord-035016-ipv8npdy	14	37	by	by	IN
cord-035016-ipv8npdy	14	38	trade	trade	NN
cord-035016-ipv8npdy	14	39	rules	rule	NNS
cord-035016-ipv8npdy	14	40	,	,	,
cord-035016-ipv8npdy	14	41	financial	financial	JJ
cord-035016-ipv8npdy	14	42	speculation	speculation	NN
cord-035016-ipv8npdy	14	43	and	and	CC
cord-035016-ipv8npdy	14	44	market	market	NN
cord-035016-ipv8npdy	14	45	competition	competition	NN
cord-035016-ipv8npdy	14	46	,	,	,
cord-035016-ipv8npdy	14	47	to	to	TO
cord-035016-ipv8npdy	14	48	ensure	ensure	VB
cord-035016-ipv8npdy	14	49	the	the	DT
cord-035016-ipv8npdy	14	50	development	development	NN
cord-035016-ipv8npdy	14	51	of	of	IN
cord-035016-ipv8npdy	14	52	essential	essential	JJ
cord-035016-ipv8npdy	14	53	health	health	NN
cord-035016-ipv8npdy	14	54	technologies	technology	NNS
cord-035016-ipv8npdy	14	55	.	.	.
cord-035016-ipv8npdy	15	1	In	in	IN
cord-035016-ipv8npdy	15	2	fact	fact	NN
cord-035016-ipv8npdy	15	3	,	,	,
cord-035016-ipv8npdy	15	4	it	-PRON-	PRP
cord-035016-ipv8npdy	15	5	risks	risk	VBZ
cord-035016-ipv8npdy	15	6	delivering	deliver	VBG
cord-035016-ipv8npdy	15	7	vaccines	vaccine	NNS
cord-035016-ipv8npdy	15	8	that	that	WDT
cord-035016-ipv8npdy	15	9	are	be	VBP
cord-035016-ipv8npdy	15	10	neither	neither	DT
cord-035016-ipv8npdy	15	11	adequate	adequate	JJ
cord-035016-ipv8npdy	15	12	nor	nor	CC
cord-035016-ipv8npdy	15	13	widely	widely	RB
cord-035016-ipv8npdy	15	14	accessible	accessible	JJ
cord-035016-ipv8npdy	15	15	and	and	CC
cord-035016-ipv8npdy	15	16	may	may	MD
cord-035016-ipv8npdy	15	17	stand	stand	VB
cord-035016-ipv8npdy	15	18	in	in	IN
cord-035016-ipv8npdy	15	19	the	the	DT
cord-035016-ipv8npdy	15	20	way	way	NN
cord-035016-ipv8npdy	15	21	of	of	IN
cord-035016-ipv8npdy	15	22	a	a	DT
cord-035016-ipv8npdy	15	23	truly	truly	RB
cord-035016-ipv8npdy	15	24	effective	effective	JJ
cord-035016-ipv8npdy	15	25	global	global	JJ
cord-035016-ipv8npdy	15	26	response	response	NN
cord-035016-ipv8npdy	15	27	to	to	IN
cord-035016-ipv8npdy	15	28	the	the	DT
cord-035016-ipv8npdy	15	29	pandemic	pandemic	NN
cord-035016-ipv8npdy	15	30	.	.	.
cord-035016-ipv8npdy	16	1	Vaccinating	vaccinate	VBG
cord-035016-ipv8npdy	16	2	against	against	IN
cord-035016-ipv8npdy	16	3	infectious	infectious	JJ
cord-035016-ipv8npdy	16	4	diseases	disease	NNS
cord-035016-ipv8npdy	16	5	has	have	VBZ
cord-035016-ipv8npdy	16	6	proven	prove	VBN
cord-035016-ipv8npdy	16	7	to	to	TO
cord-035016-ipv8npdy	16	8	be	be	VB
cord-035016-ipv8npdy	16	9	a	a	DT
cord-035016-ipv8npdy	16	10	highly	highly	RB
cord-035016-ipv8npdy	16	11	cost	cost	NN
cord-035016-ipv8npdy	16	12	-	-	HYPH
cord-035016-ipv8npdy	16	13	effective	effective	JJ
cord-035016-ipv8npdy	16	14	public	public	JJ
cord-035016-ipv8npdy	16	15	health	health	NN
cord-035016-ipv8npdy	16	16	intervention	intervention	NN
cord-035016-ipv8npdy	16	17	,	,	,
cord-035016-ipv8npdy	16	18	combining	combine	VBG
cord-035016-ipv8npdy	16	19	individual	individual	JJ
cord-035016-ipv8npdy	16	20	and	and	CC
cord-035016-ipv8npdy	16	21	population	population	NN
cord-035016-ipv8npdy	16	22	-	-	HYPH
cord-035016-ipv8npdy	16	23	wide	wide	JJ
cord-035016-ipv8npdy	16	24	health	health	NN
cord-035016-ipv8npdy	16	25	benefits	benefit	NNS
cord-035016-ipv8npdy	16	26	,	,	,
cord-035016-ipv8npdy	16	27	if	if	IN
cord-035016-ipv8npdy	16	28	certain	certain	JJ
cord-035016-ipv8npdy	16	29	conditions	condition	NNS
cord-035016-ipv8npdy	16	30	are	be	VBP
cord-035016-ipv8npdy	16	31	met	meet	VBN
cord-035016-ipv8npdy	16	32	.	.	.
cord-035016-ipv8npdy	17	1	These	these	DT
cord-035016-ipv8npdy	17	2	are	be	VBP
cord-035016-ipv8npdy	17	3	in	in	IN
cord-035016-ipv8npdy	17	4	the	the	DT
cord-035016-ipv8npdy	17	5	first	first	JJ
cord-035016-ipv8npdy	17	6	place	place	NN
cord-035016-ipv8npdy	17	7	that	that	WDT
cord-035016-ipv8npdy	17	8	the	the	DT
cord-035016-ipv8npdy	17	9	vaccine(s	vaccine(s	NN
cord-035016-ipv8npdy	17	10	)	)	-RRB-
cord-035016-ipv8npdy	17	11	must	must	MD
cord-035016-ipv8npdy	17	12	be	be	VB
cord-035016-ipv8npdy	17	13	safe	safe	JJ
cord-035016-ipv8npdy	17	14	and	and	CC
cord-035016-ipv8npdy	17	15	effective	effective	JJ
cord-035016-ipv8npdy	17	16	,	,	,
cord-035016-ipv8npdy	17	17	and	and	CC
cord-035016-ipv8npdy	17	18	widely	widely	RB
cord-035016-ipv8npdy	17	19	available	available	JJ
cord-035016-ipv8npdy	17	20	to	to	TO
cord-035016-ipv8npdy	17	21	vaccinate	vaccinate	VB
cord-035016-ipv8npdy	17	22	the	the	DT
cord-035016-ipv8npdy	17	23	populations	population	NNS
cord-035016-ipv8npdy	17	24	that	that	WDT
cord-035016-ipv8npdy	17	25	can	can	MD
cord-035016-ipv8npdy	17	26	most	most	RBS
cord-035016-ipv8npdy	17	27	benefit	benefit	VB
cord-035016-ipv8npdy	17	28	from	from	IN
cord-035016-ipv8npdy	17	29	it	-PRON-	PRP
cord-035016-ipv8npdy	17	30	.	.	.
cord-035016-ipv8npdy	18	1	Depending	depend	VBG
cord-035016-ipv8npdy	18	2	on	on	IN
cord-035016-ipv8npdy	18	3	the	the	DT
cord-035016-ipv8npdy	18	4	disease	disease	NN
cord-035016-ipv8npdy	18	5	,	,	,
cord-035016-ipv8npdy	18	6	how	how	WRB
cord-035016-ipv8npdy	18	7	it	-PRON-	PRP
cord-035016-ipv8npdy	18	8	is	be	VBZ
cord-035016-ipv8npdy	18	9	transmitted	transmit	VBN
cord-035016-ipv8npdy	18	10	and	and	CC
cord-035016-ipv8npdy	18	11	how	how	WRB
cord-035016-ipv8npdy	18	12	contagious	contagious	JJ
cord-035016-ipv8npdy	18	13	it	-PRON-	PRP
cord-035016-ipv8npdy	18	14	is	be	VBZ
cord-035016-ipv8npdy	18	15	,	,	,
cord-035016-ipv8npdy	18	16	an	an	DT
cord-035016-ipv8npdy	18	17	effective	effective	JJ
cord-035016-ipv8npdy	18	18	vaccine	vaccine	NN
cord-035016-ipv8npdy	18	19	would	would	MD
cord-035016-ipv8npdy	18	20	ideally	ideally	RB
cord-035016-ipv8npdy	18	21	protect	protect	VB
cord-035016-ipv8npdy	18	22	against	against	IN
cord-035016-ipv8npdy	18	23	infection	infection	NN
cord-035016-ipv8npdy	18	24	,	,	,
cord-035016-ipv8npdy	18	25	or	or	CC
cord-035016-ipv8npdy	18	26	else	else	RB
cord-035016-ipv8npdy	18	27	,	,	,
cord-035016-ipv8npdy	18	28	it	-PRON-	PRP
cord-035016-ipv8npdy	18	29	may	may	MD
cord-035016-ipv8npdy	18	30	only	only	RB
cord-035016-ipv8npdy	18	31	protect	protect	VB
cord-035016-ipv8npdy	18	32	from	from	IN
cord-035016-ipv8npdy	18	33	getting	get	VBG
cord-035016-ipv8npdy	18	34	(	(	-LRB-
cord-035016-ipv8npdy	18	35	seriously	seriously	RB
cord-035016-ipv8npdy	18	36	)	)	-RRB-
cord-035016-ipv8npdy	18	37	ill	ill	JJ
cord-035016-ipv8npdy	18	38	,	,	,
cord-035016-ipv8npdy	18	39	or	or	CC
cord-035016-ipv8npdy	18	40	dying	die	VBG
cord-035016-ipv8npdy	18	41	,	,	,
cord-035016-ipv8npdy	18	42	or	or	CC
cord-035016-ipv8npdy	18	43	from	from	IN
cord-035016-ipv8npdy	18	44	further	further	RB
cord-035016-ipv8npdy	18	45	spreading	spread	VBG
cord-035016-ipv8npdy	18	46	the	the	DT
cord-035016-ipv8npdy	18	47	disease	disease	NN
cord-035016-ipv8npdy	18	48	.	.	.
cord-035016-ipv8npdy	19	1	An	an	DT
cord-035016-ipv8npdy	19	2	additional	additional	JJ
cord-035016-ipv8npdy	19	3	condition	condition	NN
cord-035016-ipv8npdy	19	4	is	be	VBZ
cord-035016-ipv8npdy	19	5	that	that	IN
cord-035016-ipv8npdy	19	6	vaccines	vaccine	NNS
cord-035016-ipv8npdy	19	7	be	be	VB
cord-035016-ipv8npdy	19	8	deployed	deploy	VBN
cord-035016-ipv8npdy	19	9	through	through	IN
cord-035016-ipv8npdy	19	10	an	an	DT
cord-035016-ipv8npdy	19	11	appropriate	appropriate	JJ
cord-035016-ipv8npdy	19	12	vaccination	vaccination	NN
cord-035016-ipv8npdy	19	13	strategy	strategy	NN
cord-035016-ipv8npdy	19	14	.	.	.
cord-035016-ipv8npdy	20	1	Who	who	WP
cord-035016-ipv8npdy	20	2	and	and	CC
cord-035016-ipv8npdy	20	3	when	when	WRB
cord-035016-ipv8npdy	20	4	to	to	TO
cord-035016-ipv8npdy	20	5	vaccinate	vaccinate	VB
cord-035016-ipv8npdy	20	6	,	,	,
cord-035016-ipv8npdy	20	7	including	include	VBG
cord-035016-ipv8npdy	20	8	priority	priority	NN
cord-035016-ipv8npdy	20	9	allocation	allocation	NN
cord-035016-ipv8npdy	20	10	if	if	IN
cord-035016-ipv8npdy	20	11	vaccine	vaccine	NN
cord-035016-ipv8npdy	20	12	availability	availability	NN
cord-035016-ipv8npdy	20	13	is	be	VBZ
cord-035016-ipv8npdy	20	14	limited	limit	VBN
cord-035016-ipv8npdy	20	15	,	,	,
cord-035016-ipv8npdy	20	16	are	be	VBP
cord-035016-ipv8npdy	20	17	informed	inform	VBN
cord-035016-ipv8npdy	20	18	both	both	CC
cord-035016-ipv8npdy	20	19	by	by	IN
cord-035016-ipv8npdy	20	20	the	the	DT
cord-035016-ipv8npdy	20	21	epidemiology	epidemiology	NN
cord-035016-ipv8npdy	20	22	and	and	CC
cord-035016-ipv8npdy	20	23	the	the	DT
cord-035016-ipv8npdy	20	24	vaccine	vaccine	NN
cord-035016-ipv8npdy	20	25	's	's	POS
cord-035016-ipv8npdy	20	26	properties	property	NNS
cord-035016-ipv8npdy	20	27	,	,	,
cord-035016-ipv8npdy	20	28	and	and	CC
cord-035016-ipv8npdy	20	29	may	may	MD
cord-035016-ipv8npdy	20	30	need	need	VB
cord-035016-ipv8npdy	20	31	to	to	TO
cord-035016-ipv8npdy	20	32	be	be	VB
cord-035016-ipv8npdy	20	33	adapted	adapt	VBN
cord-035016-ipv8npdy	20	34	over	over	IN
cord-035016-ipv8npdy	20	35	time	time	NN
cord-035016-ipv8npdy	20	36	as	as	IN
cord-035016-ipv8npdy	20	37	the	the	DT
cord-035016-ipv8npdy	20	38	pandemic	pandemic	NN
cord-035016-ipv8npdy	20	39	evolves	evolve	VBZ
cord-035016-ipv8npdy	20	40	and	and	CC
cord-035016-ipv8npdy	20	41	more	more	JJR
cord-035016-ipv8npdy	20	42	vaccines	vaccine	NNS
cord-035016-ipv8npdy	20	43	become	become	VBP
cord-035016-ipv8npdy	20	44	available	available	JJ
cord-035016-ipv8npdy	20	45	.	.	.
cord-035016-ipv8npdy	21	1	Vaccine	vaccine	NN
cord-035016-ipv8npdy	21	2	development	development	NN
cord-035016-ipv8npdy	21	3	and	and	CC
cord-035016-ipv8npdy	21	4	optimal	optimal	JJ
cord-035016-ipv8npdy	21	5	use	use	NN
cord-035016-ipv8npdy	21	6	as	as	IN
cord-035016-ipv8npdy	21	7	public	public	JJ
cord-035016-ipv8npdy	21	8	health	health	NN
cord-035016-ipv8npdy	21	9	intervention	intervention	NN
cord-035016-ipv8npdy	21	10	therefore	therefore	RB
cord-035016-ipv8npdy	21	11	depends	depend	VBZ
cord-035016-ipv8npdy	21	12	on	on	IN
cord-035016-ipv8npdy	21	13	continuous	continuous	JJ
cord-035016-ipv8npdy	21	14	data	datum	NNS
cord-035016-ipv8npdy	21	15	-	-	HYPH
cord-035016-ipv8npdy	21	16	driven	drive	VBN
cord-035016-ipv8npdy	21	17	assessment	assessment	NN
cord-035016-ipv8npdy	21	18	of	of	IN
cord-035016-ipv8npdy	21	19	benefits	benefit	NNS
cord-035016-ipv8npdy	21	20	and	and	CC
cord-035016-ipv8npdy	21	21	risks	risk	NNS
cord-035016-ipv8npdy	21	22	in	in	IN
cord-035016-ipv8npdy	21	23	the	the	DT
cord-035016-ipv8npdy	21	24	context	context	NN
cord-035016-ipv8npdy	21	25	of	of	IN
cord-035016-ipv8npdy	21	26	the	the	DT
cord-035016-ipv8npdy	21	27	evolving	evolve	VBG
cord-035016-ipv8npdy	21	28	pandemic	pandemic	NN
cord-035016-ipv8npdy	21	29	,	,	,
cord-035016-ipv8npdy	21	30	with	with	IN
cord-035016-ipv8npdy	21	31	the	the	DT
cord-035016-ipv8npdy	21	32	view	view	NN
cord-035016-ipv8npdy	21	33	of	of	IN
cord-035016-ipv8npdy	21	34	maximizing	maximize	VBG
cord-035016-ipv8npdy	21	35	the	the	DT
cord-035016-ipv8npdy	21	36	public	public	JJ
cord-035016-ipv8npdy	21	37	health	health	NN
cord-035016-ipv8npdy	21	38	impact	impact	NN
cord-035016-ipv8npdy	21	39	of	of	IN
cord-035016-ipv8npdy	21	40	vaccination	vaccination	NN
cord-035016-ipv8npdy	21	41	strategies	strategy	NNS
cord-035016-ipv8npdy	21	42	.	.	.
cord-035016-ipv8npdy	22	1	This	this	DT
cord-035016-ipv8npdy	22	2	is	be	VBZ
cord-035016-ipv8npdy	22	3	particularly	particularly	RB
cord-035016-ipv8npdy	22	4	important	important	JJ
cord-035016-ipv8npdy	22	5	during	during	IN
cord-035016-ipv8npdy	22	6	a	a	DT
cord-035016-ipv8npdy	22	7	public	public	JJ
cord-035016-ipv8npdy	22	8	health	health	NN
cord-035016-ipv8npdy	22	9	emergency	emergency	NN
cord-035016-ipv8npdy	22	10	like	like	IN
cord-035016-ipv8npdy	22	11	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	22	12	,	,	,
cord-035016-ipv8npdy	22	13	where	where	WRB
cord-035016-ipv8npdy	22	14	vaccine	vaccine	NN
cord-035016-ipv8npdy	22	15	development	development	NN
cord-035016-ipv8npdy	22	16	,	,	,
cord-035016-ipv8npdy	22	17	regulatory	regulatory	JJ
cord-035016-ipv8npdy	22	18	review	review	NN
cord-035016-ipv8npdy	22	19	of	of	IN
cord-035016-ipv8npdy	22	20	candidates	candidate	NNS
cord-035016-ipv8npdy	22	21	and	and	CC
cord-035016-ipv8npdy	22	22	their	-PRON-	PRP$
cord-035016-ipv8npdy	22	23	deployment	deployment	NN
cord-035016-ipv8npdy	22	24	will	will	MD
cord-035016-ipv8npdy	22	25	occur	occur	VB
cord-035016-ipv8npdy	22	26	under	under	IN
cord-035016-ipv8npdy	22	27	intense	intense	JJ
cord-035016-ipv8npdy	22	28	clinical	clinical	JJ
cord-035016-ipv8npdy	22	29	,	,	,
cord-035016-ipv8npdy	22	30	economic	economic	JJ
cord-035016-ipv8npdy	22	31	,	,	,
cord-035016-ipv8npdy	22	32	and	and	CC
cord-035016-ipv8npdy	22	33	political	political	JJ
cord-035016-ipv8npdy	22	34	pressure	pressure	NN
cord-035016-ipv8npdy	22	35	(	(	-LRB-
cord-035016-ipv8npdy	22	36	Avorn	Avorn	NNP
cord-035016-ipv8npdy	22	37	and	and	CC
cord-035016-ipv8npdy	22	38	Kesselheim	Kesselheim	NNP
cord-035016-ipv8npdy	22	39	2020	2020	CD
cord-035016-ipv8npdy	22	40	)	)	-RRB-
cord-035016-ipv8npdy	22	41	.	.	.
cord-035016-ipv8npdy	23	1	The	the	DT
cord-035016-ipv8npdy	23	2	way	way	NN
cord-035016-ipv8npdy	23	3	in	in	IN
cord-035016-ipv8npdy	23	4	which	which	WDT
cord-035016-ipv8npdy	23	5	the	the	DT
cord-035016-ipv8npdy	23	6	commercial	commercial	JJ
cord-035016-ipv8npdy	23	7	and	and	CC
cord-035016-ipv8npdy	23	8	geopolitical	geopolitical	JJ
cord-035016-ipv8npdy	23	9	'	'	``
cord-035016-ipv8npdy	23	10	race	race	NN
cord-035016-ipv8npdy	23	11	'	'	''
cord-035016-ipv8npdy	23	12	for	for	IN
cord-035016-ipv8npdy	23	13	a	a	DT
cord-035016-ipv8npdy	23	14	vaccine	vaccine	NN
cord-035016-ipv8npdy	23	15	is	be	VBZ
cord-035016-ipv8npdy	23	16	playing	play	VBG
cord-035016-ipv8npdy	23	17	out	out	RP
cord-035016-ipv8npdy	23	18	,	,	,
cord-035016-ipv8npdy	23	19	however	however	RB
cord-035016-ipv8npdy	23	20	,	,	,
cord-035016-ipv8npdy	23	21	risks	risk	VBZ
cord-035016-ipv8npdy	23	22	side	side	NN
cord-035016-ipv8npdy	23	23	-	-	HYPH
cord-035016-ipv8npdy	23	24	lining	line	VBG
cord-035016-ipv8npdy	23	25	these	these	DT
cord-035016-ipv8npdy	23	26	critical	critical	JJ
cord-035016-ipv8npdy	23	27	public	public	JJ
cord-035016-ipv8npdy	23	28	health	health	NN
cord-035016-ipv8npdy	23	29	objectives	objective	NNS
cord-035016-ipv8npdy	23	30	in	in	IN
cord-035016-ipv8npdy	23	31	an	an	DT
cord-035016-ipv8npdy	23	32	R&D	r&d	NN
cord-035016-ipv8npdy	23	33	process	process	NN
cord-035016-ipv8npdy	23	34	that	that	WDT
cord-035016-ipv8npdy	23	35	hinges	hinge	VBZ
cord-035016-ipv8npdy	23	36	on	on	IN
cord-035016-ipv8npdy	23	37	the	the	DT
cord-035016-ipv8npdy	23	38	privatization	privatization	NN
cord-035016-ipv8npdy	23	39	and	and	CC
cord-035016-ipv8npdy	23	40	commercialization	commercialization	NN
cord-035016-ipv8npdy	23	41	of	of	IN
cord-035016-ipv8npdy	23	42	knowledge	knowledge	NN
cord-035016-ipv8npdy	23	43	,	,	,
cord-035016-ipv8npdy	23	44	and	and	CC
cord-035016-ipv8npdy	23	45	is	be	VBZ
cord-035016-ipv8npdy	23	46	focused	focus	VBN
cord-035016-ipv8npdy	23	47	on	on	IN
cord-035016-ipv8npdy	23	48	being	be	VBG
cord-035016-ipv8npdy	23	49	first	first	RB
cord-035016-ipv8npdy	23	50	to	to	TO
cord-035016-ipv8npdy	23	51	get	get	VB
cord-035016-ipv8npdy	23	52	a	a	DT
cord-035016-ipv8npdy	23	53	vaccine	vaccine	NN
cord-035016-ipv8npdy	23	54	to	to	IN
cord-035016-ipv8npdy	23	55	market	market	NN
cord-035016-ipv8npdy	23	56	(	(	-LRB-
cord-035016-ipv8npdy	23	57	Torreele	Torreele	NNP
cord-035016-ipv8npdy	23	58	2020a	2020a	NNS
cord-035016-ipv8npdy	23	59	)	)	-RRB-
cord-035016-ipv8npdy	23	60	.	.	.
cord-035016-ipv8npdy	24	1	There	there	EX
cord-035016-ipv8npdy	24	2	currently	currently	RB
cord-035016-ipv8npdy	24	3	is	be	VBZ
cord-035016-ipv8npdy	24	4	no	no	DT
cord-035016-ipv8npdy	24	5	mechanism	mechanism	NN
cord-035016-ipv8npdy	24	6	to	to	TO
cord-035016-ipv8npdy	24	7	ensure	ensure	VB
cord-035016-ipv8npdy	24	8	that	that	IN
cord-035016-ipv8npdy	24	9	the	the	DT
cord-035016-ipv8npdy	24	10	best	good	JJS
cord-035016-ipv8npdy	24	11	possible	possible	JJ
cord-035016-ipv8npdy	24	12	vaccines	vaccine	NNS
cord-035016-ipv8npdy	24	13	are	be	VBP
cord-035016-ipv8npdy	24	14	being	be	VBG
cord-035016-ipv8npdy	24	15	developed	develop	VBN
cord-035016-ipv8npdy	24	16	and	and	CC
cord-035016-ipv8npdy	24	17	deployed	deploy	VBN
cord-035016-ipv8npdy	24	18	.	.	.
cord-035016-ipv8npdy	25	1	The	the	DT
cord-035016-ipv8npdy	25	2	classic	classic	JJ
cord-035016-ipv8npdy	25	3	approach	approach	NN
cord-035016-ipv8npdy	25	4	to	to	IN
cord-035016-ipv8npdy	25	5	vaccine	vaccine	NN
cord-035016-ipv8npdy	25	6	development	development	NN
cord-035016-ipv8npdy	25	7	is	be	VBZ
cord-035016-ipv8npdy	25	8	that	that	IN
cord-035016-ipv8npdy	25	9	private	private	JJ
cord-035016-ipv8npdy	25	10	companies	company	NNS
cord-035016-ipv8npdy	25	11	invest	invest	VBP
cord-035016-ipv8npdy	25	12	in	in	IN
cord-035016-ipv8npdy	25	13	R&D	r&d	NN
cord-035016-ipv8npdy	25	14	based	base	VBN
cord-035016-ipv8npdy	25	15	on	on	IN
cord-035016-ipv8npdy	25	16	their	-PRON-	PRP$
cord-035016-ipv8npdy	25	17	own	own	JJ
cord-035016-ipv8npdy	25	18	proprietary	proprietary	JJ
cord-035016-ipv8npdy	25	19	platform	platform	NN
cord-035016-ipv8npdy	25	20	technologies	technology	NNS
cord-035016-ipv8npdy	25	21	(	(	-LRB-
cord-035016-ipv8npdy	25	22	vectors	vector	NNS
cord-035016-ipv8npdy	25	23	,	,	,
cord-035016-ipv8npdy	25	24	delivery	delivery	NN
cord-035016-ipv8npdy	25	25	systems	system	NNS
cord-035016-ipv8npdy	25	26	,	,	,
cord-035016-ipv8npdy	25	27	adjuvants	adjuvant	NNS
cord-035016-ipv8npdy	25	28	)	)	-RRB-
cord-035016-ipv8npdy	25	29	,	,	,
cord-035016-ipv8npdy	25	30	3	3	CD
cord-035016-ipv8npdy	25	31	in	in	IN
cord-035016-ipv8npdy	25	32	which	which	WDT
cord-035016-ipv8npdy	25	33	they	-PRON-	PRP
cord-035016-ipv8npdy	25	34	integrate	integrate	VBP
cord-035016-ipv8npdy	25	35	a	a	DT
cord-035016-ipv8npdy	25	36	specific	specific	JJ
cord-035016-ipv8npdy	25	37	antigen	antigen	NN
cord-035016-ipv8npdy	25	38	to	to	TO
cord-035016-ipv8npdy	25	39	adapt	adapt	VB
cord-035016-ipv8npdy	25	40	to	to	IN
cord-035016-ipv8npdy	25	41	the	the	DT
cord-035016-ipv8npdy	25	42	target	target	NN
cord-035016-ipv8npdy	25	43	disease	disease	NN
cord-035016-ipv8npdy	25	44	.	.	.
cord-035016-ipv8npdy	26	1	Despite	despite	IN
cord-035016-ipv8npdy	26	2	a	a	DT
cord-035016-ipv8npdy	26	3	pipeline	pipeline	NN
cord-035016-ipv8npdy	26	4	of	of	IN
cord-035016-ipv8npdy	26	5	nearly	nearly	RB
cord-035016-ipv8npdy	26	6	200	200	CD
cord-035016-ipv8npdy	26	7	vaccine	vaccine	NN
cord-035016-ipv8npdy	26	8	R&D	r&d	NN
cord-035016-ipv8npdy	26	9	projects	project	NNS
cord-035016-ipv8npdy	26	10	,	,	,
cord-035016-ipv8npdy	26	11	the	the	DT
cord-035016-ipv8npdy	26	12	'	'	``
cord-035016-ipv8npdy	26	13	race	race	NN
cord-035016-ipv8npdy	26	14	'	'	''
cord-035016-ipv8npdy	26	15	to	to	TO
cord-035016-ipv8npdy	26	16	get	get	VB
cord-035016-ipv8npdy	26	17	a	a	DT
cord-035016-ipv8npdy	26	18	vaccine	vaccine	NN
cord-035016-ipv8npdy	26	19	to	to	IN
cord-035016-ipv8npdy	26	20	market	market	NN
cord-035016-ipv8npdy	26	21	fastest	fast	JJS
cord-035016-ipv8npdy	26	22	does	do	VBZ
cord-035016-ipv8npdy	26	23	not	not	RB
cord-035016-ipv8npdy	26	24	incentivize	incentivize	VB
cord-035016-ipv8npdy	26	25	the	the	DT
cord-035016-ipv8npdy	26	26	best	good	JJS
cord-035016-ipv8npdy	26	27	science	science	NN
cord-035016-ipv8npdy	26	28	for	for	IN
cord-035016-ipv8npdy	26	29	public	public	JJ
cord-035016-ipv8npdy	26	30	health	health	NN
cord-035016-ipv8npdy	26	31	interest	interest	NN
cord-035016-ipv8npdy	26	32	.	.	.
cord-035016-ipv8npdy	27	1	Instead	instead	RB
cord-035016-ipv8npdy	27	2	,	,	,
cord-035016-ipv8npdy	27	3	it	-PRON-	PRP
cord-035016-ipv8npdy	27	4	favours	favour	VBZ
cord-035016-ipv8npdy	27	5	fragmentation	fragmentation	NN
cord-035016-ipv8npdy	27	6	and	and	CC
cord-035016-ipv8npdy	27	7	secretive	secretive	JJ
cord-035016-ipv8npdy	27	8	competition	competition	NN
cord-035016-ipv8npdy	27	9	,	,	,
cord-035016-ipv8npdy	27	10	and	and	CC
cord-035016-ipv8npdy	27	11	precludes	preclude	VBZ
cord-035016-ipv8npdy	27	12	the	the	DT
cord-035016-ipv8npdy	27	13	free	free	JJ
cord-035016-ipv8npdy	27	14	exchange	exchange	NN
cord-035016-ipv8npdy	27	15	of	of	IN
cord-035016-ipv8npdy	27	16	knowledge	knowledge	NN
cord-035016-ipv8npdy	27	17	and	and	CC
cord-035016-ipv8npdy	27	18	learning	learn	VBG
cord-035016-ipv8npdy	27	19	from	from	IN
cord-035016-ipv8npdy	27	20	each	each	DT
cord-035016-ipv8npdy	27	21	other	other	JJ
cord-035016-ipv8npdy	27	22	's	's	POS
cord-035016-ipv8npdy	27	23	successes	success	NNS
cord-035016-ipv8npdy	27	24	and	and	CC
cord-035016-ipv8npdy	27	25	failures	failure	NNS
cord-035016-ipv8npdy	27	26	in	in	IN
cord-035016-ipv8npdy	27	27	real	real	JJ
cord-035016-ipv8npdy	27	28	time	time	NN
cord-035016-ipv8npdy	27	29	,	,	,
cord-035016-ipv8npdy	27	30	or	or	CC
cord-035016-ipv8npdy	27	31	a	a	DT
cord-035016-ipv8npdy	27	32	public	public	JJ
cord-035016-ipv8npdy	27	33	health	health	NN
cord-035016-ipv8npdy	27	34	-	-	HYPH
cord-035016-ipv8npdy	27	35	driven	drive	VBN
cord-035016-ipv8npdy	27	36	and	and	CC
cord-035016-ipv8npdy	27	37	collaborative	collaborative	JJ
cord-035016-ipv8npdy	27	38	portfolio	portfolio	NN
cord-035016-ipv8npdy	27	39	approach	approach	NN
cord-035016-ipv8npdy	27	40	.	.	.
cord-035016-ipv8npdy	28	1	None	none	NN
cord-035016-ipv8npdy	28	2	of	of	IN
cord-035016-ipv8npdy	28	3	the	the	DT
cord-035016-ipv8npdy	28	4	individual	individual	JJ
cord-035016-ipv8npdy	28	5	elements	element	NNS
cord-035016-ipv8npdy	28	6	of	of	IN
cord-035016-ipv8npdy	28	7	each	each	DT
cord-035016-ipv8npdy	28	8	proprietary	proprietary	JJ
cord-035016-ipv8npdy	28	9	platform	platform	NN
cord-035016-ipv8npdy	28	10	is	be	VBZ
cord-035016-ipv8npdy	28	11	necessarily	necessarily	RB
cord-035016-ipv8npdy	28	12	the	the	DT
cord-035016-ipv8npdy	28	13	best	well	RBS
cord-035016-ipv8npdy	28	14	suited	suited	JJ
cord-035016-ipv8npdy	28	15	for	for	IN
cord-035016-ipv8npdy	28	16	a	a	DT
cord-035016-ipv8npdy	28	17	COVID-19	covid-19	JJ
cord-035016-ipv8npdy	28	18	vaccine	vaccine	NN
cord-035016-ipv8npdy	28	19	,	,	,
cord-035016-ipv8npdy	28	20	but	but	CC
cord-035016-ipv8npdy	28	21	each	each	DT
cord-035016-ipv8npdy	28	22	company	company	NN
cord-035016-ipv8npdy	28	23	will	will	MD
cord-035016-ipv8npdy	28	24	only	only	RB
cord-035016-ipv8npdy	28	25	research	research	VB
cord-035016-ipv8npdy	28	26	within	within	IN
cord-035016-ipv8npdy	28	27	the	the	DT
cord-035016-ipv8npdy	28	28	boundaries	boundary	NNS
cord-035016-ipv8npdy	28	29	of	of	IN
cord-035016-ipv8npdy	28	30	the	the	DT
cord-035016-ipv8npdy	28	31	its	-PRON-	PRP$
cord-035016-ipv8npdy	28	32	proprietary	proprietary	JJ
cord-035016-ipv8npdy	28	33	technology	technology	NN
cord-035016-ipv8npdy	28	34	(	(	-LRB-
cord-035016-ipv8npdy	28	35	covered	cover	VBN
cord-035016-ipv8npdy	28	36	by	by	IN
cord-035016-ipv8npdy	28	37	patents	patent	NNS
cord-035016-ipv8npdy	28	38	)	)	-RRB-
cord-035016-ipv8npdy	28	39	,	,	,
cord-035016-ipv8npdy	28	40	hands	hand	NNS
cord-035016-ipv8npdy	28	41	tied	tie	VBN
cord-035016-ipv8npdy	28	42	from	from	IN
cord-035016-ipv8npdy	28	43	using	use	VBG
cord-035016-ipv8npdy	28	44	other	other	JJ
cord-035016-ipv8npdy	28	45	and	and	CC
cord-035016-ipv8npdy	28	46	possibly	possibly	RB
cord-035016-ipv8npdy	28	47	better	well	RBR
cord-035016-ipv8npdy	28	48	fit	fit	JJ
cord-035016-ipv8npdy	28	49	elements	element	NNS
cord-035016-ipv8npdy	28	50	that	that	WDT
cord-035016-ipv8npdy	28	51	are	be	VBP
cord-035016-ipv8npdy	28	52	owned	own	VBN
cord-035016-ipv8npdy	28	53	by	by	IN
cord-035016-ipv8npdy	28	54	competitors	competitor	NNS
cord-035016-ipv8npdy	28	55	.	.	.
cord-035016-ipv8npdy	29	1	This	this	DT
cord-035016-ipv8npdy	29	2	is	be	VBZ
cord-035016-ipv8npdy	29	3	antithetical	antithetical	JJ
cord-035016-ipv8npdy	29	4	to	to	IN
cord-035016-ipv8npdy	29	5	a	a	DT
cord-035016-ipv8npdy	29	6	collective	collective	JJ
cord-035016-ipv8npdy	29	7	intelligence	intelligence	NN
cord-035016-ipv8npdy	29	8	effort	effort	NN
cord-035016-ipv8npdy	29	9	that	that	WDT
cord-035016-ipv8npdy	29	10	would	would	MD
cord-035016-ipv8npdy	29	11	allow	allow	VB
cord-035016-ipv8npdy	29	12	scientists	scientist	NNS
cord-035016-ipv8npdy	29	13	all	all	RB
cord-035016-ipv8npdy	29	14	over	over	IN
cord-035016-ipv8npdy	29	15	the	the	DT
cord-035016-ipv8npdy	29	16	world	world	NN
cord-035016-ipv8npdy	29	17	to	to	TO
cord-035016-ipv8npdy	29	18	creatively	creatively	RB
cord-035016-ipv8npdy	29	19	combine	combine	VB
cord-035016-ipv8npdy	29	20	the	the	DT
cord-035016-ipv8npdy	29	21	best	good	JJS
cord-035016-ipv8npdy	29	22	elements	element	NNS
cord-035016-ipv8npdy	29	23	of	of	IN
cord-035016-ipv8npdy	29	24	our	-PRON-	PRP$
cord-035016-ipv8npdy	29	25	medical	medical	JJ
cord-035016-ipv8npdy	29	26	knowledge	knowledge	NN
cord-035016-ipv8npdy	29	27	and	and	CC
cord-035016-ipv8npdy	29	28	technological	technological	JJ
cord-035016-ipv8npdy	29	29	advances	advance	NNS
cord-035016-ipv8npdy	29	30	into	into	IN
cord-035016-ipv8npdy	29	31	a	a	DT
cord-035016-ipv8npdy	29	32	diverse	diverse	JJ
cord-035016-ipv8npdy	29	33	and	and	CC
cord-035016-ipv8npdy	29	34	innovative	innovative	JJ
cord-035016-ipv8npdy	29	35	portfolio	portfolio	NN
cord-035016-ipv8npdy	29	36	of	of	IN
cord-035016-ipv8npdy	29	37	vaccine	vaccine	NN
cord-035016-ipv8npdy	29	38	candidates	candidate	NNS
cord-035016-ipv8npdy	29	39	with	with	IN
cord-035016-ipv8npdy	29	40	the	the	DT
cord-035016-ipv8npdy	29	41	best	good	JJS
cord-035016-ipv8npdy	29	42	chance	chance	NN
cord-035016-ipv8npdy	29	43	to	to	TO
cord-035016-ipv8npdy	29	44	achieve	achieve	VB
cord-035016-ipv8npdy	29	45	our	-PRON-	PRP$
cord-035016-ipv8npdy	29	46	common	common	JJ
cord-035016-ipv8npdy	29	47	public	public	JJ
cord-035016-ipv8npdy	29	48	health	health	NN
cord-035016-ipv8npdy	29	49	goal	goal	NN
cord-035016-ipv8npdy	29	50	(	(	-LRB-
cord-035016-ipv8npdy	29	51	Torreele	Torreele	NNP
cord-035016-ipv8npdy	29	52	2020b	2020b	CD
cord-035016-ipv8npdy	29	53	)	)	-RRB-
cord-035016-ipv8npdy	29	54	.	.	.
cord-035016-ipv8npdy	30	1	Failing	fail	VBG
cord-035016-ipv8npdy	30	2	moreover	moreover	RB
cord-035016-ipv8npdy	30	3	to	to	TO
cord-035016-ipv8npdy	30	4	compare	compare	VB
cord-035016-ipv8npdy	30	5	the	the	DT
cord-035016-ipv8npdy	30	6	performance	performance	NN
cord-035016-ipv8npdy	30	7	of	of	IN
cord-035016-ipv8npdy	30	8	the	the	DT
cord-035016-ipv8npdy	30	9	different	different	JJ
cord-035016-ipv8npdy	30	10	candidates	candidate	NNS
cord-035016-ipv8npdy	30	11	directly	directly	RB
cord-035016-ipv8npdy	30	12	,	,	,
cord-035016-ipv8npdy	30	13	the	the	DT
cord-035016-ipv8npdy	30	14	current	current	JJ
cord-035016-ipv8npdy	30	15	process	process	NN
cord-035016-ipv8npdy	30	16	is	be	VBZ
cord-035016-ipv8npdy	30	17	bound	bind	VBN
cord-035016-ipv8npdy	30	18	to	to	TO
cord-035016-ipv8npdy	30	19	create	create	VB
cord-035016-ipv8npdy	30	20	a	a	DT
cord-035016-ipv8npdy	30	21	portfolio	portfolio	NN
cord-035016-ipv8npdy	30	22	of	of	IN
cord-035016-ipv8npdy	30	23	suboptimal	suboptimal	JJ
cord-035016-ipv8npdy	30	24	candidates	candidate	NNS
cord-035016-ipv8npdy	30	25	that	that	WDT
cord-035016-ipv8npdy	30	26	are	be	VBP
cord-035016-ipv8npdy	30	27	neither	neither	CC
cord-035016-ipv8npdy	30	28	the	the	DT
cord-035016-ipv8npdy	30	29	best	good	JJS
cord-035016-ipv8npdy	30	30	in	in	IN
cord-035016-ipv8npdy	30	31	their	-PRON-	PRP$
cord-035016-ipv8npdy	30	32	class	class	NN
cord-035016-ipv8npdy	30	33	,	,	,
cord-035016-ipv8npdy	30	34	nor	nor	CC
cord-035016-ipv8npdy	30	35	diverse	diverse	JJ
cord-035016-ipv8npdy	30	36	or	or	CC
cord-035016-ipv8npdy	30	37	complementary	complementary	JJ
cord-035016-ipv8npdy	30	38	.	.	.
cord-035016-ipv8npdy	31	1	In	in	IN
cord-035016-ipv8npdy	31	2	our	-PRON-	PRP$
cord-035016-ipv8npdy	31	3	supply	supply	NN
cord-035016-ipv8npdy	31	4	-	-	HYPH
cord-035016-ipv8npdy	31	5	driven	drive	VBN
cord-035016-ipv8npdy	31	6	innovation	innovation	NN
cord-035016-ipv8npdy	31	7	system	system	NN
cord-035016-ipv8npdy	31	8	(	(	-LRB-
cord-035016-ipv8npdy	31	9	in	in	IN
cord-035016-ipv8npdy	31	10	which	which	WDT
cord-035016-ipv8npdy	31	11	the	the	DT
cord-035016-ipv8npdy	31	12	market	market	NN
cord-035016-ipv8npdy	31	13	is	be	VBZ
cord-035016-ipv8npdy	31	14	considered	consider	VBN
cord-035016-ipv8npdy	31	15	the	the	DT
cord-035016-ipv8npdy	31	16	ultimate	ultimate	JJ
cord-035016-ipv8npdy	31	17	arbiter	arbiter	NN
cord-035016-ipv8npdy	31	18	)	)	-RRB-
cord-035016-ipv8npdy	31	19	,	,	,
cord-035016-ipv8npdy	31	20	there	there	EX
cord-035016-ipv8npdy	31	21	is	be	VBZ
cord-035016-ipv8npdy	31	22	no	no	DT
cord-035016-ipv8npdy	31	23	public	public	JJ
cord-035016-ipv8npdy	31	24	health	health	NN
cord-035016-ipv8npdy	31	25	mechanism	mechanism	NN
cord-035016-ipv8npdy	31	26	to	to	TO
cord-035016-ipv8npdy	31	27	demand	demand	VB
cord-035016-ipv8npdy	31	28	or	or	CC
cord-035016-ipv8npdy	31	29	impose	impose	VB
cord-035016-ipv8npdy	31	30	that	that	IN
cord-035016-ipv8npdy	31	31	companies	company	NNS
cord-035016-ipv8npdy	31	32	develop	develop	VBP
cord-035016-ipv8npdy	31	33	products	product	NNS
cord-035016-ipv8npdy	31	34	according	accord	VBG
cord-035016-ipv8npdy	31	35	to	to	IN
cord-035016-ipv8npdy	31	36	pre	pre	JJ
cord-035016-ipv8npdy	31	37	-	-	VB
cord-035016-ipv8npdy	31	38	set	set	JJ
cord-035016-ipv8npdy	31	39	and	and	CC
cord-035016-ipv8npdy	31	40	public	public	JJ
cord-035016-ipv8npdy	31	41	health	health	NN
cord-035016-ipv8npdy	31	42	-	-	HYPH
cord-035016-ipv8npdy	31	43	driven	drive	VBN
cord-035016-ipv8npdy	31	44	performance	performance	NN
cord-035016-ipv8npdy	31	45	criteria	criterion	NNS
cord-035016-ipv8npdy	31	46	.	.	.
cord-035016-ipv8npdy	32	1	As	as	IN
cord-035016-ipv8npdy	32	2	a	a	DT
cord-035016-ipv8npdy	32	3	result	result	NN
cord-035016-ipv8npdy	32	4	,	,	,
cord-035016-ipv8npdy	32	5	less	less	JJR
cord-035016-ipv8npdy	32	6	than	than	IN
cord-035016-ipv8npdy	32	7	optimal	optimal	JJ
cord-035016-ipv8npdy	32	8	candidates	candidate	NNS
cord-035016-ipv8npdy	32	9	can	can	MD
cord-035016-ipv8npdy	32	10	move	move	VB
cord-035016-ipv8npdy	32	11	through	through	IN
cord-035016-ipv8npdy	32	12	the	the	DT
cord-035016-ipv8npdy	32	13	pipeline	pipeline	NN
cord-035016-ipv8npdy	32	14	,	,	,
cord-035016-ipv8npdy	32	15	if	if	IN
cord-035016-ipv8npdy	32	16	sufficient	sufficient	JJ
cord-035016-ipv8npdy	32	17	resources	resource	NNS
cord-035016-ipv8npdy	32	18	are	be	VBP
cord-035016-ipv8npdy	32	19	poured	pour	VBN
cord-035016-ipv8npdy	32	20	into	into	IN
cord-035016-ipv8npdy	32	21	it	-PRON-	PRP
cord-035016-ipv8npdy	32	22	.	.	.
cord-035016-ipv8npdy	33	1	In	in	IN
cord-035016-ipv8npdy	33	2	April	April	NNP
cord-035016-ipv8npdy	33	3	2020	2020	CD
cord-035016-ipv8npdy	33	4	,	,	,
cord-035016-ipv8npdy	33	5	the	the	DT
cord-035016-ipv8npdy	33	6	World	World	NNP
cord-035016-ipv8npdy	33	7	Health	Health	NNP
cord-035016-ipv8npdy	33	8	Organization	Organization	NNP
cord-035016-ipv8npdy	33	9	(	(	-LRB-
cord-035016-ipv8npdy	33	10	WHO	who	WP
cord-035016-ipv8npdy	33	11	)	)	-RRB-
cord-035016-ipv8npdy	33	12	published	publish	VBD
cord-035016-ipv8npdy	33	13	a	a	DT
cord-035016-ipv8npdy	33	14	Target	Target	NNP
cord-035016-ipv8npdy	33	15	Product	Product	NNP
cord-035016-ipv8npdy	33	16	Profile	Profile	NNP
cord-035016-ipv8npdy	33	17	4	4	CD
cord-035016-ipv8npdy	33	18	(	(	-LRB-
cord-035016-ipv8npdy	33	19	TPP	TPP	NNP
cord-035016-ipv8npdy	33	20	)	)	-RRB-
cord-035016-ipv8npdy	33	21	for	for	IN
cord-035016-ipv8npdy	33	22	COVID-19	covid-19	JJ
cord-035016-ipv8npdy	33	23	vaccines	vaccine	NNS
cord-035016-ipv8npdy	33	24	with	with	IN
cord-035016-ipv8npdy	33	25	minimal	minimal	JJ
cord-035016-ipv8npdy	33	26	and	and	CC
cord-035016-ipv8npdy	33	27	ideal	ideal	JJ
cord-035016-ipv8npdy	33	28	vaccine	vaccine	NN
cord-035016-ipv8npdy	33	29	characteristics	characteristic	NNS
cord-035016-ipv8npdy	33	30	to	to	TO
cord-035016-ipv8npdy	33	31	guide	guide	VB
cord-035016-ipv8npdy	33	32	developers	developer	NNS
cord-035016-ipv8npdy	33	33	.	.	.
cord-035016-ipv8npdy	34	1	It	-PRON-	PRP
cord-035016-ipv8npdy	34	2	lays	lay	VBZ
cord-035016-ipv8npdy	34	3	out	out	RP
cord-035016-ipv8npdy	34	4	safety	safety	NN
cord-035016-ipv8npdy	34	5	and	and	CC
cord-035016-ipv8npdy	34	6	efficacy	efficacy	NN
cord-035016-ipv8npdy	34	7	targets	target	NNS
cord-035016-ipv8npdy	34	8	,	,	,
cord-035016-ipv8npdy	34	9	to	to	TO
cord-035016-ipv8npdy	34	10	be	be	VB
cord-035016-ipv8npdy	34	11	demonstrated	demonstrate	VBN
cord-035016-ipv8npdy	34	12	in	in	IN
cord-035016-ipv8npdy	34	13	people	people	NNS
cord-035016-ipv8npdy	34	14	of	of	IN
cord-035016-ipv8npdy	34	15	all	all	DT
cord-035016-ipv8npdy	34	16	age	age	NN
cord-035016-ipv8npdy	34	17	groups	group	NNS
cord-035016-ipv8npdy	34	18	,	,	,
cord-035016-ipv8npdy	34	19	ethnicities	ethnicity	NNS
cord-035016-ipv8npdy	34	20	and	and	CC
cord-035016-ipv8npdy	34	21	including	include	VBG
cord-035016-ipv8npdy	34	22	subpopulations	subpopulation	NNS
cord-035016-ipv8npdy	34	23	with	with	IN
cord-035016-ipv8npdy	34	24	certain	certain	JJ
cord-035016-ipv8npdy	34	25	co	co	NNS
cord-035016-ipv8npdy	34	26	-	-	NNS
cord-035016-ipv8npdy	34	27	morbidities	morbidity	NNS
cord-035016-ipv8npdy	34	28	.	.	.
cord-035016-ipv8npdy	35	1	The	the	DT
cord-035016-ipv8npdy	35	2	WHO	WHO	NNP
cord-035016-ipv8npdy	35	3	Target	Target	NNP
cord-035016-ipv8npdy	35	4	Product	Product	NNP
cord-035016-ipv8npdy	35	5	Profile	Profile	NNP
cord-035016-ipv8npdy	35	6	also	also	RB
cord-035016-ipv8npdy	35	7	outlines	outline	VBZ
cord-035016-ipv8npdy	35	8	preferred	prefer	VBN
cord-035016-ipv8npdy	35	9	features	feature	NNS
cord-035016-ipv8npdy	35	10	to	to	TO
cord-035016-ipv8npdy	35	11	make	make	VB
cord-035016-ipv8npdy	35	12	the	the	DT
cord-035016-ipv8npdy	35	13	vaccine	vaccine	NN
cord-035016-ipv8npdy	35	14	well	well	RB
cord-035016-ipv8npdy	35	15	-	-	HYPH
cord-035016-ipv8npdy	35	16	suited	suit	VBN
cord-035016-ipv8npdy	35	17	for	for	IN
cord-035016-ipv8npdy	35	18	a	a	DT
cord-035016-ipv8npdy	35	19	large	large	JJ
cord-035016-ipv8npdy	35	20	-	-	HYPH
cord-035016-ipv8npdy	35	21	scale	scale	NN
cord-035016-ipv8npdy	35	22	interventions	intervention	NNS
cord-035016-ipv8npdy	35	23	,	,	,
cord-035016-ipv8npdy	35	24	for	for	IN
cord-035016-ipv8npdy	35	25	instance	instance	NN
cord-035016-ipv8npdy	35	26	good	good	JJ
cord-035016-ipv8npdy	35	27	temperature	temperature	NN
cord-035016-ipv8npdy	35	28	stability	stability	NN
cord-035016-ipv8npdy	35	29	and	and	CC
cord-035016-ipv8npdy	35	30	a	a	DT
cord-035016-ipv8npdy	35	31	single	single	JJ
cord-035016-ipv8npdy	35	32	dose	dose	NN
cord-035016-ipv8npdy	35	33	regimen	regimen	NN
cord-035016-ipv8npdy	35	34	,	,	,
cord-035016-ipv8npdy	35	35	or	or	CC
cord-035016-ipv8npdy	35	36	scalable	scalable	JJ
cord-035016-ipv8npdy	35	37	and	and	CC
cord-035016-ipv8npdy	35	38	low	low	JJ
cord-035016-ipv8npdy	35	39	-	-	HYPH
cord-035016-ipv8npdy	35	40	cost	cost	NN
cord-035016-ipv8npdy	35	41	manufacturing	manufacturing	NN
cord-035016-ipv8npdy	35	42	.	.	.
cord-035016-ipv8npdy	36	1	Unfortunately	unfortunately	RB
cord-035016-ipv8npdy	36	2	,	,	,
cord-035016-ipv8npdy	36	3	WHO	who	WP
cord-035016-ipv8npdy	36	4	's	's	POS
cord-035016-ipv8npdy	36	5	target	target	NN
cord-035016-ipv8npdy	36	6	product	product	NN
cord-035016-ipv8npdy	36	7	profiles	profile	NNS
cord-035016-ipv8npdy	36	8	are	be	VBP
cord-035016-ipv8npdy	36	9	only	only	RB
cord-035016-ipv8npdy	36	10	aspirational	aspirational	JJ
cord-035016-ipv8npdy	36	11	and	and	CC
cord-035016-ipv8npdy	36	12	vaccine	vaccine	NN
cord-035016-ipv8npdy	36	13	developers	developer	NNS
cord-035016-ipv8npdy	36	14	are	be	VBP
cord-035016-ipv8npdy	36	15	under	under	IN
cord-035016-ipv8npdy	36	16	no	no	DT
cord-035016-ipv8npdy	36	17	obligation	obligation	NN
cord-035016-ipv8npdy	36	18	to	to	TO
cord-035016-ipv8npdy	36	19	comply	comply	VB
cord-035016-ipv8npdy	36	20	with	with	IN
cord-035016-ipv8npdy	36	21	such	such	JJ
cord-035016-ipv8npdy	36	22	criteria	criterion	NNS
cord-035016-ipv8npdy	36	23	and	and	CC
cord-035016-ipv8npdy	36	24	ensure	ensure	VB
cord-035016-ipv8npdy	36	25	the	the	DT
cord-035016-ipv8npdy	36	26	products	product	NNS
cord-035016-ipv8npdy	36	27	they	-PRON-	PRP
cord-035016-ipv8npdy	36	28	are	be	VBP
cord-035016-ipv8npdy	36	29	developing	develop	VBG
cord-035016-ipv8npdy	36	30	will	will	MD
cord-035016-ipv8npdy	36	31	be	be	VB
cord-035016-ipv8npdy	36	32	adequate	adequate	JJ
cord-035016-ipv8npdy	36	33	as	as	IN
cord-035016-ipv8npdy	36	34	a	a	DT
cord-035016-ipv8npdy	36	35	public	public	JJ
cord-035016-ipv8npdy	36	36	health	health	NN
cord-035016-ipv8npdy	36	37	intervention	intervention	NN
cord-035016-ipv8npdy	36	38	.	.	.
cord-035016-ipv8npdy	37	1	And	and	CC
cord-035016-ipv8npdy	37	2	regulatory	regulatory	JJ
cord-035016-ipv8npdy	37	3	authorities	authority	NNS
cord-035016-ipv8npdy	37	4	are	be	VBP
cord-035016-ipv8npdy	37	5	not	not	RB
cord-035016-ipv8npdy	37	6	empowered	empower	VBN
cord-035016-ipv8npdy	37	7	to	to	TO
cord-035016-ipv8npdy	37	8	demand	demand	VB
cord-035016-ipv8npdy	37	9	that	that	IN
cord-035016-ipv8npdy	37	10	either	either	RB
cord-035016-ipv8npdy	37	11	.	.	.
cord-035016-ipv8npdy	38	1	While	while	IN
cord-035016-ipv8npdy	38	2	there	there	EX
cord-035016-ipv8npdy	38	3	exists	exist	VBZ
cord-035016-ipv8npdy	38	4	no	no	DT
cord-035016-ipv8npdy	38	5	absolute	absolute	JJ
cord-035016-ipv8npdy	38	6	threshold	threshold	NN
cord-035016-ipv8npdy	38	7	for	for	IN
cord-035016-ipv8npdy	38	8	vaccine	vaccine	NN
cord-035016-ipv8npdy	38	9	efficacy	efficacy	NN
cord-035016-ipv8npdy	38	10	,	,	,
cord-035016-ipv8npdy	38	11	WHO	who	WP
cord-035016-ipv8npdy	38	12	's	be	VBZ
cord-035016-ipv8npdy	38	13	TPP	TPP	NNP
cord-035016-ipv8npdy	38	14	proposes	propose	VBZ
cord-035016-ipv8npdy	38	15	that	that	IN
cord-035016-ipv8npdy	38	16	vaccines	vaccine	NNS
cord-035016-ipv8npdy	38	17	should	should	MD
cord-035016-ipv8npdy	38	18	have	have	VB
cord-035016-ipv8npdy	38	19	a	a	DT
cord-035016-ipv8npdy	38	20	minimum	minimum	JJ
cord-035016-ipv8npdy	38	21	efficacy	efficacy	NN
cord-035016-ipv8npdy	38	22	of	of	IN
cord-035016-ipv8npdy	38	23	50	50	CD
cord-035016-ipv8npdy	38	24	%	%	NN
cord-035016-ipv8npdy	38	25	to	to	TO
cord-035016-ipv8npdy	38	26	be	be	VB
cord-035016-ipv8npdy	38	27	a	a	DT
cord-035016-ipv8npdy	38	28	useful	useful	JJ
cord-035016-ipv8npdy	38	29	tool	tool	NN
cord-035016-ipv8npdy	38	30	against	against	IN
cord-035016-ipv8npdy	38	31	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	38	32	.	.	.
cord-035016-ipv8npdy	39	1	To	to	TO
cord-035016-ipv8npdy	39	2	effectively	effectively	RB
cord-035016-ipv8npdy	39	3	curb	curb	VB
cord-035016-ipv8npdy	39	4	the	the	DT
cord-035016-ipv8npdy	39	5	pandemic	pandemic	NN
cord-035016-ipv8npdy	39	6	and	and	CC
cord-035016-ipv8npdy	39	7	reach	reach	VB
cord-035016-ipv8npdy	39	8	adequate	adequate	JJ
cord-035016-ipv8npdy	39	9	population	population	NN
cord-035016-ipv8npdy	39	10	immunity	immunity	NN
cord-035016-ipv8npdy	39	11	,	,	,
cord-035016-ipv8npdy	39	12	it	-PRON-	PRP
cord-035016-ipv8npdy	39	13	has	have	VBZ
cord-035016-ipv8npdy	39	14	been	be	VBN
cord-035016-ipv8npdy	39	15	calculated	calculate	VBN
cord-035016-ipv8npdy	39	16	that	that	IN
cord-035016-ipv8npdy	39	17	vaccines	vaccine	NNS
cord-035016-ipv8npdy	39	18	should	should	MD
cord-035016-ipv8npdy	39	19	be	be	VB
cord-035016-ipv8npdy	39	20	70	70	CD
cord-035016-ipv8npdy	39	21	-	-	SYM
cord-035016-ipv8npdy	39	22	80	80	CD
cord-035016-ipv8npdy	39	23	%	%	NN
cord-035016-ipv8npdy	39	24	effective	effective	JJ
cord-035016-ipv8npdy	39	25	in	in	IN
cord-035016-ipv8npdy	39	26	preventing	prevent	VBG
cord-035016-ipv8npdy	39	27	infections	infection	NNS
cord-035016-ipv8npdy	39	28	(	(	-LRB-
cord-035016-ipv8npdy	39	29	Bartsch	Bartsch	NNP
cord-035016-ipv8npdy	39	30	et	et	NNP
cord-035016-ipv8npdy	39	31	al	al	NNP
cord-035016-ipv8npdy	39	32	.	.	NNP
cord-035016-ipv8npdy	39	33	2020	2020	CD
cord-035016-ipv8npdy	39	34	)	)	-RRB-
cord-035016-ipv8npdy	39	35	.	.	.
cord-035016-ipv8npdy	40	1	It	-PRON-	PRP
cord-035016-ipv8npdy	40	2	remains	remain	VBZ
cord-035016-ipv8npdy	40	3	uncertain	uncertain	JJ
cord-035016-ipv8npdy	40	4	how	how	WRB
cord-035016-ipv8npdy	40	5	useful	useful	JJ
cord-035016-ipv8npdy	40	6	vaccines	vaccine	NNS
cord-035016-ipv8npdy	40	7	with	with	IN
cord-035016-ipv8npdy	40	8	much	much	JJ
cord-035016-ipv8npdy	40	9	lower	low	JJR
cord-035016-ipv8npdy	40	10	efficacy	efficacy	NN
cord-035016-ipv8npdy	40	11	can	can	MD
cord-035016-ipv8npdy	40	12	be	be	VB
cord-035016-ipv8npdy	40	13	,	,	,
cord-035016-ipv8npdy	40	14	or	or	CC
cord-035016-ipv8npdy	40	15	vaccines	vaccine	NNS
cord-035016-ipv8npdy	40	16	that	that	WDT
cord-035016-ipv8npdy	40	17	only	only	RB
cord-035016-ipv8npdy	40	18	reduce	reduce	VBP
cord-035016-ipv8npdy	40	19	disease	disease	NN
cord-035016-ipv8npdy	40	20	severity	severity	NN
cord-035016-ipv8npdy	40	21	,	,	,
cord-035016-ipv8npdy	40	22	or	or	CC
cord-035016-ipv8npdy	40	23	only	only	RB
cord-035016-ipv8npdy	40	24	work	work	VB
cord-035016-ipv8npdy	40	25	in	in	IN
cord-035016-ipv8npdy	40	26	certain	certain	JJ
cord-035016-ipv8npdy	40	27	subpopulations	subpopulation	NNS
cord-035016-ipv8npdy	40	28	(	(	-LRB-
cord-035016-ipv8npdy	40	29	Avorn	Avorn	NNP
cord-035016-ipv8npdy	40	30	and	and	CC
cord-035016-ipv8npdy	40	31	Kesselheim	Kesselheim	NNP
cord-035016-ipv8npdy	40	32	2020	2020	CD
cord-035016-ipv8npdy	40	33	)	)	-RRB-
cord-035016-ipv8npdy	40	34	.	.	.
cord-035016-ipv8npdy	41	1	In	in	IN
cord-035016-ipv8npdy	41	2	any	any	DT
cord-035016-ipv8npdy	41	3	case	case	NN
cord-035016-ipv8npdy	41	4	,	,	,
cord-035016-ipv8npdy	41	5	the	the	DT
cord-035016-ipv8npdy	41	6	TPP	TPP	NNP
cord-035016-ipv8npdy	41	7	and	and	CC
cord-035016-ipv8npdy	41	8	the	the	DT
cord-035016-ipv8npdy	41	9	different	different	JJ
cord-035016-ipv8npdy	41	10	ways	way	NNS
cord-035016-ipv8npdy	41	11	in	in	IN
cord-035016-ipv8npdy	41	12	which	which	WDT
cord-035016-ipv8npdy	41	13	vaccines	vaccine	NNS
cord-035016-ipv8npdy	41	14	can	can	MD
cord-035016-ipv8npdy	41	15	work	work	VB
cord-035016-ipv8npdy	41	16	must	must	MD
cord-035016-ipv8npdy	41	17	be	be	VB
cord-035016-ipv8npdy	41	18	considered	consider	VBN
cord-035016-ipv8npdy	41	19	when	when	WRB
cord-035016-ipv8npdy	41	20	designing	design	VBG
cord-035016-ipv8npdy	41	21	clinical	clinical	JJ
cord-035016-ipv8npdy	41	22	trials	trial	NNS
cord-035016-ipv8npdy	41	23	for	for	IN
cord-035016-ipv8npdy	41	24	COVID-19	covid-19	JJ
cord-035016-ipv8npdy	41	25	vaccine	vaccine	NN
cord-035016-ipv8npdy	41	26	candidates	candidate	NNS
cord-035016-ipv8npdy	41	27	.	.	.
cord-035016-ipv8npdy	42	1	In	in	IN
cord-035016-ipv8npdy	42	2	the	the	DT
cord-035016-ipv8npdy	42	3	current	current	JJ
cord-035016-ipv8npdy	42	4	R&D	r&d	NN
cord-035016-ipv8npdy	42	5	model	model	NN
cord-035016-ipv8npdy	42	6	,	,	,
cord-035016-ipv8npdy	42	7	it	-PRON-	PRP
cord-035016-ipv8npdy	42	8	is	be	VBZ
cord-035016-ipv8npdy	42	9	left	leave	VBN
cord-035016-ipv8npdy	42	10	at	at	IN
cord-035016-ipv8npdy	42	11	the	the	DT
cord-035016-ipv8npdy	42	12	discretion	discretion	NN
cord-035016-ipv8npdy	42	13	of	of	IN
cord-035016-ipv8npdy	42	14	companies	company	NNS
cord-035016-ipv8npdy	42	15	to	to	TO
cord-035016-ipv8npdy	42	16	set	set	VB
cord-035016-ipv8npdy	42	17	the	the	DT
cord-035016-ipv8npdy	42	18	vaccine	vaccine	NN
cord-035016-ipv8npdy	42	19	efficacy	efficacy	NN
cord-035016-ipv8npdy	42	20	targets	target	NNS
cord-035016-ipv8npdy	42	21	they	-PRON-	PRP
cord-035016-ipv8npdy	42	22	will	will	MD
cord-035016-ipv8npdy	42	23	measure	measure	VB
cord-035016-ipv8npdy	42	24	in	in	IN
cord-035016-ipv8npdy	42	25	the	the	DT
cord-035016-ipv8npdy	42	26	clinical	clinical	JJ
cord-035016-ipv8npdy	42	27	trials	trial	NNS
cord-035016-ipv8npdy	42	28	,	,	,
cord-035016-ipv8npdy	42	29	which	which	WDT
cord-035016-ipv8npdy	42	30	moreover	moreover	RB
cord-035016-ipv8npdy	42	31	they	-PRON-	PRP
cord-035016-ipv8npdy	42	32	design	design	VBP
cord-035016-ipv8npdy	42	33	,	,	,
cord-035016-ipv8npdy	42	34	conduct	conduct	VB
cord-035016-ipv8npdy	42	35	and	and	CC
cord-035016-ipv8npdy	42	36	analyze	analyze	VB
cord-035016-ipv8npdy	42	37	themselves	-PRON-	PRP
cord-035016-ipv8npdy	42	38	,	,	,
cord-035016-ipv8npdy	42	39	notwithstanding	notwithstanding	IN
cord-035016-ipv8npdy	42	40	the	the	DT
cord-035016-ipv8npdy	42	41	conflict	conflict	NN
cord-035016-ipv8npdy	42	42	of	of	IN
cord-035016-ipv8npdy	42	43	interest	interest	NN
cord-035016-ipv8npdy	42	44	given	give	VBN
cord-035016-ipv8npdy	42	45	their	-PRON-	PRP$
cord-035016-ipv8npdy	42	46	vested	vested	JJ
cord-035016-ipv8npdy	42	47	interest	interest	NN
cord-035016-ipv8npdy	42	48	in	in	IN
cord-035016-ipv8npdy	42	49	the	the	DT
cord-035016-ipv8npdy	42	50	outcome	outcome	NN
cord-035016-ipv8npdy	42	51	(	(	-LRB-
cord-035016-ipv8npdy	42	52	Quigley	Quigley	NNP
cord-035016-ipv8npdy	42	53	2017	2017	CD
cord-035016-ipv8npdy	42	54	)	)	-RRB-
cord-035016-ipv8npdy	42	55	.	.	.
cord-035016-ipv8npdy	43	1	Moreover	moreover	RB
cord-035016-ipv8npdy	43	2	,	,	,
cord-035016-ipv8npdy	43	3	the	the	DT
cord-035016-ipv8npdy	43	4	study	study	NN
cord-035016-ipv8npdy	43	5	protocols	protocol	NNS
cord-035016-ipv8npdy	43	6	that	that	WDT
cord-035016-ipv8npdy	43	7	detail	detail	VBP
cord-035016-ipv8npdy	43	8	what	what	WP
cord-035016-ipv8npdy	43	9	is	be	VBZ
cord-035016-ipv8npdy	43	10	being	be	VBG
cord-035016-ipv8npdy	43	11	compared	compare	VBN
cord-035016-ipv8npdy	43	12	in	in	IN
cord-035016-ipv8npdy	43	13	such	such	JJ
cord-035016-ipv8npdy	43	14	trials	trial	NNS
cord-035016-ipv8npdy	43	15	,	,	,
cord-035016-ipv8npdy	43	16	and	and	CC
cord-035016-ipv8npdy	43	17	how	how	WRB
cord-035016-ipv8npdy	43	18	meaningful	meaningful	JJ
cord-035016-ipv8npdy	43	19	differences	difference	NNS
cord-035016-ipv8npdy	43	20	are	be	VBP
cord-035016-ipv8npdy	43	21	going	go	VBG
cord-035016-ipv8npdy	43	22	to	to	TO
cord-035016-ipv8npdy	43	23	be	be	VB
cord-035016-ipv8npdy	43	24	measured	measure	VBN
cord-035016-ipv8npdy	43	25	,	,	,
cord-035016-ipv8npdy	43	26	are	be	VBP
cord-035016-ipv8npdy	43	27	generally	generally	RB
cord-035016-ipv8npdy	43	28	kept	keep	VBN
cord-035016-ipv8npdy	43	29	confidential	confidential	JJ
cord-035016-ipv8npdy	43	30	for	for	IN
cord-035016-ipv8npdy	43	31	the	the	DT
cord-035016-ipv8npdy	43	32	public	public	NN
cord-035016-ipv8npdy	43	33	,	,	,
cord-035016-ipv8npdy	43	34	as	as	IN
cord-035016-ipv8npdy	43	35	are	be	VBP
cord-035016-ipv8npdy	43	36	the	the	DT
cord-035016-ipv8npdy	43	37	full	full	JJ
cord-035016-ipv8npdy	43	38	study	study	NN
cord-035016-ipv8npdy	43	39	data	datum	NNS
cord-035016-ipv8npdy	43	40	and	and	CC
cord-035016-ipv8npdy	43	41	analyses	analysis	NNS
cord-035016-ipv8npdy	43	42	.	.	.
cord-035016-ipv8npdy	44	1	5	5	LS
cord-035016-ipv8npdy	45	1	A	a	DT
cord-035016-ipv8npdy	45	2	milestone	milestone	NN
cord-035016-ipv8npdy	45	3	resolution	resolution	NN
cord-035016-ipv8npdy	45	4	on	on	IN
cord-035016-ipv8npdy	45	5	transparency	transparency	NN
cord-035016-ipv8npdy	45	6	around	around	IN
cord-035016-ipv8npdy	45	7	medical	medical	JJ
cord-035016-ipv8npdy	45	8	R&D	R&D	NNP
cord-035016-ipv8npdy	45	9	was	be	VBD
cord-035016-ipv8npdy	45	10	passed	pass	VBN
cord-035016-ipv8npdy	45	11	at	at	IN
cord-035016-ipv8npdy	45	12	the	the	DT
cord-035016-ipv8npdy	45	13	2019	2019	CD
cord-035016-ipv8npdy	45	14	World	World	NNP
cord-035016-ipv8npdy	45	15	Health	Health	NNP
cord-035016-ipv8npdy	45	16	Assembly	Assembly	NNP
cord-035016-ipv8npdy	45	17	(	(	-LRB-
cord-035016-ipv8npdy	45	18	Fletcher	Fletcher	NNP
cord-035016-ipv8npdy	45	19	2019	2019	CD
cord-035016-ipv8npdy	45	20	)	)	-RRB-
cord-035016-ipv8npdy	45	21	,	,	,
cord-035016-ipv8npdy	45	22	yet	yet	CC
cord-035016-ipv8npdy	45	23	governments	government	NNS
cord-035016-ipv8npdy	45	24	so	so	RB
cord-035016-ipv8npdy	45	25	far	far	RB
cord-035016-ipv8npdy	45	26	have	have	VBP
cord-035016-ipv8npdy	45	27	failed	fail	VBN
cord-035016-ipv8npdy	45	28	to	to	TO
cord-035016-ipv8npdy	45	29	implement	implement	VB
cord-035016-ipv8npdy	45	30	these	these	DT
cord-035016-ipv8npdy	45	31	commitments	commitment	NNS
cord-035016-ipv8npdy	45	32	,	,	,
cord-035016-ipv8npdy	45	33	despite	despite	IN
cord-035016-ipv8npdy	45	34	huge	huge	JJ
cord-035016-ipv8npdy	45	35	financial	financial	JJ
cord-035016-ipv8npdy	45	36	investments	investment	NNS
cord-035016-ipv8npdy	45	37	in	in	IN
cord-035016-ipv8npdy	45	38	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	45	39	R&D	R&D	NNP
cord-035016-ipv8npdy	45	40	that	that	WDT
cord-035016-ipv8npdy	45	41	could	could	MD
cord-035016-ipv8npdy	45	42	have	have	VB
cord-035016-ipv8npdy	45	43	been	be	VBN
cord-035016-ipv8npdy	45	44	used	use	VBN
cord-035016-ipv8npdy	45	45	as	as	IN
cord-035016-ipv8npdy	45	46	leverage	leverage	NN
cord-035016-ipv8npdy	45	47	to	to	TO
cord-035016-ipv8npdy	45	48	demand	demand	VB
cord-035016-ipv8npdy	45	49	transparency	transparency	NN
cord-035016-ipv8npdy	45	50	on	on	IN
cord-035016-ipv8npdy	45	51	scientific	scientific	JJ
cord-035016-ipv8npdy	45	52	methods	method	NNS
cord-035016-ipv8npdy	45	53	and	and	CC
cord-035016-ipv8npdy	45	54	data	datum	NNS
cord-035016-ipv8npdy	45	55	,	,	,
cord-035016-ipv8npdy	45	56	as	as	RB
cord-035016-ipv8npdy	45	57	well	well	RB
cord-035016-ipv8npdy	45	58	as	as	IN
cord-035016-ipv8npdy	45	59	clinical	clinical	JJ
cord-035016-ipv8npdy	45	60	trial	trial	NN
cord-035016-ipv8npdy	45	61	costs	cost	NNS
cord-035016-ipv8npdy	45	62	,	,	,
cord-035016-ipv8npdy	45	63	and	and	CC
cord-035016-ipv8npdy	45	64	set	set	VBD
cord-035016-ipv8npdy	45	65	performance	performance	NN
cord-035016-ipv8npdy	45	66	targets	target	NNS
cord-035016-ipv8npdy	45	67	for	for	IN
cord-035016-ipv8npdy	45	68	the	the	DT
cord-035016-ipv8npdy	45	69	vaccines	vaccine	NNS
cord-035016-ipv8npdy	45	70	.	.	.
cord-035016-ipv8npdy	46	1	As	as	IN
cord-035016-ipv8npdy	46	2	companies	company	NNS
cord-035016-ipv8npdy	46	3	'	'	POS
cord-035016-ipv8npdy	46	4	primary	primary	JJ
cord-035016-ipv8npdy	46	5	goal	goal	NN
cord-035016-ipv8npdy	46	6	is	be	VBZ
cord-035016-ipv8npdy	46	7	to	to	TO
cord-035016-ipv8npdy	46	8	obtain	obtain	VB
cord-035016-ipv8npdy	46	9	marketing	marketing	NN
cord-035016-ipv8npdy	46	10	approval	approval	NN
cord-035016-ipv8npdy	46	11	from	from	IN
cord-035016-ipv8npdy	46	12	regulators	regulator	NNS
cord-035016-ipv8npdy	46	13	,	,	,
cord-035016-ipv8npdy	46	14	they	-PRON-	PRP
cord-035016-ipv8npdy	46	15	will	will	MD
cord-035016-ipv8npdy	46	16	design	design	VB
cord-035016-ipv8npdy	46	17	trials	trial	NNS
cord-035016-ipv8npdy	46	18	in	in	IN
cord-035016-ipv8npdy	46	19	ways	way	NNS
cord-035016-ipv8npdy	46	20	that	that	WDT
cord-035016-ipv8npdy	46	21	gives	give	VBZ
cord-035016-ipv8npdy	46	22	the	the	DT
cord-035016-ipv8npdy	46	23	fastest	fast	JJS
cord-035016-ipv8npdy	46	24	and	and	CC
cord-035016-ipv8npdy	46	25	easiest	easy	JJS
cord-035016-ipv8npdy	46	26	way	way	NN
cord-035016-ipv8npdy	46	27	to	to	IN
cord-035016-ipv8npdy	46	28	success	success	NN
cord-035016-ipv8npdy	46	29	,	,	,
cord-035016-ipv8npdy	46	30	which	which	WDT
cord-035016-ipv8npdy	46	31	does	do	VBZ
cord-035016-ipv8npdy	46	32	not	not	RB
cord-035016-ipv8npdy	46	33	necessarily	necessarily	RB
cord-035016-ipv8npdy	46	34	coincide	coincide	VB
cord-035016-ipv8npdy	46	35	with	with	IN
cord-035016-ipv8npdy	46	36	asking	ask	VBG
cord-035016-ipv8npdy	46	37	the	the	DT
cord-035016-ipv8npdy	46	38	clinically	clinically	RB
cord-035016-ipv8npdy	46	39	most	most	RBS
cord-035016-ipv8npdy	46	40	relevant	relevant	JJ
cord-035016-ipv8npdy	46	41	questions	question	NNS
cord-035016-ipv8npdy	46	42	.	.	.
cord-035016-ipv8npdy	47	1	When	when	WRB
cord-035016-ipv8npdy	47	2	front	front	JJ
cord-035016-ipv8npdy	47	3	running	run	VBG
cord-035016-ipv8npdy	47	4	COVID-19	covid-19	JJ
cord-035016-ipv8npdy	47	5	vaccine	vaccine	NN
cord-035016-ipv8npdy	47	6	developers	developer	NNS
cord-035016-ipv8npdy	47	7	Moderna	Moderna	NNP
cord-035016-ipv8npdy	47	8	,	,	,
cord-035016-ipv8npdy	47	9	Pfizer	Pfizer	NNP
cord-035016-ipv8npdy	47	10	,	,	,
cord-035016-ipv8npdy	47	11	and	and	CC
cord-035016-ipv8npdy	47	12	AstraZeneca	AstraZeneca	NNP
cord-035016-ipv8npdy	47	13	ceded	cede	VBD
cord-035016-ipv8npdy	47	14	to	to	IN
cord-035016-ipv8npdy	47	15	public	public	JJ
cord-035016-ipv8npdy	47	16	pressure	pressure	NN
cord-035016-ipv8npdy	47	17	and	and	CC
cord-035016-ipv8npdy	47	18	shared	share	VBD
cord-035016-ipv8npdy	47	19	their	-PRON-	PRP$
cord-035016-ipv8npdy	47	20	phase	phase	NN
cord-035016-ipv8npdy	47	21	III	iii	CD
cord-035016-ipv8npdy	47	22	trial	trial	NN
cord-035016-ipv8npdy	47	23	protocols	protocol	NNS
cord-035016-ipv8npdy	47	24	,	,	,
cord-035016-ipv8npdy	47	25	we	-PRON-	PRP
cord-035016-ipv8npdy	47	26	learnt	learn	VBD
cord-035016-ipv8npdy	47	27	that	that	IN
cord-035016-ipv8npdy	47	28	they	-PRON-	PRP
cord-035016-ipv8npdy	47	29	are	be	VBP
cord-035016-ipv8npdy	47	30	indeed	indeed	RB
cord-035016-ipv8npdy	47	31	designed	design	VBN
cord-035016-ipv8npdy	47	32	to	to	TO
cord-035016-ipv8npdy	47	33	get	get	VB
cord-035016-ipv8npdy	47	34	quick	quick	JJ
cord-035016-ipv8npdy	47	35	answers	answer	NNS
cord-035016-ipv8npdy	47	36	,	,	,
cord-035016-ipv8npdy	47	37	not	not	RB
cord-035016-ipv8npdy	47	38	to	to	TO
cord-035016-ipv8npdy	47	39	demonstrate	demonstrate	VB
cord-035016-ipv8npdy	47	40	the	the	DT
cord-035016-ipv8npdy	47	41	vaccines	vaccine	NNS
cord-035016-ipv8npdy	47	42	are	be	VBP
cord-035016-ipv8npdy	47	43	truly	truly	RB
cord-035016-ipv8npdy	47	44	effective	effective	JJ
cord-035016-ipv8npdy	48	1	(	(	-LRB-
cord-035016-ipv8npdy	48	2	Doshi	Doshi	NNP
cord-035016-ipv8npdy	48	3	and	and	CC
cord-035016-ipv8npdy	48	4	Topol	Topol	NNP
cord-035016-ipv8npdy	48	5	2020	2020	CD
cord-035016-ipv8npdy	48	6	)	)	-RRB-
cord-035016-ipv8npdy	48	7	.	.	.
cord-035016-ipv8npdy	49	1	And	and	CC
cord-035016-ipv8npdy	49	2	while	while	IN
cord-035016-ipv8npdy	49	3	the	the	DT
cord-035016-ipv8npdy	49	4	three	three	CD
cord-035016-ipv8npdy	49	5	protocols	protocol	NNS
cord-035016-ipv8npdy	49	6	differ	differ	VBP
cord-035016-ipv8npdy	49	7	in	in	IN
cord-035016-ipv8npdy	49	8	the	the	DT
cord-035016-ipv8npdy	49	9	details	detail	NNS
cord-035016-ipv8npdy	49	10	of	of	IN
cord-035016-ipv8npdy	49	11	how	how	WRB
cord-035016-ipv8npdy	49	12	they	-PRON-	PRP
cord-035016-ipv8npdy	49	13	measure	measure	VBP
cord-035016-ipv8npdy	49	14	efficacy	efficacy	NN
cord-035016-ipv8npdy	49	15	(	(	-LRB-
cord-035016-ipv8npdy	49	16	which	which	WDT
cord-035016-ipv8npdy	49	17	conveniently	conveniently	RB
cord-035016-ipv8npdy	49	18	will	will	MD
cord-035016-ipv8npdy	49	19	make	make	VB
cord-035016-ipv8npdy	49	20	the	the	DT
cord-035016-ipv8npdy	49	21	results	result	NNS
cord-035016-ipv8npdy	49	22	impossible	impossible	JJ
cord-035016-ipv8npdy	49	23	to	to	TO
cord-035016-ipv8npdy	49	24	compare	compare	VB
cord-035016-ipv8npdy	49	25	)	)	-RRB-
cord-035016-ipv8npdy	50	1	they	-PRON-	PRP
cord-035016-ipv8npdy	50	2	all	all	DT
cord-035016-ipv8npdy	50	3	look	look	VBP
cord-035016-ipv8npdy	50	4	at	at	IN
cord-035016-ipv8npdy	50	5	reducing	reduce	VBG
cord-035016-ipv8npdy	50	6	the	the	DT
cord-035016-ipv8npdy	50	7	number	number	NN
cord-035016-ipv8npdy	50	8	of	of	IN
cord-035016-ipv8npdy	50	9	mild	mild	JJ
cord-035016-ipv8npdy	50	10	COVID-19	covid-19	JJ
cord-035016-ipv8npdy	50	11	cases	case	NNS
cord-035016-ipv8npdy	50	12	as	as	IN
cord-035016-ipv8npdy	50	13	primary	primary	JJ
cord-035016-ipv8npdy	50	14	endpoint	endpoint	NN
cord-035016-ipv8npdy	50	15	.	.	.
cord-035016-ipv8npdy	51	1	The	the	DT
cord-035016-ipv8npdy	51	2	more	more	RBR
cord-035016-ipv8npdy	51	3	clinically	clinically	RB
cord-035016-ipv8npdy	51	4	relevant	relevant	JJ
cord-035016-ipv8npdy	51	5	endpoint	endpoint	NN
cord-035016-ipv8npdy	51	6	of	of	IN
cord-035016-ipv8npdy	51	7	reducing	reduce	VBG
cord-035016-ipv8npdy	51	8	severe	severe	JJ
cord-035016-ipv8npdy	51	9	disease	disease	NN
cord-035016-ipv8npdy	51	10	and	and	CC
cord-035016-ipv8npdy	51	11	death	death	NN
cord-035016-ipv8npdy	51	12	would	would	MD
cord-035016-ipv8npdy	51	13	take	take	VB
cord-035016-ipv8npdy	51	14	longer	long	RBR
cord-035016-ipv8npdy	51	15	to	to	TO
cord-035016-ipv8npdy	51	16	achieve	achieve	VB
cord-035016-ipv8npdy	51	17	(	(	-LRB-
cord-035016-ipv8npdy	51	18	given	give	VBN
cord-035016-ipv8npdy	51	19	that	that	IN
cord-035016-ipv8npdy	51	20	only	only	RB
cord-035016-ipv8npdy	51	21	a	a	DT
cord-035016-ipv8npdy	51	22	minority	minority	NN
cord-035016-ipv8npdy	51	23	of	of	IN
cord-035016-ipv8npdy	51	24	those	those	DT
cord-035016-ipv8npdy	51	25	infected	infect	VBN
cord-035016-ipv8npdy	51	26	develop	develop	VBP
cord-035016-ipv8npdy	51	27	severe	severe	JJ
cord-035016-ipv8npdy	51	28	disease	disease	NN
cord-035016-ipv8npdy	51	29	)	)	-RRB-
cord-035016-ipv8npdy	51	30	,	,	,
cord-035016-ipv8npdy	51	31	as	as	IN
cord-035016-ipv8npdy	51	32	would	would	MD
cord-035016-ipv8npdy	51	33	demonstrating	demonstrate	VBG
cord-035016-ipv8npdy	51	34	that	that	IN
cord-035016-ipv8npdy	51	35	the	the	DT
cord-035016-ipv8npdy	51	36	vaccine	vaccine	NN
cord-035016-ipv8npdy	51	37	protects	protect	VBZ
cord-035016-ipv8npdy	51	38	against	against	IN
cord-035016-ipv8npdy	51	39	infection	infection	NN
cord-035016-ipv8npdy	51	40	altogether	altogether	RB
cord-035016-ipv8npdy	51	41	-	-	:
cord-035016-ipv8npdy	51	42	which	which	WDT
cord-035016-ipv8npdy	51	43	is	be	VBZ
cord-035016-ipv8npdy	51	44	the	the	DT
cord-035016-ipv8npdy	51	45	most	most	RBS
cord-035016-ipv8npdy	51	46	desirable	desirable	JJ
cord-035016-ipv8npdy	51	47	form	form	NN
cord-035016-ipv8npdy	51	48	of	of	IN
cord-035016-ipv8npdy	51	49	efficacy	efficacy	NN
cord-035016-ipv8npdy	51	50	.	.	.
cord-035016-ipv8npdy	52	1	WHO	who	WP
cord-035016-ipv8npdy	52	2	has	have	VBZ
cord-035016-ipv8npdy	52	3	proposed	propose	VBN
cord-035016-ipv8npdy	52	4	a	a	DT
cord-035016-ipv8npdy	52	5	collaborative	collaborative	JJ
cord-035016-ipv8npdy	52	6	efficacy	efficacy	NN
cord-035016-ipv8npdy	52	7	trial	trial	NN
cord-035016-ipv8npdy	52	8	,	,	,
cord-035016-ipv8npdy	52	9	called	call	VBN
cord-035016-ipv8npdy	52	10	'	'	``
cord-035016-ipv8npdy	52	11	Solidarity	Solidarity	NNP
cord-035016-ipv8npdy	52	12	'	'	''
cord-035016-ipv8npdy	52	13	,	,	,
cord-035016-ipv8npdy	52	14	6	6	CD
cord-035016-ipv8npdy	52	15	that	that	WDT
cord-035016-ipv8npdy	52	16	would	would	MD
cord-035016-ipv8npdy	52	17	allow	allow	VB
cord-035016-ipv8npdy	52	18	to	to	TO
cord-035016-ipv8npdy	52	19	directly	directly	RB
cord-035016-ipv8npdy	52	20	compare	compare	VB
cord-035016-ipv8npdy	52	21	the	the	DT
cord-035016-ipv8npdy	52	22	performance	performance	NN
cord-035016-ipv8npdy	52	23	of	of	IN
cord-035016-ipv8npdy	52	24	different	different	JJ
cord-035016-ipv8npdy	52	25	vaccines	vaccine	NNS
cord-035016-ipv8npdy	52	26	in	in	IN
cord-035016-ipv8npdy	52	27	light	light	NN
cord-035016-ipv8npdy	52	28	of	of	IN
cord-035016-ipv8npdy	52	29	the	the	DT
cord-035016-ipv8npdy	52	30	TPP	TPP	NNP
cord-035016-ipv8npdy	52	31	.	.	.
cord-035016-ipv8npdy	53	1	However	however	RB
cord-035016-ipv8npdy	53	2	,	,	,
cord-035016-ipv8npdy	53	3	commercial	commercial	JJ
cord-035016-ipv8npdy	53	4	vaccine	vaccine	NN
cord-035016-ipv8npdy	53	5	developers	developer	NNS
cord-035016-ipv8npdy	53	6	prefer	prefer	VBP
cord-035016-ipv8npdy	53	7	to	to	TO
cord-035016-ipv8npdy	53	8	set	set	VB
cord-035016-ipv8npdy	53	9	up	up	RP
cord-035016-ipv8npdy	53	10	their	-PRON-	PRP$
cord-035016-ipv8npdy	53	11	own	own	JJ
cord-035016-ipv8npdy	53	12	placebo	placebo	NN
cord-035016-ipv8npdy	53	13	-	-	HYPH
cord-035016-ipv8npdy	53	14	controlled	control	VBN
cord-035016-ipv8npdy	53	15	trials	trial	NNS
cord-035016-ipv8npdy	53	16	rather	rather	RB
cord-035016-ipv8npdy	53	17	than	than	IN
cord-035016-ipv8npdy	53	18	have	have	VBP
cord-035016-ipv8npdy	53	19	their	-PRON-	PRP$
cord-035016-ipv8npdy	53	20	vaccines	vaccine	NNS
cord-035016-ipv8npdy	53	21	compared	compare	VBN
cord-035016-ipv8npdy	53	22	to	to	IN
cord-035016-ipv8npdy	53	23	other	other	JJ
cord-035016-ipv8npdy	53	24	candidates	candidate	NNS
cord-035016-ipv8npdy	53	25	by	by	IN
cord-035016-ipv8npdy	53	26	independent	independent	JJ
cord-035016-ipv8npdy	53	27	researchers	researcher	NNS
cord-035016-ipv8npdy	53	28	and	and	CC
cord-035016-ipv8npdy	53	29	held	hold	VBD
cord-035016-ipv8npdy	53	30	up	up	RP
cord-035016-ipv8npdy	53	31	to	to	IN
cord-035016-ipv8npdy	53	32	stringent	stringent	JJ
cord-035016-ipv8npdy	53	33	public	public	JJ
cord-035016-ipv8npdy	53	34	health	health	NN
cord-035016-ipv8npdy	53	35	targets	target	NNS
cord-035016-ipv8npdy	53	36	.	.	.
cord-035016-ipv8npdy	54	1	And	and	CC
cord-035016-ipv8npdy	54	2	while	while	IN
cord-035016-ipv8npdy	54	3	contrary	contrary	JJ
cord-035016-ipv8npdy	54	4	to	to	IN
cord-035016-ipv8npdy	54	5	good	good	JJ
cord-035016-ipv8npdy	54	6	scientific	scientific	JJ
cord-035016-ipv8npdy	54	7	practice	practice	NN
cord-035016-ipv8npdy	54	8	,	,	,
cord-035016-ipv8npdy	54	9	governments	government	NNS
cord-035016-ipv8npdy	54	10	too	too	RB
cord-035016-ipv8npdy	54	11	have	have	VBP
cord-035016-ipv8npdy	54	12	chosen	choose	VBN
cord-035016-ipv8npdy	54	13	speed	speed	NN
cord-035016-ipv8npdy	54	14	and	and	CC
cord-035016-ipv8npdy	54	15	political	political	JJ
cord-035016-ipv8npdy	54	16	expediency	expediency	NN
cord-035016-ipv8npdy	54	17	over	over	IN
cord-035016-ipv8npdy	54	18	quality	quality	NN
cord-035016-ipv8npdy	54	19	,	,	,
cord-035016-ipv8npdy	54	20	generously	generously	RB
cord-035016-ipv8npdy	54	21	supporting	support	VBG
cord-035016-ipv8npdy	54	22	company	company	NN
cord-035016-ipv8npdy	54	23	trials	trial	NNS
cord-035016-ipv8npdy	54	24	as	as	IN
cord-035016-ipv8npdy	54	25	part	part	NN
cord-035016-ipv8npdy	54	26	of	of	IN
cord-035016-ipv8npdy	54	27	their	-PRON-	PRP$
cord-035016-ipv8npdy	54	28	geopolitical	geopolitical	JJ
cord-035016-ipv8npdy	54	29	vaccine	vaccine	NN
cord-035016-ipv8npdy	54	30	race	race	NN
cord-035016-ipv8npdy	54	31	through	through	IN
cord-035016-ipv8npdy	54	32	funding	funding	NN
cord-035016-ipv8npdy	54	33	and	and	CC
cord-035016-ipv8npdy	54	34	access	access	NN
cord-035016-ipv8npdy	54	35	to	to	IN
cord-035016-ipv8npdy	54	36	public	public	JJ
cord-035016-ipv8npdy	54	37	clinical	clinical	JJ
cord-035016-ipv8npdy	54	38	trial	trial	NN
cord-035016-ipv8npdy	54	39	infrastructure	infrastructure	NN
cord-035016-ipv8npdy	54	40	and	and	CC
cord-035016-ipv8npdy	54	41	capabilities	capability	NNS
cord-035016-ipv8npdy	54	42	.	.	.
cord-035016-ipv8npdy	55	1	Meanwhile	meanwhile	RB
cord-035016-ipv8npdy	55	2	,	,	,
cord-035016-ipv8npdy	55	3	leading	lead	VBG
cord-035016-ipv8npdy	55	4	scientists	scientist	NNS
cord-035016-ipv8npdy	55	5	advising	advise	VBG
cord-035016-ipv8npdy	55	6	WHO	who	WP
cord-035016-ipv8npdy	55	7	are	be	VBP
cord-035016-ipv8npdy	55	8	left	leave	VBN
cord-035016-ipv8npdy	55	9	to	to	TO
cord-035016-ipv8npdy	55	10	plead	plead	VB
cord-035016-ipv8npdy	55	11	in	in	IN
cord-035016-ipv8npdy	55	12	scientific	scientific	JJ
cord-035016-ipv8npdy	55	13	journals	journal	NNS
cord-035016-ipv8npdy	55	14	for	for	IN
cord-035016-ipv8npdy	55	15	trials	trial	NNS
cord-035016-ipv8npdy	55	16	to	to	TO
cord-035016-ipv8npdy	55	17	look	look	VB
cord-035016-ipv8npdy	55	18	for	for	IN
cord-035016-ipv8npdy	55	19	'	'	``
cord-035016-ipv8npdy	55	20	worthwhile	worthwhile	JJ
cord-035016-ipv8npdy	55	21	efficacy	efficacy	NN
cord-035016-ipv8npdy	55	22	'	'	''
cord-035016-ipv8npdy	55	23	(	(	-LRB-
cord-035016-ipv8npdy	55	24	Krause	Krause	NNP
cord-035016-ipv8npdy	55	25	et	et	NNP
cord-035016-ipv8npdy	55	26	al	al	NNP
cord-035016-ipv8npdy	55	27	.	.	NNP
cord-035016-ipv8npdy	55	28	2020	2020	CD
cord-035016-ipv8npdy	55	29	)	)	-RRB-
cord-035016-ipv8npdy	55	30	,	,	,
cord-035016-ipv8npdy	55	31	lacking	lack	VBG
cord-035016-ipv8npdy	55	32	ways	way	NNS
cord-035016-ipv8npdy	55	33	to	to	TO
cord-035016-ipv8npdy	55	34	impose	impose	VB
cord-035016-ipv8npdy	55	35	public	public	JJ
cord-035016-ipv8npdy	55	36	health	health	NN
cord-035016-ipv8npdy	55	37	imperatives	imperative	NNS
cord-035016-ipv8npdy	55	38	to	to	IN
cord-035016-ipv8npdy	55	39	commercial	commercial	JJ
cord-035016-ipv8npdy	55	40	developers	developer	NNS
cord-035016-ipv8npdy	55	41	.	.	.
cord-035016-ipv8npdy	56	1	Only	only	RB
cord-035016-ipv8npdy	56	2	radical	radical	JJ
cord-035016-ipv8npdy	56	3	transparency	transparency	NN
cord-035016-ipv8npdy	56	4	of	of	IN
cord-035016-ipv8npdy	56	5	clinical	clinical	JJ
cord-035016-ipv8npdy	56	6	trial	trial	NN
cord-035016-ipv8npdy	56	7	protocols	protocol	NNS
cord-035016-ipv8npdy	56	8	and	and	CC
cord-035016-ipv8npdy	56	9	data	datum	NNS
cord-035016-ipv8npdy	56	10	,	,	,
cord-035016-ipv8npdy	56	11	and	and	CC
cord-035016-ipv8npdy	56	12	a	a	DT
cord-035016-ipv8npdy	56	13	robust	robust	JJ
cord-035016-ipv8npdy	56	14	and	and	CC
cord-035016-ipv8npdy	56	15	independent	independent	JJ
cord-035016-ipv8npdy	56	16	review	review	NN
cord-035016-ipv8npdy	56	17	of	of	IN
cord-035016-ipv8npdy	56	18	the	the	DT
cord-035016-ipv8npdy	56	19	results	result	NNS
cord-035016-ipv8npdy	56	20	will	will	MD
cord-035016-ipv8npdy	56	21	allow	allow	VB
cord-035016-ipv8npdy	56	22	to	to	TO
cord-035016-ipv8npdy	56	23	ensure	ensure	VB
cord-035016-ipv8npdy	56	24	we	-PRON-	PRP
cord-035016-ipv8npdy	56	25	fully	fully	RB
cord-035016-ipv8npdy	56	26	understand	understand	VBP
cord-035016-ipv8npdy	56	27	the	the	DT
cord-035016-ipv8npdy	56	28	performance	performance	NN
cord-035016-ipv8npdy	56	29	,	,	,
cord-035016-ipv8npdy	56	30	and	and	CC
cord-035016-ipv8npdy	56	31	limitations	limitation	NNS
cord-035016-ipv8npdy	56	32	,	,	,
cord-035016-ipv8npdy	56	33	of	of	IN
cord-035016-ipv8npdy	56	34	each	each	DT
cord-035016-ipv8npdy	56	35	vaccine	vaccine	NN
cord-035016-ipv8npdy	56	36	,	,	,
cord-035016-ipv8npdy	56	37	and	and	CC
cord-035016-ipv8npdy	56	38	restore	restore	VB
cord-035016-ipv8npdy	56	39	trust	trust	NN
cord-035016-ipv8npdy	56	40	that	that	DT
cord-035016-ipv8npdy	56	41	study	study	NN
cord-035016-ipv8npdy	56	42	conclusions	conclusion	NNS
cord-035016-ipv8npdy	56	43	are	be	VBP
cord-035016-ipv8npdy	56	44	valid	valid	JJ
cord-035016-ipv8npdy	56	45	(	(	-LRB-
cord-035016-ipv8npdy	56	46	Torreele	Torreele	NNP
cord-035016-ipv8npdy	56	47	2020c	2020c	CD
cord-035016-ipv8npdy	56	48	)	)	-RRB-
cord-035016-ipv8npdy	56	49	.	.	.
cord-035016-ipv8npdy	57	1	Amidst	amidst	IN
cord-035016-ipv8npdy	57	2	growing	grow	VBG
cord-035016-ipv8npdy	57	3	antiscience	antiscience	NN
cord-035016-ipv8npdy	57	4	and	and	CC
cord-035016-ipv8npdy	57	5	anti	anti	JJ
cord-035016-ipv8npdy	57	6	-	-	JJ
cord-035016-ipv8npdy	57	7	vax	vax	JJ
cord-035016-ipv8npdy	57	8	tendencies	tendency	NNS
cord-035016-ipv8npdy	57	9	,	,	,
cord-035016-ipv8npdy	57	10	it	-PRON-	PRP
cord-035016-ipv8npdy	57	11	is	be	VBZ
cord-035016-ipv8npdy	57	12	critical	critical	JJ
cord-035016-ipv8npdy	57	13	that	that	IN
cord-035016-ipv8npdy	57	14	commercial	commercial	JJ
cord-035016-ipv8npdy	57	15	and	and	CC
cord-035016-ipv8npdy	57	16	other	other	JJ
cord-035016-ipv8npdy	57	17	vested	vested	JJ
cord-035016-ipv8npdy	57	18	interests	interest	NNS
cord-035016-ipv8npdy	57	19	are	be	VBP
cord-035016-ipv8npdy	57	20	being	be	VBG
cord-035016-ipv8npdy	57	21	removed	remove	VBN
cord-035016-ipv8npdy	57	22	from	from	IN
cord-035016-ipv8npdy	57	23	the	the	DT
cord-035016-ipv8npdy	57	24	assessment	assessment	NN
cord-035016-ipv8npdy	57	25	of	of	IN
cord-035016-ipv8npdy	57	26	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	57	27	vaccines	vaccine	NNS
cord-035016-ipv8npdy	57	28	,	,	,
cord-035016-ipv8npdy	57	29	allowing	allow	VBG
cord-035016-ipv8npdy	57	30	public	public	JJ
cord-035016-ipv8npdy	57	31	health	health	NN
cord-035016-ipv8npdy	57	32	scientists	scientist	NNS
cord-035016-ipv8npdy	57	33	,	,	,
cord-035016-ipv8npdy	57	34	vaccination	vaccination	NN
cord-035016-ipv8npdy	57	35	experts	expert	NNS
cord-035016-ipv8npdy	57	36	and	and	CC
cord-035016-ipv8npdy	57	37	other	other	JJ
cord-035016-ipv8npdy	57	38	relevant	relevant	JJ
cord-035016-ipv8npdy	57	39	stakeholders	stakeholder	NNS
cord-035016-ipv8npdy	57	40	full	full	JJ
cord-035016-ipv8npdy	57	41	access	access	NN
cord-035016-ipv8npdy	57	42	to	to	IN
cord-035016-ipv8npdy	57	43	the	the	DT
cord-035016-ipv8npdy	57	44	data	datum	NNS
cord-035016-ipv8npdy	57	45	and	and	CC
cord-035016-ipv8npdy	57	46	analyses	analysis	NNS
cord-035016-ipv8npdy	57	47	to	to	TO
cord-035016-ipv8npdy	57	48	redress	redress	VB
cord-035016-ipv8npdy	57	49	the	the	DT
cord-035016-ipv8npdy	57	50	already	already	RB
cord-035016-ipv8npdy	57	51	shaken	shake	VBN
cord-035016-ipv8npdy	57	52	public	public	JJ
cord-035016-ipv8npdy	57	53	confidence	confidence	NN
cord-035016-ipv8npdy	57	54	in	in	IN
cord-035016-ipv8npdy	57	55	public	public	JJ
cord-035016-ipv8npdy	57	56	health	health	NN
cord-035016-ipv8npdy	57	57	interventions	intervention	NNS
cord-035016-ipv8npdy	57	58	to	to	TO
cord-035016-ipv8npdy	57	59	control	control	VB
cord-035016-ipv8npdy	57	60	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	57	61	(	(	-LRB-
cord-035016-ipv8npdy	57	62	Jha	Jha	NNP
cord-035016-ipv8npdy	57	63	2020	2020	CD
cord-035016-ipv8npdy	57	64	)	)	-RRB-
cord-035016-ipv8npdy	57	65	.	.	.
cord-035016-ipv8npdy	58	1	A	a	DT
cord-035016-ipv8npdy	58	2	further	further	JJ
cord-035016-ipv8npdy	58	3	risk	risk	NN
cord-035016-ipv8npdy	58	4	of	of	IN
cord-035016-ipv8npdy	58	5	focusing	focus	VBG
cord-035016-ipv8npdy	58	6	on	on	IN
cord-035016-ipv8npdy	58	7	speed	speed	NN
cord-035016-ipv8npdy	58	8	is	be	VBZ
cord-035016-ipv8npdy	58	9	that	that	IN
cord-035016-ipv8npdy	58	10	researchers	researcher	NNS
cord-035016-ipv8npdy	58	11	may	may	MD
cord-035016-ipv8npdy	58	12	not	not	RB
cord-035016-ipv8npdy	58	13	take	take	VB
cord-035016-ipv8npdy	58	14	the	the	DT
cord-035016-ipv8npdy	58	15	time	time	NN
cord-035016-ipv8npdy	58	16	to	to	TO
cord-035016-ipv8npdy	58	17	work	work	VB
cord-035016-ipv8npdy	58	18	with	with	IN
cord-035016-ipv8npdy	58	19	communities	community	NNS
cord-035016-ipv8npdy	58	20	to	to	TO
cord-035016-ipv8npdy	58	21	educate	educate	VB
cord-035016-ipv8npdy	58	22	them	-PRON-	PRP
cord-035016-ipv8npdy	58	23	about	about	IN
cord-035016-ipv8npdy	58	24	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	58	25	,	,	,
cord-035016-ipv8npdy	58	26	its	-PRON-	PRP$
cord-035016-ipv8npdy	58	27	risk	risk	NN
cord-035016-ipv8npdy	58	28	,	,	,
cord-035016-ipv8npdy	58	29	the	the	DT
cord-035016-ipv8npdy	58	30	promise	promise	NN
cord-035016-ipv8npdy	58	31	of	of	IN
cord-035016-ipv8npdy	58	32	vaccines	vaccine	NNS
cord-035016-ipv8npdy	58	33	and	and	CC
cord-035016-ipv8npdy	58	34	the	the	DT
cord-035016-ipv8npdy	58	35	mechanics	mechanic	NNS
cord-035016-ipv8npdy	58	36	of	of	IN
cord-035016-ipv8npdy	58	37	developing	develop	VBG
cord-035016-ipv8npdy	58	38	them	-PRON-	PRP
cord-035016-ipv8npdy	58	39	,	,	,
cord-035016-ipv8npdy	58	40	including	include	VBG
cord-035016-ipv8npdy	58	41	doing	do	VBG
cord-035016-ipv8npdy	58	42	trials	trial	NNS
cord-035016-ipv8npdy	58	43	,	,	,
cord-035016-ipv8npdy	58	44	and	and	CC
cord-035016-ipv8npdy	58	45	get	get	VB
cord-035016-ipv8npdy	58	46	communities	community	NNS
cord-035016-ipv8npdy	58	47	on	on	IN
cord-035016-ipv8npdy	58	48	board	board	NN
cord-035016-ipv8npdy	58	49	for	for	IN
cord-035016-ipv8npdy	58	50	trials	trial	NNS
cord-035016-ipv8npdy	58	51	and	and	CC
cord-035016-ipv8npdy	58	52	use	use	NN
cord-035016-ipv8npdy	58	53	of	of	IN
cord-035016-ipv8npdy	58	54	the	the	DT
cord-035016-ipv8npdy	58	55	vaccine	vaccine	NN
cord-035016-ipv8npdy	58	56	.	.	.
cord-035016-ipv8npdy	59	1	In	in	IN
cord-035016-ipv8npdy	59	2	addition	addition	NN
cord-035016-ipv8npdy	59	3	to	to	IN
cord-035016-ipv8npdy	59	4	the	the	DT
cord-035016-ipv8npdy	59	5	risks	risk	NNS
cord-035016-ipv8npdy	59	6	of	of	IN
cord-035016-ipv8npdy	59	7	suboptimal	suboptimal	JJ
cord-035016-ipv8npdy	59	8	research	research	NN
cord-035016-ipv8npdy	59	9	ethics	ethic	NNS
cord-035016-ipv8npdy	59	10	practices	practice	NNS
cord-035016-ipv8npdy	59	11	,	,	,
cord-035016-ipv8npdy	59	12	this	this	DT
cord-035016-ipv8npdy	59	13	may	may	MD
cord-035016-ipv8npdy	59	14	also	also	RB
cord-035016-ipv8npdy	59	15	create	create	VB
cord-035016-ipv8npdy	59	16	barriers	barrier	NNS
cord-035016-ipv8npdy	59	17	and	and	CC
cord-035016-ipv8npdy	59	18	delays	delay	NNS
cord-035016-ipv8npdy	59	19	for	for	IN
cord-035016-ipv8npdy	59	20	rollout	rollout	NN
cord-035016-ipv8npdy	59	21	afterwards	afterwards	RB
cord-035016-ipv8npdy	59	22	,	,	,
cord-035016-ipv8npdy	59	23	because	because	IN
cord-035016-ipv8npdy	59	24	of	of	IN
cord-035016-ipv8npdy	59	25	distrust	distrust	NN
cord-035016-ipv8npdy	59	26	,	,	,
cord-035016-ipv8npdy	59	27	vaccine	vaccine	NN
cord-035016-ipv8npdy	59	28	refusal	refusal	NN
cord-035016-ipv8npdy	59	29	,	,	,
cord-035016-ipv8npdy	59	30	science	science	NN
cord-035016-ipv8npdy	59	31	misconceptions	misconception	NNS
cord-035016-ipv8npdy	59	32	,	,	,
cord-035016-ipv8npdy	59	33	etc	etc	FW
cord-035016-ipv8npdy	59	34	.	.	.
cord-035016-ipv8npdy	60	1	The	the	DT
cord-035016-ipv8npdy	60	2	vaccine	vaccine	NN
cord-035016-ipv8npdy	60	3	R&D	r&d	NN
cord-035016-ipv8npdy	60	4	playing	playing	NN
cord-035016-ipv8npdy	60	5	field	field	NN
cord-035016-ipv8npdy	60	6	is	be	VBZ
cord-035016-ipv8npdy	60	7	not	not	RB
cord-035016-ipv8npdy	60	8	designed	design	VBN
cord-035016-ipv8npdy	60	9	to	to	TO
cord-035016-ipv8npdy	60	10	enable	enable	VB
cord-035016-ipv8npdy	61	1	the	the	DT
cord-035016-ipv8npdy	61	2	best	good	JJS
cord-035016-ipv8npdy	61	3	COVID-19	covid-19	JJ
cord-035016-ipv8npdy	61	4	vaccines	vaccine	NNS
cord-035016-ipv8npdy	61	5	to	to	TO
cord-035016-ipv8npdy	61	6	move	move	VB
cord-035016-ipv8npdy	61	7	forward	forward	RB
cord-035016-ipv8npdy	61	8	based	base	VBN
cord-035016-ipv8npdy	61	9	on	on	IN
cord-035016-ipv8npdy	61	10	scientific	scientific	JJ
cord-035016-ipv8npdy	61	11	and	and	CC
cord-035016-ipv8npdy	61	12	public	public	JJ
cord-035016-ipv8npdy	61	13	health	health	NN
cord-035016-ipv8npdy	61	14	merit	merit	NN
cord-035016-ipv8npdy	61	15	.	.	.
cord-035016-ipv8npdy	62	1	Instead	instead	RB
cord-035016-ipv8npdy	62	2	,	,	,
cord-035016-ipv8npdy	62	3	it	-PRON-	PRP
cord-035016-ipv8npdy	62	4	is	be	VBZ
cord-035016-ipv8npdy	62	5	shaped	shape	VBN
cord-035016-ipv8npdy	62	6	by	by	IN
cord-035016-ipv8npdy	62	7	wealthy	wealthy	JJ
cord-035016-ipv8npdy	62	8	countries	country	NNS
cord-035016-ipv8npdy	62	9	and	and	CC
cord-035016-ipv8npdy	62	10	powerful	powerful	JJ
cord-035016-ipv8npdy	62	11	actors	actor	NNS
cord-035016-ipv8npdy	62	12	like	like	IN
cord-035016-ipv8npdy	62	13	pharmaceutical	pharmaceutical	JJ
cord-035016-ipv8npdy	62	14	corporations	corporation	NNS
cord-035016-ipv8npdy	62	15	who	who	WP
cord-035016-ipv8npdy	62	16	place	place	VBP
cord-035016-ipv8npdy	62	17	their	-PRON-	PRP$
cord-035016-ipv8npdy	62	18	bets	bet	NNS
cord-035016-ipv8npdy	62	19	(	(	-LRB-
cord-035016-ipv8npdy	62	20	Knaus	Knaus	NNP
cord-035016-ipv8npdy	62	21	2020)-allotting	2020)-allotte	VBG
cord-035016-ipv8npdy	62	22	large	large	JJ
cord-035016-ipv8npdy	62	23	amounts	amount	NNS
cord-035016-ipv8npdy	62	24	of	of	IN
cord-035016-ipv8npdy	62	25	money	money	NN
cord-035016-ipv8npdy	62	26	to	to	TO
cord-035016-ipv8npdy	62	27	propel	propel	VB
cord-035016-ipv8npdy	62	28	a	a	DT
cord-035016-ipv8npdy	62	29	chosen	choose	VBN
cord-035016-ipv8npdy	62	30	candidate	candidate	NN
cord-035016-ipv8npdy	62	31	forward	forward	RB
cord-035016-ipv8npdy	62	32	towards	towards	IN
cord-035016-ipv8npdy	62	33	(	(	-LRB-
cord-035016-ipv8npdy	62	34	possible	possible	JJ
cord-035016-ipv8npdy	62	35	emergency	emergency	NN
cord-035016-ipv8npdy	62	36	use	use	NN
cord-035016-ipv8npdy	62	37	)	)	-RRB-
cord-035016-ipv8npdy	62	38	authorization	authorization	NN
cord-035016-ipv8npdy	62	39	.	.	.
cord-035016-ipv8npdy	63	1	Financial	financial	JJ
cord-035016-ipv8npdy	63	2	and	and	CC
cord-035016-ipv8npdy	63	3	industrial	industrial	JJ
cord-035016-ipv8npdy	63	4	backing	backing	NN
cord-035016-ipv8npdy	63	5	such	such	JJ
cord-035016-ipv8npdy	63	6	as	as	IN
cord-035016-ipv8npdy	63	7	through	through	IN
cord-035016-ipv8npdy	63	8	Operation	Operation	NNP
cord-035016-ipv8npdy	63	9	Warp	Warp	NNP
cord-035016-ipv8npdy	63	10	Speed	Speed	NNP
cord-035016-ipv8npdy	63	11	,	,	,
cord-035016-ipv8npdy	63	12	7	7	CD
cord-035016-ipv8npdy	63	13	more	more	JJR
cord-035016-ipv8npdy	63	14	than	than	IN
cord-035016-ipv8npdy	63	15	desirable	desirable	JJ
cord-035016-ipv8npdy	63	16	product	product	NN
cord-035016-ipv8npdy	63	17	characteristics	characteristic	NNS
cord-035016-ipv8npdy	63	18	,	,	,
cord-035016-ipv8npdy	63	19	will	will	MD
cord-035016-ipv8npdy	63	20	determine	determine	VB
cord-035016-ipv8npdy	63	21	the	the	DT
cord-035016-ipv8npdy	63	22	likely	likely	JJ
cord-035016-ipv8npdy	63	23	winners	winner	NNS
cord-035016-ipv8npdy	63	24	of	of	IN
cord-035016-ipv8npdy	63	25	this	this	DT
cord-035016-ipv8npdy	63	26	race	race	NN
cord-035016-ipv8npdy	63	27	,	,	,
cord-035016-ipv8npdy	63	28	for	for	IN
cord-035016-ipv8npdy	63	29	which	which	WDT
cord-035016-ipv8npdy	63	30	the	the	DT
cord-035016-ipv8npdy	63	31	primary	primary	JJ
cord-035016-ipv8npdy	63	32	finish	finish	NN
cord-035016-ipv8npdy	63	33	line	line	NN
cord-035016-ipv8npdy	63	34	is	be	VBZ
cord-035016-ipv8npdy	63	35	obtaining	obtain	VBG
cord-035016-ipv8npdy	63	36	marketing	marketing	NN
cord-035016-ipv8npdy	63	37	approval	approval	NN
cord-035016-ipv8npdy	63	38	-	-	:
cord-035016-ipv8npdy	63	39	typically	typically	RB
cord-035016-ipv8npdy	63	40	at	at	IN
cord-035016-ipv8npdy	63	41	the	the	DT
cord-035016-ipv8npdy	63	42	United	United	NNP
cord-035016-ipv8npdy	63	43	States	States	NNP
cord-035016-ipv8npdy	63	44	Food	Food	NNP
cord-035016-ipv8npdy	63	45	and	and	CC
cord-035016-ipv8npdy	63	46	Drug	Drug	NNP
cord-035016-ipv8npdy	63	47	Administration	Administration	NNP
cord-035016-ipv8npdy	63	48	(	(	-LRB-
cord-035016-ipv8npdy	63	49	FDA	FDA	NNP
cord-035016-ipv8npdy	63	50	)	)	-RRB-
cord-035016-ipv8npdy	63	51	and/or	and/or	CC
cord-035016-ipv8npdy	63	52	the	the	DT
cord-035016-ipv8npdy	63	53	European	European	NNP
cord-035016-ipv8npdy	63	54	Medicines	Medicines	NNPS
cord-035016-ipv8npdy	63	55	Agency	Agency	NNP
cord-035016-ipv8npdy	63	56	(	(	-LRB-
cord-035016-ipv8npdy	63	57	EMA	EMA	NNP
cord-035016-ipv8npdy	63	58	)	)	-RRB-
cord-035016-ipv8npdy	63	59	.	.	.
cord-035016-ipv8npdy	64	1	Yet	yet	CC
cord-035016-ipv8npdy	64	2	the	the	DT
cord-035016-ipv8npdy	64	3	criteria	criterion	NNS
cord-035016-ipv8npdy	64	4	used	use	VBN
cord-035016-ipv8npdy	64	5	by	by	IN
cord-035016-ipv8npdy	64	6	regulators	regulator	NNS
cord-035016-ipv8npdy	64	7	to	to	TO
cord-035016-ipv8npdy	64	8	allow	allow	VB
cord-035016-ipv8npdy	64	9	a	a	DT
cord-035016-ipv8npdy	64	10	vaccine	vaccine	NN
cord-035016-ipv8npdy	64	11	on	on	IN
cord-035016-ipv8npdy	64	12	the	the	DT
cord-035016-ipv8npdy	64	13	market	market	NN
cord-035016-ipv8npdy	64	14	are	be	VBP
cord-035016-ipv8npdy	64	15	not	not	RB
cord-035016-ipv8npdy	64	16	necessarily	necessarily	RB
cord-035016-ipv8npdy	64	17	responding	respond	VBG
cord-035016-ipv8npdy	64	18	to	to	IN
cord-035016-ipv8npdy	64	19	the	the	DT
cord-035016-ipv8npdy	64	20	critical	critical	JJ
cord-035016-ipv8npdy	64	21	question	question	NN
cord-035016-ipv8npdy	64	22	at	at	IN
cord-035016-ipv8npdy	64	23	hand	hand	NN
cord-035016-ipv8npdy	64	24	:	:	:
cord-035016-ipv8npdy	64	25	which	which	WDT
cord-035016-ipv8npdy	64	26	vaccine	vaccine	NN
cord-035016-ipv8npdy	64	27	has	have	VBZ
cord-035016-ipv8npdy	64	28	the	the	DT
cord-035016-ipv8npdy	64	29	potential	potential	NN
cord-035016-ipv8npdy	64	30	to	to	TO
cord-035016-ipv8npdy	64	31	significantly	significantly	RB
cord-035016-ipv8npdy	64	32	impact	impact	VB
cord-035016-ipv8npdy	64	33	global	global	JJ
cord-035016-ipv8npdy	64	34	public	public	JJ
cord-035016-ipv8npdy	64	35	health	health	NN
cord-035016-ipv8npdy	64	36	outcomes	outcome	NNS
cord-035016-ipv8npdy	64	37	for	for	IN
cord-035016-ipv8npdy	64	38	COVID-19	covid-19	NN
cord-035016-ipv8npdy	64	39	?	?	.
cord-035016-ipv8npdy	65	1	The	the	DT
cord-035016-ipv8npdy	65	2	primary	primary	JJ
cord-035016-ipv8npdy	65	3	role	role	NN
cord-035016-ipv8npdy	65	4	of	of	IN
cord-035016-ipv8npdy	65	5	regulatory	regulatory	JJ
cord-035016-ipv8npdy	65	6	authorities	authority	NNS
cord-035016-ipv8npdy	65	7	is	be	VBZ
cord-035016-ipv8npdy	65	8	to	to	TO
cord-035016-ipv8npdy	65	9	safeguard	safeguard	VB
cord-035016-ipv8npdy	65	10	the	the	DT
cord-035016-ipv8npdy	65	11	public	public	NN
cord-035016-ipv8npdy	65	12	against	against	IN
cord-035016-ipv8npdy	65	13	exposure	exposure	NN
cord-035016-ipv8npdy	65	14	to	to	IN
cord-035016-ipv8npdy	65	15	potential	potential	JJ
cord-035016-ipv8npdy	65	16	harmful	harmful	JJ
cord-035016-ipv8npdy	65	17	products	product	NNS
cord-035016-ipv8npdy	65	18	.	.	.
cord-035016-ipv8npdy	66	1	Regulators	regulator	NNS
cord-035016-ipv8npdy	66	2	will	will	MD
cord-035016-ipv8npdy	66	3	assess	assess	VB
cord-035016-ipv8npdy	66	4	the	the	DT
cord-035016-ipv8npdy	66	5	potential	potential	JJ
cord-035016-ipv8npdy	66	6	benefits	benefit	NNS
cord-035016-ipv8npdy	66	7	and	and	CC
cord-035016-ipv8npdy	66	8	risks	risk	NNS
cord-035016-ipv8npdy	66	9	of	of	IN
cord-035016-ipv8npdy	66	10	individual	individual	JJ
cord-035016-ipv8npdy	66	11	vaccines	vaccine	NNS
cord-035016-ipv8npdy	66	12	based	base	VBN
cord-035016-ipv8npdy	66	13	on	on	IN
cord-035016-ipv8npdy	66	14	the	the	DT
cord-035016-ipv8npdy	66	15	company	company	NN
cord-035016-ipv8npdy	66	16	's	's	POS
cord-035016-ipv8npdy	66	17	data	datum	NNS
cord-035016-ipv8npdy	66	18	and	and	CC
cord-035016-ipv8npdy	66	19	determine	determine	VB
cord-035016-ipv8npdy	66	20	whether	whether	IN
cord-035016-ipv8npdy	66	21	the	the	DT
cord-035016-ipv8npdy	66	22	presented	present	VBN
cord-035016-ipv8npdy	66	23	benefit	benefit	NN
cord-035016-ipv8npdy	66	24	/	/	SYM
cord-035016-ipv8npdy	66	25	risk	risk	NN
cord-035016-ipv8npdy	66	26	balance	balance	NN
cord-035016-ipv8npdy	66	27	justifies	justify	VBZ
cord-035016-ipv8npdy	66	28	commercialization	commercialization	NN
cord-035016-ipv8npdy	66	29	of	of	IN
cord-035016-ipv8npdy	66	30	that	that	DT
cord-035016-ipv8npdy	66	31	vaccine	vaccine	NN
cord-035016-ipv8npdy	66	32	.	.	.
cord-035016-ipv8npdy	67	1	It	-PRON-	PRP
cord-035016-ipv8npdy	67	2	is	be	VBZ
cord-035016-ipv8npdy	67	3	not	not	RB
cord-035016-ipv8npdy	67	4	the	the	DT
cord-035016-ipv8npdy	67	5	role	role	NN
cord-035016-ipv8npdy	67	6	of	of	IN
cord-035016-ipv8npdy	67	7	regulators	regulator	NNS
cord-035016-ipv8npdy	67	8	to	to	TO
cord-035016-ipv8npdy	67	9	determine	determine	VB
cord-035016-ipv8npdy	67	10	if	if	IN
cord-035016-ipv8npdy	67	11	a	a	DT
cord-035016-ipv8npdy	67	12	vaccine	vaccine	NN
cord-035016-ipv8npdy	67	13	is	be	VBZ
cord-035016-ipv8npdy	67	14	adequate	adequate	JJ
cord-035016-ipv8npdy	67	15	to	to	TO
cord-035016-ipv8npdy	67	16	control	control	VB
cord-035016-ipv8npdy	67	17	the	the	DT
cord-035016-ipv8npdy	67	18	pandemic	pandemic	NN
cord-035016-ipv8npdy	67	19	,	,	,
cord-035016-ipv8npdy	67	20	nor	nor	CC
cord-035016-ipv8npdy	67	21	prioritizing	prioritize	VBG
cord-035016-ipv8npdy	67	22	which	which	WDT
cord-035016-ipv8npdy	67	23	one	one	PRP
cord-035016-ipv8npdy	67	24	has	have	VBZ
cord-035016-ipv8npdy	67	25	better	well	JJR
cord-035016-ipv8npdy	67	26	safety	safety	NN
cord-035016-ipv8npdy	67	27	and	and	CC
cord-035016-ipv8npdy	67	28	efficacy	efficacy	NN
cord-035016-ipv8npdy	67	29	.	.	.
cord-035016-ipv8npdy	68	1	Notably	notably	RB
cord-035016-ipv8npdy	68	2	,	,	,
cord-035016-ipv8npdy	68	3	in	in	IN
cord-035016-ipv8npdy	68	4	their	-PRON-	PRP$
cord-035016-ipv8npdy	68	5	decisions	decision	NNS
cord-035016-ipv8npdy	68	6	to	to	TO
cord-035016-ipv8npdy	68	7	give	give	VB
cord-035016-ipv8npdy	68	8	marketing	marketing	NN
cord-035016-ipv8npdy	68	9	authorization	authorization	NN
cord-035016-ipv8npdy	68	10	,	,	,
cord-035016-ipv8npdy	68	11	regulators	regulator	NNS
cord-035016-ipv8npdy	68	12	are	be	VBP
cord-035016-ipv8npdy	68	13	not	not	RB
cord-035016-ipv8npdy	68	14	taking	take	VBG
cord-035016-ipv8npdy	68	15	into	into	IN
cord-035016-ipv8npdy	68	16	consideration	consideration	NN
cord-035016-ipv8npdy	68	17	a	a	DT
cord-035016-ipv8npdy	68	18	company	company	NN
cord-035016-ipv8npdy	68	19	's	's	POS
cord-035016-ipv8npdy	68	20	intention	intention	NN
cord-035016-ipv8npdy	68	21	to	to	TO
cord-035016-ipv8npdy	68	22	produce	produce	VB
cord-035016-ipv8npdy	68	23	a	a	DT
cord-035016-ipv8npdy	68	24	vaccine	vaccine	NN
cord-035016-ipv8npdy	68	25	at	at	IN
cord-035016-ipv8npdy	68	26	scale	scale	NN
cord-035016-ipv8npdy	68	27	or	or	CC
cord-035016-ipv8npdy	68	28	make	make	VB
cord-035016-ipv8npdy	68	29	it	-PRON-	PRP
cord-035016-ipv8npdy	68	30	available	available	JJ
cord-035016-ipv8npdy	68	31	widely	widely	RB
cord-035016-ipv8npdy	68	32	,	,	,
cord-035016-ipv8npdy	68	33	nor	nor	CC
cord-035016-ipv8npdy	68	34	what	what	WP
cord-035016-ipv8npdy	68	35	price	price	NN
cord-035016-ipv8npdy	68	36	they	-PRON-	PRP
cord-035016-ipv8npdy	68	37	are	be	VBP
cord-035016-ipv8npdy	68	38	planning	plan	VBG
cord-035016-ipv8npdy	68	39	to	to	TO
cord-035016-ipv8npdy	68	40	charge	charge	VB
cord-035016-ipv8npdy	68	41	.	.	.
cord-035016-ipv8npdy	69	1	This	this	DT
cord-035016-ipv8npdy	69	2	means	mean	VBZ
cord-035016-ipv8npdy	69	3	that	that	IN
cord-035016-ipv8npdy	69	4	companies	company	NNS
cord-035016-ipv8npdy	69	5	have	have	VBP
cord-035016-ipv8npdy	69	6	no	no	DT
cord-035016-ipv8npdy	69	7	incentive	incentive	NN
cord-035016-ipv8npdy	69	8	nor	nor	CC
cord-035016-ipv8npdy	69	9	obligation	obligation	NN
cord-035016-ipv8npdy	69	10	to	to	TO
cord-035016-ipv8npdy	69	11	prioritize	prioritize	VB
cord-035016-ipv8npdy	69	12	anything	anything	NN
cord-035016-ipv8npdy	69	13	else	else	RB
cord-035016-ipv8npdy	69	14	but	but	CC
cord-035016-ipv8npdy	69	15	speed	speed	VB
cord-035016-ipv8npdy	69	16	in	in	IN
cord-035016-ipv8npdy	69	17	obtaining	obtain	VBG
cord-035016-ipv8npdy	69	18	marketing	marketing	NN
cord-035016-ipv8npdy	69	19	approval	approval	NN
cord-035016-ipv8npdy	69	20	,	,	,
cord-035016-ipv8npdy	69	21	based	base	VBN
cord-035016-ipv8npdy	69	22	on	on	IN
cord-035016-ipv8npdy	69	23	self	self	NN
cord-035016-ipv8npdy	69	24	-	-	HYPH
cord-035016-ipv8npdy	69	25	chosen	choose	VBN
cord-035016-ipv8npdy	69	26	measures	measure	NNS
cord-035016-ipv8npdy	69	27	of	of	IN
cord-035016-ipv8npdy	69	28	efficacy	efficacy	NN
cord-035016-ipv8npdy	69	29	.	.	.
cord-035016-ipv8npdy	70	1	In	in	IN
cord-035016-ipv8npdy	70	2	addition	addition	NN
cord-035016-ipv8npdy	70	3	,	,	,
cord-035016-ipv8npdy	70	4	as	as	IN
cord-035016-ipv8npdy	70	5	the	the	DT
cord-035016-ipv8npdy	70	6	race	race	NN
cord-035016-ipv8npdy	70	7	for	for	IN
cord-035016-ipv8npdy	70	8	a	a	DT
cord-035016-ipv8npdy	70	9	vaccine	vaccine	NN
cord-035016-ipv8npdy	70	10	became	become	VBD
cord-035016-ipv8npdy	70	11	fuelled	fuel	VBN
cord-035016-ipv8npdy	70	12	by	by	IN
cord-035016-ipv8npdy	70	13	political	political	JJ
cord-035016-ipv8npdy	70	14	,	,	,
cord-035016-ipv8npdy	70	15	financial	financial	JJ
cord-035016-ipv8npdy	70	16	and	and	CC
cord-035016-ipv8npdy	70	17	populist	populist	JJ
cord-035016-ipv8npdy	70	18	pressures	pressure	NNS
cord-035016-ipv8npdy	70	19	,	,	,
cord-035016-ipv8npdy	70	20	regulatory	regulatory	JJ
cord-035016-ipv8npdy	70	21	authorities	authority	NNS
cord-035016-ipv8npdy	70	22	may	may	MD
cord-035016-ipv8npdy	70	23	not	not	RB
cord-035016-ipv8npdy	70	24	even	even	RB
cord-035016-ipv8npdy	70	25	be	be	VB
cord-035016-ipv8npdy	70	26	able	able	JJ
cord-035016-ipv8npdy	70	27	to	to	TO
cord-035016-ipv8npdy	70	28	protect	protect	VB
cord-035016-ipv8npdy	70	29	us	-PRON-	PRP
cord-035016-ipv8npdy	70	30	from	from	IN
cord-035016-ipv8npdy	70	31	harm	harm	NN
cord-035016-ipv8npdy	70	32	or	or	CC
cord-035016-ipv8npdy	70	33	futility	futility	NN
cord-035016-ipv8npdy	70	34	.	.	.
cord-035016-ipv8npdy	71	1	Concerns	concern	NNS
cord-035016-ipv8npdy	71	2	among	among	IN
cord-035016-ipv8npdy	71	3	scientists	scientist	NNS
cord-035016-ipv8npdy	71	4	and	and	CC
cord-035016-ipv8npdy	71	5	experts	expert	NNS
cord-035016-ipv8npdy	71	6	are	be	VBP
cord-035016-ipv8npdy	71	7	growing	grow	VBG
cord-035016-ipv8npdy	71	8	over	over	IN
cord-035016-ipv8npdy	71	9	the	the	DT
cord-035016-ipv8npdy	71	10	political	political	JJ
cord-035016-ipv8npdy	71	11	pressure	pressure	NN
cord-035016-ipv8npdy	71	12	the	the	DT
cord-035016-ipv8npdy	71	13	US	US	NNP
cord-035016-ipv8npdy	71	14	administration	administration	NN
cord-035016-ipv8npdy	71	15	is	be	VBZ
cord-035016-ipv8npdy	71	16	putting	put	VBG
cord-035016-ipv8npdy	71	17	on	on	RP
cord-035016-ipv8npdy	71	18	the	the	DT
cord-035016-ipv8npdy	71	19	FDA	FDA	NNP
cord-035016-ipv8npdy	71	20	.	.	.
cord-035016-ipv8npdy	72	1	Especially	especially	RB
cord-035016-ipv8npdy	72	2	the	the	DT
cord-035016-ipv8npdy	72	3	announcement	announcement	NN
cord-035016-ipv8npdy	72	4	that	that	IN
cord-035016-ipv8npdy	72	5	the	the	DT
cord-035016-ipv8npdy	72	6	FDA	FDA	NNP
cord-035016-ipv8npdy	72	7	would	would	MD
cord-035016-ipv8npdy	72	8	consider	consider	VB
cord-035016-ipv8npdy	72	9	emergency	emergency	NN
cord-035016-ipv8npdy	72	10	authorization	authorization	NN
cord-035016-ipv8npdy	72	11	for	for	IN
cord-035016-ipv8npdy	72	12	COVID-19	covid-19	JJ
cord-035016-ipv8npdy	72	13	vaccines	vaccine	NNS
cord-035016-ipv8npdy	72	14	before	before	IN
cord-035016-ipv8npdy	72	15	phase	phase	NN
cord-035016-ipv8npdy	72	16	3	3	CD
cord-035016-ipv8npdy	72	17	trials	trial	NNS
cord-035016-ipv8npdy	72	18	are	be	VBP
cord-035016-ipv8npdy	72	19	complete	complete	JJ
cord-035016-ipv8npdy	72	20	,	,	,
cord-035016-ipv8npdy	72	21	8	8	CD
cord-035016-ipv8npdy	72	22	has	have	VBZ
cord-035016-ipv8npdy	72	23	caused	cause	VBN
cord-035016-ipv8npdy	72	24	concern	concern	NN
cord-035016-ipv8npdy	72	25	.	.	.
cord-035016-ipv8npdy	73	1	If	if	IN
cord-035016-ipv8npdy	73	2	that	that	DT
cord-035016-ipv8npdy	73	3	happens	happen	VBZ
cord-035016-ipv8npdy	73	4	,	,	,
cord-035016-ipv8npdy	73	5	European	european	JJ
cord-035016-ipv8npdy	73	6	countries	country	NNS
cord-035016-ipv8npdy	73	7	will	will	MD
cord-035016-ipv8npdy	73	8	be	be	VB
cord-035016-ipv8npdy	73	9	hard	hard	RB
cord-035016-ipv8npdy	73	10	pressed	pressed	JJ
cord-035016-ipv8npdy	73	11	to	to	TO
cord-035016-ipv8npdy	73	12	follow	follow	VB
cord-035016-ipv8npdy	73	13	suit	suit	NN
cord-035016-ipv8npdy	73	14	.	.	.
cord-035016-ipv8npdy	74	1	Yet	yet	RB
cord-035016-ipv8npdy	74	2	,	,	,
cord-035016-ipv8npdy	74	3	as	as	IN
cord-035016-ipv8npdy	74	4	vaccine	vaccine	NN
cord-035016-ipv8npdy	74	5	and	and	CC
cord-035016-ipv8npdy	74	6	public	public	JJ
cord-035016-ipv8npdy	74	7	health	health	NN
cord-035016-ipv8npdy	74	8	experts	expert	NNS
cord-035016-ipv8npdy	74	9	keep	keep	VBP
cord-035016-ipv8npdy	74	10	emphasizing	emphasize	VBG
cord-035016-ipv8npdy	74	11	,	,	,
cord-035016-ipv8npdy	74	12	robust	robust	JJ
cord-035016-ipv8npdy	74	13	phase	phase	NN
cord-035016-ipv8npdy	74	14	3	3	CD
cord-035016-ipv8npdy	74	15	efficacy	efficacy	NN
cord-035016-ipv8npdy	74	16	trials	trial	NNS
cord-035016-ipv8npdy	74	17	are	be	VBP
cord-035016-ipv8npdy	74	18	the	the	DT
cord-035016-ipv8npdy	74	19	only	only	JJ
cord-035016-ipv8npdy	74	20	way	way	NN
cord-035016-ipv8npdy	74	21	to	to	TO
cord-035016-ipv8npdy	74	22	establish	establish	VB
cord-035016-ipv8npdy	74	23	whether	whether	IN
cord-035016-ipv8npdy	74	24	a	a	DT
cord-035016-ipv8npdy	74	25	vaccine	vaccine	NN
cord-035016-ipv8npdy	74	26	is	be	VBZ
cord-035016-ipv8npdy	74	27	effective	effective	JJ
cord-035016-ipv8npdy	74	28	in	in	IN
cord-035016-ipv8npdy	74	29	protecting	protect	VBG
cord-035016-ipv8npdy	74	30	against	against	IN
cord-035016-ipv8npdy	74	31	infections	infection	NNS
cord-035016-ipv8npdy	74	32	and	and	CC
cord-035016-ipv8npdy	74	33	disease	disease	NN
cord-035016-ipv8npdy	74	34	,	,	,
cord-035016-ipv8npdy	74	35	and	and	CC
cord-035016-ipv8npdy	74	36	safe	safe	JJ
cord-035016-ipv8npdy	74	37	to	to	TO
cord-035016-ipv8npdy	74	38	administer	administer	VB
cord-035016-ipv8npdy	74	39	to	to	IN
cord-035016-ipv8npdy	74	40	large	large	JJ
cord-035016-ipv8npdy	74	41	groups	group	NNS
cord-035016-ipv8npdy	74	42	.	.	.
cord-035016-ipv8npdy	75	1	9	9	CD
cord-035016-ipv8npdy	76	1	Having	have	VBG
cord-035016-ipv8npdy	76	2	become	become	VBN
cord-035016-ipv8npdy	76	3	increasingly	increasingly	RB
cord-035016-ipv8npdy	76	4	financialized	financialized	JJ
cord-035016-ipv8npdy	76	5	(	(	-LRB-
cord-035016-ipv8npdy	76	6	Lazonick	Lazonick	NNP
cord-035016-ipv8npdy	76	7	et	et	NNP
cord-035016-ipv8npdy	76	8	al	al	NNP
cord-035016-ipv8npdy	76	9	.	.	.
cord-035016-ipv8npdy	76	10	2019	2019	CD
cord-035016-ipv8npdy	76	11	)	)	-RRB-
cord-035016-ipv8npdy	76	12	,	,	,
cord-035016-ipv8npdy	76	13	pharmaceutical	pharmaceutical	NN
cord-035016-ipv8npdy	76	14	corporations	corporation	NNS
cord-035016-ipv8npdy	76	15	will	will	MD
cord-035016-ipv8npdy	76	16	not	not	RB
cord-035016-ipv8npdy	76	17	invest	invest	VB
cord-035016-ipv8npdy	76	18	in	in	IN
cord-035016-ipv8npdy	76	19	R&D	r&d	NN
cord-035016-ipv8npdy	76	20	for	for	IN
cord-035016-ipv8npdy	76	21	products	product	NNS
cord-035016-ipv8npdy	76	22	that	that	WDT
cord-035016-ipv8npdy	76	23	do	do	VBP
cord-035016-ipv8npdy	76	24	not	not	RB
cord-035016-ipv8npdy	76	25	constitute	constitute	VB
cord-035016-ipv8npdy	76	26	guaranteed	guarantee	VBN
cord-035016-ipv8npdy	76	27	and	and	CC
cord-035016-ipv8npdy	76	28	profitable	profitable	JJ
cord-035016-ipv8npdy	76	29	business	business	NN
cord-035016-ipv8npdy	76	30	opportunities	opportunity	NNS
cord-035016-ipv8npdy	76	31	.	.	.
cord-035016-ipv8npdy	77	1	Despite	despite	IN
cord-035016-ipv8npdy	77	2	the	the	DT
cord-035016-ipv8npdy	77	3	excellent	excellent	JJ
cord-035016-ipv8npdy	77	4	public	public	JJ
cord-035016-ipv8npdy	77	5	health	health	NN
cord-035016-ipv8npdy	77	6	value	value	NN
cord-035016-ipv8npdy	77	7	of	of	IN
cord-035016-ipv8npdy	77	8	vaccines	vaccine	NNS
cord-035016-ipv8npdy	77	9	,	,	,
cord-035016-ipv8npdy	77	10	producing	produce	VBG
cord-035016-ipv8npdy	77	11	and	and	CC
cord-035016-ipv8npdy	77	12	selling	sell	VBG
cord-035016-ipv8npdy	77	13	vaccines	vaccine	NNS
cord-035016-ipv8npdy	77	14	is	be	VBZ
cord-035016-ipv8npdy	77	15	considered	consider	VBN
cord-035016-ipv8npdy	77	16	unattractive	unattractive	JJ
cord-035016-ipv8npdy	77	17	from	from	IN
cord-035016-ipv8npdy	77	18	a	a	DT
cord-035016-ipv8npdy	77	19	commercial	commercial	JJ
cord-035016-ipv8npdy	77	20	perspective	perspective	NN
cord-035016-ipv8npdy	77	21	.	.	.
cord-035016-ipv8npdy	78	1	Mass	mass	JJ
cord-035016-ipv8npdy	78	2	manufacturing	manufacturing	NN
cord-035016-ipv8npdy	78	3	and	and	CC
cord-035016-ipv8npdy	78	4	distribution	distribution	NN
cord-035016-ipv8npdy	78	5	of	of	IN
cord-035016-ipv8npdy	78	6	low	low	JJ
cord-035016-ipv8npdy	78	7	-	-	HYPH
cord-035016-ipv8npdy	78	8	cost	cost	NN
cord-035016-ipv8npdy	78	9	products	product	NNS
cord-035016-ipv8npdy	78	10	,	,	,
cord-035016-ipv8npdy	78	11	with	with	IN
cord-035016-ipv8npdy	78	12	only	only	JJ
cord-035016-ipv8npdy	78	13	marginal	marginal	JJ
cord-035016-ipv8npdy	78	14	profits	profit	NNS
cord-035016-ipv8npdy	78	15	per	per	IN
cord-035016-ipv8npdy	78	16	unit	unit	NN
cord-035016-ipv8npdy	78	17	,	,	,
cord-035016-ipv8npdy	78	18	compares	compare	VBZ
cord-035016-ipv8npdy	78	19	poorly	poorly	RB
cord-035016-ipv8npdy	78	20	to	to	IN
cord-035016-ipv8npdy	78	21	the	the	DT
cord-035016-ipv8npdy	78	22	growing	grow	VBG
cord-035016-ipv8npdy	78	23	medicines	medicine	NNS
cord-035016-ipv8npdy	78	24	market	market	NN
cord-035016-ipv8npdy	78	25	with	with	IN
cord-035016-ipv8npdy	78	26	its	-PRON-	PRP$
cord-035016-ipv8npdy	78	27	uniquely	uniquely	RB
cord-035016-ipv8npdy	78	28	profitable	profitable	JJ
cord-035016-ipv8npdy	78	29	lowvolume	lowvolume	NN
cord-035016-ipv8npdy	78	30	specialty	specialty	NN
cord-035016-ipv8npdy	78	31	drugs	drug	NNS
cord-035016-ipv8npdy	78	32	for	for	IN
cord-035016-ipv8npdy	78	33	which	which	WDT
cord-035016-ipv8npdy	78	34	companies	company	NNS
cord-035016-ipv8npdy	78	35	can	can	MD
cord-035016-ipv8npdy	78	36	charge	charge	VB
cord-035016-ipv8npdy	78	37	very	very	RB
cord-035016-ipv8npdy	78	38	high	high	JJ
cord-035016-ipv8npdy	78	39	prices	price	NNS
cord-035016-ipv8npdy	78	40	.	.	.
cord-035016-ipv8npdy	79	1	At	at	IN
cord-035016-ipv8npdy	79	2	the	the	DT
cord-035016-ipv8npdy	79	3	same	same	JJ
cord-035016-ipv8npdy	79	4	time	time	NN
cord-035016-ipv8npdy	79	5	,	,	,
cord-035016-ipv8npdy	79	6	the	the	DT
cord-035016-ipv8npdy	79	7	R&D	r&d	NN
cord-035016-ipv8npdy	79	8	process	process	NN
cord-035016-ipv8npdy	79	9	for	for	IN
cord-035016-ipv8npdy	79	10	vaccines	vaccine	NNS
cord-035016-ipv8npdy	79	11	is	be	VBZ
cord-035016-ipv8npdy	79	12	typically	typically	RB
cord-035016-ipv8npdy	79	13	lengthy	lengthy	JJ
cord-035016-ipv8npdy	79	14	and	and	CC
cord-035016-ipv8npdy	79	15	costly	costly	JJ
cord-035016-ipv8npdy	79	16	,	,	,
cord-035016-ipv8npdy	79	17	with	with	IN
cord-035016-ipv8npdy	79	18	large	large	JJ
cord-035016-ipv8npdy	79	19	clinical	clinical	JJ
cord-035016-ipv8npdy	79	20	trials	trial	NNS
cord-035016-ipv8npdy	79	21	required	require	VBN
cord-035016-ipv8npdy	79	22	to	to	TO
cord-035016-ipv8npdy	79	23	demonstrate	demonstrate	VB
cord-035016-ipv8npdy	79	24	that	that	IN
cord-035016-ipv8npdy	79	25	it	-PRON-	PRP
cord-035016-ipv8npdy	79	26	will	will	MD
cord-035016-ipv8npdy	79	27	be	be	VB
cord-035016-ipv8npdy	79	28	safe	safe	JJ
cord-035016-ipv8npdy	79	29	to	to	TO
cord-035016-ipv8npdy	79	30	administer	administer	VB
cord-035016-ipv8npdy	79	31	a	a	DT
cord-035016-ipv8npdy	79	32	product	product	NN
cord-035016-ipv8npdy	79	33	to	to	IN
cord-035016-ipv8npdy	79	34	many	many	JJ
cord-035016-ipv8npdy	79	35	millions	million	NNS
cord-035016-ipv8npdy	79	36	essentially	essentially	RB
cord-035016-ipv8npdy	79	37	healthy	healthy	JJ
cord-035016-ipv8npdy	79	38	people	people	NNS
cord-035016-ipv8npdy	79	39	,	,	,
cord-035016-ipv8npdy	79	40	and	and	CC
cord-035016-ipv8npdy	79	41	also	also	RB
cord-035016-ipv8npdy	79	42	effective	effective	JJ
cord-035016-ipv8npdy	79	43	in	in	IN
cord-035016-ipv8npdy	79	44	protecting	protect	VBG
cord-035016-ipv8npdy	79	45	against	against	IN
cord-035016-ipv8npdy	79	46	a	a	DT
cord-035016-ipv8npdy	79	47	given	give	VBN
cord-035016-ipv8npdy	79	48	disease	disease	NN
cord-035016-ipv8npdy	79	49	.	.	.
cord-035016-ipv8npdy	80	1	Only	only	RB
cord-035016-ipv8npdy	80	2	a	a	DT
cord-035016-ipv8npdy	80	3	handful	handful	NN
cord-035016-ipv8npdy	80	4	of	of	IN
cord-035016-ipv8npdy	80	5	companies	company	NNS
cord-035016-ipv8npdy	80	6	dominate	dominate	VBP
cord-035016-ipv8npdy	80	7	the	the	DT
cord-035016-ipv8npdy	80	8	global	global	JJ
cord-035016-ipv8npdy	80	9	vaccine	vaccine	NN
cord-035016-ipv8npdy	80	10	market	market	NN
cord-035016-ipv8npdy	80	11	,	,	,
cord-035016-ipv8npdy	80	12	selling	sell	VBG
cord-035016-ipv8npdy	80	13	essentially	essentially	RB
cord-035016-ipv8npdy	80	14	variations	variation	NNS
cord-035016-ipv8npdy	80	15	of	of	IN
cord-035016-ipv8npdy	80	16	the	the	DT
cord-035016-ipv8npdy	80	17	same	same	JJ
cord-035016-ipv8npdy	80	18	10	10	CD
cord-035016-ipv8npdy	80	19	-	-	SYM
cord-035016-ipv8npdy	80	20	15	15	CD
cord-035016-ipv8npdy	80	21	existing	exist	VBG
cord-035016-ipv8npdy	80	22	vaccines	vaccine	NNS
cord-035016-ipv8npdy	80	23	,	,	,
cord-035016-ipv8npdy	80	24	with	with	IN
cord-035016-ipv8npdy	80	25	relatively	relatively	RB
cord-035016-ipv8npdy	80	26	little	little	JJ
cord-035016-ipv8npdy	80	27	innovation	innovation	NN
cord-035016-ipv8npdy	80	28	in	in	IN
cord-035016-ipv8npdy	80	29	new	new	JJ
cord-035016-ipv8npdy	80	30	disease	disease	NN
cord-035016-ipv8npdy	80	31	areas	area	NNS
cord-035016-ipv8npdy	80	32	,	,	,
cord-035016-ipv8npdy	80	33	despite	despite	IN
cord-035016-ipv8npdy	80	34	many	many	JJ
cord-035016-ipv8npdy	80	35	infectious	infectious	JJ
cord-035016-ipv8npdy	80	36	diseases	disease	NNS
cord-035016-ipv8npdy	80	37	that	that	WDT
cord-035016-ipv8npdy	80	38	could	could	MD
cord-035016-ipv8npdy	80	39	benefit	benefit	VB
cord-035016-ipv8npdy	80	40	from	from	IN
cord-035016-ipv8npdy	80	41	a	a	DT
cord-035016-ipv8npdy	80	42	vaccine	vaccine	NN
cord-035016-ipv8npdy	80	43	.	.	.
cord-035016-ipv8npdy	81	1	Emerging	emerge	VBG
cord-035016-ipv8npdy	81	2	infectious	infectious	JJ
cord-035016-ipv8npdy	81	3	diseases	disease	NNS
cord-035016-ipv8npdy	81	4	are	be	VBP
cord-035016-ipv8npdy	81	5	a	a	DT
cord-035016-ipv8npdy	81	6	case	case	NN
cord-035016-ipv8npdy	81	7	in	in	IN
cord-035016-ipv8npdy	81	8	point	point	NN
cord-035016-ipv8npdy	81	9	.	.	.
cord-035016-ipv8npdy	82	1	As	as	IN
cord-035016-ipv8npdy	82	2	exemplified	exemplify	VBN
cord-035016-ipv8npdy	82	3	again	again	RB
cord-035016-ipv8npdy	82	4	with	with	IN
cord-035016-ipv8npdy	82	5	the	the	DT
cord-035016-ipv8npdy	82	6	2014	2014	CD
cord-035016-ipv8npdy	82	7	-	-	SYM
cord-035016-ipv8npdy	82	8	2016	2016	CD
cord-035016-ipv8npdy	82	9	West	west	JJ
cord-035016-ipv8npdy	82	10	African	african	JJ
cord-035016-ipv8npdy	82	11	Ebola	Ebola	NNP
cord-035016-ipv8npdy	82	12	outbreak	outbreak	NN
cord-035016-ipv8npdy	82	13	that	that	WDT
cord-035016-ipv8npdy	82	14	killed	kill	VBD
cord-035016-ipv8npdy	82	15	over	over	IN
cord-035016-ipv8npdy	82	16	11,000	11,000	CD
cord-035016-ipv8npdy	82	17	people	people	NNS
cord-035016-ipv8npdy	82	18	,	,	,
cord-035016-ipv8npdy	82	19	commercial	commercial	JJ
cord-035016-ipv8npdy	82	20	R&D	r&d	NN
cord-035016-ipv8npdy	82	21	fails	fail	VBZ
cord-035016-ipv8npdy	82	22	to	to	TO
cord-035016-ipv8npdy	82	23	deliver	deliver	VB
cord-035016-ipv8npdy	82	24	needed	need	VBN
cord-035016-ipv8npdy	82	25	health	health	NN
cord-035016-ipv8npdy	82	26	technologies	technology	NNS
cord-035016-ipv8npdy	82	27	for	for	IN
cord-035016-ipv8npdy	82	28	outbreaks	outbreak	NNS
cord-035016-ipv8npdy	82	29	of	of	IN
cord-035016-ipv8npdy	82	30	infectious	infectious	JJ
cord-035016-ipv8npdy	82	31	diseases	disease	NNS
cord-035016-ipv8npdy	82	32	.	.	.
cord-035016-ipv8npdy	83	1	Despite	despite	IN
cord-035016-ipv8npdy	83	2	knowing	know	VBG
cord-035016-ipv8npdy	83	3	the	the	DT
cord-035016-ipv8npdy	83	4	Ebola	Ebola	NNP
cord-035016-ipv8npdy	83	5	virus	virus	NN
cord-035016-ipv8npdy	83	6	and	and	CC
cord-035016-ipv8npdy	83	7	its	-PRON-	PRP$
cord-035016-ipv8npdy	83	8	lethal	lethal	JJ
cord-035016-ipv8npdy	83	9	epidemic	epidemic	NN
cord-035016-ipv8npdy	83	10	potential	potential	NN
cord-035016-ipv8npdy	83	11	since	since	IN
cord-035016-ipv8npdy	83	12	the	the	DT
cord-035016-ipv8npdy	83	13	1970s	1970	NNS
cord-035016-ipv8npdy	83	14	,	,	,
cord-035016-ipv8npdy	83	15	and	and	CC
cord-035016-ipv8npdy	83	16	vaccine	vaccine	NN
cord-035016-ipv8npdy	83	17	research	research	NN
cord-035016-ipv8npdy	83	18	having	have	VBG
cord-035016-ipv8npdy	83	19	advanced	advance	VBN
cord-035016-ipv8npdy	83	20	in	in	IN
cord-035016-ipv8npdy	83	21	the	the	DT
cord-035016-ipv8npdy	83	22	public	public	JJ
cord-035016-ipv8npdy	83	23	sector	sector	NN
cord-035016-ipv8npdy	83	24	,	,	,
cord-035016-ipv8npdy	83	25	there	there	EX
cord-035016-ipv8npdy	83	26	was	be	VBD
cord-035016-ipv8npdy	83	27	neither	neither	DT
cord-035016-ipv8npdy	83	28	treatment	treatment	NN
cord-035016-ipv8npdy	83	29	nor	nor	CC
cord-035016-ipv8npdy	83	30	vaccine	vaccine	NN
cord-035016-ipv8npdy	83	31	available	available	JJ
cord-035016-ipv8npdy	83	32	when	when	WRB
cord-035016-ipv8npdy	83	33	a	a	DT
cord-035016-ipv8npdy	83	34	long	long	RB
cord-035016-ipv8npdy	83	35	expected	expect	VBN
cord-035016-ipv8npdy	83	36	major	major	JJ
cord-035016-ipv8npdy	83	37	outbreak	outbreak	NN
cord-035016-ipv8npdy	83	38	devastated	devastate	VBD
cord-035016-ipv8npdy	83	39	Guinea	Guinea	NNP
cord-035016-ipv8npdy	83	40	,	,	,
cord-035016-ipv8npdy	83	41	Liberia	Liberia	NNP
cord-035016-ipv8npdy	83	42	and	and	CC
cord-035016-ipv8npdy	83	43	Sierra	Sierra	NNP
cord-035016-ipv8npdy	83	44	Leone	Leone	NNP
cord-035016-ipv8npdy	83	45	,	,	,
cord-035016-ipv8npdy	83	46	and	and	CC
cord-035016-ipv8npdy	83	47	caused	cause	VBD
cord-035016-ipv8npdy	83	48	a	a	DT
cord-035016-ipv8npdy	83	49	global	global	JJ
cord-035016-ipv8npdy	83	50	panic	panic	NN
cord-035016-ipv8npdy	83	51	(	(	-LRB-
cord-035016-ipv8npdy	83	52	Torreele	Torreele	NNP
cord-035016-ipv8npdy	83	53	and	and	CC
cord-035016-ipv8npdy	83	54	Olliaro	Olliaro	NNP
cord-035016-ipv8npdy	83	55	2014	2014	CD
cord-035016-ipv8npdy	83	56	)	)	-RRB-
cord-035016-ipv8npdy	83	57	.	.	.
cord-035016-ipv8npdy	84	1	And	and	CC
cord-035016-ipv8npdy	84	2	while	while	IN
cord-035016-ipv8npdy	84	3	a	a	DT
cord-035016-ipv8npdy	84	4	consortium	consortium	NN
cord-035016-ipv8npdy	84	5	of	of	IN
cord-035016-ipv8npdy	84	6	mainly	mainly	RB
cord-035016-ipv8npdy	84	7	public	public	JJ
cord-035016-ipv8npdy	84	8	partners	partner	NNS
cord-035016-ipv8npdy	84	9	came	come	VBD
cord-035016-ipv8npdy	84	10	together	together	RB
cord-035016-ipv8npdy	84	11	to	to	TO
cord-035016-ipv8npdy	84	12	conduct	conduct	VB
cord-035016-ipv8npdy	84	13	a	a	DT
cord-035016-ipv8npdy	84	14	clinical	clinical	JJ
cord-035016-ipv8npdy	84	15	trial	trial	NN
cord-035016-ipv8npdy	84	16	in	in	IN
cord-035016-ipv8npdy	84	17	2016	2016	CD
cord-035016-ipv8npdy	84	18	that	that	WDT
cord-035016-ipv8npdy	84	19	demonstrated	demonstrate	VBD
cord-035016-ipv8npdy	84	20	the	the	DT
cord-035016-ipv8npdy	84	21	safety	safety	NN
cord-035016-ipv8npdy	84	22	and	and	CC
cord-035016-ipv8npdy	84	23	efficacy	efficacy	NN
cord-035016-ipv8npdy	84	24	of	of	IN
cord-035016-ipv8npdy	84	25	a	a	DT
cord-035016-ipv8npdy	84	26	vaccine	vaccine	NN
cord-035016-ipv8npdy	84	27	candidate	candidate	NN
cord-035016-ipv8npdy	84	28	,	,	,
cord-035016-ipv8npdy	84	29	initially	initially	RB
cord-035016-ipv8npdy	84	30	developed	develop	VBN
cord-035016-ipv8npdy	84	31	by	by	IN
cord-035016-ipv8npdy	84	32	Canadian	canadian	JJ
cord-035016-ipv8npdy	84	33	public	public	JJ
cord-035016-ipv8npdy	84	34	health	health	NN
cord-035016-ipv8npdy	84	35	researchers	researcher	NNS
cord-035016-ipv8npdy	84	36	10	10	CD
cord-035016-ipv8npdy	84	37	and	and	CC
cord-035016-ipv8npdy	84	38	later	later	RB
cord-035016-ipv8npdy	84	39	licensed	license	VBN
cord-035016-ipv8npdy	84	40	to	to	IN
cord-035016-ipv8npdy	84	41	Merck	Merck	NNP
cord-035016-ipv8npdy	84	42	,	,	,
cord-035016-ipv8npdy	84	43	there	there	EX
cord-035016-ipv8npdy	84	44	was	be	VBD
cord-035016-ipv8npdy	84	45	still	still	RB
cord-035016-ipv8npdy	84	46	no	no	DT
cord-035016-ipv8npdy	84	47	registered	registered	JJ
cord-035016-ipv8npdy	84	48	vaccine	vaccine	NN
cord-035016-ipv8npdy	84	49	available	available	JJ
cord-035016-ipv8npdy	84	50	when	when	WRB
cord-035016-ipv8npdy	84	51	a	a	DT
cord-035016-ipv8npdy	84	52	new	new	JJ
cord-035016-ipv8npdy	84	53	Ebola	Ebola	NNP
cord-035016-ipv8npdy	84	54	outbreak	outbreak	NN
cord-035016-ipv8npdy	84	55	hit	hit	VBD
cord-035016-ipv8npdy	84	56	DRC	DRC	NNP
cord-035016-ipv8npdy	84	57	in	in	IN
cord-035016-ipv8npdy	84	58	2018	2018	CD
cord-035016-ipv8npdy	84	59	-	-	SYM
cord-035016-ipv8npdy	84	60	2019	2019	CD
cord-035016-ipv8npdy	84	61	.	.	.
cord-035016-ipv8npdy	85	1	11	11	CD
cord-035016-ipv8npdy	86	1	Affirming	affirm	VBG
cord-035016-ipv8npdy	86	2	the	the	DT
cord-035016-ipv8npdy	86	3	need	need	NN
cord-035016-ipv8npdy	86	4	for	for	IN
cord-035016-ipv8npdy	86	5	public	public	JJ
cord-035016-ipv8npdy	86	6	responsibility	responsibility	NN
cord-035016-ipv8npdy	86	7	to	to	TO
cord-035016-ipv8npdy	86	8	drive	drive	VB
cord-035016-ipv8npdy	86	9	R&D	r&d	NN
cord-035016-ipv8npdy	86	10	to	to	TO
cord-035016-ipv8npdy	86	11	improve	improve	VB
cord-035016-ipv8npdy	86	12	outbreak	outbreak	NN
cord-035016-ipv8npdy	86	13	preparedness	preparedness	NN
cord-035016-ipv8npdy	86	14	,	,	,
cord-035016-ipv8npdy	86	15	a	a	DT
cord-035016-ipv8npdy	86	16	group	group	NN
cord-035016-ipv8npdy	86	17	of	of	IN
cord-035016-ipv8npdy	86	18	countries	country	NNS
cord-035016-ipv8npdy	86	19	and	and	CC
cord-035016-ipv8npdy	86	20	donors	donor	NNS
cord-035016-ipv8npdy	86	21	came	come	VBD
cord-035016-ipv8npdy	86	22	together	together	RB
cord-035016-ipv8npdy	86	23	in	in	IN
cord-035016-ipv8npdy	86	24	the	the	DT
cord-035016-ipv8npdy	86	25	wake	wake	NN
cord-035016-ipv8npdy	86	26	of	of	IN
cord-035016-ipv8npdy	86	27	the	the	DT
cord-035016-ipv8npdy	86	28	West	west	JJ
cord-035016-ipv8npdy	86	29	African	african	JJ
cord-035016-ipv8npdy	86	30	Ebola	Ebola	NNP
cord-035016-ipv8npdy	86	31	crisis	crisis	NN
cord-035016-ipv8npdy	86	32	to	to	TO
cord-035016-ipv8npdy	86	33	create	create	VB
cord-035016-ipv8npdy	86	34	the	the	DT
cord-035016-ipv8npdy	86	35	Coalition	Coalition	NNP
cord-035016-ipv8npdy	86	36	for	for	IN
cord-035016-ipv8npdy	86	37	Epidemic	Epidemic	NNP
cord-035016-ipv8npdy	86	38	Preparedness	Preparedness	NNP
cord-035016-ipv8npdy	86	39	Innovations	Innovations	NNPS
cord-035016-ipv8npdy	86	40	(	(	-LRB-
cord-035016-ipv8npdy	86	41	CEPI	CEPI	NNP
cord-035016-ipv8npdy	86	42	)	)	-RRB-
cord-035016-ipv8npdy	86	43	,	,	,
cord-035016-ipv8npdy	86	44	12	12	CD
cord-035016-ipv8npdy	86	45	with	with	IN
cord-035016-ipv8npdy	86	46	the	the	DT
cord-035016-ipv8npdy	86	47	mandate	mandate	NN
cord-035016-ipv8npdy	86	48	to	to	TO
cord-035016-ipv8npdy	86	49	accelerate	accelerate	VB
cord-035016-ipv8npdy	86	50	development	development	NN
cord-035016-ipv8npdy	86	51	of	of	IN
cord-035016-ipv8npdy	86	52	vaccines	vaccine	NNS
cord-035016-ipv8npdy	86	53	against	against	IN
cord-035016-ipv8npdy	86	54	outbreak	outbreak	NN
cord-035016-ipv8npdy	86	55	diseases	disease	NNS
cord-035016-ipv8npdy	86	56	and	and	CC
cord-035016-ipv8npdy	86	57	ensure	ensure	VB
cord-035016-ipv8npdy	86	58	access	access	NN
cord-035016-ipv8npdy	86	59	.	.	.
cord-035016-ipv8npdy	87	1	With	with	IN
cord-035016-ipv8npdy	87	2	a	a	DT
cord-035016-ipv8npdy	87	3	massive	massive	JJ
cord-035016-ipv8npdy	87	4	injection	injection	NN
cord-035016-ipv8npdy	87	5	of	of	IN
cord-035016-ipv8npdy	87	6	public	public	JJ
cord-035016-ipv8npdy	87	7	and	and	CC
cord-035016-ipv8npdy	87	8	philanthropic	philanthropic	JJ
cord-035016-ipv8npdy	87	9	funds	fund	NNS
cord-035016-ipv8npdy	87	10	,	,	,
cord-035016-ipv8npdy	87	11	in	in	IN
cord-035016-ipv8npdy	87	12	2017	2017	CD
cord-035016-ipv8npdy	87	13	CEPI	CEPI	NNP
cord-035016-ipv8npdy	87	14	started	start	VBD
cord-035016-ipv8npdy	87	15	financing	finance	VBG
cord-035016-ipv8npdy	87	16	public	public	JJ
cord-035016-ipv8npdy	87	17	-	-	HYPH
cord-035016-ipv8npdy	87	18	private	private	JJ
cord-035016-ipv8npdy	87	19	partnerships	partnership	NNS
cord-035016-ipv8npdy	87	20	aiming	aim	VBG
cord-035016-ipv8npdy	87	21	to	to	TO
cord-035016-ipv8npdy	87	22	bring	bring	VB
cord-035016-ipv8npdy	87	23	candidate	candidate	NN
cord-035016-ipv8npdy	87	24	vaccines	vaccine	NNS
cord-035016-ipv8npdy	87	25	for	for	IN
cord-035016-ipv8npdy	87	26	MERS	MERS	NNP
cord-035016-ipv8npdy	87	27	-	-	HYPH
cord-035016-ipv8npdy	87	28	CoV	CoV	NNP
cord-035016-ipv8npdy	87	29	(	(	-LRB-
cord-035016-ipv8npdy	87	30	also	also	RB
cord-035016-ipv8npdy	87	31	a	a	DT
cord-035016-ipv8npdy	87	32	coronavirus	coronavirus	NN
cord-035016-ipv8npdy	87	33	)	)	-RRB-
cord-035016-ipv8npdy	87	34	,	,	,
cord-035016-ipv8npdy	87	35	Lassa	Lassa	NNP
cord-035016-ipv8npdy	87	36	Fever	Fever	NNP
cord-035016-ipv8npdy	87	37	and	and	CC
cord-035016-ipv8npdy	87	38	Nipah	Nipah	NNP
cord-035016-ipv8npdy	87	39	forward	forward	RB
cord-035016-ipv8npdy	87	40	.	.	.
cord-035016-ipv8npdy	88	1	In	in	IN
cord-035016-ipv8npdy	88	2	parallel	parallel	NN
cord-035016-ipv8npdy	88	3	,	,	,
cord-035016-ipv8npdy	88	4	CEPI	CEPI	NNP
cord-035016-ipv8npdy	88	5	also	also	RB
cord-035016-ipv8npdy	88	6	invested	invest	VBD
cord-035016-ipv8npdy	88	7	in	in	IN
cord-035016-ipv8npdy	88	8	generic	generic	JJ
cord-035016-ipv8npdy	88	9	vaccine	vaccine	NN
cord-035016-ipv8npdy	88	10	technology	technology	NN
cord-035016-ipv8npdy	88	11	platforms	platform	NNS
cord-035016-ipv8npdy	88	12	that	that	WDT
cord-035016-ipv8npdy	88	13	could	could	MD
cord-035016-ipv8npdy	88	14	be	be	VB
cord-035016-ipv8npdy	88	15	quickly	quickly	RB
cord-035016-ipv8npdy	88	16	adapted	adapt	VBN
cord-035016-ipv8npdy	88	17	to	to	IN
cord-035016-ipv8npdy	88	18	any	any	DT
cord-035016-ipv8npdy	88	19	emerging	emerge	VBG
cord-035016-ipv8npdy	88	20	infection	infection	NN
cord-035016-ipv8npdy	88	21	of	of	IN
cord-035016-ipv8npdy	88	22	a	a	DT
cord-035016-ipv8npdy	88	23	so	so	RB
cord-035016-ipv8npdy	88	24	far	far	RB
cord-035016-ipv8npdy	88	25	unknown	unknown	JJ
cord-035016-ipv8npdy	88	26	pathogen	pathogen	NN
cord-035016-ipv8npdy	88	27	,	,	,
cord-035016-ipv8npdy	88	28	the	the	DT
cord-035016-ipv8npdy	88	29	socalled	socalled	JJ
cord-035016-ipv8npdy	88	30	'	'	POS
cord-035016-ipv8npdy	88	31	disease	disease	NN
cord-035016-ipv8npdy	88	32	-	-	HYPH
cord-035016-ipv8npdy	88	33	X	x	NN
cord-035016-ipv8npdy	88	34	'	'	''
cord-035016-ipv8npdy	88	35	(	(	-LRB-
cord-035016-ipv8npdy	88	36	Simpson	Simpson	NNP
cord-035016-ipv8npdy	88	37	et	et	NNP
cord-035016-ipv8npdy	88	38	al	al	NNP
cord-035016-ipv8npdy	88	39	.	.	NNP
cord-035016-ipv8npdy	88	40	2020	2020	CD
cord-035016-ipv8npdy	88	41	)	)	-RRB-
cord-035016-ipv8npdy	88	42	.	.	.
cord-035016-ipv8npdy	89	1	As	as	RB
cord-035016-ipv8npdy	89	2	soon	soon	RB
cord-035016-ipv8npdy	89	3	as	as	IN
cord-035016-ipv8npdy	89	4	SARS	SARS	NNP
cord-035016-ipv8npdy	89	5	-	-	HYPH
cord-035016-ipv8npdy	89	6	CoV-2	CoV-2	NNP
cord-035016-ipv8npdy	89	7	emerged	emerge	VBD
cord-035016-ipv8npdy	89	8	,	,	,
cord-035016-ipv8npdy	89	9	CEPI	CEPI	NNP
cord-035016-ipv8npdy	89	10	mobilized	mobilize	VBD
cord-035016-ipv8npdy	89	11	funds	fund	NNS
cord-035016-ipv8npdy	89	12	to	to	TO
cord-035016-ipv8npdy	89	13	apply	apply	VB
cord-035016-ipv8npdy	89	14	existing	exist	VBG
cord-035016-ipv8npdy	89	15	vaccine	vaccine	NN
cord-035016-ipv8npdy	89	16	technologies	technology	NNS
cord-035016-ipv8npdy	89	17	to	to	IN
cord-035016-ipv8npdy	89	18	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	89	19	,	,	,
cord-035016-ipv8npdy	89	20	piggybacking	piggyback	VBG
cord-035016-ipv8npdy	89	21	on	on	IN
cord-035016-ipv8npdy	89	22	earlier	early	JJR
cord-035016-ipv8npdy	89	23	investments	investment	NNS
cord-035016-ipv8npdy	89	24	in	in	IN
cord-035016-ipv8npdy	89	25	disease	disease	NN
cord-035016-ipv8npdy	89	26	-	-	HYPH
cord-035016-ipv8npdy	89	27	X	x	NN
cord-035016-ipv8npdy	89	28	and	and	CC
cord-035016-ipv8npdy	89	29	MERS	MERS	NNP
cord-035016-ipv8npdy	89	30	-	-	HYPH
cord-035016-ipv8npdy	89	31	CoV	CoV	NNP
cord-035016-ipv8npdy	89	32	programmes	programme	NNS
cord-035016-ipv8npdy	89	33	,	,	,
cord-035016-ipv8npdy	89	34	thus	thus	RB
cord-035016-ipv8npdy	89	35	quickly	quickly	RB
cord-035016-ipv8npdy	89	36	moving	move	VBG
cord-035016-ipv8npdy	89	37	several	several	JJ
cord-035016-ipv8npdy	89	38	candidates	candidate	NNS
cord-035016-ipv8npdy	89	39	into	into	IN
cord-035016-ipv8npdy	89	40	clinical	clinical	JJ
cord-035016-ipv8npdy	89	41	trials	trial	NNS
cord-035016-ipv8npdy	89	42	.	.	.
cord-035016-ipv8npdy	90	1	Taking	take	VBG
cord-035016-ipv8npdy	90	2	advantage	advantage	NN
cord-035016-ipv8npdy	90	3	of	of	IN
cord-035016-ipv8npdy	90	4	the	the	DT
cord-035016-ipv8npdy	90	5	massive	massive	JJ
cord-035016-ipv8npdy	90	6	public	public	JJ
cord-035016-ipv8npdy	90	7	subsidies	subsidy	NNS
cord-035016-ipv8npdy	90	8	that	that	WDT
cord-035016-ipv8npdy	90	9	started	start	VBD
cord-035016-ipv8npdy	90	10	flowing	flow	VBG
cord-035016-ipv8npdy	90	11	towards	towards	IN
cord-035016-ipv8npdy	90	12	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	90	13	R&D	R&D	NNP
cord-035016-ipv8npdy	90	14	,	,	,
cord-035016-ipv8npdy	90	15	both	both	DT
cord-035016-ipv8npdy	90	16	small	small	JJ
cord-035016-ipv8npdy	90	17	biotechs	biotech	NNS
cord-035016-ipv8npdy	90	18	and	and	CC
cord-035016-ipv8npdy	90	19	major	major	JJ
cord-035016-ipv8npdy	90	20	pharmaceutical	pharmaceutical	JJ
cord-035016-ipv8npdy	90	21	companies	company	NNS
cord-035016-ipv8npdy	90	22	jumped	jump	VBD
cord-035016-ipv8npdy	90	23	on	on	IN
cord-035016-ipv8npdy	90	24	the	the	DT
cord-035016-ipv8npdy	90	25	opportunity	opportunity	NN
cord-035016-ipv8npdy	90	26	to	to	TO
cord-035016-ipv8npdy	90	27	adapt	adapt	VB
cord-035016-ipv8npdy	90	28	or	or	CC
cord-035016-ipv8npdy	90	29	reorient	reorient	VB
cord-035016-ipv8npdy	90	30	their	-PRON-	PRP$
cord-035016-ipv8npdy	90	31	proprietary	proprietary	JJ
cord-035016-ipv8npdy	90	32	vaccine	vaccine	NN
cord-035016-ipv8npdy	90	33	technology	technology	NN
cord-035016-ipv8npdy	90	34	platforms	platform	NNS
cord-035016-ipv8npdy	90	35	towards	towards	IN
cord-035016-ipv8npdy	90	36	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	90	37	,	,	,
cord-035016-ipv8npdy	90	38	allowing	allow	VBG
cord-035016-ipv8npdy	90	39	to	to	IN
cord-035016-ipv8npdy	90	40	fast	fast	JJ
cord-035016-ipv8npdy	90	41	-	-	HYPH
cord-035016-ipv8npdy	90	42	track	track	NN
cord-035016-ipv8npdy	90	43	what	what	WP
cord-035016-ipv8npdy	90	44	otherwise	otherwise	RB
cord-035016-ipv8npdy	90	45	would	would	MD
cord-035016-ipv8npdy	90	46	require	require	VB
cord-035016-ipv8npdy	90	47	many	many	JJ
cord-035016-ipv8npdy	90	48	years	year	NNS
cord-035016-ipv8npdy	90	49	of	of	IN
cord-035016-ipv8npdy	90	50	research	research	NN
cord-035016-ipv8npdy	90	51	.	.	.
cord-035016-ipv8npdy	91	1	For	for	IN
cord-035016-ipv8npdy	91	2	instance	instance	NN
cord-035016-ipv8npdy	91	3	Moderna	Moderna	NNP
cord-035016-ipv8npdy	91	4	's	's	POS
cord-035016-ipv8npdy	91	5	and	and	CC
cord-035016-ipv8npdy	91	6	BioNTech	BioNTech	NNP
cord-035016-ipv8npdy	91	7	/	/	SYM
cord-035016-ipv8npdy	91	8	Pfizer	Pfizer	NNP
cord-035016-ipv8npdy	91	9	's	's	POS
cord-035016-ipv8npdy	91	10	leading	lead	VBG
cord-035016-ipv8npdy	91	11	mRNA	mRNA	NNP
cord-035016-ipv8npdy	91	12	vaccine	vaccine	NN
cord-035016-ipv8npdy	91	13	candidates	candidate	NNS
cord-035016-ipv8npdy	91	14	built	build	VBN
cord-035016-ipv8npdy	91	15	on	on	IN
cord-035016-ipv8npdy	91	16	30	30	CD
cord-035016-ipv8npdy	91	17	years	year	NNS
cord-035016-ipv8npdy	91	18	of	of	IN
cord-035016-ipv8npdy	91	19	public	public	JJ
cord-035016-ipv8npdy	91	20	and	and	CC
cord-035016-ipv8npdy	91	21	private	private	JJ
cord-035016-ipv8npdy	91	22	research	research	NN
cord-035016-ipv8npdy	91	23	into	into	IN
cord-035016-ipv8npdy	91	24	the	the	DT
cord-035016-ipv8npdy	91	25	potential	potential	NN
cord-035016-ipv8npdy	91	26	of	of	IN
cord-035016-ipv8npdy	91	27	RNA	RNA	NNP
cord-035016-ipv8npdy	91	28	and	and	CC
cord-035016-ipv8npdy	91	29	DNA	dna	NN
cord-035016-ipv8npdy	91	30	vaccines	vaccine	NNS
cord-035016-ipv8npdy	91	31	(	(	-LRB-
cord-035016-ipv8npdy	91	32	yet	yet	RB
cord-035016-ipv8npdy	91	33	none	none	NN
cord-035016-ipv8npdy	91	34	of	of	IN
cord-035016-ipv8npdy	91	35	them	-PRON-	PRP
cord-035016-ipv8npdy	91	36	made	make	VBD
cord-035016-ipv8npdy	91	37	into	into	IN
cord-035016-ipv8npdy	91	38	a	a	DT
cord-035016-ipv8npdy	91	39	vaccine	vaccine	NN
cord-035016-ipv8npdy	91	40	approved	approve	VBN
cord-035016-ipv8npdy	91	41	for	for	IN
cord-035016-ipv8npdy	91	42	human	human	JJ
cord-035016-ipv8npdy	91	43	use	use	NN
cord-035016-ipv8npdy	91	44	)	)	-RRB-
cord-035016-ipv8npdy	92	1	(	(	-LRB-
cord-035016-ipv8npdy	92	2	Akpan	Akpan	NNP
cord-035016-ipv8npdy	92	3	2020	2020	CD
cord-035016-ipv8npdy	92	4	)	)	-RRB-
cord-035016-ipv8npdy	92	5	.	.	.
cord-035016-ipv8npdy	93	1	Similarly	similarly	RB
cord-035016-ipv8npdy	93	2	,	,	,
cord-035016-ipv8npdy	93	3	Oxford	Oxford	NNP
cord-035016-ipv8npdy	93	4	University	University	NNP
cord-035016-ipv8npdy	93	5	(	(	-LRB-
cord-035016-ipv8npdy	93	6	who	who	WP
cord-035016-ipv8npdy	93	7	later	later	RB
cord-035016-ipv8npdy	93	8	partnered	partner	VBD
cord-035016-ipv8npdy	93	9	with	with	IN
cord-035016-ipv8npdy	93	10	AstraZeneca	AstraZeneca	NNP
cord-035016-ipv8npdy	93	11	)	)	-RRB-
cord-035016-ipv8npdy	93	12	,	,	,
cord-035016-ipv8npdy	93	13	J&J	J&J	NNP
cord-035016-ipv8npdy	93	14	,	,	,
cord-035016-ipv8npdy	93	15	CanSino	CanSino	NNP
cord-035016-ipv8npdy	93	16	and	and	CC
cord-035016-ipv8npdy	93	17	Gamaleya	Gamaleya	NNP
cord-035016-ipv8npdy	93	18	have	have	VBP
cord-035016-ipv8npdy	93	19	rapidly	rapidly	RB
cord-035016-ipv8npdy	93	20	repurposed	repurpose	VBN
cord-035016-ipv8npdy	93	21	for	for	IN
cord-035016-ipv8npdy	93	22	COVID-19	COVID-19	JJR
cord-035016-ipv8npdy	93	23	their	-PRON-	PRP$
cord-035016-ipv8npdy	93	24	adenovirus	adenovirus	NN
cord-035016-ipv8npdy	93	25	-	-	HYPH
cord-035016-ipv8npdy	93	26	based	base	VBN
cord-035016-ipv8npdy	93	27	vaccine	vaccine	NN
cord-035016-ipv8npdy	93	28	platforms	platform	NNS
cord-035016-ipv8npdy	93	29	which	which	WDT
cord-035016-ipv8npdy	93	30	had	have	VBD
cord-035016-ipv8npdy	93	31	been	be	VBN
cord-035016-ipv8npdy	93	32	explored	explore	VBN
cord-035016-ipv8npdy	93	33	for	for	IN
cord-035016-ipv8npdy	93	34	many	many	JJ
cord-035016-ipv8npdy	93	35	years	year	NNS
cord-035016-ipv8npdy	93	36	and	and	CC
cord-035016-ipv8npdy	93	37	a	a	DT
cord-035016-ipv8npdy	93	38	variety	variety	NN
cord-035016-ipv8npdy	93	39	of	of	IN
cord-035016-ipv8npdy	93	40	diseases	disease	NNS
cord-035016-ipv8npdy	93	41	,	,	,
cord-035016-ipv8npdy	93	42	including	include	VBG
cord-035016-ipv8npdy	93	43	most	most	RBS
cord-035016-ipv8npdy	93	44	recently	recently	RB
cord-035016-ipv8npdy	93	45	MERS	MERS	NNP
cord-035016-ipv8npdy	93	46	-	-	HYPH
cord-035016-ipv8npdy	93	47	CoV	CoV	NNP
cord-035016-ipv8npdy	93	48	,	,	,
cord-035016-ipv8npdy	93	49	Zika	Zika	NNP
cord-035016-ipv8npdy	93	50	and	and	CC
cord-035016-ipv8npdy	93	51	Ebola	Ebola	NNP
cord-035016-ipv8npdy	93	52	.	.	.
cord-035016-ipv8npdy	94	1	13	13	CD
cord-035016-ipv8npdy	95	1	Despite	despite	IN
cord-035016-ipv8npdy	95	2	each	each	DT
cord-035016-ipv8npdy	95	3	of	of	IN
cord-035016-ipv8npdy	95	4	these	these	DT
cord-035016-ipv8npdy	95	5	R&D	r&d	NN
cord-035016-ipv8npdy	95	6	efforts	effort	NNS
cord-035016-ipv8npdy	95	7	building	build	VBG
cord-035016-ipv8npdy	95	8	on	on	IN
cord-035016-ipv8npdy	95	9	a	a	DT
cord-035016-ipv8npdy	95	10	wealth	wealth	NN
cord-035016-ipv8npdy	95	11	of	of	IN
cord-035016-ipv8npdy	95	12	earlier	early	JJR
cord-035016-ipv8npdy	95	13	research	research	NN
cord-035016-ipv8npdy	95	14	by	by	IN
cord-035016-ipv8npdy	95	15	the	the	DT
cord-035016-ipv8npdy	95	16	global	global	JJ
cord-035016-ipv8npdy	95	17	vaccine	vaccine	NN
cord-035016-ipv8npdy	95	18	research	research	NN
cord-035016-ipv8npdy	95	19	communitymuch	communitymuch	NNP
cord-035016-ipv8npdy	95	20	of	of	IN
cord-035016-ipv8npdy	95	21	which	which	WDT
cord-035016-ipv8npdy	95	22	is	be	VBZ
cord-035016-ipv8npdy	95	23	traditionally	traditionally	RB
cord-035016-ipv8npdy	95	24	done	do	VBN
cord-035016-ipv8npdy	95	25	and	and	CC
cord-035016-ipv8npdy	95	26	funded	fund	VBN
cord-035016-ipv8npdy	95	27	by	by	IN
cord-035016-ipv8npdy	95	28	the	the	DT
cord-035016-ipv8npdy	95	29	public	public	JJ
cord-035016-ipv8npdy	95	30	sector	sector	NN
cord-035016-ipv8npdy	95	31	-	-	:
cord-035016-ipv8npdy	95	32	the	the	DT
cord-035016-ipv8npdy	95	33	basis	basis	NN
cord-035016-ipv8npdy	95	34	of	of	IN
cord-035016-ipv8npdy	95	35	our	-PRON-	PRP$
cord-035016-ipv8npdy	95	36	commercial	commercial	JJ
cord-035016-ipv8npdy	95	37	R&D	r&d	NN
cord-035016-ipv8npdy	95	38	model	model	NN
cord-035016-ipv8npdy	95	39	is	be	VBZ
cord-035016-ipv8npdy	95	40	that	that	IN
cord-035016-ipv8npdy	95	41	universities	university	NNS
cord-035016-ipv8npdy	95	42	and	and	CC
cord-035016-ipv8npdy	95	43	companies	company	NNS
cord-035016-ipv8npdy	95	44	are	be	VBP
cord-035016-ipv8npdy	95	45	allowed	allow	VBN
cord-035016-ipv8npdy	95	46	to	to	TO
cord-035016-ipv8npdy	95	47	appropriate	appropriate	VB
cord-035016-ipv8npdy	95	48	such	such	JJ
cord-035016-ipv8npdy	95	49	technology	technology	NN
cord-035016-ipv8npdy	95	50	platforms	platform	NNS
cord-035016-ipv8npdy	95	51	as	as	IN
cord-035016-ipv8npdy	95	52	their	-PRON-	PRP$
cord-035016-ipv8npdy	95	53	own	own	JJ
cord-035016-ipv8npdy	95	54	.	.	.
cord-035016-ipv8npdy	96	1	Governed	govern	VBN
cord-035016-ipv8npdy	96	2	by	by	IN
cord-035016-ipv8npdy	96	3	the	the	DT
cord-035016-ipv8npdy	96	4	World	World	NNP
cord-035016-ipv8npdy	96	5	Trade	Trade	NNP
cord-035016-ipv8npdy	96	6	Organization	Organization	NNP
cord-035016-ipv8npdy	96	7	's	's	POS
cord-035016-ipv8npdy	96	8	1995	1995	CD
cord-035016-ipv8npdy	96	9	TRIPS	trip	NNS
cord-035016-ipv8npdy	96	10	agreement	agreement	NN
cord-035016-ipv8npdy	96	11	that	that	WDT
cord-035016-ipv8npdy	96	12	obliged	oblige	VBD
cord-035016-ipv8npdy	96	13	countries	country	NNS
cord-035016-ipv8npdy	96	14	to	to	TO
cord-035016-ipv8npdy	96	15	grant	grant	VB
cord-035016-ipv8npdy	96	16	and	and	CC
cord-035016-ipv8npdy	96	17	enforce	enforce	VB
cord-035016-ipv8npdy	96	18	patents	patent	NNS
cord-035016-ipv8npdy	96	19	on	on	IN
cord-035016-ipv8npdy	96	20	pharmaceutical	pharmaceutical	NN
cord-035016-ipv8npdy	96	21	'	'	``
cord-035016-ipv8npdy	96	22	inventions	invention	NNS
cord-035016-ipv8npdy	96	23	'	'	POS
cord-035016-ipv8npdy	96	24	,	,	,
cord-035016-ipv8npdy	96	25	medical	medical	JJ
cord-035016-ipv8npdy	96	26	knowledge	knowledge	NN
cord-035016-ipv8npdy	96	27	and	and	CC
cord-035016-ipv8npdy	96	28	technologies	technology	NNS
cord-035016-ipv8npdy	96	29	have	have	VBP
cord-035016-ipv8npdy	96	30	largely	largely	RB
cord-035016-ipv8npdy	96	31	been	be	VBN
cord-035016-ipv8npdy	96	32	privatized	privatize	VBN
cord-035016-ipv8npdy	96	33	,	,	,
cord-035016-ipv8npdy	96	34	owned	own	VBN
cord-035016-ipv8npdy	96	35	and	and	CC
cord-035016-ipv8npdy	96	36	traded	trade	VBN
cord-035016-ipv8npdy	96	37	as	as	IN
cord-035016-ipv8npdy	96	38	commodities	commodity	NNS
cord-035016-ipv8npdy	96	39	,	,	,
cord-035016-ipv8npdy	96	40	even	even	RB
cord-035016-ipv8npdy	96	41	when	when	WRB
cord-035016-ipv8npdy	96	42	of	of	IN
cord-035016-ipv8npdy	96	43	critical	critical	JJ
cord-035016-ipv8npdy	96	44	public	public	JJ
cord-035016-ipv8npdy	96	45	health	health	NN
cord-035016-ipv8npdy	96	46	importance	importance	NN
cord-035016-ipv8npdy	96	47	.	.	.
cord-035016-ipv8npdy	97	1	As	as	IN
cord-035016-ipv8npdy	97	2	a	a	DT
cord-035016-ipv8npdy	97	3	result	result	NN
cord-035016-ipv8npdy	97	4	,	,	,
cord-035016-ipv8npdy	97	5	vaccine	vaccine	NN
cord-035016-ipv8npdy	97	6	candidates	candidate	NNS
cord-035016-ipv8npdy	97	7	essentially	essentially	RB
cord-035016-ipv8npdy	97	8	move	move	VBP
cord-035016-ipv8npdy	97	9	through	through	IN
cord-035016-ipv8npdy	97	10	the	the	DT
cord-035016-ipv8npdy	97	11	pipeline	pipeline	NN
cord-035016-ipv8npdy	97	12	as	as	IN
cord-035016-ipv8npdy	97	13	speculative	speculative	JJ
cord-035016-ipv8npdy	97	14	commercial	commercial	JJ
cord-035016-ipv8npdy	97	15	assets	asset	NNS
cord-035016-ipv8npdy	97	16	,	,	,
cord-035016-ipv8npdy	97	17	whose	whose	WP$
cord-035016-ipv8npdy	97	18	market	market	NN
cord-035016-ipv8npdy	97	19	valuation	valuation	NN
cord-035016-ipv8npdy	97	20	can	can	MD
cord-035016-ipv8npdy	97	21	be	be	VB
cord-035016-ipv8npdy	97	22	followed	follow	VBN
cord-035016-ipv8npdy	97	23	through	through	IN
cord-035016-ipv8npdy	97	24	the	the	DT
cord-035016-ipv8npdy	97	25	share	share	NN
cord-035016-ipv8npdy	97	26	price	price	NN
cord-035016-ipv8npdy	97	27	of	of	IN
cord-035016-ipv8npdy	97	28	the	the	DT
cord-035016-ipv8npdy	97	29	companies	company	NNS
cord-035016-ipv8npdy	97	30	owning	own	VBG
cord-035016-ipv8npdy	97	31	them	-PRON-	PRP
cord-035016-ipv8npdy	97	32	.	.	.
cord-035016-ipv8npdy	98	1	14	14	CD
cord-035016-ipv8npdy	99	1	While	while	IN
cord-035016-ipv8npdy	99	2	governments	government	NNS
cord-035016-ipv8npdy	99	3	generously	generously	RB
cord-035016-ipv8npdy	99	4	subsidize	subsidize	VBP
cord-035016-ipv8npdy	99	5	the	the	DT
cord-035016-ipv8npdy	99	6	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	99	7	vaccines	vaccine	NNS
cord-035016-ipv8npdy	99	8	candidates	candidate	NNS
cord-035016-ipv8npdy	99	9	of	of	IN
cord-035016-ipv8npdy	99	10	a	a	DT
cord-035016-ipv8npdy	99	11	handful	handful	NN
cord-035016-ipv8npdy	99	12	of	of	IN
cord-035016-ipv8npdy	99	13	companies	company	NNS
cord-035016-ipv8npdy	99	14	,	,	,
cord-035016-ipv8npdy	99	15	it	-PRON-	PRP
cord-035016-ipv8npdy	99	16	is	be	VBZ
cord-035016-ipv8npdy	99	17	unclear	unclear	JJ
cord-035016-ipv8npdy	99	18	whether	whether	IN
cord-035016-ipv8npdy	99	19	the	the	DT
cord-035016-ipv8npdy	99	20	financing	financing	NN
cord-035016-ipv8npdy	99	21	agreements	agreement	NNS
cord-035016-ipv8npdy	99	22	are	be	VBP
cord-035016-ipv8npdy	99	23	structured	structure	VBN
cord-035016-ipv8npdy	99	24	to	to	TO
cord-035016-ipv8npdy	99	25	recognize	recognize	VB
cord-035016-ipv8npdy	99	26	this	this	DT
cord-035016-ipv8npdy	99	27	co	co	NN
cord-035016-ipv8npdy	99	28	-	-	NN
cord-035016-ipv8npdy	99	29	investment	investment	NN
cord-035016-ipv8npdy	99	30	and	and	CC
cord-035016-ipv8npdy	99	31	ensure	ensure	VB
cord-035016-ipv8npdy	99	32	there	there	EX
cord-035016-ipv8npdy	99	33	will	will	MD
cord-035016-ipv8npdy	99	34	be	be	VB
cord-035016-ipv8npdy	99	35	commensurate	commensurate	JJ
cord-035016-ipv8npdy	99	36	sharing	sharing	NN
cord-035016-ipv8npdy	99	37	of	of	IN
cord-035016-ipv8npdy	99	38	the	the	DT
cord-035016-ipv8npdy	99	39	resulting	result	VBG
cord-035016-ipv8npdy	99	40	outcomes	outcome	NNS
cord-035016-ipv8npdy	99	41	in	in	IN
cord-035016-ipv8npdy	99	42	terms	term	NNS
cord-035016-ipv8npdy	99	43	of	of	IN
cord-035016-ipv8npdy	99	44	access	access	NN
cord-035016-ipv8npdy	99	45	and	and	CC
cord-035016-ipv8npdy	99	46	pricing	pricing	NN
cord-035016-ipv8npdy	99	47	(	(	-LRB-
cord-035016-ipv8npdy	99	48	the	the	DT
cord-035016-ipv8npdy	99	49	agreements	agreement	NNS
cord-035016-ipv8npdy	99	50	have	have	VBP
cord-035016-ipv8npdy	99	51	remained	remain	VBN
cord-035016-ipv8npdy	99	52	confidential	confidential	JJ
cord-035016-ipv8npdy	99	53	)	)	-RRB-
cord-035016-ipv8npdy	99	54	.	.	.
cord-035016-ipv8npdy	100	1	Realizing	realize	VBG
cord-035016-ipv8npdy	100	2	that	that	IN
cord-035016-ipv8npdy	100	3	providing	provide	VBG
cord-035016-ipv8npdy	100	4	global	global	JJ
cord-035016-ipv8npdy	100	5	access	access	NN
cord-035016-ipv8npdy	100	6	to	to	IN
cord-035016-ipv8npdy	100	7	an	an	DT
cord-035016-ipv8npdy	100	8	eventual	eventual	JJ
cord-035016-ipv8npdy	100	9	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	100	10	vaccine	vaccine	NN
cord-035016-ipv8npdy	100	11	would	would	MD
cord-035016-ipv8npdy	100	12	require	require	VB
cord-035016-ipv8npdy	100	13	manufacturing	manufacture	VBG
cord-035016-ipv8npdy	100	14	at	at	IN
cord-035016-ipv8npdy	100	15	unprecedented	unprecedented	JJ
cord-035016-ipv8npdy	100	16	scale	scale	NN
cord-035016-ipv8npdy	100	17	,	,	,
cord-035016-ipv8npdy	100	18	governments	government	NNS
cord-035016-ipv8npdy	100	19	also	also	RB
cord-035016-ipv8npdy	100	20	provided	provide	VBD
cord-035016-ipv8npdy	100	21	upfront	upfront	JJ
cord-035016-ipv8npdy	100	22	investments	investment	NNS
cord-035016-ipv8npdy	100	23	in	in	IN
cord-035016-ipv8npdy	100	24	the	the	DT
cord-035016-ipv8npdy	100	25	companies	company	NNS
cord-035016-ipv8npdy	100	26	'	'	POS
cord-035016-ipv8npdy	100	27	manufacturing	manufacturing	NN
cord-035016-ipv8npdy	100	28	capacity	capacity	NN
cord-035016-ipv8npdy	100	29	and	and	CC
cord-035016-ipv8npdy	100	30	infrastructure	infrastructure	NN
cord-035016-ipv8npdy	100	31	.	.	.
cord-035016-ipv8npdy	101	1	Not	not	RB
cord-035016-ipv8npdy	101	2	only	only	RB
cord-035016-ipv8npdy	101	3	have	have	VBP
cord-035016-ipv8npdy	101	4	they	-PRON-	PRP
cord-035016-ipv8npdy	101	5	agreed	agree	VBN
cord-035016-ipv8npdy	101	6	to	to	TO
cord-035016-ipv8npdy	101	7	massively	massively	RB
cord-035016-ipv8npdy	101	8	finance	finance	VB
cord-035016-ipv8npdy	101	9	the	the	DT
cord-035016-ipv8npdy	101	10	expansion	expansion	NN
cord-035016-ipv8npdy	101	11	of	of	IN
cord-035016-ipv8npdy	101	12	private	private	JJ
cord-035016-ipv8npdy	101	13	vaccine	vaccine	NN
cord-035016-ipv8npdy	101	14	manufacturing	manufacturing	NN
cord-035016-ipv8npdy	101	15	infrastructure	infrastructure	NN
cord-035016-ipv8npdy	101	16	,	,	,
cord-035016-ipv8npdy	101	17	with	with	IN
cord-035016-ipv8npdy	101	18	seemingly	seemingly	RB
cord-035016-ipv8npdy	101	19	little	little	JJ
cord-035016-ipv8npdy	101	20	or	or	CC
cord-035016-ipv8npdy	101	21	no	no	DT
cord-035016-ipv8npdy	101	22	strings	string	NNS
cord-035016-ipv8npdy	101	23	attached	attach	VBN
cord-035016-ipv8npdy	101	24	,	,	,
cord-035016-ipv8npdy	101	25	they	-PRON-	PRP
cord-035016-ipv8npdy	101	26	also	also	RB
cord-035016-ipv8npdy	101	27	agreed	agree	VBD
cord-035016-ipv8npdy	101	28	to	to	TO
cord-035016-ipv8npdy	101	29	pay	pay	VB
cord-035016-ipv8npdy	101	30	for	for	IN
cord-035016-ipv8npdy	101	31	the	the	DT
cord-035016-ipv8npdy	101	32	actual	actual	JJ
cord-035016-ipv8npdy	101	33	manufacturing	manufacturing	NN
cord-035016-ipv8npdy	101	34	of	of	IN
cord-035016-ipv8npdy	101	35	large	large	JJ
cord-035016-ipv8npdy	101	36	volumes	volume	NNS
cord-035016-ipv8npdy	101	37	of	of	IN
cord-035016-ipv8npdy	101	38	selected	select	VBN
cord-035016-ipv8npdy	101	39	vaccines	vaccine	NNS
cord-035016-ipv8npdy	101	40	before	before	IN
cord-035016-ipv8npdy	101	41	their	-PRON-	PRP$
cord-035016-ipv8npdy	101	42	safety	safety	NN
cord-035016-ipv8npdy	101	43	and	and	CC
cord-035016-ipv8npdy	101	44	efficacy	efficacy	NN
cord-035016-ipv8npdy	101	45	is	be	VBZ
cord-035016-ipv8npdy	101	46	proven	prove	VBN
cord-035016-ipv8npdy	101	47	and	and	CC
cord-035016-ipv8npdy	101	48	committed	commit	VBN
cord-035016-ipv8npdy	101	49	to	to	TO
cord-035016-ipv8npdy	101	50	buy	buy	VB
cord-035016-ipv8npdy	101	51	large	large	JJ
cord-035016-ipv8npdy	101	52	volumes	volume	NNS
cord-035016-ipv8npdy	101	53	once	once	IN
cord-035016-ipv8npdy	101	54	they	-PRON-	PRP
cord-035016-ipv8npdy	101	55	were	be	VBD
cord-035016-ipv8npdy	101	56	approved	approve	VBN
cord-035016-ipv8npdy	101	57	(	(	-LRB-
cord-035016-ipv8npdy	101	58	at	at	IN
cord-035016-ipv8npdy	101	59	undisclosed	undisclosed	JJ
cord-035016-ipv8npdy	101	60	prices	price	NNS
cord-035016-ipv8npdy	101	61	)	)	-RRB-
cord-035016-ipv8npdy	101	62	through	through	IN
cord-035016-ipv8npdy	101	63	so	so	RB
cord-035016-ipv8npdy	101	64	-	-	HYPH
cord-035016-ipv8npdy	101	65	called	call	VBN
cord-035016-ipv8npdy	101	66	advance	advance	NN
cord-035016-ipv8npdy	101	67	purchase	purchase	NN
cord-035016-ipv8npdy	101	68	commitments	commitment	NNS
cord-035016-ipv8npdy	101	69	(	(	-LRB-
cord-035016-ipv8npdy	101	70	APCs	apc	NNS
cord-035016-ipv8npdy	101	71	)	)	-RRB-
cord-035016-ipv8npdy	101	72	15	15	CD
cord-035016-ipv8npdy	101	73	.	.	.
cord-035016-ipv8npdy	102	1	On	on	IN
cord-035016-ipv8npdy	102	2	top	top	NN
cord-035016-ipv8npdy	102	3	of	of	IN
cord-035016-ipv8npdy	102	4	this	this	DT
cord-035016-ipv8npdy	102	5	,	,	,
cord-035016-ipv8npdy	102	6	companies	company	NNS
cord-035016-ipv8npdy	102	7	have	have	VBP
cord-035016-ipv8npdy	102	8	negotiated	negotiate	VBN
cord-035016-ipv8npdy	102	9	confidential	confidential	JJ
cord-035016-ipv8npdy	102	10	liability	liability	NN
cord-035016-ipv8npdy	102	11	transfers	transfer	NNS
cord-035016-ipv8npdy	102	12	to	to	IN
cord-035016-ipv8npdy	102	13	governments	government	NNS
cord-035016-ipv8npdy	102	14	,	,	,
cord-035016-ipv8npdy	102	15	in	in	IN
cord-035016-ipv8npdy	102	16	case	case	NN
cord-035016-ipv8npdy	102	17	the	the	DT
cord-035016-ipv8npdy	102	18	vaccines	vaccine	NNS
cord-035016-ipv8npdy	102	19	would	would	MD
cord-035016-ipv8npdy	102	20	exhibit	exhibit	VB
cord-035016-ipv8npdy	102	21	side	side	JJ
cord-035016-ipv8npdy	102	22	effects	effect	NNS
cord-035016-ipv8npdy	102	23	that	that	WDT
cord-035016-ipv8npdy	102	24	were	be	VBD
cord-035016-ipv8npdy	102	25	not	not	RB
cord-035016-ipv8npdy	102	26	observed	observe	VBN
cord-035016-ipv8npdy	102	27	in	in	IN
cord-035016-ipv8npdy	102	28	the	the	DT
cord-035016-ipv8npdy	102	29	accelerated	accelerated	JJ
cord-035016-ipv8npdy	102	30	R&D	r&d	NN
cord-035016-ipv8npdy	102	31	process	process	NN
cord-035016-ipv8npdy	102	32	(	(	-LRB-
cord-035016-ipv8npdy	102	33	Halabi	Halabi	NNP
cord-035016-ipv8npdy	102	34	et	et	NNP
cord-035016-ipv8npdy	102	35	al	al	NNP
cord-035016-ipv8npdy	102	36	.	.	NNP
cord-035016-ipv8npdy	102	37	2020	2020	CD
cord-035016-ipv8npdy	102	38	)	)	-RRB-
cord-035016-ipv8npdy	102	39	.	.	.
cord-035016-ipv8npdy	103	1	In	in	IN
cord-035016-ipv8npdy	103	2	contrast	contrast	NN
cord-035016-ipv8npdy	103	3	to	to	IN
cord-035016-ipv8npdy	103	4	generic	generic	JJ
cord-035016-ipv8npdy	103	5	drug	drug	NN
cord-035016-ipv8npdy	103	6	manufacturing	manufacturing	NN
cord-035016-ipv8npdy	103	7	,	,	,
cord-035016-ipv8npdy	103	8	there	there	EX
cord-035016-ipv8npdy	103	9	is	be	VBZ
cord-035016-ipv8npdy	103	10	relatively	relatively	RB
cord-035016-ipv8npdy	103	11	little	little	JJ
cord-035016-ipv8npdy	103	12	vaccine	vaccine	NN
cord-035016-ipv8npdy	103	13	manufacturing	manufacturing	NN
cord-035016-ipv8npdy	103	14	capacity	capacity	NN
cord-035016-ipv8npdy	103	15	able	able	JJ
cord-035016-ipv8npdy	103	16	to	to	TO
cord-035016-ipv8npdy	103	17	produce	produce	VB
cord-035016-ipv8npdy	103	18	at	at	IN
cord-035016-ipv8npdy	103	19	large	large	JJ
cord-035016-ipv8npdy	103	20	scale	scale	NN
cord-035016-ipv8npdy	103	21	outside	outside	IN
cord-035016-ipv8npdy	103	22	of	of	IN
cord-035016-ipv8npdy	103	23	the	the	DT
cord-035016-ipv8npdy	103	24	major	major	JJ
cord-035016-ipv8npdy	103	25	(	(	-LRB-
cord-035016-ipv8npdy	103	26	Western	western	JJ
cord-035016-ipv8npdy	103	27	)	)	-RRB-
cord-035016-ipv8npdy	103	28	vaccine	vaccine	NN
cord-035016-ipv8npdy	103	29	corporations	corporation	NNS
cord-035016-ipv8npdy	103	30	,	,	,
cord-035016-ipv8npdy	103	31	with	with	IN
cord-035016-ipv8npdy	103	32	the	the	DT
cord-035016-ipv8npdy	103	33	notable	notable	JJ
cord-035016-ipv8npdy	103	34	exception	exception	NN
cord-035016-ipv8npdy	103	35	of	of	IN
cord-035016-ipv8npdy	103	36	the	the	DT
cord-035016-ipv8npdy	103	37	Serum	Serum	NNP
cord-035016-ipv8npdy	103	38	Institute	Institute	NNP
cord-035016-ipv8npdy	103	39	of	of	IN
cord-035016-ipv8npdy	103	40	India	India	NNP
cord-035016-ipv8npdy	103	41	,	,	,
cord-035016-ipv8npdy	103	42	that	that	WDT
cord-035016-ipv8npdy	103	43	has	have	VBZ
cord-035016-ipv8npdy	103	44	taken	take	VBN
cord-035016-ipv8npdy	103	45	many	many	JJ
cord-035016-ipv8npdy	103	46	years	year	NNS
cord-035016-ipv8npdy	103	47	to	to	TO
cord-035016-ipv8npdy	103	48	build	build	VB
cord-035016-ipv8npdy	103	49	its	-PRON-	PRP$
cord-035016-ipv8npdy	103	50	meanwhile	meanwhile	JJ
cord-035016-ipv8npdy	103	51	state	state	NN
cord-035016-ipv8npdy	103	52	-	-	HYPH
cord-035016-ipv8npdy	103	53	of	of	IN
cord-035016-ipv8npdy	103	54	-	-	HYPH
cord-035016-ipv8npdy	103	55	the	the	DT
cord-035016-ipv8npdy	103	56	-	-	HYPH
cord-035016-ipv8npdy	103	57	art	art	NN
cord-035016-ipv8npdy	103	58	capability	capability	NN
cord-035016-ipv8npdy	103	59	.	.	.
cord-035016-ipv8npdy	104	1	While	while	IN
cord-035016-ipv8npdy	104	2	strictly	strictly	RB
cord-035016-ipv8npdy	104	3	speaking	speak	VBG
cord-035016-ipv8npdy	104	4	there	there	EX
cord-035016-ipv8npdy	104	5	is	be	VBZ
cord-035016-ipv8npdy	104	6	no	no	DT
cord-035016-ipv8npdy	104	7	such	such	JJ
cord-035016-ipv8npdy	104	8	thing	thing	NN
cord-035016-ipv8npdy	104	9	as	as	IN
cord-035016-ipv8npdy	104	10	generic	generic	JJ
cord-035016-ipv8npdy	104	11	vaccines	vaccine	NNS
cord-035016-ipv8npdy	104	12	,	,	,
cord-035016-ipv8npdy	104	13	vaccine	vaccine	NN
cord-035016-ipv8npdy	104	14	manufacturing	manufacturing	NN
cord-035016-ipv8npdy	104	15	is	be	VBZ
cord-035016-ipv8npdy	104	16	technologically	technologically	RB
cord-035016-ipv8npdy	104	17	much	much	RB
cord-035016-ipv8npdy	104	18	more	more	RBR
cord-035016-ipv8npdy	104	19	complex	complex	JJ
cord-035016-ipv8npdy	104	20	than	than	IN
cord-035016-ipv8npdy	104	21	small	small	JJ
cord-035016-ipv8npdy	104	22	chemicals	chemical	NNS
cord-035016-ipv8npdy	104	23	,	,	,
cord-035016-ipv8npdy	104	24	and	and	CC
cord-035016-ipv8npdy	104	25	setting	set	VBG
cord-035016-ipv8npdy	104	26	up	up	RP
cord-035016-ipv8npdy	104	27	the	the	DT
cord-035016-ipv8npdy	104	28	production	production	NN
cord-035016-ipv8npdy	104	29	of	of	IN
cord-035016-ipv8npdy	104	30	an	an	DT
cord-035016-ipv8npdy	104	31	existing	exist	VBG
cord-035016-ipv8npdy	104	32	vaccine	vaccine	NN
cord-035016-ipv8npdy	104	33	typically	typically	RB
cord-035016-ipv8npdy	104	34	requires	require	VBZ
cord-035016-ipv8npdy	104	35	lengthy	lengthy	JJ
cord-035016-ipv8npdy	104	36	technology	technology	NN
cord-035016-ipv8npdy	104	37	transfer	transfer	NN
cord-035016-ipv8npdy	104	38	,	,	,
cord-035016-ipv8npdy	104	39	including	include	VBG
cord-035016-ipv8npdy	104	40	know	know	NN
cord-035016-ipv8npdy	104	41	-	-	HYPH
cord-035016-ipv8npdy	104	42	how	how	WRB
cord-035016-ipv8npdy	104	43	sharing	sharing	NN
cord-035016-ipv8npdy	104	44	,	,	,
cord-035016-ipv8npdy	104	45	for	for	IN
cord-035016-ipv8npdy	104	46	a	a	DT
cord-035016-ipv8npdy	104	47	newcomer	newcomer	NN
cord-035016-ipv8npdy	104	48	to	to	TO
cord-035016-ipv8npdy	104	49	become	become	VB
cord-035016-ipv8npdy	104	50	operational	operational	JJ
cord-035016-ipv8npdy	104	51	.	.	.
cord-035016-ipv8npdy	105	1	The	the	DT
cord-035016-ipv8npdy	105	2	massive	massive	JJ
cord-035016-ipv8npdy	105	3	investments	investment	NNS
cord-035016-ipv8npdy	105	4	of	of	IN
cord-035016-ipv8npdy	105	5	governments	government	NNS
cord-035016-ipv8npdy	105	6	into	into	IN
cord-035016-ipv8npdy	105	7	scaling	scale	VBG
cord-035016-ipv8npdy	105	8	up	up	RP
cord-035016-ipv8npdy	105	9	manufacturing	manufacturing	NN
cord-035016-ipv8npdy	105	10	capacity	capacity	NN
cord-035016-ipv8npdy	105	11	for	for	IN
cord-035016-ipv8npdy	105	12	the	the	DT
cord-035016-ipv8npdy	105	13	COVID-19	covid-19	JJ
cord-035016-ipv8npdy	105	14	candidates	candidate	NNS
cord-035016-ipv8npdy	105	15	seem	seem	VBP
cord-035016-ipv8npdy	105	16	to	to	TO
cord-035016-ipv8npdy	105	17	have	have	VB
cord-035016-ipv8npdy	105	18	all	all	DT
cord-035016-ipv8npdy	105	19	gone	go	VBN
cord-035016-ipv8npdy	105	20	into	into	IN
cord-035016-ipv8npdy	105	21	private	private	JJ
cord-035016-ipv8npdy	105	22	companies	company	NNS
cord-035016-ipv8npdy	105	23	under	under	IN
cord-035016-ipv8npdy	105	24	license	license	NN
cord-035016-ipv8npdy	105	25	from	from	IN
cord-035016-ipv8npdy	105	26	the	the	DT
cord-035016-ipv8npdy	105	27	'	'	``
cord-035016-ipv8npdy	105	28	originator	originator	NN
cord-035016-ipv8npdy	105	29	'	'	''
cord-035016-ipv8npdy	105	30	companies	company	NNS
cord-035016-ipv8npdy	105	31	,	,	,
cord-035016-ipv8npdy	105	32	which	which	WDT
cord-035016-ipv8npdy	105	33	is	be	VBZ
cord-035016-ipv8npdy	105	34	a	a	DT
cord-035016-ipv8npdy	105	35	missed	missed	JJ
cord-035016-ipv8npdy	105	36	opportunity	opportunity	NN
cord-035016-ipv8npdy	105	37	for	for	IN
cord-035016-ipv8npdy	105	38	the	the	DT
cord-035016-ipv8npdy	105	39	global	global	JJ
cord-035016-ipv8npdy	105	40	health	health	NN
cord-035016-ipv8npdy	105	41	community	community	NN
cord-035016-ipv8npdy	105	42	to	to	TO
cord-035016-ipv8npdy	105	43	have	have	VB
cord-035016-ipv8npdy	105	44	invested	invest	VBN
cord-035016-ipv8npdy	105	45	in	in	IN
cord-035016-ipv8npdy	105	46	expanding	expand	VBG
cord-035016-ipv8npdy	105	47	the	the	DT
cord-035016-ipv8npdy	105	48	global	global	JJ
cord-035016-ipv8npdy	105	49	technological	technological	JJ
cord-035016-ipv8npdy	105	50	capacity	capacity	NN
cord-035016-ipv8npdy	105	51	to	to	TO
cord-035016-ipv8npdy	105	52	produce	produce	VB
cord-035016-ipv8npdy	105	53	vaccines	vaccine	NNS
cord-035016-ipv8npdy	105	54	as	as	IN
cord-035016-ipv8npdy	105	55	commons	common	NNS
cord-035016-ipv8npdy	105	56	,	,	,
cord-035016-ipv8npdy	105	57	and	and	CC
cord-035016-ipv8npdy	105	58	start	start	VB
cord-035016-ipv8npdy	105	59	challenging	challenge	VBG
cord-035016-ipv8npdy	105	60	the	the	DT
cord-035016-ipv8npdy	105	61	oligopoly	oligopoly	NN
cord-035016-ipv8npdy	105	62	that	that	WDT
cord-035016-ipv8npdy	105	63	now	now	RB
cord-035016-ipv8npdy	105	64	exists	exist	VBZ
cord-035016-ipv8npdy	105	65	among	among	IN
cord-035016-ipv8npdy	105	66	major	major	JJ
cord-035016-ipv8npdy	105	67	vaccine	vaccine	NN
cord-035016-ipv8npdy	105	68	producers	producer	NNS
cord-035016-ipv8npdy	105	69	.	.	.
cord-035016-ipv8npdy	106	1	Taken	take	VBN
cord-035016-ipv8npdy	106	2	together	together	RB
cord-035016-ipv8npdy	106	3	,	,	,
cord-035016-ipv8npdy	106	4	the	the	DT
cord-035016-ipv8npdy	106	5	unprecedented	unprecedented	JJ
cord-035016-ipv8npdy	106	6	public	public	JJ
cord-035016-ipv8npdy	106	7	investments	investment	NNS
cord-035016-ipv8npdy	106	8	in	in	IN
cord-035016-ipv8npdy	106	9	R&D	r&d	NN
cord-035016-ipv8npdy	106	10	and	and	CC
cord-035016-ipv8npdy	106	11	manufacturing	manufacturing	NN
cord-035016-ipv8npdy	106	12	capacities	capacity	NNS
cord-035016-ipv8npdy	106	13	for	for	IN
cord-035016-ipv8npdy	106	14	COVID-19	covid-19	JJ
cord-035016-ipv8npdy	106	15	vaccines	vaccine	NNS
cord-035016-ipv8npdy	106	16	,	,	,
cord-035016-ipv8npdy	106	17	and	and	CC
cord-035016-ipv8npdy	106	18	the	the	DT
cord-035016-ipv8npdy	106	19	purchase	purchase	NN
cord-035016-ipv8npdy	106	20	commitments	commitment	NNS
cord-035016-ipv8npdy	106	21	and	and	CC
cord-035016-ipv8npdy	106	22	liability	liability	NN
cord-035016-ipv8npdy	106	23	transfers	transfer	NNS
cord-035016-ipv8npdy	106	24	,	,	,
cord-035016-ipv8npdy	106	25	all	all	DT
cord-035016-ipv8npdy	106	26	directly	directly	RB
cord-035016-ipv8npdy	106	27	benefit	benefit	VBP
cord-035016-ipv8npdy	106	28	companies	company	NNS
cord-035016-ipv8npdy	106	29	that	that	IN
cord-035016-ipv8npdy	106	30	'	'	``
cord-035016-ipv8npdy	106	31	own	own	VBP
cord-035016-ipv8npdy	106	32	'	'	''
cord-035016-ipv8npdy	106	33	these	these	DT
cord-035016-ipv8npdy	106	34	technologies	technology	NNS
cord-035016-ipv8npdy	106	35	,	,	,
cord-035016-ipv8npdy	106	36	and	and	CC
cord-035016-ipv8npdy	106	37	have	have	VBP
cord-035016-ipv8npdy	106	38	come	come	VBN
cord-035016-ipv8npdy	106	39	with	with	IN
cord-035016-ipv8npdy	106	40	little	little	JJ
cord-035016-ipv8npdy	106	41	or	or	CC
cord-035016-ipv8npdy	106	42	no	no	DT
cord-035016-ipv8npdy	106	43	strings	string	NNS
cord-035016-ipv8npdy	106	44	attached	attach	VBN
cord-035016-ipv8npdy	106	45	,	,	,
cord-035016-ipv8npdy	106	46	de	de	FW
cord-035016-ipv8npdy	106	47	facto	facto	FW
cord-035016-ipv8npdy	106	48	privatizing	privatize	VBG
cord-035016-ipv8npdy	106	49	all	all	PDT
cord-035016-ipv8npdy	106	50	those	those	DT
cord-035016-ipv8npdy	106	51	public	public	JJ
cord-035016-ipv8npdy	106	52	investments	investment	NNS
cord-035016-ipv8npdy	106	53	and	and	CC
cord-035016-ipv8npdy	106	54	the	the	DT
cord-035016-ipv8npdy	106	55	control	control	NN
cord-035016-ipv8npdy	106	56	over	over	IN
cord-035016-ipv8npdy	106	57	potentially	potentially	RB
cord-035016-ipv8npdy	106	58	hugely	hugely	RB
cord-035016-ipv8npdy	106	59	important	important	JJ
cord-035016-ipv8npdy	106	60	public	public	JJ
cord-035016-ipv8npdy	106	61	health	health	NN
cord-035016-ipv8npdy	106	62	interventions	intervention	NNS
cord-035016-ipv8npdy	106	63	,	,	,
cord-035016-ipv8npdy	106	64	which	which	WDT
cord-035016-ipv8npdy	106	65	essentially	essentially	RB
cord-035016-ipv8npdy	106	66	should	should	MD
cord-035016-ipv8npdy	106	67	have	have	VB
cord-035016-ipv8npdy	106	68	been	be	VBN
cord-035016-ipv8npdy	106	69	global	global	JJ
cord-035016-ipv8npdy	106	70	health	health	NN
cord-035016-ipv8npdy	106	71	commons	common	NNS
cord-035016-ipv8npdy	106	72	.	.	.
cord-035016-ipv8npdy	107	1	Vaccines	vaccine	NNS
cord-035016-ipv8npdy	107	2	are	be	VBP
cord-035016-ipv8npdy	107	3	a	a	DT
cord-035016-ipv8npdy	107	4	public	public	JJ
cord-035016-ipv8npdy	107	5	health	health	NN
cord-035016-ipv8npdy	107	6	intervention	intervention	NN
cord-035016-ipv8npdy	107	7	which	which	WDT
cord-035016-ipv8npdy	107	8	,	,	,
cord-035016-ipv8npdy	107	9	more	more	JJR
cord-035016-ipv8npdy	107	10	than	than	IN
cord-035016-ipv8npdy	107	11	any	any	DT
cord-035016-ipv8npdy	107	12	other	other	JJ
cord-035016-ipv8npdy	107	13	,	,	,
cord-035016-ipv8npdy	107	14	require	require	VBP
cord-035016-ipv8npdy	107	15	people	people	NNS
cord-035016-ipv8npdy	107	16	's	's	POS
cord-035016-ipv8npdy	107	17	collective	collective	JJ
cord-035016-ipv8npdy	107	18	buy	buy	NN
cord-035016-ipv8npdy	107	19	-	-	HYPH
cord-035016-ipv8npdy	107	20	in	in	NN
cord-035016-ipv8npdy	107	21	and	and	CC
cord-035016-ipv8npdy	107	22	trust	trust	NN
cord-035016-ipv8npdy	107	23	.	.	.
cord-035016-ipv8npdy	108	1	While	while	IN
cord-035016-ipv8npdy	108	2	some	some	DT
cord-035016-ipv8npdy	108	3	people	people	NNS
cord-035016-ipv8npdy	108	4	argue	argue	VBP
cord-035016-ipv8npdy	108	5	that	that	IN
cord-035016-ipv8npdy	108	6	having	have	VBG
cord-035016-ipv8npdy	108	7	a	a	DT
cord-035016-ipv8npdy	108	8	COVID-19	covid-19	JJ
cord-035016-ipv8npdy	108	9	vaccine	vaccine	NN
cord-035016-ipv8npdy	108	10	that	that	WDT
cord-035016-ipv8npdy	108	11	works	work	VBZ
cord-035016-ipv8npdy	108	12	a	a	DT
cord-035016-ipv8npdy	108	13	little	little	JJ
cord-035016-ipv8npdy	108	14	,	,	,
cord-035016-ipv8npdy	108	15	and	and	CC
cord-035016-ipv8npdy	108	16	for	for	IN
cord-035016-ipv8npdy	108	17	some	some	DT
cord-035016-ipv8npdy	108	18	,	,	,
cord-035016-ipv8npdy	108	19	is	be	VBZ
cord-035016-ipv8npdy	108	20	better	well	JJR
cord-035016-ipv8npdy	108	21	than	than	IN
cord-035016-ipv8npdy	108	22	having	have	VBG
cord-035016-ipv8npdy	108	23	no	no	DT
cord-035016-ipv8npdy	108	24	vaccine	vaccine	NN
cord-035016-ipv8npdy	108	25	at	at	RB
cord-035016-ipv8npdy	108	26	all	all	RB
cord-035016-ipv8npdy	108	27	,	,	,
cord-035016-ipv8npdy	108	28	there	there	EX
cord-035016-ipv8npdy	108	29	are	be	VBP
cord-035016-ipv8npdy	108	30	major	major	JJ
cord-035016-ipv8npdy	108	31	risks	risk	NNS
cord-035016-ipv8npdy	108	32	and	and	CC
cord-035016-ipv8npdy	108	33	opportunity	opportunity	NN
cord-035016-ipv8npdy	108	34	costs	cost	NNS
cord-035016-ipv8npdy	108	35	for	for	IN
cord-035016-ipv8npdy	108	36	prioritizing	prioritize	VBG
cord-035016-ipv8npdy	108	37	speed	speed	NN
cord-035016-ipv8npdy	108	38	over	over	IN
cord-035016-ipv8npdy	108	39	adequate	adequate	JJ
cord-035016-ipv8npdy	108	40	efficacy	efficacy	NN
cord-035016-ipv8npdy	108	41	and	and	CC
cord-035016-ipv8npdy	108	42	safety	safety	NN
cord-035016-ipv8npdy	108	43	.	.	.
cord-035016-ipv8npdy	109	1	Roll	roll	NN
cord-035016-ipv8npdy	109	2	-	-	HYPH
cord-035016-ipv8npdy	109	3	out	out	NN
cord-035016-ipv8npdy	109	4	of	of	IN
cord-035016-ipv8npdy	109	5	a	a	DT
cord-035016-ipv8npdy	109	6	weakly	weakly	RB
cord-035016-ipv8npdy	109	7	effective	effective	JJ
cord-035016-ipv8npdy	109	8	vaccine	vaccine	NN
cord-035016-ipv8npdy	109	9	in	in	IN
cord-035016-ipv8npdy	109	10	fact	fact	NN
cord-035016-ipv8npdy	109	11	could	could	MD
cord-035016-ipv8npdy	109	12	worsen	worsen	VB
cord-035016-ipv8npdy	109	13	the	the	DT
cord-035016-ipv8npdy	109	14	pandemic	pandemic	NN
cord-035016-ipv8npdy	109	15	in	in	IN
cord-035016-ipv8npdy	109	16	multiple	multiple	JJ
cord-035016-ipv8npdy	109	17	ways	way	NNS
cord-035016-ipv8npdy	109	18	(	(	-LRB-
cord-035016-ipv8npdy	109	19	Krause	Krause	NNP
cord-035016-ipv8npdy	109	20	et	et	NNP
cord-035016-ipv8npdy	109	21	al	al	NNP
cord-035016-ipv8npdy	109	22	.	.	NNP
cord-035016-ipv8npdy	109	23	2020	2020	CD
cord-035016-ipv8npdy	109	24	)	)	-RRB-
cord-035016-ipv8npdy	109	25	.	.	.
cord-035016-ipv8npdy	110	1	If	if	IN
cord-035016-ipv8npdy	110	2	authorities	authority	NNS
cord-035016-ipv8npdy	110	3	wrongly	wrongly	RB
cord-035016-ipv8npdy	110	4	assume	assume	VBP
cord-035016-ipv8npdy	110	5	there	there	EX
cord-035016-ipv8npdy	110	6	is	be	VBZ
cord-035016-ipv8npdy	110	7	a	a	DT
cord-035016-ipv8npdy	110	8	substantial	substantial	JJ
cord-035016-ipv8npdy	110	9	reduction	reduction	NN
cord-035016-ipv8npdy	110	10	in	in	IN
cord-035016-ipv8npdy	110	11	risk	risk	NN
cord-035016-ipv8npdy	110	12	in	in	IN
cord-035016-ipv8npdy	110	13	the	the	DT
cord-035016-ipv8npdy	110	14	population	population	NN
cord-035016-ipv8npdy	110	15	,	,	,
cord-035016-ipv8npdy	110	16	they	-PRON-	PRP
cord-035016-ipv8npdy	110	17	may	may	MD
cord-035016-ipv8npdy	110	18	choose	choose	VB
cord-035016-ipv8npdy	110	19	to	to	TO
cord-035016-ipv8npdy	110	20	scale	scale	VB
cord-035016-ipv8npdy	110	21	down	down	RP
cord-035016-ipv8npdy	110	22	other	other	JJ
cord-035016-ipv8npdy	110	23	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	110	24	control	control	NN
cord-035016-ipv8npdy	110	25	measures	measure	NNS
cord-035016-ipv8npdy	110	26	and	and	CC
cord-035016-ipv8npdy	110	27	re	re	VB
cord-035016-ipv8npdy	110	28	-	-	VB
cord-035016-ipv8npdy	110	29	open	open	VB
cord-035016-ipv8npdy	110	30	the	the	DT
cord-035016-ipv8npdy	110	31	economy	economy	NN
cord-035016-ipv8npdy	110	32	.	.	.
cord-035016-ipv8npdy	111	1	If	if	IN
cord-035016-ipv8npdy	111	2	the	the	DT
cord-035016-ipv8npdy	111	3	pandemic	pandemic	NN
cord-035016-ipv8npdy	111	4	continues	continue	VBZ
cord-035016-ipv8npdy	111	5	to	to	TO
cord-035016-ipv8npdy	111	6	grow	grow	VB
cord-035016-ipv8npdy	111	7	despite	despite	IN
cord-035016-ipv8npdy	111	8	having	have	VBG
cord-035016-ipv8npdy	111	9	massively	massively	RB
cord-035016-ipv8npdy	111	10	invested	invest	VBN
cord-035016-ipv8npdy	111	11	in	in	IN
cord-035016-ipv8npdy	111	12	vaccines	vaccine	NNS
cord-035016-ipv8npdy	111	13	,	,	,
cord-035016-ipv8npdy	111	14	they	-PRON-	PRP
cord-035016-ipv8npdy	111	15	may	may	MD
cord-035016-ipv8npdy	111	16	not	not	RB
cord-035016-ipv8npdy	111	17	be	be	VB
cord-035016-ipv8npdy	111	18	willing	willing	JJ
cord-035016-ipv8npdy	111	19	to	to	TO
cord-035016-ipv8npdy	111	20	continue	continue	VB
cord-035016-ipv8npdy	111	21	investing	invest	VBG
cord-035016-ipv8npdy	111	22	in	in	IN
cord-035016-ipv8npdy	111	23	a	a	DT
cord-035016-ipv8npdy	111	24	potentially	potentially	RB
cord-035016-ipv8npdy	111	25	better	well	JJR
cord-035016-ipv8npdy	111	26	next	next	JJ
cord-035016-ipv8npdy	111	27	generation	generation	NN
cord-035016-ipv8npdy	111	28	vaccines	vaccine	NNS
cord-035016-ipv8npdy	111	29	.	.	.
cord-035016-ipv8npdy	112	1	Similarly	similarly	RB
cord-035016-ipv8npdy	112	2	,	,	,
cord-035016-ipv8npdy	112	3	if	if	IN
cord-035016-ipv8npdy	112	4	vaccinated	vaccinate	VBN
cord-035016-ipv8npdy	112	5	individuals	individual	NNS
cord-035016-ipv8npdy	112	6	wrongly	wrongly	RB
cord-035016-ipv8npdy	112	7	believe	believe	VBP
cord-035016-ipv8npdy	112	8	they	-PRON-	PRP
cord-035016-ipv8npdy	112	9	are	be	VBP
cord-035016-ipv8npdy	112	10	protected	protect	VBN
cord-035016-ipv8npdy	112	11	against	against	IN
cord-035016-ipv8npdy	112	12	infection	infection	NN
cord-035016-ipv8npdy	112	13	,	,	,
cord-035016-ipv8npdy	112	14	compliance	compliance	NN
cord-035016-ipv8npdy	112	15	with	with	IN
cord-035016-ipv8npdy	112	16	other	other	JJ
cord-035016-ipv8npdy	112	17	protective	protective	JJ
cord-035016-ipv8npdy	112	18	measures	measure	NNS
cord-035016-ipv8npdy	112	19	such	such	JJ
cord-035016-ipv8npdy	112	20	as	as	IN
cord-035016-ipv8npdy	112	21	wearing	wear	VBG
cord-035016-ipv8npdy	112	22	masks	mask	NNS
cord-035016-ipv8npdy	112	23	or	or	CC
cord-035016-ipv8npdy	112	24	physical	physical	JJ
cord-035016-ipv8npdy	112	25	distancing	distancing	NN
cord-035016-ipv8npdy	112	26	may	may	MD
cord-035016-ipv8npdy	112	27	be	be	VB
cord-035016-ipv8npdy	112	28	lowered	lower	VBN
cord-035016-ipv8npdy	112	29	.	.	.
cord-035016-ipv8npdy	113	1	When	when	WRB
cord-035016-ipv8npdy	113	2	people	people	NNS
cord-035016-ipv8npdy	113	3	realize	realize	VBP
cord-035016-ipv8npdy	113	4	they	-PRON-	PRP
cord-035016-ipv8npdy	113	5	get	get	VBP
cord-035016-ipv8npdy	113	6	infected	infect	VBN
cord-035016-ipv8npdy	113	7	despite	despite	IN
cord-035016-ipv8npdy	113	8	being	be	VBG
cord-035016-ipv8npdy	113	9	vaccinated	vaccinate	VBN
cord-035016-ipv8npdy	113	10	,	,	,
cord-035016-ipv8npdy	113	11	their	-PRON-	PRP$
cord-035016-ipv8npdy	113	12	confidence	confidence	NN
cord-035016-ipv8npdy	113	13	in	in	IN
cord-035016-ipv8npdy	113	14	vaccines	vaccine	NNS
cord-035016-ipv8npdy	113	15	may	may	MD
cord-035016-ipv8npdy	113	16	drop	drop	VB
cord-035016-ipv8npdy	113	17	,	,	,
cord-035016-ipv8npdy	113	18	leading	lead	VBG
cord-035016-ipv8npdy	113	19	them	-PRON-	PRP
cord-035016-ipv8npdy	113	20	to	to	TO
cord-035016-ipv8npdy	113	21	refuse	refuse	VB
cord-035016-ipv8npdy	113	22	other	other	JJ
cord-035016-ipv8npdy	113	23	more	more	JJR
cord-035016-ipv8npdy	113	24	effective	effective	JJ
cord-035016-ipv8npdy	113	25	vaccines	vaccine	NNS
cord-035016-ipv8npdy	113	26	that	that	WDT
cord-035016-ipv8npdy	113	27	would	would	MD
cord-035016-ipv8npdy	113	28	become	become	VB
cord-035016-ipv8npdy	113	29	available	available	JJ
cord-035016-ipv8npdy	113	30	later	later	RB
cord-035016-ipv8npdy	113	31	on	on	RB
cord-035016-ipv8npdy	113	32	.	.	.
cord-035016-ipv8npdy	114	1	Deployment	deployment	NN
cord-035016-ipv8npdy	114	2	of	of	IN
cord-035016-ipv8npdy	114	3	a	a	DT
cord-035016-ipv8npdy	114	4	marginally	marginally	RB
cord-035016-ipv8npdy	114	5	effective	effective	JJ
cord-035016-ipv8npdy	114	6	vaccine	vaccine	NN
cord-035016-ipv8npdy	114	7	could	could	MD
cord-035016-ipv8npdy	114	8	also	also	RB
cord-035016-ipv8npdy	114	9	interfere	interfere	VB
cord-035016-ipv8npdy	114	10	with	with	IN
cord-035016-ipv8npdy	114	11	the	the	DT
cord-035016-ipv8npdy	114	12	evaluation	evaluation	NN
cord-035016-ipv8npdy	114	13	of	of	IN
cord-035016-ipv8npdy	114	14	other	other	JJ
cord-035016-ipv8npdy	114	15	vaccines	vaccine	NNS
cord-035016-ipv8npdy	114	16	.	.	.
cord-035016-ipv8npdy	115	1	It	-PRON-	PRP
cord-035016-ipv8npdy	115	2	may	may	MD
cord-035016-ipv8npdy	115	3	become	become	VB
cord-035016-ipv8npdy	115	4	challenging	challenging	JJ
cord-035016-ipv8npdy	115	5	to	to	TO
cord-035016-ipv8npdy	115	6	find	find	VB
cord-035016-ipv8npdy	115	7	enough	enough	JJ
cord-035016-ipv8npdy	115	8	unvaccinated	unvaccinated	JJ
cord-035016-ipv8npdy	115	9	trial	trial	NN
cord-035016-ipv8npdy	115	10	volunteers	volunteer	NNS
cord-035016-ipv8npdy	115	11	to	to	TO
cord-035016-ipv8npdy	115	12	enrol	enrol	VB
cord-035016-ipv8npdy	115	13	in	in	IN
cord-035016-ipv8npdy	115	14	new	new	JJ
cord-035016-ipv8npdy	115	15	vaccine	vaccine	NN
cord-035016-ipv8npdy	115	16	trials	trial	NNS
cord-035016-ipv8npdy	115	17	,	,	,
cord-035016-ipv8npdy	115	18	while	while	IN
cord-035016-ipv8npdy	115	19	conducting	conduct	VBG
cord-035016-ipv8npdy	115	20	a	a	DT
cord-035016-ipv8npdy	115	21	trial	trial	NN
cord-035016-ipv8npdy	115	22	in	in	IN
cord-035016-ipv8npdy	115	23	a	a	DT
cord-035016-ipv8npdy	115	24	population	population	NN
cord-035016-ipv8npdy	115	25	that	that	WDT
cord-035016-ipv8npdy	115	26	is	be	VBZ
cord-035016-ipv8npdy	115	27	partially	partially	RB
cord-035016-ipv8npdy	115	28	protected	protect	VBN
cord-035016-ipv8npdy	115	29	due	due	IN
cord-035016-ipv8npdy	115	30	to	to	IN
cord-035016-ipv8npdy	115	31	prior	prior	RB
cord-035016-ipv8npdy	115	32	(	(	-LRB-
cord-035016-ipv8npdy	115	33	poorly	poorly	RB
cord-035016-ipv8npdy	115	34	effective	effective	JJ
cord-035016-ipv8npdy	115	35	)	)	-RRB-
cord-035016-ipv8npdy	115	36	vaccination	vaccination	NN
cord-035016-ipv8npdy	115	37	may	may	MD
cord-035016-ipv8npdy	115	38	lead	lead	VB
cord-035016-ipv8npdy	115	39	to	to	IN
cord-035016-ipv8npdy	115	40	results	result	NNS
cord-035016-ipv8npdy	115	41	that	that	WDT
cord-035016-ipv8npdy	115	42	are	be	VBP
cord-035016-ipv8npdy	115	43	very	very	RB
cord-035016-ipv8npdy	115	44	difficult	difficult	JJ
cord-035016-ipv8npdy	115	45	to	to	TO
cord-035016-ipv8npdy	115	46	interpret	interpret	VB
cord-035016-ipv8npdy	115	47	.	.	.
cord-035016-ipv8npdy	116	1	Additionally	additionally	RB
cord-035016-ipv8npdy	116	2	,	,	,
cord-035016-ipv8npdy	116	3	once	once	RB
cord-035016-ipv8npdy	116	4	a	a	DT
cord-035016-ipv8npdy	116	5	COVID-19	covid-19	JJ
cord-035016-ipv8npdy	116	6	vaccine	vaccine	NN
cord-035016-ipv8npdy	116	7	gets	get	VBZ
cord-035016-ipv8npdy	116	8	approved	approve	VBN
cord-035016-ipv8npdy	116	9	,	,	,
cord-035016-ipv8npdy	116	10	subsequent	subsequent	JJ
cord-035016-ipv8npdy	116	11	vaccine	vaccine	NN
cord-035016-ipv8npdy	116	12	candidates	candidate	NNS
cord-035016-ipv8npdy	116	13	will	will	MD
cord-035016-ipv8npdy	116	14	have	have	VB
cord-035016-ipv8npdy	116	15	to	to	TO
cord-035016-ipv8npdy	116	16	be	be	VB
cord-035016-ipv8npdy	116	17	compared	compare	VBN
cord-035016-ipv8npdy	116	18	to	to	IN
cord-035016-ipv8npdy	116	19	it	-PRON-	PRP
cord-035016-ipv8npdy	116	20	rather	rather	RB
cord-035016-ipv8npdy	116	21	than	than	IN
cord-035016-ipv8npdy	116	22	to	to	IN
cord-035016-ipv8npdy	116	23	a	a	DT
cord-035016-ipv8npdy	116	24	placebo	placebo	NN
cord-035016-ipv8npdy	116	25	.	.	.
cord-035016-ipv8npdy	117	1	As	as	IN
cord-035016-ipv8npdy	117	2	this	this	DT
cord-035016-ipv8npdy	117	3	necessarily	necessarily	RB
cord-035016-ipv8npdy	117	4	will	will	MD
cord-035016-ipv8npdy	117	5	be	be	VB
cord-035016-ipv8npdy	117	6	done	do	VBN
cord-035016-ipv8npdy	117	7	via	via	IN
cord-035016-ipv8npdy	117	8	what	what	WP
cord-035016-ipv8npdy	117	9	is	be	VBZ
cord-035016-ipv8npdy	117	10	called	call	VBN
cord-035016-ipv8npdy	117	11	'	'	``
cord-035016-ipv8npdy	117	12	non	non	JJ
cord-035016-ipv8npdy	117	13	-	-	JJ
cord-035016-ipv8npdy	117	14	inferiority	inferiority	JJ
cord-035016-ipv8npdy	117	15	'	'	''
cord-035016-ipv8npdy	117	16	trials	trial	NNS
cord-035016-ipv8npdy	117	17	,	,	,
cord-035016-ipv8npdy	117	18	there	there	EX
cord-035016-ipv8npdy	117	19	's	be	VBZ
cord-035016-ipv8npdy	117	20	a	a	DT
cord-035016-ipv8npdy	117	21	risk	risk	NN
cord-035016-ipv8npdy	117	22	that	that	IN
cord-035016-ipv8npdy	117	23	vaccines	vaccine	NNS
cord-035016-ipv8npdy	117	24	with	with	IN
cord-035016-ipv8npdy	117	25	even	even	RB
cord-035016-ipv8npdy	117	26	worse	bad	JJR
cord-035016-ipv8npdy	117	27	performance	performance	NN
cord-035016-ipv8npdy	117	28	might	may	MD
cord-035016-ipv8npdy	117	29	still	still	RB
cord-035016-ipv8npdy	117	30	get	get	VB
cord-035016-ipv8npdy	117	31	approved	approve	VBN
cord-035016-ipv8npdy	117	32	,	,	,
cord-035016-ipv8npdy	117	33	a	a	DT
cord-035016-ipv8npdy	117	34	methodological	methodological	JJ
cord-035016-ipv8npdy	117	35	quirk	quirk	NN
cord-035016-ipv8npdy	117	36	which	which	WDT
cord-035016-ipv8npdy	117	37	has	have	VBZ
cord-035016-ipv8npdy	117	38	been	be	VBN
cord-035016-ipv8npdy	117	39	referred	refer	VBN
cord-035016-ipv8npdy	117	40	to	to	IN
cord-035016-ipv8npdy	117	41	as	as	IN
cord-035016-ipv8npdy	117	42	'	'	``
cord-035016-ipv8npdy	117	43	bio	bio	JJ
cord-035016-ipv8npdy	117	44	-	-	HYPH
cord-035016-ipv8npdy	117	45	creep	creep	NNP
cord-035016-ipv8npdy	117	46	'	'	''
cord-035016-ipv8npdy	117	47	(	(	-LRB-
cord-035016-ipv8npdy	117	48	Everson	Everson	NNP
cord-035016-ipv8npdy	117	49	-	-	HYPH
cord-035016-ipv8npdy	117	50	Stewart	Stewart	NNP
cord-035016-ipv8npdy	117	51	and	and	CC
cord-035016-ipv8npdy	117	52	Emerson	Emerson	NNP
cord-035016-ipv8npdy	117	53	2010	2010	CD
cord-035016-ipv8npdy	117	54	)	)	-RRB-
cord-035016-ipv8npdy	117	55	.	.	.
cord-035016-ipv8npdy	118	1	A	a	DT
cord-035016-ipv8npdy	118	2	final	final	JJ
cord-035016-ipv8npdy	118	3	collateral	collateral	JJ
cord-035016-ipv8npdy	118	4	effect	effect	NN
cord-035016-ipv8npdy	118	5	of	of	IN
cord-035016-ipv8npdy	118	6	poorly	poorly	RB
cord-035016-ipv8npdy	118	7	effective	effective	JJ
cord-035016-ipv8npdy	118	8	vaccines	vaccine	NNS
cord-035016-ipv8npdy	118	9	is	be	VBZ
cord-035016-ipv8npdy	118	10	that	that	IN
cord-035016-ipv8npdy	118	11	the	the	DT
cord-035016-ipv8npdy	118	12	legitimacy	legitimacy	NN
cord-035016-ipv8npdy	118	13	of	of	IN
cord-035016-ipv8npdy	118	14	scientists	scientist	NNS
cord-035016-ipv8npdy	118	15	and	and	CC
cord-035016-ipv8npdy	118	16	the	the	DT
cord-035016-ipv8npdy	118	17	scientific	scientific	JJ
cord-035016-ipv8npdy	118	18	process	process	NN
cord-035016-ipv8npdy	118	19	might	may	MD
cord-035016-ipv8npdy	118	20	be	be	VB
cord-035016-ipv8npdy	118	21	undermined	undermine	VBN
cord-035016-ipv8npdy	118	22	if	if	IN
cord-035016-ipv8npdy	118	23	researchers	researcher	NNS
cord-035016-ipv8npdy	118	24	can	can	MD
cord-035016-ipv8npdy	118	25	not	not	RB
cord-035016-ipv8npdy	118	26	prevent	prevent	VB
cord-035016-ipv8npdy	118	27	commercial	commercial	JJ
cord-035016-ipv8npdy	118	28	interests	interest	NNS
cord-035016-ipv8npdy	118	29	to	to	TO
cord-035016-ipv8npdy	118	30	overtake	overtake	VB
cord-035016-ipv8npdy	118	31	quality	quality	NN
cord-035016-ipv8npdy	118	32	science	science	NN
cord-035016-ipv8npdy	118	33	.	.	.
cord-035016-ipv8npdy	119	1	From	from	IN
cord-035016-ipv8npdy	119	2	the	the	DT
cord-035016-ipv8npdy	119	3	early	early	JJ
cord-035016-ipv8npdy	119	4	days	day	NNS
cord-035016-ipv8npdy	119	5	of	of	IN
cord-035016-ipv8npdy	119	6	the	the	DT
cord-035016-ipv8npdy	119	7	pandemic	pandemic	NN
cord-035016-ipv8npdy	119	8	,	,	,
cord-035016-ipv8npdy	119	9	influential	influential	JJ
cord-035016-ipv8npdy	119	10	voices	voice	NNS
cord-035016-ipv8npdy	119	11	including	include	VBG
cord-035016-ipv8npdy	119	12	UN	UN	NNP
cord-035016-ipv8npdy	119	13	Secretary	Secretary	NNP
cord-035016-ipv8npdy	119	14	-	-	HYPH
cord-035016-ipv8npdy	119	15	General	General	NNP
cord-035016-ipv8npdy	119	16	António	António	NNP
cord-035016-ipv8npdy	119	17	Guterres	Guterres	NNP
cord-035016-ipv8npdy	119	18	,	,	,
cord-035016-ipv8npdy	119	19	European	european	JJ
cord-035016-ipv8npdy	119	20	President	President	NNP
cord-035016-ipv8npdy	119	21	Ursula	Ursula	NNP
cord-035016-ipv8npdy	119	22	von	von	NNP
cord-035016-ipv8npdy	119	23	der	der	NNP
cord-035016-ipv8npdy	119	24	Leyen	Leyen	NNP
cord-035016-ipv8npdy	119	25	and	and	CC
cord-035016-ipv8npdy	119	26	political	political	JJ
cord-035016-ipv8npdy	119	27	leaders	leader	NNS
cord-035016-ipv8npdy	119	28	and	and	CC
cord-035016-ipv8npdy	119	29	academics	academic	NNS
cord-035016-ipv8npdy	119	30	from	from	IN
cord-035016-ipv8npdy	119	31	all	all	DT
cord-035016-ipv8npdy	119	32	continents	continent	NNS
cord-035016-ipv8npdy	119	33	have	have	VBP
cord-035016-ipv8npdy	119	34	argued	argue	VBN
cord-035016-ipv8npdy	119	35	that	that	IN
cord-035016-ipv8npdy	119	36	the	the	DT
cord-035016-ipv8npdy	119	37	exceptional	exceptional	JJ
cord-035016-ipv8npdy	119	38	nature	nature	NN
cord-035016-ipv8npdy	119	39	and	and	CC
cord-035016-ipv8npdy	119	40	huge	huge	JJ
cord-035016-ipv8npdy	119	41	impact	impact	NN
cord-035016-ipv8npdy	119	42	of	of	IN
cord-035016-ipv8npdy	119	43	the	the	DT
cord-035016-ipv8npdy	119	44	pandemic	pandemic	NN
cord-035016-ipv8npdy	119	45	justifies	justify	VBZ
cord-035016-ipv8npdy	119	46	that	that	IN
cord-035016-ipv8npdy	119	47	COVID-19	covid-19	JJ
cord-035016-ipv8npdy	119	48	vaccines	vaccine	NNS
cord-035016-ipv8npdy	119	49	must	must	MD
cord-035016-ipv8npdy	119	50	be	be	VB
cord-035016-ipv8npdy	119	51	considered	consider	VBN
cord-035016-ipv8npdy	119	52	'	'	``
cord-035016-ipv8npdy	119	53	people	people	NNS
cord-035016-ipv8npdy	119	54	's	's	POS
cord-035016-ipv8npdy	119	55	vaccines	vaccine	NNS
cord-035016-ipv8npdy	119	56	'	'	POS
cord-035016-ipv8npdy	119	57	,	,	,
cord-035016-ipv8npdy	119	58	16	16	CD
cord-035016-ipv8npdy	119	59	or	or	CC
cord-035016-ipv8npdy	119	60	'	'	``
cord-035016-ipv8npdy	119	61	global	global	JJ
cord-035016-ipv8npdy	119	62	public	public	JJ
cord-035016-ipv8npdy	119	63	goods	good	NNS
cord-035016-ipv8npdy	119	64	'	'	POS
cord-035016-ipv8npdy	119	65	,	,	,
cord-035016-ipv8npdy	119	66	or	or	CC
cord-035016-ipv8npdy	119	67	'	'	``
cord-035016-ipv8npdy	119	68	global	global	JJ
cord-035016-ipv8npdy	119	69	health	health	NN
cord-035016-ipv8npdy	119	70	commons	common	NNS
cord-035016-ipv8npdy	119	71	'	'	''
cord-035016-ipv8npdy	119	72	and	and	CC
cord-035016-ipv8npdy	119	73	be	be	VB
cord-035016-ipv8npdy	119	74	available	available	JJ
cord-035016-ipv8npdy	119	75	and	and	CC
cord-035016-ipv8npdy	119	76	affordable	affordable	JJ
cord-035016-ipv8npdy	119	77	(	(	-LRB-
cord-035016-ipv8npdy	119	78	for	for	IN
cord-035016-ipv8npdy	119	79	free	free	JJ
cord-035016-ipv8npdy	119	80	)	)	-RRB-
cord-035016-ipv8npdy	119	81	to	to	IN
cord-035016-ipv8npdy	119	82	all	all	DT
cord-035016-ipv8npdy	119	83	.	.	.
cord-035016-ipv8npdy	120	1	However	however	RB
cord-035016-ipv8npdy	120	2	,	,	,
cord-035016-ipv8npdy	120	3	this	this	DT
cord-035016-ipv8npdy	120	4	voluntarist	voluntarist	JJ
cord-035016-ipv8npdy	120	5	discourse	discourse	NN
cord-035016-ipv8npdy	120	6	has	have	VBZ
cord-035016-ipv8npdy	120	7	not	not	RB
cord-035016-ipv8npdy	120	8	been	be	VBN
cord-035016-ipv8npdy	120	9	followed	follow	VBN
cord-035016-ipv8npdy	120	10	with	with	IN
cord-035016-ipv8npdy	120	11	consequent	consequent	JJ
cord-035016-ipv8npdy	120	12	actions	action	NNS
cord-035016-ipv8npdy	120	13	.	.	.
cord-035016-ipv8npdy	121	1	Instead	instead	RB
cord-035016-ipv8npdy	121	2	,	,	,
cord-035016-ipv8npdy	121	3	we	-PRON-	PRP
cord-035016-ipv8npdy	121	4	've	have	VB
cord-035016-ipv8npdy	121	5	seen	see	VBN
cord-035016-ipv8npdy	121	6	unapologetic	unapologetic	JJ
cord-035016-ipv8npdy	121	7	vaccine	vaccine	NN
cord-035016-ipv8npdy	121	8	nationalism	nationalism	NN
cord-035016-ipv8npdy	121	9	(	(	-LRB-
cord-035016-ipv8npdy	121	10	Kamradt	Kamradt	NNP
cord-035016-ipv8npdy	121	11	-	-	HYPH
cord-035016-ipv8npdy	121	12	Scott	Scott	NNP
cord-035016-ipv8npdy	121	13	2020	2020	CD
cord-035016-ipv8npdy	121	14	)	)	-RRB-
cord-035016-ipv8npdy	121	15	from	from	IN
cord-035016-ipv8npdy	121	16	the	the	DT
cord-035016-ipv8npdy	121	17	US	US	NNP
cord-035016-ipv8npdy	121	18	,	,	,
cord-035016-ipv8npdy	121	19	soon	soon	RB
cord-035016-ipv8npdy	121	20	followed	follow	VBN
cord-035016-ipv8npdy	121	21	by	by	IN
cord-035016-ipv8npdy	121	22	other	other	JJ
cord-035016-ipv8npdy	121	23	wealthy	wealthy	JJ
cord-035016-ipv8npdy	121	24	countries	country	NNS
cord-035016-ipv8npdy	121	25	including	include	VBG
cord-035016-ipv8npdy	121	26	the	the	DT
cord-035016-ipv8npdy	121	27	European	European	NNP
cord-035016-ipv8npdy	121	28	Commission	Commission	NNP
cord-035016-ipv8npdy	121	29	,	,	,
cord-035016-ipv8npdy	121	30	signing	sign	VBG
cord-035016-ipv8npdy	121	31	bilateral	bilateral	JJ
cord-035016-ipv8npdy	121	32	deals	deal	NNS
cord-035016-ipv8npdy	121	33	with	with	IN
cord-035016-ipv8npdy	121	34	companies	company	NNS
cord-035016-ipv8npdy	121	35	to	to	TO
cord-035016-ipv8npdy	121	36	reserve	reserve	VB
cord-035016-ipv8npdy	121	37	the	the	DT
cord-035016-ipv8npdy	121	38	majority	majority	NN
cord-035016-ipv8npdy	121	39	of	of	IN
cord-035016-ipv8npdy	121	40	early	early	JJ
cord-035016-ipv8npdy	121	41	productions	production	NNS
cord-035016-ipv8npdy	121	42	for	for	IN
cord-035016-ipv8npdy	121	43	their	-PRON-	PRP$
cord-035016-ipv8npdy	121	44	own	own	JJ
cord-035016-ipv8npdy	121	45	populations	population	NNS
cord-035016-ipv8npdy	121	46	in	in	IN
cord-035016-ipv8npdy	121	47	what	what	WP
cord-035016-ipv8npdy	121	48	essentially	essentially	RB
cord-035016-ipv8npdy	121	49	is	be	VBZ
cord-035016-ipv8npdy	121	50	an	an	DT
cord-035016-ipv8npdy	121	51	unequal	unequal	JJ
cord-035016-ipv8npdy	121	52	scramble	scramble	NN
cord-035016-ipv8npdy	121	53	for	for	IN
cord-035016-ipv8npdy	121	54	vaccines	vaccine	NNS
cord-035016-ipv8npdy	121	55	(	(	-LRB-
cord-035016-ipv8npdy	121	56	Callaway	Callaway	NNP
cord-035016-ipv8npdy	121	57	2020	2020	CD
cord-035016-ipv8npdy	121	58	)	)	-RRB-
cord-035016-ipv8npdy	121	59	.	.	.
cord-035016-ipv8npdy	122	1	A	a	DT
cord-035016-ipv8npdy	122	2	multilateral	multilateral	JJ
cord-035016-ipv8npdy	122	3	effort	effort	NN
cord-035016-ipv8npdy	122	4	coordinated	coordinate	VBN
cord-035016-ipv8npdy	122	5	by	by	IN
cord-035016-ipv8npdy	122	6	WHO	WHO	NNP
cord-035016-ipv8npdy	122	7	in	in	IN
cord-035016-ipv8npdy	122	8	the	the	DT
cord-035016-ipv8npdy	122	9	context	context	NN
cord-035016-ipv8npdy	122	10	of	of	IN
cord-035016-ipv8npdy	122	11	their	-PRON-	PRP$
cord-035016-ipv8npdy	122	12	Accelerated	Accelerated	NNP
cord-035016-ipv8npdy	122	13	Access	Access	NNP
cord-035016-ipv8npdy	122	14	to	to	IN
cord-035016-ipv8npdy	122	15	Covid	Covid	NNP
cord-035016-ipv8npdy	122	16	Technologies	Technologies	NNP
cord-035016-ipv8npdy	122	17	(	(	-LRB-
cord-035016-ipv8npdy	122	18	ACT	ACT	NNP
cord-035016-ipv8npdy	122	19	-	-	HYPH
cord-035016-ipv8npdy	122	20	A	a	NN
cord-035016-ipv8npdy	122	21	)	)	-RRB-
cord-035016-ipv8npdy	122	22	initiative	initiative	NN
cord-035016-ipv8npdy	122	23	to	to	TO
cord-035016-ipv8npdy	122	24	also	also	RB
cord-035016-ipv8npdy	122	25	ensure	ensure	VB
cord-035016-ipv8npdy	122	26	vaccine	vaccine	NN
cord-035016-ipv8npdy	122	27	availability	availability	NN
cord-035016-ipv8npdy	122	28	for	for	IN
cord-035016-ipv8npdy	122	29	poorer	poor	JJR
cord-035016-ipv8npdy	122	30	countries	country	NNS
cord-035016-ipv8npdy	122	31	in	in	IN
cord-035016-ipv8npdy	122	32	parallel	parallel	NN
cord-035016-ipv8npdy	122	33	(	(	-LRB-
cord-035016-ipv8npdy	122	34	COVAX	COVAX	NNP
cord-035016-ipv8npdy	122	35	)	)	-RRB-
cord-035016-ipv8npdy	122	36	17	17	CD
cord-035016-ipv8npdy	122	37	has	have	VBZ
cord-035016-ipv8npdy	122	38	met	meet	VBN
cord-035016-ipv8npdy	122	39	with	with	IN
cord-035016-ipv8npdy	122	40	mixed	mixed	JJ
cord-035016-ipv8npdy	122	41	success	success	NN
cord-035016-ipv8npdy	122	42	-	-	HYPH
cord-035016-ipv8npdy	122	43	lots	lot	NNS
cord-035016-ipv8npdy	122	44	of	of	IN
cord-035016-ipv8npdy	122	45	verbal	verbal	JJ
cord-035016-ipv8npdy	122	46	support	support	NN
cord-035016-ipv8npdy	122	47	but	but	CC
cord-035016-ipv8npdy	122	48	so	so	RB
cord-035016-ipv8npdy	122	49	far	far	RB
cord-035016-ipv8npdy	122	50	limited	limited	JJ
cord-035016-ipv8npdy	122	51	concrete	concrete	JJ
cord-035016-ipv8npdy	122	52	financial	financial	JJ
cord-035016-ipv8npdy	122	53	commitments	commitment	NNS
cord-035016-ipv8npdy	122	54	.	.	.
cord-035016-ipv8npdy	123	1	It	-PRON-	PRP
cord-035016-ipv8npdy	123	2	is	be	VBZ
cord-035016-ipv8npdy	123	3	also	also	RB
cord-035016-ipv8npdy	123	4	being	be	VBG
cord-035016-ipv8npdy	123	5	criticized	criticize	VBN
cord-035016-ipv8npdy	123	6	for	for	IN
cord-035016-ipv8npdy	123	7	lack	lack	NN
cord-035016-ipv8npdy	123	8	of	of	IN
cord-035016-ipv8npdy	123	9	transparency	transparency	NN
cord-035016-ipv8npdy	123	10	and	and	CC
cord-035016-ipv8npdy	123	11	representation	representation	NN
cord-035016-ipv8npdy	123	12	from	from	IN
cord-035016-ipv8npdy	123	13	the	the	DT
cord-035016-ipv8npdy	123	14	countries	country	NNS
cord-035016-ipv8npdy	123	15	for	for	IN
cord-035016-ipv8npdy	123	16	whom	whom	WP
cord-035016-ipv8npdy	123	17	COVAX	COVAX	NNP
cord-035016-ipv8npdy	123	18	is	be	VBZ
cord-035016-ipv8npdy	123	19	supposed	suppose	VBN
cord-035016-ipv8npdy	123	20	to	to	TO
cord-035016-ipv8npdy	123	21	deliver	deliver	VB
cord-035016-ipv8npdy	123	22	solutions	solution	NNS
cord-035016-ipv8npdy	123	23	.	.	.
cord-035016-ipv8npdy	124	1	18	18	CD
cord-035016-ipv8npdy	125	1	The	the	DT
cord-035016-ipv8npdy	125	2	main	main	JJ
cord-035016-ipv8npdy	125	3	strategy	strategy	NN
cord-035016-ipv8npdy	125	4	used	use	VBN
cord-035016-ipv8npdy	125	5	by	by	IN
cord-035016-ipv8npdy	125	6	governments	government	NNS
cord-035016-ipv8npdy	125	7	to	to	TO
cord-035016-ipv8npdy	125	8	'	'	``
cord-035016-ipv8npdy	125	9	ensure	ensure	VB
cord-035016-ipv8npdy	125	10	'	'	''
cord-035016-ipv8npdy	125	11	access	access	NN
cord-035016-ipv8npdy	125	12	is	be	VBZ
cord-035016-ipv8npdy	125	13	through	through	IN
cord-035016-ipv8npdy	125	14	signing	sign	VBG
cord-035016-ipv8npdy	125	15	advance	advance	NN
cord-035016-ipv8npdy	125	16	purchase	purchase	NN
cord-035016-ipv8npdy	125	17	commitments	commitment	NNS
cord-035016-ipv8npdy	125	18	with	with	IN
cord-035016-ipv8npdy	125	19	the	the	DT
cord-035016-ipv8npdy	125	20	front	front	JJ
cord-035016-ipv8npdy	125	21	-	-	HYPH
cord-035016-ipv8npdy	125	22	runner	runner	NN
cord-035016-ipv8npdy	125	23	vaccine	vaccine	NN
cord-035016-ipv8npdy	125	24	developers	developer	NNS
cord-035016-ipv8npdy	125	25	(	(	-LRB-
cord-035016-ipv8npdy	125	26	often	often	RB
cord-035016-ipv8npdy	125	27	in	in	IN
cord-035016-ipv8npdy	125	28	combination	combination	NN
cord-035016-ipv8npdy	125	29	with	with	IN
cord-035016-ipv8npdy	125	30	significant	significant	JJ
cord-035016-ipv8npdy	125	31	investments	investment	NNS
cord-035016-ipv8npdy	125	32	in	in	IN
cord-035016-ipv8npdy	125	33	R&D	r&d	NN
cord-035016-ipv8npdy	125	34	and	and	CC
cord-035016-ipv8npdy	125	35	even	even	RB
cord-035016-ipv8npdy	125	36	manufacturing	manufacture	VBG
cord-035016-ipv8npdy	125	37	)	)	-RRB-
cord-035016-ipv8npdy	125	38	.	.	.
cord-035016-ipv8npdy	126	1	While	while	IN
cord-035016-ipv8npdy	126	2	initially	initially	RB
cord-035016-ipv8npdy	126	3	designed	design	VBN
cord-035016-ipv8npdy	126	4	as	as	IN
cord-035016-ipv8npdy	126	5	a	a	DT
cord-035016-ipv8npdy	126	6	market	market	NN
cord-035016-ipv8npdy	126	7	fixing	fix	VBG
cord-035016-ipv8npdy	126	8	pull	pull	NN
cord-035016-ipv8npdy	126	9	mechanism	mechanism	NN
cord-035016-ipv8npdy	126	10	to	to	TO
cord-035016-ipv8npdy	126	11	incentivize	incentivize	VB
cord-035016-ipv8npdy	126	12	companies	company	NNS
cord-035016-ipv8npdy	126	13	to	to	TO
cord-035016-ipv8npdy	126	14	do	do	VB
cord-035016-ipv8npdy	126	15	R&D	r&d	NN
cord-035016-ipv8npdy	126	16	in	in	IN
cord-035016-ipv8npdy	126	17	directions	direction	NNS
cord-035016-ipv8npdy	126	18	they	-PRON-	PRP
cord-035016-ipv8npdy	126	19	would	would	MD
cord-035016-ipv8npdy	126	20	not	not	RB
cord-035016-ipv8npdy	126	21	otherwise	otherwise	RB
cord-035016-ipv8npdy	126	22	go	go	VB
cord-035016-ipv8npdy	126	23	,	,	,
cord-035016-ipv8npdy	126	24	governments	government	NNS
cord-035016-ipv8npdy	126	25	have	have	VBP
cord-035016-ipv8npdy	126	26	perverted	pervert	VBN
cord-035016-ipv8npdy	126	27	APCs	apc	NNS
cord-035016-ipv8npdy	126	28	to	to	TO
cord-035016-ipv8npdy	126	29	guarantee	guarantee	VB
cord-035016-ipv8npdy	126	30	supply	supply	NN
cord-035016-ipv8npdy	126	31	and	and	CC
cord-035016-ipv8npdy	126	32	buy	buy	VB
cord-035016-ipv8npdy	126	33	up	up	RP
cord-035016-ipv8npdy	126	34	the	the	DT
cord-035016-ipv8npdy	126	35	first	first	JJ
cord-035016-ipv8npdy	126	36	in	in	IN
cord-035016-ipv8npdy	126	37	line	line	NN
cord-035016-ipv8npdy	126	38	positions	position	NNS
cord-035016-ipv8npdy	126	39	for	for	IN
cord-035016-ipv8npdy	126	40	once	once	RB
cord-035016-ipv8npdy	126	41	the	the	DT
cord-035016-ipv8npdy	126	42	vaccines	vaccine	NNS
cord-035016-ipv8npdy	126	43	become	become	VBP
cord-035016-ipv8npdy	126	44	available	available	JJ
cord-035016-ipv8npdy	126	45	,	,	,
cord-035016-ipv8npdy	126	46	without	without	IN
cord-035016-ipv8npdy	126	47	even	even	RB
cord-035016-ipv8npdy	126	48	putting	put	VBG
cord-035016-ipv8npdy	126	49	demands	demand	NNS
cord-035016-ipv8npdy	126	50	in	in	IN
cord-035016-ipv8npdy	126	51	terms	term	NNS
cord-035016-ipv8npdy	126	52	of	of	IN
cord-035016-ipv8npdy	126	53	desired	desire	VBN
cord-035016-ipv8npdy	126	54	product	product	NN
cord-035016-ipv8npdy	126	55	profile	profile	NN
cord-035016-ipv8npdy	126	56	or	or	CC
cord-035016-ipv8npdy	126	57	pricing	pricing	NN
cord-035016-ipv8npdy	126	58	.	.	.
cord-035016-ipv8npdy	127	1	This	this	DT
cord-035016-ipv8npdy	127	2	further	further	JJ
cord-035016-ipv8npdy	127	3	shifts	shift	VBZ
cord-035016-ipv8npdy	127	4	the	the	DT
cord-035016-ipv8npdy	127	5	power	power	NN
cord-035016-ipv8npdy	127	6	imbalance	imbalance	NN
cord-035016-ipv8npdy	127	7	between	between	IN
cord-035016-ipv8npdy	127	8	governments	government	NNS
cord-035016-ipv8npdy	127	9	and	and	CC
cord-035016-ipv8npdy	127	10	vaccines	vaccine	NNS
cord-035016-ipv8npdy	127	11	companies	company	NNS
cord-035016-ipv8npdy	127	12	,	,	,
cord-035016-ipv8npdy	127	13	who	who	WP
cord-035016-ipv8npdy	127	14	successfully	successfully	RB
cord-035016-ipv8npdy	127	15	turned	turn	VBD
cord-035016-ipv8npdy	127	16	the	the	DT
cord-035016-ipv8npdy	127	17	COVID-19	covid-19	JJ
cord-035016-ipv8npdy	127	18	crisis	crisis	NN
cord-035016-ipv8npdy	127	19	to	to	IN
cord-035016-ipv8npdy	127	20	their	-PRON-	PRP$
cord-035016-ipv8npdy	127	21	advantage	advantage	NN
cord-035016-ipv8npdy	127	22	and	and	CC
cord-035016-ipv8npdy	127	23	positioned	position	VBD
cord-035016-ipv8npdy	127	24	themselves	-PRON-	PRP
cord-035016-ipv8npdy	127	25	as	as	IN
cord-035016-ipv8npdy	127	26	key	key	NN
cord-035016-ipv8npdy	127	27	to	to	IN
cord-035016-ipv8npdy	127	28	the	the	DT
cord-035016-ipv8npdy	127	29	solutions	solution	NNS
cord-035016-ipv8npdy	127	30	,	,	,
cord-035016-ipv8npdy	127	31	while	while	IN
cord-035016-ipv8npdy	127	32	largely	largely	RB
cord-035016-ipv8npdy	127	33	dictating	dictate	VBG
cord-035016-ipv8npdy	127	34	the	the	DT
cord-035016-ipv8npdy	127	35	terms	term	NNS
cord-035016-ipv8npdy	127	36	of	of	IN
cord-035016-ipv8npdy	127	37	engagement	engagement	NN
cord-035016-ipv8npdy	127	38	,	,	,
cord-035016-ipv8npdy	127	39	not	not	RB
cord-035016-ipv8npdy	127	40	only	only	RB
cord-035016-ipv8npdy	127	41	for	for	IN
cord-035016-ipv8npdy	127	42	availability	availability	NN
cord-035016-ipv8npdy	127	43	and	and	CC
cord-035016-ipv8npdy	127	44	access	access	NN
cord-035016-ipv8npdy	127	45	to	to	IN
cord-035016-ipv8npdy	127	46	vaccines	vaccine	NNS
cord-035016-ipv8npdy	127	47	in	in	IN
cord-035016-ipv8npdy	127	48	wealth	wealth	NN
cord-035016-ipv8npdy	127	49	countries	country	NNS
cord-035016-ipv8npdy	127	50	but	but	CC
cord-035016-ipv8npdy	127	51	also	also	RB
cord-035016-ipv8npdy	127	52	globally	globally	RB
cord-035016-ipv8npdy	127	53	.	.	.
cord-035016-ipv8npdy	128	1	At	at	IN
cord-035016-ipv8npdy	128	2	the	the	DT
cord-035016-ipv8npdy	128	3	same	same	JJ
cord-035016-ipv8npdy	128	4	time	time	NN
cord-035016-ipv8npdy	128	5	,	,	,
cord-035016-ipv8npdy	128	6	acknowledging	acknowledge	VBG
cord-035016-ipv8npdy	128	7	that	that	IN
cord-035016-ipv8npdy	128	8	there	there	EX
cord-035016-ipv8npdy	128	9	will	will	MD
cord-035016-ipv8npdy	128	10	likely	likely	RB
cord-035016-ipv8npdy	128	11	be	be	VB
cord-035016-ipv8npdy	128	12	a	a	DT
cord-035016-ipv8npdy	128	13	period	period	NN
cord-035016-ipv8npdy	128	14	during	during	IN
cord-035016-ipv8npdy	128	15	which	which	WDT
cord-035016-ipv8npdy	128	16	supply	supply	NN
cord-035016-ipv8npdy	128	17	will	will	MD
cord-035016-ipv8npdy	128	18	not	not	RB
cord-035016-ipv8npdy	128	19	be	be	VB
cord-035016-ipv8npdy	128	20	able	able	JJ
cord-035016-ipv8npdy	128	21	to	to	TO
cord-035016-ipv8npdy	128	22	meet	meet	VB
cord-035016-ipv8npdy	128	23	demand	demand	NN
cord-035016-ipv8npdy	128	24	,	,	,
cord-035016-ipv8npdy	128	25	difficult	difficult	JJ
cord-035016-ipv8npdy	128	26	discussions	discussion	NNS
cord-035016-ipv8npdy	128	27	are	be	VBP
cord-035016-ipv8npdy	128	28	ongoing	ongoing	JJ
cord-035016-ipv8npdy	128	29	about	about	IN
cord-035016-ipv8npdy	128	30	(	(	-LRB-
cord-035016-ipv8npdy	128	31	principles	principle	NNS
cord-035016-ipv8npdy	128	32	for	for	IN
cord-035016-ipv8npdy	128	33	)	)	-RRB-
cord-035016-ipv8npdy	128	34	fair	fair	JJ
cord-035016-ipv8npdy	128	35	and	and	CC
cord-035016-ipv8npdy	128	36	equitable	equitable	JJ
cord-035016-ipv8npdy	128	37	allocation	allocation	NN
cord-035016-ipv8npdy	128	38	frameworks	framework	NNS
cord-035016-ipv8npdy	128	39	,	,	,
cord-035016-ipv8npdy	128	40	both	both	CC
cord-035016-ipv8npdy	128	41	globally	globally	RB
cord-035016-ipv8npdy	128	42	and	and	CC
cord-035016-ipv8npdy	128	43	within	within	IN
cord-035016-ipv8npdy	128	44	countries	country	NNS
cord-035016-ipv8npdy	128	45	(	(	-LRB-
cord-035016-ipv8npdy	128	46	Samuel	Samuel	NNP
cord-035016-ipv8npdy	128	47	2020	2020	CD
cord-035016-ipv8npdy	128	48	)	)	-RRB-
cord-035016-ipv8npdy	128	49	.	.	.
cord-035016-ipv8npdy	129	1	While	while	IN
cord-035016-ipv8npdy	129	2	it	-PRON-	PRP
cord-035016-ipv8npdy	129	3	is	be	VBZ
cord-035016-ipv8npdy	129	4	beyond	beyond	IN
cord-035016-ipv8npdy	129	5	the	the	DT
cord-035016-ipv8npdy	129	6	scope	scope	NN
cord-035016-ipv8npdy	129	7	of	of	IN
cord-035016-ipv8npdy	129	8	this	this	DT
cord-035016-ipv8npdy	129	9	article	article	NN
cord-035016-ipv8npdy	129	10	to	to	TO
cord-035016-ipv8npdy	129	11	go	go	VB
cord-035016-ipv8npdy	129	12	into	into	IN
cord-035016-ipv8npdy	129	13	detail	detail	NN
cord-035016-ipv8npdy	129	14	on	on	IN
cord-035016-ipv8npdy	129	15	these	these	DT
cord-035016-ipv8npdy	129	16	,	,	,
cord-035016-ipv8npdy	129	17	it	-PRON-	PRP
cord-035016-ipv8npdy	129	18	is	be	VBZ
cord-035016-ipv8npdy	129	19	important	important	JJ
cord-035016-ipv8npdy	129	20	to	to	TO
cord-035016-ipv8npdy	129	21	highlight	highlight	VB
cord-035016-ipv8npdy	129	22	how	how	WRB
cord-035016-ipv8npdy	129	23	allocation	allocation	NN
cord-035016-ipv8npdy	129	24	frameworks	framework	NNS
cord-035016-ipv8npdy	129	25	and	and	CC
cord-035016-ipv8npdy	129	26	vaccination	vaccination	NN
cord-035016-ipv8npdy	129	27	strategies	strategy	NNS
cord-035016-ipv8npdy	129	28	can	can	MD
cord-035016-ipv8npdy	129	29	not	not	RB
cord-035016-ipv8npdy	129	30	be	be	VB
cord-035016-ipv8npdy	129	31	seen	see	VBN
cord-035016-ipv8npdy	129	32	independently	independently	RB
cord-035016-ipv8npdy	129	33	of	of	IN
cord-035016-ipv8npdy	129	34	the	the	DT
cord-035016-ipv8npdy	129	35	exact	exact	JJ
cord-035016-ipv8npdy	129	36	profile	profile	NN
cord-035016-ipv8npdy	129	37	and	and	CC
cord-035016-ipv8npdy	129	38	characteristics	characteristic	NNS
cord-035016-ipv8npdy	129	39	of	of	IN
cord-035016-ipv8npdy	129	40	the	the	DT
cord-035016-ipv8npdy	129	41	available	available	JJ
cord-035016-ipv8npdy	129	42	vaccines	vaccine	NNS
cord-035016-ipv8npdy	129	43	-	-	:
cord-035016-ipv8npdy	129	44	which	which	WDT
cord-035016-ipv8npdy	129	45	we	-PRON-	PRP
cord-035016-ipv8npdy	129	46	still	still	RB
cord-035016-ipv8npdy	129	47	do	do	VBP
cord-035016-ipv8npdy	129	48	n't	not	RB
cord-035016-ipv8npdy	129	49	know	know	VB
cord-035016-ipv8npdy	129	50	.	.	.
cord-035016-ipv8npdy	130	1	Most	most	RBS
cord-035016-ipv8npdy	130	2	critically	critically	RB
cord-035016-ipv8npdy	130	3	however	however	RB
cord-035016-ipv8npdy	130	4	,	,	,
cord-035016-ipv8npdy	130	5	having	have	VBG
cord-035016-ipv8npdy	130	6	left	leave	VBN
cord-035016-ipv8npdy	130	7	ownership	ownership	NN
cord-035016-ipv8npdy	130	8	and	and	CC
cord-035016-ipv8npdy	130	9	control	control	NN
cord-035016-ipv8npdy	130	10	over	over	IN
cord-035016-ipv8npdy	130	11	the	the	DT
cord-035016-ipv8npdy	130	12	vaccines	vaccine	NNS
cord-035016-ipv8npdy	130	13	to	to	IN
cord-035016-ipv8npdy	130	14	pharmaceutical	pharmaceutical	JJ
cord-035016-ipv8npdy	130	15	companies	company	NNS
cord-035016-ipv8npdy	130	16	,	,	,
cord-035016-ipv8npdy	130	17	we	-PRON-	PRP
cord-035016-ipv8npdy	130	18	do	do	VBP
cord-035016-ipv8npdy	130	19	not	not	RB
cord-035016-ipv8npdy	130	20	have	have	VB
cord-035016-ipv8npdy	130	21	a	a	DT
cord-035016-ipv8npdy	130	22	collective	collective	JJ
cord-035016-ipv8npdy	130	23	and	and	CC
cord-035016-ipv8npdy	130	24	public	public	JJ
cord-035016-ipv8npdy	130	25	-	-	HYPH
cord-035016-ipv8npdy	130	26	health	health	NN
cord-035016-ipv8npdy	130	27	driven	drive	VBN
cord-035016-ipv8npdy	130	28	governance	governance	NN
cord-035016-ipv8npdy	130	29	mechanism	mechanism	NN
cord-035016-ipv8npdy	130	30	that	that	WDT
cord-035016-ipv8npdy	130	31	is	be	VBZ
cord-035016-ipv8npdy	130	32	able	able	JJ
cord-035016-ipv8npdy	130	33	to	to	TO
cord-035016-ipv8npdy	130	34	organize	organize	VB
cord-035016-ipv8npdy	130	35	and	and	CC
cord-035016-ipv8npdy	130	36	steer	steer	VB
cord-035016-ipv8npdy	130	37	vaccine	vaccine	NN
cord-035016-ipv8npdy	130	38	allocation	allocation	NN
cord-035016-ipv8npdy	130	39	and	and	CC
cord-035016-ipv8npdy	130	40	access	access	NN
cord-035016-ipv8npdy	130	41	in	in	IN
cord-035016-ipv8npdy	130	42	ways	way	NNS
cord-035016-ipv8npdy	130	43	that	that	WDT
cord-035016-ipv8npdy	130	44	maximize	maximize	VBP
cord-035016-ipv8npdy	130	45	health	health	NN
cord-035016-ipv8npdy	130	46	impact	impact	NN
cord-035016-ipv8npdy	130	47	(	(	-LRB-
cord-035016-ipv8npdy	130	48	Mazzucato	Mazzucato	NNP
cord-035016-ipv8npdy	130	49	and	and	CC
cord-035016-ipv8npdy	130	50	Torreele	Torreele	NNP
cord-035016-ipv8npdy	130	51	2020	2020	CD
cord-035016-ipv8npdy	130	52	)	)	-RRB-
cord-035016-ipv8npdy	130	53	.	.	.
cord-035016-ipv8npdy	131	1	The	the	DT
cord-035016-ipv8npdy	131	2	race	race	NN
cord-035016-ipv8npdy	131	3	for	for	IN
cord-035016-ipv8npdy	131	4	a	a	DT
cord-035016-ipv8npdy	131	5	COVID-19	covid-19	JJ
cord-035016-ipv8npdy	131	6	vaccine	vaccine	NN
cord-035016-ipv8npdy	131	7	exposes	expose	VBZ
cord-035016-ipv8npdy	131	8	the	the	DT
cord-035016-ipv8npdy	131	9	many	many	JJ
cord-035016-ipv8npdy	131	10	ways	way	NNS
cord-035016-ipv8npdy	131	11	in	in	IN
cord-035016-ipv8npdy	131	12	which	which	WDT
cord-035016-ipv8npdy	131	13	a	a	DT
cord-035016-ipv8npdy	131	14	proprietary	proprietary	JJ
cord-035016-ipv8npdy	131	15	and	and	CC
cord-035016-ipv8npdy	131	16	market	market	NN
cord-035016-ipv8npdy	131	17	-	-	HYPH
cord-035016-ipv8npdy	131	18	based	base	VBN
cord-035016-ipv8npdy	131	19	R&D	r&d	NN
cord-035016-ipv8npdy	131	20	model	model	NN
cord-035016-ipv8npdy	131	21	is	be	VBZ
cord-035016-ipv8npdy	131	22	illsuited	illsuite	VBN
cord-035016-ipv8npdy	131	23	,	,	,
cord-035016-ipv8npdy	131	24	by	by	IN
cord-035016-ipv8npdy	131	25	design	design	NN
cord-035016-ipv8npdy	131	26	,	,	,
cord-035016-ipv8npdy	131	27	to	to	TO
cord-035016-ipv8npdy	131	28	deliver	deliver	VB
cord-035016-ipv8npdy	131	29	appropriate	appropriate	JJ
cord-035016-ipv8npdy	131	30	vaccines	vaccine	NNS
cord-035016-ipv8npdy	131	31	to	to	TO
cord-035016-ipv8npdy	131	32	implement	implement	VB
cord-035016-ipv8npdy	131	33	effective	effective	JJ
cord-035016-ipv8npdy	131	34	vaccination	vaccination	NN
cord-035016-ipv8npdy	131	35	strategies	strategy	NNS
cord-035016-ipv8npdy	131	36	to	to	TO
cord-035016-ipv8npdy	131	37	tackle	tackle	VB
cord-035016-ipv8npdy	131	38	this	this	DT
cord-035016-ipv8npdy	131	39	pandemic	pandemic	NN
cord-035016-ipv8npdy	131	40	.	.	.
cord-035016-ipv8npdy	132	1	Vaccines	vaccine	NNS
cord-035016-ipv8npdy	132	2	and	and	CC
cord-035016-ipv8npdy	132	3	other	other	JJ
cord-035016-ipv8npdy	132	4	health	health	NN
cord-035016-ipv8npdy	132	5	technologies	technology	NNS
cord-035016-ipv8npdy	132	6	are	be	VBP
cord-035016-ipv8npdy	132	7	particularly	particularly	RB
cord-035016-ipv8npdy	132	8	suited	suit	VBN
cord-035016-ipv8npdy	132	9	to	to	TO
cord-035016-ipv8npdy	132	10	be	be	VB
cord-035016-ipv8npdy	132	11	considered	consider	VBN
cord-035016-ipv8npdy	132	12	global	global	JJ
cord-035016-ipv8npdy	132	13	commons	common	NNS
cord-035016-ipv8npdy	132	14	and	and	CC
cord-035016-ipv8npdy	132	15	benefit	benefit	VBP
cord-035016-ipv8npdy	132	16	from	from	IN
cord-035016-ipv8npdy	132	17	open	open	JJ
cord-035016-ipv8npdy	132	18	scientific	scientific	JJ
cord-035016-ipv8npdy	132	19	collaboration	collaboration	NN
cord-035016-ipv8npdy	132	20	,	,	,
cord-035016-ipv8npdy	132	21	especially	especially	RB
cord-035016-ipv8npdy	132	22	when	when	WRB
cord-035016-ipv8npdy	132	23	they	-PRON-	PRP
cord-035016-ipv8npdy	132	24	protect	protect	VBP
cord-035016-ipv8npdy	132	25	us	-PRON-	PRP
cord-035016-ipv8npdy	132	26	against	against	IN
cord-035016-ipv8npdy	132	27	infectious	infectious	JJ
cord-035016-ipv8npdy	132	28	diseases	disease	NNS
cord-035016-ipv8npdy	132	29	that	that	WDT
cord-035016-ipv8npdy	132	30	do	do	VBP
cord-035016-ipv8npdy	132	31	not	not	RB
cord-035016-ipv8npdy	132	32	care	care	VB
cord-035016-ipv8npdy	132	33	for	for	IN
cord-035016-ipv8npdy	132	34	national	national	JJ
cord-035016-ipv8npdy	132	35	borders	border	NNS
cord-035016-ipv8npdy	132	36	,	,	,
cord-035016-ipv8npdy	132	37	private	private	JJ
cord-035016-ipv8npdy	132	38	(	(	-LRB-
cord-035016-ipv8npdy	132	39	intellectual	intellectual	JJ
cord-035016-ipv8npdy	132	40	)	)	-RRB-
cord-035016-ipv8npdy	132	41	property	property	NN
cord-035016-ipv8npdy	132	42	,	,	,
cord-035016-ipv8npdy	132	43	shareholder	shareholder	NN
cord-035016-ipv8npdy	132	44	value	value	NN
cord-035016-ipv8npdy	132	45	or	or	CC
cord-035016-ipv8npdy	132	46	market	market	NN
cord-035016-ipv8npdy	132	47	dynamics	dynamic	NNS
cord-035016-ipv8npdy	132	48	.	.	.
cord-035016-ipv8npdy	133	1	Policy	policy	NN
cord-035016-ipv8npdy	133	2	makers	maker	NNS
cord-035016-ipv8npdy	133	3	all	all	RB
cord-035016-ipv8npdy	133	4	over	over	IN
cord-035016-ipv8npdy	133	5	the	the	DT
cord-035016-ipv8npdy	133	6	world	world	NN
cord-035016-ipv8npdy	133	7	can	can	MD
cord-035016-ipv8npdy	133	8	and	and	CC
cord-035016-ipv8npdy	133	9	must	must	MD
cord-035016-ipv8npdy	133	10	assume	assume	VB
cord-035016-ipv8npdy	133	11	responsibility	responsibility	NN
cord-035016-ipv8npdy	133	12	for	for	IN
cord-035016-ipv8npdy	133	13	delivering	deliver	VBG
cord-035016-ipv8npdy	133	14	such	such	JJ
cord-035016-ipv8npdy	133	15	global	global	JJ
cord-035016-ipv8npdy	133	16	health	health	NN
cord-035016-ipv8npdy	133	17	commons	common	NNS
cord-035016-ipv8npdy	133	18	and	and	CC
cord-035016-ipv8npdy	133	19	shape	shape	VB
cord-035016-ipv8npdy	133	20	the	the	DT
cord-035016-ipv8npdy	133	21	R&D	r&d	NN
cord-035016-ipv8npdy	133	22	ecosystem	ecosystem	NN
cord-035016-ipv8npdy	133	23	accordingly	accordingly	RB
cord-035016-ipv8npdy	133	24	.	.	.
cord-035016-ipv8npdy	134	1	Driving	drive	VBG
cord-035016-ipv8npdy	134	2	medical	medical	JJ
cord-035016-ipv8npdy	134	3	innovation	innovation	NN
cord-035016-ipv8npdy	134	4	in	in	IN
cord-035016-ipv8npdy	134	5	that	that	DT
cord-035016-ipv8npdy	134	6	direction	direction	NN
cord-035016-ipv8npdy	134	7	requires	require	VBZ
cord-035016-ipv8npdy	134	8	a	a	DT
cord-035016-ipv8npdy	134	9	major	major	JJ
cord-035016-ipv8npdy	134	10	shift	shift	NN
cord-035016-ipv8npdy	134	11	in	in	IN
cord-035016-ipv8npdy	134	12	how	how	WRB
cord-035016-ipv8npdy	134	13	governments	government	NNS
cord-035016-ipv8npdy	134	14	see	see	VBP
cord-035016-ipv8npdy	134	15	and	and	CC
cord-035016-ipv8npdy	134	16	exercise	exercise	VB
cord-035016-ipv8npdy	134	17	their	-PRON-	PRP$
cord-035016-ipv8npdy	134	18	role	role	NN
cord-035016-ipv8npdy	134	19	,	,	,
cord-035016-ipv8npdy	134	20	from	from	IN
cord-035016-ipv8npdy	134	21	by	by	IN
cord-035016-ipv8npdy	134	22	-	-	HYPH
cord-035016-ipv8npdy	134	23	stander	stander	NN
cord-035016-ipv8npdy	134	24	market	market	NN
cord-035016-ipv8npdy	134	25	fixing	fix	VBG
cord-035016-ipv8npdy	134	26	to	to	IN
cord-035016-ipv8npdy	134	27	proactive	proactive	JJ
cord-035016-ipv8npdy	134	28	entrepreneurial	entrepreneurial	JJ
cord-035016-ipv8npdy	134	29	states	state	NNS
cord-035016-ipv8npdy	134	30	(	(	-LRB-
cord-035016-ipv8npdy	134	31	Mazzucato	Mazzucato	NNP
cord-035016-ipv8npdy	134	32	2013	2013	CD
cord-035016-ipv8npdy	134	33	)	)	-RRB-
cord-035016-ipv8npdy	134	34	.	.	.
cord-035016-ipv8npdy	135	1	Instead	instead	RB
cord-035016-ipv8npdy	135	2	of	of	IN
cord-035016-ipv8npdy	135	3	handing	hand	VBG
cord-035016-ipv8npdy	135	4	out	out	RP
cord-035016-ipv8npdy	135	5	subsidies	subsidy	NNS
cord-035016-ipv8npdy	135	6	and	and	CC
cord-035016-ipv8npdy	135	7	market	market	NN
cord-035016-ipv8npdy	135	8	commitments	commitment	NNS
cord-035016-ipv8npdy	135	9	without	without	IN
cord-035016-ipv8npdy	135	10	strings	string	NNS
cord-035016-ipv8npdy	135	11	attached	attach	VBN
cord-035016-ipv8npdy	135	12	,	,	,
cord-035016-ipv8npdy	135	13	this	this	DT
cord-035016-ipv8npdy	135	14	means	mean	VBZ
cord-035016-ipv8npdy	135	15	the	the	DT
cord-035016-ipv8npdy	135	16	active	active	JJ
cord-035016-ipv8npdy	135	17	steering	steering	NN
cord-035016-ipv8npdy	135	18	of	of	IN
cord-035016-ipv8npdy	135	19	innovation	innovation	NN
cord-035016-ipv8npdy	135	20	towards	towards	IN
cord-035016-ipv8npdy	135	21	the	the	DT
cord-035016-ipv8npdy	135	22	desired	desire	VBN
cord-035016-ipv8npdy	135	23	product	product	NN
cord-035016-ipv8npdy	135	24	characteristics	characteristic	NNS
cord-035016-ipv8npdy	135	25	and	and	CC
cord-035016-ipv8npdy	135	26	mobilizing	mobilize	VBG
cord-035016-ipv8npdy	135	27	the	the	DT
cord-035016-ipv8npdy	135	28	collective	collective	JJ
cord-035016-ipv8npdy	135	29	intelligence	intelligence	NN
cord-035016-ipv8npdy	135	30	of	of	IN
cord-035016-ipv8npdy	135	31	researchers	researcher	NNS
cord-035016-ipv8npdy	135	32	globally	globally	RB
cord-035016-ipv8npdy	135	33	(	(	-LRB-
cord-035016-ipv8npdy	135	34	Mazzucato	Mazzucato	NNP
cord-035016-ipv8npdy	135	35	2020	2020	CD
cord-035016-ipv8npdy	135	36	)	)	-RRB-
cord-035016-ipv8npdy	135	37	.	.	.
cord-035016-ipv8npdy	136	1	It	-PRON-	PRP
cord-035016-ipv8npdy	136	2	includes	include	VBZ
cord-035016-ipv8npdy	136	3	shaping	shape	VBG
cord-035016-ipv8npdy	136	4	the	the	DT
cord-035016-ipv8npdy	136	5	incentives	incentive	NNS
cord-035016-ipv8npdy	136	6	and	and	CC
cord-035016-ipv8npdy	136	7	rules	rule	NNS
cord-035016-ipv8npdy	136	8	for	for	IN
cord-035016-ipv8npdy	136	9	public	public	JJ
cord-035016-ipv8npdy	136	10	and	and	CC
cord-035016-ipv8npdy	136	11	private	private	JJ
cord-035016-ipv8npdy	136	12	sector	sector	NN
cord-035016-ipv8npdy	136	13	collaboration	collaboration	NN
cord-035016-ipv8npdy	136	14	,	,	,
cord-035016-ipv8npdy	136	15	in	in	IN
cord-035016-ipv8npdy	136	16	particular	particular	JJ
cord-035016-ipv8npdy	136	17	knowledge	knowledge	NN
cord-035016-ipv8npdy	136	18	management	management	NN
cord-035016-ipv8npdy	136	19	,	,	,
cord-035016-ipv8npdy	136	20	to	to	TO
cord-035016-ipv8npdy	136	21	optimally	optimally	RB
cord-035016-ipv8npdy	136	22	work	work	VB
cord-035016-ipv8npdy	136	23	together	together	RB
cord-035016-ipv8npdy	136	24	towards	towards	IN
cord-035016-ipv8npdy	136	25	achieving	achieve	VBG
cord-035016-ipv8npdy	136	26	the	the	DT
cord-035016-ipv8npdy	136	27	public	public	JJ
cord-035016-ipv8npdy	136	28	interest	interest	NN
cord-035016-ipv8npdy	136	29	goals	goal	NNS
cord-035016-ipv8npdy	136	30	.	.	.
cord-035016-ipv8npdy	137	1	The	the	DT
cord-035016-ipv8npdy	137	2	scientific	scientific	JJ
cord-035016-ipv8npdy	137	3	community	community	NN
cord-035016-ipv8npdy	137	4	,	,	,
cord-035016-ipv8npdy	137	5	with	with	IN
cord-035016-ipv8npdy	137	6	its	-PRON-	PRP$
cord-035016-ipv8npdy	137	7	wealth	wealth	NN
cord-035016-ipv8npdy	137	8	of	of	IN
cord-035016-ipv8npdy	137	9	public	public	JJ
cord-035016-ipv8npdy	137	10	health	health	NN
cord-035016-ipv8npdy	137	11	and	and	CC
cord-035016-ipv8npdy	137	12	infectious	infectious	JJ
cord-035016-ipv8npdy	137	13	diseases	disease	NNS
cord-035016-ipv8npdy	137	14	expertise	expertise	NN
cord-035016-ipv8npdy	137	15	could	could	MD
cord-035016-ipv8npdy	137	16	be	be	VB
cord-035016-ipv8npdy	137	17	a	a	DT
cord-035016-ipv8npdy	137	18	key	key	JJ
cord-035016-ipv8npdy	137	19	driver	driver	NN
cord-035016-ipv8npdy	137	20	to	to	IN
cord-035016-ipv8npdy	137	21	this	this	DT
cord-035016-ipv8npdy	137	22	effect	effect	NN
cord-035016-ipv8npdy	137	23	,	,	,
cord-035016-ipv8npdy	137	24	redefining	redefine	VBG
cord-035016-ipv8npdy	137	25	health	health	NN
cord-035016-ipv8npdy	137	26	innovation	innovation	NN
cord-035016-ipv8npdy	137	27	to	to	TO
cord-035016-ipv8npdy	137	28	address	address	VB
cord-035016-ipv8npdy	137	29	public	public	JJ
cord-035016-ipv8npdy	137	30	health	health	NN
cord-035016-ipv8npdy	137	31	needs	need	NNS
cord-035016-ipv8npdy	137	32	,	,	,
cord-035016-ipv8npdy	137	33	not	not	RB
cord-035016-ipv8npdy	137	34	commercial	commercial	JJ
cord-035016-ipv8npdy	137	35	success	success	NN
cord-035016-ipv8npdy	137	36	.	.	.
cord-035016-ipv8npdy	138	1	These	these	DT
cord-035016-ipv8npdy	138	2	ideas	idea	NNS
cord-035016-ipv8npdy	138	3	are	be	VBP
cord-035016-ipv8npdy	138	4	not	not	RB
cord-035016-ipv8npdy	138	5	as	as	RB
cord-035016-ipv8npdy	138	6	far	far	RB
cord-035016-ipv8npdy	138	7	-	-	HYPH
cord-035016-ipv8npdy	138	8	fetched	fetch	VBN
cord-035016-ipv8npdy	138	9	as	as	IN
cord-035016-ipv8npdy	138	10	one	one	PRP
cord-035016-ipv8npdy	138	11	might	may	MD
cord-035016-ipv8npdy	138	12	thinkthe	thinkthe	VB
cord-035016-ipv8npdy	138	13	US	US	NNP
cord-035016-ipv8npdy	138	14	Department	Department	NNP
cord-035016-ipv8npdy	138	15	of	of	IN
cord-035016-ipv8npdy	138	16	Defence	Defence	NNP
cord-035016-ipv8npdy	138	17	,	,	,
cord-035016-ipv8npdy	138	18	in	in	IN
cord-035016-ipv8npdy	138	19	particular	particular	JJ
cord-035016-ipv8npdy	138	20	through	through	IN
cord-035016-ipv8npdy	138	21	their	-PRON-	PRP$
cord-035016-ipv8npdy	138	22	Defence	Defence	NNP
cord-035016-ipv8npdy	138	23	Advanced	Advanced	NNP
cord-035016-ipv8npdy	138	24	Research	Research	NNP
cord-035016-ipv8npdy	138	25	Projects	Projects	NNPS
cord-035016-ipv8npdy	138	26	Agency	Agency	NNP
cord-035016-ipv8npdy	138	27	(	(	-LRB-
cord-035016-ipv8npdy	138	28	DARPA	DARPA	NNP
cord-035016-ipv8npdy	138	29	)	)	-RRB-
cord-035016-ipv8npdy	138	30	,	,	,
cord-035016-ipv8npdy	138	31	has	have	VBZ
cord-035016-ipv8npdy	138	32	long	long	RB
cord-035016-ipv8npdy	138	33	understood	understand	VBN
cord-035016-ipv8npdy	138	34	how	how	WRB
cord-035016-ipv8npdy	138	35	to	to	TO
cord-035016-ipv8npdy	138	36	steer	steer	VB
cord-035016-ipv8npdy	138	37	public	public	JJ
cord-035016-ipv8npdy	138	38	and	and	CC
cord-035016-ipv8npdy	138	39	private	private	JJ
cord-035016-ipv8npdy	138	40	sector	sector	NN
cord-035016-ipv8npdy	138	41	innovators	innovator	NNS
cord-035016-ipv8npdy	138	42	towards	towards	IN
cord-035016-ipv8npdy	138	43	national	national	JJ
cord-035016-ipv8npdy	138	44	strategic	strategic	JJ
cord-035016-ipv8npdy	138	45	objectives	objective	NNS
cord-035016-ipv8npdy	138	46	,	,	,
cord-035016-ipv8npdy	138	47	with	with	IN
cord-035016-ipv8npdy	138	48	distinctive	distinctive	JJ
cord-035016-ipv8npdy	138	49	success	success	NN
cord-035016-ipv8npdy	138	50	.	.	.
cord-035016-ipv8npdy	139	1	DARPA	DARPA	NNP
cord-035016-ipv8npdy	139	2	's	's	POS
cord-035016-ipv8npdy	139	3	strategic	strategic	JJ
cord-035016-ipv8npdy	139	4	investments	investment	NNS
cord-035016-ipv8npdy	139	5	underly	underly	VBP
cord-035016-ipv8npdy	139	6	the	the	DT
cord-035016-ipv8npdy	139	7	US	US	NNP
cord-035016-ipv8npdy	139	8	strength	strength	NN
cord-035016-ipv8npdy	139	9	in	in	IN
cord-035016-ipv8npdy	139	10	military	military	NN
cord-035016-ipv8npdy	139	11	and	and	CC
cord-035016-ipv8npdy	139	12	space	space	NN
cord-035016-ipv8npdy	139	13	technologies	technology	NNS
cord-035016-ipv8npdy	139	14	(	(	-LRB-
cord-035016-ipv8npdy	139	15	Medeiros	Medeiros	NNP
cord-035016-ipv8npdy	139	16	2019	2019	CD
cord-035016-ipv8npdy	139	17	)	)	-RRB-
cord-035016-ipv8npdy	139	18	,	,	,
cord-035016-ipv8npdy	139	19	and	and	CC
cord-035016-ipv8npdy	139	20	the	the	DT
cord-035016-ipv8npdy	139	21	rise	rise	NN
cord-035016-ipv8npdy	139	22	of	of	IN
cord-035016-ipv8npdy	139	23	Silicon	Silicon	NNP
cord-035016-ipv8npdy	139	24	Valley	Valley	NNP
cord-035016-ipv8npdy	139	25	(	(	-LRB-
cord-035016-ipv8npdy	139	26	Cameron	Cameron	NNP
cord-035016-ipv8npdy	139	27	2018	2018	CD
cord-035016-ipv8npdy	139	28	)	)	-RRB-
cord-035016-ipv8npdy	139	29	.	.	.
cord-035016-ipv8npdy	140	1	As	as	IN
cord-035016-ipv8npdy	140	2	exorbitant	exorbitant	JJ
cord-035016-ipv8npdy	140	3	drug	drug	NN
cord-035016-ipv8npdy	140	4	pricing	pricing	NN
cord-035016-ipv8npdy	140	5	and	and	CC
cord-035016-ipv8npdy	140	6	lack	lack	NN
cord-035016-ipv8npdy	140	7	of	of	IN
cord-035016-ipv8npdy	140	8	critical	critical	JJ
cord-035016-ipv8npdy	140	9	R&D	r&d	NN
cord-035016-ipv8npdy	140	10	for	for	IN
cord-035016-ipv8npdy	140	11	life	life	NN
cord-035016-ipv8npdy	140	12	threatening	threaten	VBG
cord-035016-ipv8npdy	140	13	conditions	condition	NNS
cord-035016-ipv8npdy	140	14	,	,	,
cord-035016-ipv8npdy	140	15	including	include	VBG
cord-035016-ipv8npdy	140	16	the	the	DT
cord-035016-ipv8npdy	140	17	growing	grow	VBG
cord-035016-ipv8npdy	140	18	threat	threat	NN
cord-035016-ipv8npdy	140	19	of	of	IN
cord-035016-ipv8npdy	140	20	antibiotic	antibiotic	JJ
cord-035016-ipv8npdy	140	21	resistance	resistance	NN
cord-035016-ipv8npdy	140	22	,	,	,
cord-035016-ipv8npdy	140	23	exposed	expose	VBD
cord-035016-ipv8npdy	140	24	the	the	DT
cord-035016-ipv8npdy	140	25	deficiencies	deficiency	NNS
cord-035016-ipv8npdy	140	26	of	of	IN
cord-035016-ipv8npdy	140	27	our	-PRON-	PRP$
cord-035016-ipv8npdy	140	28	pharmaceutical	pharmaceutical	JJ
cord-035016-ipv8npdy	140	29	R&D	r&d	NN
cord-035016-ipv8npdy	140	30	ecosystem	ecosystem	NN
cord-035016-ipv8npdy	140	31	,	,	,
cord-035016-ipv8npdy	140	32	alternatives	alternative	NNS
cord-035016-ipv8npdy	140	33	rooted	root	VBN
cord-035016-ipv8npdy	140	34	in	in	IN
cord-035016-ipv8npdy	140	35	the	the	DT
cord-035016-ipv8npdy	140	36	fundamental	fundamental	JJ
cord-035016-ipv8npdy	140	37	responsibility	responsibility	NN
cord-035016-ipv8npdy	140	38	of	of	IN
cord-035016-ipv8npdy	140	39	states	state	NNS
cord-035016-ipv8npdy	140	40	to	to	TO
cord-035016-ipv8npdy	140	41	actively	actively	RB
cord-035016-ipv8npdy	140	42	shape	shape	VB
cord-035016-ipv8npdy	140	43	medical	medical	JJ
cord-035016-ipv8npdy	140	44	innovation	innovation	NN
cord-035016-ipv8npdy	140	45	for	for	IN
cord-035016-ipv8npdy	140	46	the	the	DT
cord-035016-ipv8npdy	140	47	public	public	JJ
cord-035016-ipv8npdy	140	48	interest	interest	NN
cord-035016-ipv8npdy	140	49	have	have	VBP
cord-035016-ipv8npdy	140	50	been	be	VBN
cord-035016-ipv8npdy	140	51	proposed	propose	VBN
cord-035016-ipv8npdy	140	52	,	,	,
cord-035016-ipv8npdy	140	53	for	for	IN
cord-035016-ipv8npdy	140	54	instance	instance	NN
cord-035016-ipv8npdy	140	55	in	in	IN
cord-035016-ipv8npdy	140	56	the	the	DT
cord-035016-ipv8npdy	140	57	context	context	NN
cord-035016-ipv8npdy	140	58	of	of	IN
cord-035016-ipv8npdy	140	59	the	the	DT
cord-035016-ipv8npdy	140	60	2016	2016	CD
cord-035016-ipv8npdy	140	61	UN	UN	NNP
cord-035016-ipv8npdy	140	62	High	High	NNP
cord-035016-ipv8npdy	140	63	Level	Level	NNP
cord-035016-ipv8npdy	140	64	Panel	Panel	NNP
cord-035016-ipv8npdy	140	65	on	on	IN
cord-035016-ipv8npdy	140	66	Access	Access	NNP
cord-035016-ipv8npdy	140	67	to	to	IN
cord-035016-ipv8npdy	140	68	Medicines	medicine	NNS
cord-035016-ipv8npdy	141	1	(	(	-LRB-
cord-035016-ipv8npdy	141	2	Torreele	Torreele	NNP
cord-035016-ipv8npdy	141	3	2016	2016	CD
cord-035016-ipv8npdy	141	4	)	)	-RRB-
cord-035016-ipv8npdy	141	5	.	.	.
cord-035016-ipv8npdy	142	1	In	in	IN
cord-035016-ipv8npdy	142	2	the	the	DT
cord-035016-ipv8npdy	142	3	2018	2018	CD
cord-035016-ipv8npdy	142	4	People	People	NNPS
cord-035016-ipv8npdy	142	5	's	's	POS
cord-035016-ipv8npdy	142	6	Prescription	Prescription	NNP
cord-035016-ipv8npdy	142	7	report	report	NN
cord-035016-ipv8npdy	142	8	,	,	,
cord-035016-ipv8npdy	142	9	19	19	CD
cord-035016-ipv8npdy	142	10	Mazzucato	Mazzucato	NNP
cord-035016-ipv8npdy	142	11	calls	call	VBZ
cord-035016-ipv8npdy	142	12	for	for	IN
cord-035016-ipv8npdy	142	13	a	a	DT
cord-035016-ipv8npdy	142	14	DARPA	DARPA	NNP
cord-035016-ipv8npdy	142	15	for	for	IN
cord-035016-ipv8npdy	142	16	health	health	NN
cord-035016-ipv8npdy	142	17	,	,	,
cord-035016-ipv8npdy	142	18	HARPA	HARPA	NNP
cord-035016-ipv8npdy	142	19	:	:	:
cord-035016-ipv8npdy	142	20	Health	health	NN
cord-035016-ipv8npdy	142	21	innovation	innovation	NN
cord-035016-ipv8npdy	142	22	aimed	aim	VBN
cord-035016-ipv8npdy	142	23	at	at	IN
cord-035016-ipv8npdy	142	24	public	public	JJ
cord-035016-ipv8npdy	142	25	value	value	NN
cord-035016-ipv8npdy	142	26	,	,	,
cord-035016-ipv8npdy	142	27	while	while	IN
cord-035016-ipv8npdy	142	28	more	more	RBR
cord-035016-ipv8npdy	142	29	recently	recently	RB
cord-035016-ipv8npdy	142	30	,	,	,
cord-035016-ipv8npdy	142	31	a	a	DT
cord-035016-ipv8npdy	142	32	fully	fully	RB
cord-035016-ipv8npdy	142	33	publicly	publicly	RB
cord-035016-ipv8npdy	142	34	owned	own	VBN
cord-035016-ipv8npdy	142	35	pharmaceutical	pharmaceutical	NN
cord-035016-ipv8npdy	142	36	'	'	''
cord-035016-ipv8npdy	142	37	industry	industry	NN
cord-035016-ipv8npdy	142	38	'	'	''
cord-035016-ipv8npdy	142	39	was	be	VBD
cord-035016-ipv8npdy	142	40	proposed	propose	VBN
cord-035016-ipv8npdy	142	41	for	for	IN
cord-035016-ipv8npdy	142	42	the	the	DT
cord-035016-ipv8npdy	142	43	US	US	NNP
cord-035016-ipv8npdy	142	44	(	(	-LRB-
cord-035016-ipv8npdy	142	45	Brown	Brown	NNP
cord-035016-ipv8npdy	142	46	2020	2020	CD
cord-035016-ipv8npdy	142	47	)	)	-RRB-
cord-035016-ipv8npdy	142	48	.	.	.
cord-035016-ipv8npdy	143	1	While	while	IN
cord-035016-ipv8npdy	143	2	that	that	DT
cord-035016-ipv8npdy	143	3	may	may	MD
cord-035016-ipv8npdy	143	4	sound	sound	VB
cord-035016-ipv8npdy	143	5	radical	radical	JJ
cord-035016-ipv8npdy	143	6	,	,	,
cord-035016-ipv8npdy	143	7	especially	especially	RB
cord-035016-ipv8npdy	143	8	in	in	IN
cord-035016-ipv8npdy	143	9	a	a	DT
cord-035016-ipv8npdy	143	10	US	US	NNP
cord-035016-ipv8npdy	143	11	context	context	NN
cord-035016-ipv8npdy	143	12	,	,	,
cord-035016-ipv8npdy	143	13	it	-PRON-	PRP
cord-035016-ipv8npdy	143	14	is	be	VBZ
cord-035016-ipv8npdy	143	15	important	important	JJ
cord-035016-ipv8npdy	143	16	to	to	TO
cord-035016-ipv8npdy	143	17	keep	keep	VB
cord-035016-ipv8npdy	143	18	in	in	IN
cord-035016-ipv8npdy	143	19	mind	mind	NN
cord-035016-ipv8npdy	143	20	that	that	IN
cord-035016-ipv8npdy	143	21	until	until	IN
cord-035016-ipv8npdy	143	22	recently	recently	RB
cord-035016-ipv8npdy	143	23	,	,	,
cord-035016-ipv8npdy	143	24	many	many	JJ
cord-035016-ipv8npdy	143	25	countries	country	NNS
cord-035016-ipv8npdy	143	26	including	include	VBG
cord-035016-ipv8npdy	143	27	in	in	IN
cord-035016-ipv8npdy	143	28	Europe	Europe	NNP
cord-035016-ipv8npdy	143	29	had	have	VBD
cord-035016-ipv8npdy	143	30	kept	keep	VBN
cord-035016-ipv8npdy	143	31	critical	critical	JJ
cord-035016-ipv8npdy	143	32	parts	part	NNS
cord-035016-ipv8npdy	143	33	of	of	IN
cord-035016-ipv8npdy	143	34	the	the	DT
cord-035016-ipv8npdy	143	35	pharmaceutical	pharmaceutical	JJ
cord-035016-ipv8npdy	143	36	value	value	NN
cord-035016-ipv8npdy	143	37	chain	chain	NN
cord-035016-ipv8npdy	143	38	under	under	IN
cord-035016-ipv8npdy	143	39	the	the	DT
cord-035016-ipv8npdy	143	40	control	control	NN
cord-035016-ipv8npdy	143	41	of	of	IN
cord-035016-ipv8npdy	143	42	the	the	DT
cord-035016-ipv8npdy	143	43	public	public	JJ
cord-035016-ipv8npdy	143	44	sector	sector	NN
cord-035016-ipv8npdy	143	45	,	,	,
cord-035016-ipv8npdy	143	46	in	in	IN
cord-035016-ipv8npdy	143	47	particular	particular	JJ
cord-035016-ipv8npdy	143	48	vaccines	vaccine	NNS
cord-035016-ipv8npdy	143	49	(	(	-LRB-
cord-035016-ipv8npdy	143	50	Blume	Blume	NNP
cord-035016-ipv8npdy	143	51	2017	2017	CD
cord-035016-ipv8npdy	143	52	)	)	-RRB-
cord-035016-ipv8npdy	143	53	.	.	.
cord-035016-ipv8npdy	144	1	Countries	country	NNS
cord-035016-ipv8npdy	144	2	like	like	IN
cord-035016-ipv8npdy	144	3	Brazil	Brazil	NNP
cord-035016-ipv8npdy	144	4	and	and	CC
cord-035016-ipv8npdy	144	5	Thailand	Thailand	NNP
cord-035016-ipv8npdy	144	6	still	still	RB
cord-035016-ipv8npdy	144	7	have	have	VBP
cord-035016-ipv8npdy	144	8	significant	significant	JJ
cord-035016-ipv8npdy	144	9	government	government	NN
cord-035016-ipv8npdy	144	10	involvement	involvement	NN
cord-035016-ipv8npdy	144	11	in	in	IN
cord-035016-ipv8npdy	144	12	their	-PRON-	PRP$
cord-035016-ipv8npdy	144	13	pharmaceutical	pharmaceutical	JJ
cord-035016-ipv8npdy	144	14	production	production	NN
cord-035016-ipv8npdy	144	15	,	,	,
cord-035016-ipv8npdy	144	16	contributing	contribute	VBG
cord-035016-ipv8npdy	144	17	to	to	IN
cord-035016-ipv8npdy	144	18	their	-PRON-	PRP$
cord-035016-ipv8npdy	144	19	relative	relative	JJ
cord-035016-ipv8npdy	144	20	resilience	resilience	NN
cord-035016-ipv8npdy	144	21	and	and	CC
cord-035016-ipv8npdy	144	22	autonomy	autonomy	NN
cord-035016-ipv8npdy	144	23	for	for	IN
cord-035016-ipv8npdy	144	24	the	the	DT
cord-035016-ipv8npdy	144	25	production	production	NN
cord-035016-ipv8npdy	144	26	of	of	IN
cord-035016-ipv8npdy	144	27	essential	essential	JJ
cord-035016-ipv8npdy	144	28	health	health	NN
cord-035016-ipv8npdy	144	29	products	product	NNS
cord-035016-ipv8npdy	144	30	,	,	,
cord-035016-ipv8npdy	144	31	for	for	IN
cord-035016-ipv8npdy	144	32	instance	instance	NN
cord-035016-ipv8npdy	144	33	antiretroviral	antiretroviral	JJ
cord-035016-ipv8npdy	144	34	therapy	therapy	NN
cord-035016-ipv8npdy	144	35	for	for	IN
cord-035016-ipv8npdy	144	36	HIV/	HIV/	NNP
cord-035016-ipv8npdy	144	37	AIDS	AIDS	NNP
cord-035016-ipv8npdy	145	1	(	(	-LRB-
cord-035016-ipv8npdy	145	2	Ford	Ford	NNP
cord-035016-ipv8npdy	145	3	et	et	NNP
cord-035016-ipv8npdy	145	4	al	al	NNP
cord-035016-ipv8npdy	145	5	.	.	NNP
cord-035016-ipv8npdy	145	6	2007	2007	CD
cord-035016-ipv8npdy	145	7	)	)	-RRB-
cord-035016-ipv8npdy	145	8	.	.	.
cord-035016-ipv8npdy	146	1	Deprived	deprive	VBN
cord-035016-ipv8npdy	146	2	of	of	IN
cord-035016-ipv8npdy	146	3	access	access	NN
cord-035016-ipv8npdy	146	4	to	to	IN
cord-035016-ipv8npdy	146	5	the	the	DT
cord-035016-ipv8npdy	146	6	global	global	JJ
cord-035016-ipv8npdy	146	7	commercial	commercial	JJ
cord-035016-ipv8npdy	146	8	market	market	NN
cord-035016-ipv8npdy	146	9	,	,	,
cord-035016-ipv8npdy	146	10	Cuba	Cuba	NNP
cord-035016-ipv8npdy	146	11	has	have	VBZ
cord-035016-ipv8npdy	146	12	developed	develop	VBN
cord-035016-ipv8npdy	146	13	a	a	DT
cord-035016-ipv8npdy	146	14	strong	strong	JJ
cord-035016-ipv8npdy	146	15	public	public	JJ
cord-035016-ipv8npdy	146	16	innovation	innovation	NN
cord-035016-ipv8npdy	146	17	system	system	NN
cord-035016-ipv8npdy	146	18	for	for	IN
cord-035016-ipv8npdy	146	19	health	health	NN
cord-035016-ipv8npdy	146	20	,	,	,
cord-035016-ipv8npdy	146	21	responding	respond	VBG
cord-035016-ipv8npdy	146	22	to	to	IN
cord-035016-ipv8npdy	146	23	the	the	DT
cord-035016-ipv8npdy	146	24	country	country	NN
cord-035016-ipv8npdy	146	25	's	's	POS
cord-035016-ipv8npdy	146	26	health	health	NN
cord-035016-ipv8npdy	146	27	needs	need	NNS
cord-035016-ipv8npdy	146	28	(	(	-LRB-
cord-035016-ipv8npdy	146	29	Pérez	Pérez	NNP
cord-035016-ipv8npdy	146	30	et	et	FW
cord-035016-ipv8npdy	146	31	al	al	NNP
cord-035016-ipv8npdy	146	32	.	.	.
cord-035016-ipv8npdy	146	33	2018	2018	CD
cord-035016-ipv8npdy	146	34	)	)	-RRB-
cord-035016-ipv8npdy	146	35	.	.	.
cord-035016-ipv8npdy	147	1	Calls	call	NNS
cord-035016-ipv8npdy	147	2	for	for	IN
cord-035016-ipv8npdy	147	3	stronger	strong	JJR
cord-035016-ipv8npdy	147	4	public	public	JJ
cord-035016-ipv8npdy	147	5	leadership	leadership	NN
cord-035016-ipv8npdy	147	6	in	in	IN
cord-035016-ipv8npdy	147	7	medical	medical	JJ
cord-035016-ipv8npdy	147	8	R&D	r&d	NN
cord-035016-ipv8npdy	147	9	and	and	CC
cord-035016-ipv8npdy	147	10	access	access	NN
cord-035016-ipv8npdy	147	11	,	,	,
cord-035016-ipv8npdy	147	12	and	and	CC
cord-035016-ipv8npdy	147	13	for	for	IN
cord-035016-ipv8npdy	147	14	transparency	transparency	NN
cord-035016-ipv8npdy	147	15	,	,	,
cord-035016-ipv8npdy	147	16	are	be	VBP
cord-035016-ipv8npdy	147	17	gaining	gain	VBG
cord-035016-ipv8npdy	147	18	traction	traction	NN
cord-035016-ipv8npdy	147	19	in	in	IN
cord-035016-ipv8npdy	147	20	the	the	DT
cord-035016-ipv8npdy	147	21	context	context	NN
cord-035016-ipv8npdy	147	22	of	of	IN
cord-035016-ipv8npdy	147	23	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	147	24	.	.	.
cord-035016-ipv8npdy	148	1	From	from	IN
cord-035016-ipv8npdy	148	2	the	the	DT
cord-035016-ipv8npdy	148	3	early	early	JJ
cord-035016-ipv8npdy	148	4	days	day	NNS
cord-035016-ipv8npdy	148	5	,	,	,
cord-035016-ipv8npdy	148	6	there	there	EX
cord-035016-ipv8npdy	148	7	have	have	VBP
cord-035016-ipv8npdy	148	8	been	be	VBN
cord-035016-ipv8npdy	148	9	calls	call	NNS
cord-035016-ipv8npdy	148	10	to	to	TO
cord-035016-ipv8npdy	148	11	ensure	ensure	VB
cord-035016-ipv8npdy	148	12	that	that	IN
cord-035016-ipv8npdy	148	13	commercial	commercial	JJ
cord-035016-ipv8npdy	148	14	monopolies	monopoly	NNS
cord-035016-ipv8npdy	148	15	do	do	VBP
cord-035016-ipv8npdy	148	16	not	not	RB
cord-035016-ipv8npdy	148	17	stand	stand	VB
cord-035016-ipv8npdy	148	18	in	in	IN
cord-035016-ipv8npdy	148	19	the	the	DT
cord-035016-ipv8npdy	148	20	way	way	NN
cord-035016-ipv8npdy	148	21	of	of	IN
cord-035016-ipv8npdy	148	22	access	access	NN
cord-035016-ipv8npdy	148	23	,	,	,
cord-035016-ipv8npdy	148	24	and	and	CC
cord-035016-ipv8npdy	148	25	to	to	TO
cord-035016-ipv8npdy	148	26	consider	consider	VB
cord-035016-ipv8npdy	148	27	the	the	DT
cord-035016-ipv8npdy	148	28	Covid	Covid	NNP
cord-035016-ipv8npdy	148	29	-	-	HYPH
cord-035016-ipv8npdy	148	30	related	relate	VBN
cord-035016-ipv8npdy	148	31	knowledge	knowledge	NN
cord-035016-ipv8npdy	148	32	and	and	CC
cord-035016-ipv8npdy	148	33	technologies	technology	NNS
cord-035016-ipv8npdy	148	34	as	as	IN
cord-035016-ipv8npdy	148	35	knowledge	knowledge	NN
cord-035016-ipv8npdy	148	36	commons	common	NNS
cord-035016-ipv8npdy	148	37	.	.	.
cord-035016-ipv8npdy	149	1	20	20	CD
cord-035016-ipv8npdy	149	2	Concrete	concrete	JJ
cord-035016-ipv8npdy	149	3	proposals	proposal	NNS
cord-035016-ipv8npdy	149	4	have	have	VBP
cord-035016-ipv8npdy	149	5	been	be	VBN
cord-035016-ipv8npdy	149	6	put	put	VBN
cord-035016-ipv8npdy	149	7	forward	forward	RB
cord-035016-ipv8npdy	149	8	to	to	IN
cord-035016-ipv8npdy	149	9	either	either	CC
cord-035016-ipv8npdy	149	10	share	share	VB
cord-035016-ipv8npdy	149	11	and	and	CC
cord-035016-ipv8npdy	149	12	pool	pool	NN
cord-035016-ipv8npdy	149	13	knowledge	knowledge	NN
cord-035016-ipv8npdy	149	14	,	,	,
cord-035016-ipv8npdy	149	15	for	for	IN
cord-035016-ipv8npdy	149	16	instance	instance	NN
cord-035016-ipv8npdy	149	17	through	through	IN
cord-035016-ipv8npdy	149	18	the	the	DT
cord-035016-ipv8npdy	149	19	meanwhile	meanwhile	RB
cord-035016-ipv8npdy	149	20	established	establish	VBN
cord-035016-ipv8npdy	149	21	WHO	who	WP
cord-035016-ipv8npdy	149	22	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	149	23	Technology	Technology	NNP
cord-035016-ipv8npdy	149	24	Access	Access	NNP
cord-035016-ipv8npdy	149	25	Pool	Pool	NNP
cord-035016-ipv8npdy	149	26	(	(	-LRB-
cord-035016-ipv8npdy	149	27	C	C	NNP
cord-035016-ipv8npdy	149	28	-	-	HYPH
cord-035016-ipv8npdy	149	29	TAB	TAB	NNP
cord-035016-ipv8npdy	149	30	)	)	-RRB-
cord-035016-ipv8npdy	149	31	,	,	.
cord-035016-ipv8npdy	150	1	21	21	CD
cord-035016-ipv8npdy	150	2	or	or	CC
cord-035016-ipv8npdy	150	3	else	else	RB
cord-035016-ipv8npdy	150	4	to	to	TO
cord-035016-ipv8npdy	150	5	not	not	RB
cord-035016-ipv8npdy	150	6	grant	grant	VB
cord-035016-ipv8npdy	150	7	or	or	CC
cord-035016-ipv8npdy	150	8	enforce	enforce	VB
cord-035016-ipv8npdy	150	9	intellectual	intellectual	JJ
cord-035016-ipv8npdy	150	10	property	property	NN
cord-035016-ipv8npdy	150	11	rights	right	NNS
cord-035016-ipv8npdy	150	12	on	on	IN
cord-035016-ipv8npdy	150	13	them	-PRON-	PRP
cord-035016-ipv8npdy	150	14	,	,	,
cord-035016-ipv8npdy	150	15	as	as	IN
cord-035016-ipv8npdy	150	16	the	the	DT
cord-035016-ipv8npdy	150	17	proposal	proposal	NN
cord-035016-ipv8npdy	150	18	of	of	IN
cord-035016-ipv8npdy	150	19	South	South	NNP
cord-035016-ipv8npdy	150	20	Africa	Africa	NNP
cord-035016-ipv8npdy	150	21	and	and	CC
cord-035016-ipv8npdy	150	22	India	India	NNP
cord-035016-ipv8npdy	150	23	to	to	IN
cord-035016-ipv8npdy	150	24	the	the	DT
cord-035016-ipv8npdy	150	25	WTO	WTO	NNP
cord-035016-ipv8npdy	150	26	for	for	IN
cord-035016-ipv8npdy	150	27	a	a	DT
cord-035016-ipv8npdy	150	28	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	150	29	Waiver	Waiver	NNP
cord-035016-ipv8npdy	150	30	on	on	IN
cord-035016-ipv8npdy	150	31	certain	certain	JJ
cord-035016-ipv8npdy	150	32	provisions	provision	NNS
cord-035016-ipv8npdy	150	33	of	of	IN
cord-035016-ipv8npdy	150	34	the	the	DT
cord-035016-ipv8npdy	150	35	TRIPS	TRIPS	NNP
cord-035016-ipv8npdy	150	36	agreement	agreement	NN
cord-035016-ipv8npdy	150	37	(	(	-LRB-
cord-035016-ipv8npdy	150	38	Silverman	Silverman	NNP
cord-035016-ipv8npdy	150	39	2020	2020	CD
cord-035016-ipv8npdy	150	40	)	)	-RRB-
cord-035016-ipv8npdy	150	41	.	.	.
cord-035016-ipv8npdy	151	1	Open	open	JJ
cord-035016-ipv8npdy	151	2	access	access	NN
cord-035016-ipv8npdy	151	3	to	to	IN
cord-035016-ipv8npdy	151	4	knowledge	knowledge	NN
cord-035016-ipv8npdy	151	5	and	and	CC
cord-035016-ipv8npdy	151	6	technologies	technology	NNS
cord-035016-ipv8npdy	151	7	needed	need	VBN
cord-035016-ipv8npdy	151	8	to	to	TO
cord-035016-ipv8npdy	151	9	respond	respond	VB
cord-035016-ipv8npdy	151	10	to	to	IN
cord-035016-ipv8npdy	151	11	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	151	12	would	would	MD
cord-035016-ipv8npdy	151	13	be	be	VB
cord-035016-ipv8npdy	151	14	a	a	DT
cord-035016-ipv8npdy	151	15	major	major	JJ
cord-035016-ipv8npdy	151	16	step	step	NN
cord-035016-ipv8npdy	151	17	towards	towards	IN
cord-035016-ipv8npdy	151	18	more	more	JJR
cord-035016-ipv8npdy	151	19	autonomy	autonomy	NN
cord-035016-ipv8npdy	151	20	for	for	IN
cord-035016-ipv8npdy	151	21	countries	country	NNS
cord-035016-ipv8npdy	151	22	or	or	CC
cord-035016-ipv8npdy	151	23	regions	region	NNS
cord-035016-ipv8npdy	151	24	to	to	TO
cord-035016-ipv8npdy	151	25	produce	produce	VB
cord-035016-ipv8npdy	151	26	needed	need	VBN
cord-035016-ipv8npdy	151	27	health	health	NN
cord-035016-ipv8npdy	151	28	technologies	technology	NNS
cord-035016-ipv8npdy	151	29	.	.	.
cord-035016-ipv8npdy	152	1	It	-PRON-	PRP
cord-035016-ipv8npdy	152	2	will	will	MD
cord-035016-ipv8npdy	152	3	also	also	RB
cord-035016-ipv8npdy	152	4	require	require	VB
cord-035016-ipv8npdy	152	5	establishing	establish	VBG
cord-035016-ipv8npdy	152	6	adequate	adequate	JJ
cord-035016-ipv8npdy	152	7	infrastructure	infrastructure	NN
cord-035016-ipv8npdy	152	8	and	and	CC
cord-035016-ipv8npdy	152	9	capability	capability	NN
cord-035016-ipv8npdy	152	10	and	and	CC
cord-035016-ipv8npdy	152	11	strategic	strategic	JJ
cord-035016-ipv8npdy	152	12	government	government	NN
cord-035016-ipv8npdy	152	13	interventions	intervention	NNS
cord-035016-ipv8npdy	152	14	(	(	-LRB-
cord-035016-ipv8npdy	152	15	finance	finance	NN
cord-035016-ipv8npdy	152	16	,	,	,
cord-035016-ipv8npdy	152	17	science	science	NN
cord-035016-ipv8npdy	152	18	and	and	CC
cord-035016-ipv8npdy	152	19	technology	technology	NN
cord-035016-ipv8npdy	152	20	,	,	,
cord-035016-ipv8npdy	152	21	health	health	NN
cord-035016-ipv8npdy	152	22	systems	system	NNS
cord-035016-ipv8npdy	152	23	,	,	,
cord-035016-ipv8npdy	152	24	industrial	industrial	JJ
cord-035016-ipv8npdy	152	25	policy	policy	NN
cord-035016-ipv8npdy	152	26	etc	etc	NN
cord-035016-ipv8npdy	152	27	.	.	.
cord-035016-ipv8npdy	152	28	)	)	-RRB-
cord-035016-ipv8npdy	152	29	to	to	TO
cord-035016-ipv8npdy	152	30	generate	generate	VB
cord-035016-ipv8npdy	152	31	such	such	JJ
cord-035016-ipv8npdy	152	32	health	health	NN
cord-035016-ipv8npdy	152	33	technologies	technology	NNS
cord-035016-ipv8npdy	152	34	and	and	CC
cord-035016-ipv8npdy	152	35	make	make	VB
cord-035016-ipv8npdy	152	36	available	available	JJ
cord-035016-ipv8npdy	152	37	for	for	IN
cord-035016-ipv8npdy	152	38	the	the	DT
cord-035016-ipv8npdy	152	39	population	population	NN
cord-035016-ipv8npdy	152	40	.	.	.
cord-035016-ipv8npdy	153	1	The	the	DT
cord-035016-ipv8npdy	153	2	announcement	announcement	NN
cord-035016-ipv8npdy	153	3	of	of	IN
cord-035016-ipv8npdy	153	4	EU	EU	NNP
cord-035016-ipv8npdy	153	5	President	President	NNP
cord-035016-ipv8npdy	153	6	von	von	NNP
cord-035016-ipv8npdy	153	7	der	der	NNP
cord-035016-ipv8npdy	153	8	Leyen	Leyen	NNP
cord-035016-ipv8npdy	153	9	to	to	TO
cord-035016-ipv8npdy	153	10	create	create	VB
cord-035016-ipv8npdy	153	11	a	a	DT
cord-035016-ipv8npdy	153	12	European	european	JJ
cord-035016-ipv8npdy	153	13	BARDA	BARDA	NNP
cord-035016-ipv8npdy	153	14	may	may	MD
cord-035016-ipv8npdy	153	15	be	be	VB
cord-035016-ipv8npdy	153	16	an	an	DT
cord-035016-ipv8npdy	153	17	important	important	JJ
cord-035016-ipv8npdy	153	18	step	step	NN
cord-035016-ipv8npdy	153	19	in	in	IN
cord-035016-ipv8npdy	153	20	that	that	DT
cord-035016-ipv8npdy	153	21	direction	direction	NN
cord-035016-ipv8npdy	153	22	,	,	,
cord-035016-ipv8npdy	153	23	22	22	CD
cord-035016-ipv8npdy	153	24	at	at	IN
cord-035016-ipv8npdy	153	25	least	least	JJS
cord-035016-ipv8npdy	153	26	for	for	IN
cord-035016-ipv8npdy	153	27	the	the	DT
cord-035016-ipv8npdy	153	28	region	region	NN
cord-035016-ipv8npdy	153	29	.	.	.
cord-035016-ipv8npdy	154	1	However	however	RB
cord-035016-ipv8npdy	154	2	it	-PRON-	PRP
cord-035016-ipv8npdy	154	3	will	will	MD
cord-035016-ipv8npdy	154	4	be	be	VB
cord-035016-ipv8npdy	154	5	important	important	JJ
cord-035016-ipv8npdy	154	6	to	to	TO
cord-035016-ipv8npdy	154	7	ensure	ensure	VB
cord-035016-ipv8npdy	154	8	that	that	IN
cord-035016-ipv8npdy	154	9	its	-PRON-	PRP$
cord-035016-ipv8npdy	154	10	focus	focus	NN
cord-035016-ipv8npdy	154	11	is	be	VBZ
cord-035016-ipv8npdy	154	12	squarely	squarely	RB
cord-035016-ipv8npdy	154	13	on	on	IN
cord-035016-ipv8npdy	154	14	improving	improve	VBG
cord-035016-ipv8npdy	154	15	people	people	NNS
cord-035016-ipv8npdy	154	16	's	's	POS
cord-035016-ipv8npdy	154	17	health	health	NN
cord-035016-ipv8npdy	154	18	outcomes	outcome	NNS
cord-035016-ipv8npdy	154	19	and	and	CC
cord-035016-ipv8npdy	154	20	deliver	deliver	VB
cord-035016-ipv8npdy	154	21	health	health	NN
cord-035016-ipv8npdy	154	22	technologies	technology	NNS
cord-035016-ipv8npdy	154	23	that	that	WDT
cord-035016-ipv8npdy	154	24	are	be	VBP
cord-035016-ipv8npdy	154	25	widely	widely	RB
cord-035016-ipv8npdy	154	26	available	available	JJ
cord-035016-ipv8npdy	154	27	and	and	CC
cord-035016-ipv8npdy	154	28	accessible	accessible	JJ
cord-035016-ipv8npdy	154	29	.	.	.
cord-035016-ipv8npdy	155	1	Success	success	NN
cord-035016-ipv8npdy	155	2	must	must	MD
cord-035016-ipv8npdy	155	3	be	be	VB
cord-035016-ipv8npdy	155	4	measured	measure	VBN
cord-035016-ipv8npdy	155	5	in	in	IN
cord-035016-ipv8npdy	155	6	value	value	NN
cord-035016-ipv8npdy	155	7	for	for	IN
cord-035016-ipv8npdy	155	8	health	health	NN
cord-035016-ipv8npdy	155	9	,	,	,
cord-035016-ipv8npdy	155	10	not	not	RB
cord-035016-ipv8npdy	155	11	for	for	IN
cord-035016-ipv8npdy	155	12	business	business	NN
cord-035016-ipv8npdy	155	13	.	.	.
cord-035016-ipv8npdy	156	1	To	to	IN
cord-035016-ipv8npdy	156	2	that	that	DT
cord-035016-ipv8npdy	156	3	effect	effect	NN
cord-035016-ipv8npdy	156	4	,	,	,
cord-035016-ipv8npdy	156	5	this	this	DT
cord-035016-ipv8npdy	156	6	initiative	initiative	NN
cord-035016-ipv8npdy	156	7	must	must	MD
cord-035016-ipv8npdy	156	8	be	be	VB
cord-035016-ipv8npdy	156	9	firmly	firmly	RB
cord-035016-ipv8npdy	156	10	rooted	root	VBN
cord-035016-ipv8npdy	156	11	in	in	IN
cord-035016-ipv8npdy	156	12	the	the	DT
cord-035016-ipv8npdy	156	13	existing	exist	VBG
cord-035016-ipv8npdy	156	14	European	european	JJ
cord-035016-ipv8npdy	156	15	health	health	NN
cord-035016-ipv8npdy	156	16	innovation	innovation	NN
cord-035016-ipv8npdy	156	17	infrastructure	infrastructure	NN
cord-035016-ipv8npdy	156	18	,	,	,
cord-035016-ipv8npdy	156	19	for	for	IN
cord-035016-ipv8npdy	156	20	instance	instance	NN
cord-035016-ipv8npdy	156	21	through	through	IN
cord-035016-ipv8npdy	156	22	the	the	DT
cord-035016-ipv8npdy	156	23	proposed	propose	VBN
cord-035016-ipv8npdy	156	24	BIOMED	BIOMED	NNP
cord-035016-ipv8npdy	156	25	Europa	Europa	NNP
cord-035016-ipv8npdy	156	26	(	(	-LRB-
cord-035016-ipv8npdy	156	27	Florio	Florio	NNP
cord-035016-ipv8npdy	156	28	2020	2020	CD
cord-035016-ipv8npdy	156	29	)	)	-RRB-
cord-035016-ipv8npdy	156	30	that	that	WDT
cord-035016-ipv8npdy	156	31	could	could	MD
cord-035016-ipv8npdy	156	32	be	be	VB
cord-035016-ipv8npdy	156	33	adapted	adapt	VBN
cord-035016-ipv8npdy	156	34	after	after	IN
cord-035016-ipv8npdy	156	35	the	the	DT
cord-035016-ipv8npdy	156	36	US	US	NNP
cord-035016-ipv8npdy	156	37	National	National	NNP
cord-035016-ipv8npdy	156	38	Institutes	Institutes	NNPS
cord-035016-ipv8npdy	156	39	of	of	IN
cord-035016-ipv8npdy	156	40	Health	Health	NNP
cord-035016-ipv8npdy	156	41	,	,	,
cord-035016-ipv8npdy	156	42	except	except	IN
cord-035016-ipv8npdy	156	43	focused	focus	VBN
cord-035016-ipv8npdy	156	44	of	of	IN
cord-035016-ipv8npdy	156	45	global	global	JJ
cord-035016-ipv8npdy	156	46	health	health	NN
cord-035016-ipv8npdy	156	47	commons	common	NNS
cord-035016-ipv8npdy	156	48	,	,	,
cord-035016-ipv8npdy	156	49	not	not	RB
cord-035016-ipv8npdy	156	50	just	just	RB
cord-035016-ipv8npdy	156	51	de	de	RB
cord-035016-ipv8npdy	156	52	-	-	JJ
cord-035016-ipv8npdy	156	53	risking	risk	VBG
cord-035016-ipv8npdy	156	54	the	the	DT
cord-035016-ipv8npdy	156	55	biomedical	biomedical	JJ
cord-035016-ipv8npdy	156	56	industry	industry	NN
cord-035016-ipv8npdy	156	57	.	.	.
cord-035016-ipv8npdy	157	1	Collaboration	collaboration	NN
cord-035016-ipv8npdy	157	2	with	with	IN
cord-035016-ipv8npdy	157	3	the	the	DT
cord-035016-ipv8npdy	157	4	private	private	JJ
cord-035016-ipv8npdy	157	5	sector	sector	NN
cord-035016-ipv8npdy	157	6	is	be	VBZ
cord-035016-ipv8npdy	157	7	welcomed	welcome	VBN
cord-035016-ipv8npdy	157	8	,	,	,
cord-035016-ipv8npdy	157	9	but	but	CC
cord-035016-ipv8npdy	157	10	the	the	DT
cord-035016-ipv8npdy	157	11	terms	term	NNS
cord-035016-ipv8npdy	157	12	and	and	CC
cord-035016-ipv8npdy	157	13	conditions	condition	NNS
cord-035016-ipv8npdy	157	14	of	of	IN
cord-035016-ipv8npdy	157	15	the	the	DT
cord-035016-ipv8npdy	157	16	public	public	JJ
cord-035016-ipv8npdy	157	17	-	-	HYPH
cord-035016-ipv8npdy	157	18	private	private	JJ
cord-035016-ipv8npdy	157	19	partnerships	partnership	NNS
cord-035016-ipv8npdy	157	20	must	must	MD
cord-035016-ipv8npdy	157	21	be	be	VB
cord-035016-ipv8npdy	157	22	governed	govern	VBN
cord-035016-ipv8npdy	157	23	by	by	IN
cord-035016-ipv8npdy	157	24	public	public	JJ
cord-035016-ipv8npdy	157	25	health	health	NN
cord-035016-ipv8npdy	157	26	benefit	benefit	NN
cord-035016-ipv8npdy	157	27	(	(	-LRB-
cord-035016-ipv8npdy	157	28	Mazzucato	Mazzucato	NNP
cord-035016-ipv8npdy	157	29	and	and	CC
cord-035016-ipv8npdy	157	30	Torreele	Torreele	NNP
cord-035016-ipv8npdy	157	31	2020	2020	CD
cord-035016-ipv8npdy	157	32	)	)	-RRB-
cord-035016-ipv8npdy	157	33	,	,	,
cord-035016-ipv8npdy	157	34	and	and	CC
cord-035016-ipv8npdy	157	35	include	include	VBP
cord-035016-ipv8npdy	157	36	open	open	JJ
cord-035016-ipv8npdy	157	37	collaboration	collaboration	NN
cord-035016-ipv8npdy	157	38	,	,	,
cord-035016-ipv8npdy	157	39	sharing	sharing	NN
cord-035016-ipv8npdy	157	40	of	of	IN
cord-035016-ipv8npdy	157	41	know	know	NN
cord-035016-ipv8npdy	157	42	-	-	HYPH
cord-035016-ipv8npdy	157	43	how	how	NN
cord-035016-ipv8npdy	157	44	,	,	,
cord-035016-ipv8npdy	157	45	technologies	technology	NNS
cord-035016-ipv8npdy	157	46	and	and	CC
cord-035016-ipv8npdy	157	47	infrastructure	infrastructure	NN
cord-035016-ipv8npdy	157	48	,	,	,
cord-035016-ipv8npdy	157	49	and	and	CC
cord-035016-ipv8npdy	157	50	building	build	VBG
cord-035016-ipv8npdy	157	51	collective	collective	JJ
cord-035016-ipv8npdy	157	52	intelligence	intelligence	NN
cord-035016-ipv8npdy	157	53	.	.	.
cord-035016-ipv8npdy	158	1	Instead	instead	RB
cord-035016-ipv8npdy	158	2	of	of	IN
cord-035016-ipv8npdy	158	3	secrecy	secrecy	NN
cord-035016-ipv8npdy	158	4	and	and	CC
cord-035016-ipv8npdy	158	5	competition	competition	NN
cord-035016-ipv8npdy	158	6	,	,	,
cord-035016-ipv8npdy	158	7	this	this	DT
cord-035016-ipv8npdy	158	8	approach	approach	NN
cord-035016-ipv8npdy	158	9	embraces	embrace	VBZ
cord-035016-ipv8npdy	158	10	radical	radical	JJ
cord-035016-ipv8npdy	158	11	transparency	transparency	NN
cord-035016-ipv8npdy	158	12	,	,	,
cord-035016-ipv8npdy	158	13	both	both	CC
cord-035016-ipv8npdy	158	14	on	on	IN
cord-035016-ipv8npdy	158	15	the	the	DT
cord-035016-ipv8npdy	158	16	scientific	scientific	JJ
cord-035016-ipv8npdy	158	17	methods	method	NNS
cord-035016-ipv8npdy	158	18	and	and	CC
cord-035016-ipv8npdy	158	19	data	datum	NNS
cord-035016-ipv8npdy	158	20	,	,	,
cord-035016-ipv8npdy	158	21	and	and	CC
cord-035016-ipv8npdy	158	22	financially	financially	RB
cord-035016-ipv8npdy	158	23	,	,	,
cord-035016-ipv8npdy	158	24	detailing	detail	VBG
cord-035016-ipv8npdy	158	25	each	each	DT
cord-035016-ipv8npdy	158	26	one	one	NN
cord-035016-ipv8npdy	158	27	's	's	POS
cord-035016-ipv8npdy	158	28	contributions	contribution	NNS
cord-035016-ipv8npdy	158	29	in	in	IN
cord-035016-ipv8npdy	158	30	investment	investment	NN
cord-035016-ipv8npdy	158	31	and	and	CC
cord-035016-ipv8npdy	158	32	risk	risk	NN
cord-035016-ipv8npdy	158	33	taking	taking	NN
cord-035016-ipv8npdy	158	34	.	.	.
cord-035016-ipv8npdy	159	1	To	to	TO
cord-035016-ipv8npdy	159	2	ensure	ensure	VB
cord-035016-ipv8npdy	159	3	truly	truly	RB
cord-035016-ipv8npdy	159	4	global	global	JJ
cord-035016-ipv8npdy	159	5	health	health	NN
cord-035016-ipv8npdy	159	6	commons	common	NNS
cord-035016-ipv8npdy	159	7	,	,	,
cord-035016-ipv8npdy	159	8	technology	technology	NN
cord-035016-ipv8npdy	159	9	transfer	transfer	NN
cord-035016-ipv8npdy	159	10	to	to	IN
cord-035016-ipv8npdy	159	11	third	third	JJ
cord-035016-ipv8npdy	159	12	countries	country	NNS
cord-035016-ipv8npdy	159	13	who	who	WP
cord-035016-ipv8npdy	159	14	wish	wish	VBP
cord-035016-ipv8npdy	159	15	to	to	TO
cord-035016-ipv8npdy	159	16	develop	develop	VB
cord-035016-ipv8npdy	159	17	their	-PRON-	PRP$
cord-035016-ipv8npdy	159	18	own	own	JJ
cord-035016-ipv8npdy	159	19	capabilities	capability	NNS
cord-035016-ipv8npdy	159	20	should	should	MD
cord-035016-ipv8npdy	159	21	be	be	VB
cord-035016-ipv8npdy	159	22	built	build	VBN
cord-035016-ipv8npdy	159	23	in	in	IN
cord-035016-ipv8npdy	159	24	from	from	IN
cord-035016-ipv8npdy	159	25	the	the	DT
cord-035016-ipv8npdy	159	26	start	start	NN
cord-035016-ipv8npdy	159	27	.	.	.
cord-035016-ipv8npdy	160	1	Humankind	humankind	NN
cord-035016-ipv8npdy	160	2	is	be	VBZ
cord-035016-ipv8npdy	160	3	facing	face	VBG
cord-035016-ipv8npdy	160	4	a	a	DT
cord-035016-ipv8npdy	160	5	global	global	JJ
cord-035016-ipv8npdy	160	6	health	health	NN
cord-035016-ipv8npdy	160	7	crisis	crisis	NN
cord-035016-ipv8npdy	160	8	,	,	,
cord-035016-ipv8npdy	160	9	perhaps	perhaps	RB
cord-035016-ipv8npdy	160	10	the	the	DT
cord-035016-ipv8npdy	160	11	biggest	big	JJS
cord-035016-ipv8npdy	160	12	crisis	crisis	NN
cord-035016-ipv8npdy	160	13	of	of	IN
cord-035016-ipv8npdy	160	14	our	-PRON-	PRP$
cord-035016-ipv8npdy	160	15	generation	generation	NN
cord-035016-ipv8npdy	160	16	.	.	.
cord-035016-ipv8npdy	161	1	The	the	DT
cord-035016-ipv8npdy	161	2	decisions	decision	NNS
cord-035016-ipv8npdy	161	3	people	people	NNS
cord-035016-ipv8npdy	161	4	and	and	CC
cord-035016-ipv8npdy	161	5	governments	government	NNS
cord-035016-ipv8npdy	161	6	take	take	VBP
cord-035016-ipv8npdy	161	7	now	now	RB
cord-035016-ipv8npdy	161	8	,	,	,
cord-035016-ipv8npdy	161	9	and	and	CC
cord-035016-ipv8npdy	161	10	the	the	DT
cord-035016-ipv8npdy	161	11	values	value	NNS
cord-035016-ipv8npdy	161	12	on	on	IN
cord-035016-ipv8npdy	161	13	which	which	WDT
cord-035016-ipv8npdy	161	14	they	-PRON-	PRP
cord-035016-ipv8npdy	161	15	rely	rely	VBP
cord-035016-ipv8npdy	161	16	,	,	,
cord-035016-ipv8npdy	161	17	will	will	MD
cord-035016-ipv8npdy	161	18	likely	likely	RB
cord-035016-ipv8npdy	161	19	shape	shape	VB
cord-035016-ipv8npdy	161	20	the	the	DT
cord-035016-ipv8npdy	161	21	world	world	NN
cord-035016-ipv8npdy	161	22	for	for	IN
cord-035016-ipv8npdy	161	23	years	year	NNS
cord-035016-ipv8npdy	161	24	to	to	TO
cord-035016-ipv8npdy	161	25	come	come	VB
cord-035016-ipv8npdy	161	26	,	,	,
cord-035016-ipv8npdy	161	27	including	include	VBG
cord-035016-ipv8npdy	161	28	our	-PRON-	PRP$
cord-035016-ipv8npdy	161	29	healthcare	healthcare	NN
cord-035016-ipv8npdy	161	30	systems	system	NNS
cord-035016-ipv8npdy	161	31	,	,	,
cord-035016-ipv8npdy	161	32	our	-PRON-	PRP$
cord-035016-ipv8npdy	161	33	economy	economy	NN
cord-035016-ipv8npdy	161	34	and	and	CC
cord-035016-ipv8npdy	161	35	our	-PRON-	PRP$
cord-035016-ipv8npdy	161	36	culture	culture	NN
cord-035016-ipv8npdy	161	37	.	.	.
cord-035016-ipv8npdy	162	1	The	the	DT
cord-035016-ipv8npdy	162	2	time	time	NN
cord-035016-ipv8npdy	162	3	has	have	VBZ
cord-035016-ipv8npdy	162	4	come	come	VBN
cord-035016-ipv8npdy	162	5	for	for	IN
cord-035016-ipv8npdy	162	6	global	global	JJ
cord-035016-ipv8npdy	162	7	leaders	leader	NNS
cord-035016-ipv8npdy	162	8	to	to	TO
cord-035016-ipv8npdy	162	9	consider	consider	VB
cord-035016-ipv8npdy	162	10	vaccines	vaccine	NNS
cord-035016-ipv8npdy	162	11	and	and	CC
cord-035016-ipv8npdy	162	12	other	other	JJ
cord-035016-ipv8npdy	162	13	health	health	NN
cord-035016-ipv8npdy	162	14	technologies	technology	NNS
cord-035016-ipv8npdy	162	15	as	as	IN
cord-035016-ipv8npdy	162	16	global	global	JJ
cord-035016-ipv8npdy	162	17	health	health	NN
cord-035016-ipv8npdy	162	18	commons	common	NNS
cord-035016-ipv8npdy	162	19	that	that	WDT
cord-035016-ipv8npdy	162	20	must	must	MD
cord-035016-ipv8npdy	162	21	be	be	VB
cord-035016-ipv8npdy	162	22	available	available	JJ
cord-035016-ipv8npdy	162	23	for	for	IN
cord-035016-ipv8npdy	162	24	all	all	DT
cord-035016-ipv8npdy	162	25	and	and	CC
cord-035016-ipv8npdy	162	26	reshape	reshape	VB
cord-035016-ipv8npdy	162	27	the	the	DT
cord-035016-ipv8npdy	162	28	medical	medical	JJ
cord-035016-ipv8npdy	162	29	R&D	r&d	NN
cord-035016-ipv8npdy	162	30	ecosystem	ecosystem	NN
cord-035016-ipv8npdy	162	31	towards	towards	IN
cord-035016-ipv8npdy	162	32	delivering	deliver	VBG
cord-035016-ipv8npdy	162	33	that	that	DT
cord-035016-ipv8npdy	162	34	.	.	.
cord-035016-ipv8npdy	163	1	Pooling	pool	VBG
cord-035016-ipv8npdy	163	2	Knowledge	knowledge	NN
cord-035016-ipv8npdy	163	3	:	:	:
cord-035016-ipv8npdy	163	4	Private	private	JJ
cord-035016-ipv8npdy	163	5	Medicine	Medicine	NNP
cord-035016-ipv8npdy	163	6	vs.	vs.	IN
cord-035016-ipv8npdy	163	7	Public	Public	NNP
cord-035016-ipv8npdy	163	8	Health	Health	NNP
cord-035016-ipv8npdy	163	9	?	?	.
cord-035016-ipv8npdy	164	1	Moderna	Moderna	NNP
cord-035016-ipv8npdy	164	2	's	's	POS
cord-035016-ipv8npdy	164	3	mRNA	mRNA	NNP
cord-035016-ipv8npdy	164	4	vaccine	vaccine	NN
cord-035016-ipv8npdy	164	5	reaches	reach	VBZ
cord-035016-ipv8npdy	164	6	its	-PRON-	PRP$
cord-035016-ipv8npdy	164	7	final	final	JJ
cord-035016-ipv8npdy	164	8	phase	phase	NN
cord-035016-ipv8npdy	164	9	.	.	.
cord-035016-ipv8npdy	165	1	Here	here	RB
cord-035016-ipv8npdy	165	2	's	be	VBZ
cord-035016-ipv8npdy	165	3	how	how	WRB
cord-035016-ipv8npdy	165	4	it	-PRON-	PRP
cord-035016-ipv8npdy	165	5	works	work	VBZ
cord-035016-ipv8npdy	165	6	Regulatory	Regulatory	NNP
cord-035016-ipv8npdy	165	7	Decision	decision	NN
cord-035016-ipv8npdy	165	8	-	-	HYPH
cord-035016-ipv8npdy	165	9	making	making	NN
cord-035016-ipv8npdy	165	10	on	on	IN
cord-035016-ipv8npdy	165	11	Covid-19	covid-19	NN
cord-035016-ipv8npdy	165	12	Vaccines	vaccine	NNS
cord-035016-ipv8npdy	165	13	During	during	IN
cord-035016-ipv8npdy	165	14	a	a	DT
cord-035016-ipv8npdy	165	15	Public	Public	NNP
cord-035016-ipv8npdy	165	16	Health	Health	NNP
cord-035016-ipv8npdy	165	17	Emergency	Emergency	NNP
cord-035016-ipv8npdy	165	18	Vaccine	Vaccine	NNP
cord-035016-ipv8npdy	165	19	Efficacy	Efficacy	NNP
cord-035016-ipv8npdy	165	20	Needed	need	VBN
cord-035016-ipv8npdy	165	21	for	for	IN
cord-035016-ipv8npdy	165	22	a	a	DT
cord-035016-ipv8npdy	165	23	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	165	24	Coronavirus	Coronavirus	NNP
cord-035016-ipv8npdy	165	25	Vaccine	Vaccine	NNP
cord-035016-ipv8npdy	165	26	to	to	IN
cord-035016-ipv8npdy	165	27	Prevent	Prevent	NNP
cord-035016-ipv8npdy	165	28	or	or	CC
cord-035016-ipv8npdy	165	29	Stop	stop	VB
cord-035016-ipv8npdy	165	30	an	an	DT
cord-035016-ipv8npdy	165	31	Epidemic	epidemic	NN
cord-035016-ipv8npdy	165	32	as	as	IN
cord-035016-ipv8npdy	165	33	the	the	DT
cord-035016-ipv8npdy	165	34	Sole	Sole	NNP
cord-035016-ipv8npdy	165	35	Intervention	Intervention	NNP
cord-035016-ipv8npdy	166	1	The	the	DT
cord-035016-ipv8npdy	166	2	erosion	erosion	NN
cord-035016-ipv8npdy	166	3	of	of	IN
cord-035016-ipv8npdy	166	4	public	public	JJ
cord-035016-ipv8npdy	166	5	sector	sector	NN
cord-035016-ipv8npdy	166	6	vaccine	vaccine	NN
cord-035016-ipv8npdy	166	7	production	production	NN
cord-035016-ipv8npdy	166	8	.	.	.
cord-035016-ipv8npdy	167	1	The	the	DT
cord-035016-ipv8npdy	167	2	case	case	NN
cord-035016-ipv8npdy	167	3	of	of	IN
cord-035016-ipv8npdy	167	4	the	the	DT
cord-035016-ipv8npdy	167	5	Netherlands	Netherlands	NNP
cord-035016-ipv8npdy	167	6	Medicine	Medicine	NNP
cord-035016-ipv8npdy	167	7	For	for	IN
cord-035016-ipv8npdy	167	8	All	all	DT
cord-035016-ipv8npdy	167	9	:	:	:
cord-035016-ipv8npdy	167	10	The	the	DT
cord-035016-ipv8npdy	167	11	case	case	NN
cord-035016-ipv8npdy	167	12	for	for	IN
cord-035016-ipv8npdy	167	13	a	a	DT
cord-035016-ipv8npdy	167	14	public	public	JJ
cord-035016-ipv8npdy	167	15	option	option	NN
cord-035016-ipv8npdy	167	16	in	in	IN
cord-035016-ipv8npdy	167	17	the	the	DT
cord-035016-ipv8npdy	167	18	pharmaceutical	pharmaceutical	NN
cord-035016-ipv8npdy	167	19	industry	industry	NN
cord-035016-ipv8npdy	167	20	The	the	DT
cord-035016-ipv8npdy	167	21	unequal	unequal	JJ
cord-035016-ipv8npdy	167	22	scramble	scramble	NN
cord-035016-ipv8npdy	167	23	for	for	IN
cord-035016-ipv8npdy	167	24	coronavirus	coronavirus	NN
cord-035016-ipv8npdy	167	25	vaccines	vaccine	NNS
cord-035016-ipv8npdy	167	26	-	-	:
cord-035016-ipv8npdy	167	27	by	by	IN
cord-035016-ipv8npdy	167	28	the	the	DT
cord-035016-ipv8npdy	167	29	numbers	number	NNS
cord-035016-ipv8npdy	168	1	The	the	DT
cord-035016-ipv8npdy	168	2	government	government	NN
cord-035016-ipv8npdy	168	3	agency	agency	NN
cord-035016-ipv8npdy	168	4	that	that	WDT
cord-035016-ipv8npdy	168	5	made	make	VBD
cord-035016-ipv8npdy	168	6	silicon	silicon	NNP
cord-035016-ipv8npdy	168	7	Valley	Valley	NNP
cord-035016-ipv8npdy	169	1	These	these	DT
cord-035016-ipv8npdy	169	2	Coronavirus	Coronavirus	NNP
cord-035016-ipv8npdy	169	3	Trials	Trials	NNPS
cord-035016-ipv8npdy	169	4	Do	do	VBP
cord-035016-ipv8npdy	169	5	n't	not	RB
cord-035016-ipv8npdy	169	6	Answer	answer	VB
cord-035016-ipv8npdy	169	7	the	the	DT
cord-035016-ipv8npdy	169	8	One	one	CD
cord-035016-ipv8npdy	169	9	Question	question	NN
cord-035016-ipv8npdy	169	10	We	-PRON-	PRP
cord-035016-ipv8npdy	169	11	Need	need	VBP
cord-035016-ipv8npdy	169	12	to	to	TO
cord-035016-ipv8npdy	169	13	Know	know	VB
cord-035016-ipv8npdy	169	14	Bio	Bio	NNP
cord-035016-ipv8npdy	169	15	-	-	HYPH
cord-035016-ipv8npdy	169	16	creep	creep	VB
cord-035016-ipv8npdy	169	17	in	in	IN
cord-035016-ipv8npdy	169	18	non	non	JJ
cord-035016-ipv8npdy	169	19	-	-	JJ
cord-035016-ipv8npdy	169	20	inferiority	inferiority	JJ
cord-035016-ipv8npdy	169	21	clinical	clinical	JJ
cord-035016-ipv8npdy	169	22	trials	trial	NNS
cord-035016-ipv8npdy	169	23	World	World	NNP
cord-035016-ipv8npdy	169	24	Health	Health	NNP
cord-035016-ipv8npdy	169	25	Assembly	Assembly	NNP
cord-035016-ipv8npdy	169	26	Approves	approve	VBZ
cord-035016-ipv8npdy	169	27	Milestone	Milestone	NNP
cord-035016-ipv8npdy	169	28	Resolution	resolution	NN
cord-035016-ipv8npdy	169	29	On	on	IN
cord-035016-ipv8npdy	169	30	Price	Price	NNP
cord-035016-ipv8npdy	169	31	Transparency	Transparency	NNP
cord-035016-ipv8npdy	169	32	,	,	,
cord-035016-ipv8npdy	169	33	Health	Health	NNP
cord-035016-ipv8npdy	169	34	Policy	Policy	NNP
cord-035016-ipv8npdy	169	35	Watch	Watch	NNP
cord-035016-ipv8npdy	169	36	28	28	CD
cord-035016-ipv8npdy	169	37	May	May	NNP
cord-035016-ipv8npdy	169	38	Biomed	Biomed	NNP
cord-035016-ipv8npdy	169	39	Europa	Europa	NNP
cord-035016-ipv8npdy	169	40	:	:	:
cord-035016-ipv8npdy	169	41	after	after	IN
cord-035016-ipv8npdy	169	42	the	the	DT
cord-035016-ipv8npdy	169	43	coronavirus	coronavirus	NN
cord-035016-ipv8npdy	169	44	,	,	,
cord-035016-ipv8npdy	169	45	a	a	DT
cord-035016-ipv8npdy	169	46	public	public	JJ
cord-035016-ipv8npdy	169	47	infrastructure	infrastructure	NN
cord-035016-ipv8npdy	169	48	to	to	TO
cord-035016-ipv8npdy	169	49	overcome	overcome	VB
cord-035016-ipv8npdy	169	50	the	the	DT
cord-035016-ipv8npdy	169	51	pharmaceutical	pharmaceutical	JJ
cord-035016-ipv8npdy	169	52	oligopoly	oligopoly	NN
cord-035016-ipv8npdy	169	53	Sustaining	sustain	VBG
cord-035016-ipv8npdy	169	54	access	access	NN
cord-035016-ipv8npdy	169	55	to	to	IN
cord-035016-ipv8npdy	169	56	antiretroviral	antiretroviral	JJ
cord-035016-ipv8npdy	169	57	therapy	therapy	NN
cord-035016-ipv8npdy	169	58	in	in	IN
cord-035016-ipv8npdy	169	59	the	the	DT
cord-035016-ipv8npdy	169	60	less	less	RBR
cord-035016-ipv8npdy	169	61	-	-	HYPH
cord-035016-ipv8npdy	169	62	developed	develop	VBN
cord-035016-ipv8npdy	169	63	world	world	NN
cord-035016-ipv8npdy	169	64	:	:	:
cord-035016-ipv8npdy	169	65	Lessons	lesson	NNS
cord-035016-ipv8npdy	169	66	from	from	IN
cord-035016-ipv8npdy	169	67	Brazil	Brazil	NNP
cord-035016-ipv8npdy	169	68	and	and	CC
cord-035016-ipv8npdy	169	69	Thailand	Thailand	NNP
cord-035016-ipv8npdy	169	70	No	no	DT
cord-035016-ipv8npdy	169	71	-	-	HYPH
cord-035016-ipv8npdy	169	72	fault	fault	NN
cord-035016-ipv8npdy	169	73	compensation	compensation	NN
cord-035016-ipv8npdy	169	74	for	for	IN
cord-035016-ipv8npdy	169	75	vaccine	vaccine	NN
cord-035016-ipv8npdy	169	76	injury	injury	NN
cord-035016-ipv8npdy	170	1	-The	-The	NFP
cord-035016-ipv8npdy	170	2	other	other	JJ
cord-035016-ipv8npdy	170	3	side	side	NN
cord-035016-ipv8npdy	170	4	of	of	IN
cord-035016-ipv8npdy	170	5	equitable	equitable	JJ
cord-035016-ipv8npdy	170	6	access	access	NN
cord-035016-ipv8npdy	170	7	to	to	TO
cord-035016-ipv8npdy	170	8	Covid-19	covid-19	VB
cord-035016-ipv8npdy	170	9	vaccines	vaccine	NNS
cord-035016-ipv8npdy	171	1	We	-PRON-	PRP
cord-035016-ipv8npdy	171	2	Need	need	VBP
cord-035016-ipv8npdy	171	3	More	More	JJR
cord-035016-ipv8npdy	171	4	Transparency	Transparency	NNP
cord-035016-ipv8npdy	171	5	in	in	IN
cord-035016-ipv8npdy	171	6	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	171	7	Vaccine	Vaccine	NNP
cord-035016-ipv8npdy	171	8	Development	Development	NNP
cord-035016-ipv8npdy	172	1	Why	why	WRB
cord-035016-ipv8npdy	172	2	'	'	``
cord-035016-ipv8npdy	172	3	vaccine	vaccine	NN
cord-035016-ipv8npdy	172	4	nationalism	nationalism	NN
cord-035016-ipv8npdy	172	5	'	'	''
cord-035016-ipv8npdy	172	6	could	could	MD
cord-035016-ipv8npdy	172	7	doom	doom	VB
cord-035016-ipv8npdy	172	8	plan	plan	NN
cord-035016-ipv8npdy	172	9	for	for	IN
cord-035016-ipv8npdy	172	10	global	global	JJ
cord-035016-ipv8npdy	172	11	access	access	NN
cord-035016-ipv8npdy	172	12	to	to	IN
cord-035016-ipv8npdy	172	13	a	a	DT
cord-035016-ipv8npdy	172	14	COVID-19	COVID-19	NNP
cord-035016-ipv8npdy	172	15	vaccine	vaccine	NN
cord-035016-ipv8npdy	172	16	Covid-19	covid-19	CD
cord-035016-ipv8npdy	172	17	vaccines	vaccine	NNS
cord-035016-ipv8npdy	172	18	:	:	:
cord-035016-ipv8npdy	172	19	pressure	pressure	NN
cord-035016-ipv8npdy	172	20	is	be	VBZ
cord-035016-ipv8npdy	172	21	on	on	IN
cord-035016-ipv8npdy	172	22	to	to	TO
cord-035016-ipv8npdy	172	23	ensure	ensure	VB
cord-035016-ipv8npdy	172	24	they	-PRON-	PRP
cord-035016-ipv8npdy	172	25	go	go	VBP
cord-035016-ipv8npdy	172	26	to	to	IN
cord-035016-ipv8npdy	172	27	the	the	DT
cord-035016-ipv8npdy	172	28	most	most	RBS
cord-035016-ipv8npdy	172	29	needy	needy	JJ
cord-035016-ipv8npdy	172	30	,	,	,
cord-035016-ipv8npdy	172	31	not	not	RB
cord-035016-ipv8npdy	172	32	the	the	DT
cord-035016-ipv8npdy	172	33	highest	high	JJS
cord-035016-ipv8npdy	172	34	bidder	bidder	NN
cord-035016-ipv8npdy	172	35	,	,	,
cord-035016-ipv8npdy	172	36	The	the	DT
cord-035016-ipv8npdy	172	37	Guardian	Guardian	NNP
cord-035016-ipv8npdy	173	1	COVID-19	covid-19	JJ
cord-035016-ipv8npdy	173	2	vaccine	vaccine	NN
cord-035016-ipv8npdy	173	3	trials	trial	NNS
cord-035016-ipv8npdy	173	4	should	should	MD
cord-035016-ipv8npdy	173	5	seek	seek	VB
cord-035016-ipv8npdy	173	6	worthwhile	worthwhile	JJ
cord-035016-ipv8npdy	173	7	efficacy	efficacy	NN
cord-035016-ipv8npdy	174	1	Capitalism	capitalism	NN
cord-035016-ipv8npdy	174	2	is	be	VBZ
cord-035016-ipv8npdy	174	3	Broken	break	VBN
cord-035016-ipv8npdy	174	4	.	.	.
cord-035016-ipv8npdy	175	1	The	the	DT
cord-035016-ipv8npdy	175	2	fix	fix	NN
cord-035016-ipv8npdy	175	3	begins	begin	VBZ
cord-035016-ipv8npdy	175	4	with	with	IN
cord-035016-ipv8npdy	175	5	a	a	DT
cord-035016-ipv8npdy	175	6	free	free	JJ
cord-035016-ipv8npdy	175	7	Covid-19	covid-19	NN
cord-035016-ipv8npdy	175	8	vaccine	vaccine	NN
cord-035016-ipv8npdy	175	9	The	the	DT
cord-035016-ipv8npdy	175	10	Entrepreneurial	Entrepreneurial	NNP
cord-035016-ipv8npdy	175	11	State	State	NNP
cord-035016-ipv8npdy	175	12	How	how	WRB
cord-035016-ipv8npdy	175	13	to	to	TO
cord-035016-ipv8npdy	175	14	develop	develop	VB
cord-035016-ipv8npdy	175	15	a	a	DT
cord-035016-ipv8npdy	175	16	Covid-19	covid-19	JJ
cord-035016-ipv8npdy	175	17	vaccine	vaccine	NN
cord-035016-ipv8npdy	175	18	for	for	IN
cord-035016-ipv8npdy	175	19	all	all	DT
cord-035016-ipv8npdy	175	20	,	,	,
cord-035016-ipv8npdy	175	21	Project	Project	NNP
cord-035016-ipv8npdy	175	22	Syndicate	Syndicate	NNP
cord-035016-ipv8npdy	176	1	This	this	DT
cord-035016-ipv8npdy	176	2	economist	economist	NN
cord-035016-ipv8npdy	176	3	has	have	VBZ
cord-035016-ipv8npdy	176	4	a	a	DT
cord-035016-ipv8npdy	176	5	plan	plan	NN
cord-035016-ipv8npdy	176	6	to	to	TO
cord-035016-ipv8npdy	176	7	fix	fix	VB
cord-035016-ipv8npdy	176	8	capitalism	capitalism	NN
cord-035016-ipv8npdy	176	9	.	.	.
cord-035016-ipv8npdy	177	1	It	-PRON-	PRP
cord-035016-ipv8npdy	177	2	's	be	VBZ
cord-035016-ipv8npdy	177	3	time	time	NN
cord-035016-ipv8npdy	177	4	we	-PRON-	PRP
cord-035016-ipv8npdy	177	5	all	all	DT
cord-035016-ipv8npdy	177	6	listened	listen	VBD
cord-035016-ipv8npdy	177	7	Science	Science	NNP
cord-035016-ipv8npdy	177	8	and	and	CC
cord-035016-ipv8npdy	177	9	technological	technological	JJ
cord-035016-ipv8npdy	177	10	innovation	innovation	NN
cord-035016-ipv8npdy	177	11	in	in	IN
cord-035016-ipv8npdy	177	12	health	health	NN
cord-035016-ipv8npdy	177	13	in	in	IN
cord-035016-ipv8npdy	177	14	Cuba	Cuba	NNP
cord-035016-ipv8npdy	177	15	.	.	.
cord-035016-ipv8npdy	178	1	Results	result	NNS
cord-035016-ipv8npdy	178	2	in	in	IN
cord-035016-ipv8npdy	178	3	selected	select	VBN
cord-035016-ipv8npdy	178	4	problems	problem	NNS
cord-035016-ipv8npdy	178	5	Remove	remove	VBP
cord-035016-ipv8npdy	178	6	the	the	DT
cord-035016-ipv8npdy	178	7	For	for	IN
cord-035016-ipv8npdy	178	8	-	-	HYPH
cord-035016-ipv8npdy	178	9	Profit	profit	NN
cord-035016-ipv8npdy	178	10	Variable	variable	NN
cord-035016-ipv8npdy	178	11	from	from	IN
cord-035016-ipv8npdy	178	12	Clinical	Clinical	NNP
cord-035016-ipv8npdy	178	13	Drug	Drug	NNP
cord-035016-ipv8npdy	178	14	Trials	Trials	NNPS
cord-035016-ipv8npdy	178	15	,	,	,
cord-035016-ipv8npdy	178	16	Health	Health	NNP
cord-035016-ipv8npdy	178	17	and	and	CC
cord-035016-ipv8npdy	178	18	Human	Human	NNP
cord-035016-ipv8npdy	178	19	Rights	Rights	NNPS
cord-035016-ipv8npdy	178	20	Journal	Journal	NNP
cord-035016-ipv8npdy	178	21	21	21	CD
cord-035016-ipv8npdy	179	1	May	May	MD
cord-035016-ipv8npdy	179	2	Who	who	WP
cord-035016-ipv8npdy	179	3	should	should	MD
cord-035016-ipv8npdy	179	4	get	get	VB
cord-035016-ipv8npdy	179	5	the	the	DT
cord-035016-ipv8npdy	179	6	Covid-19	covid-19	NN
cord-035016-ipv8npdy	179	7	vaccine	vaccine	NN
cord-035016-ipv8npdy	179	8	first	first	RB
cord-035016-ipv8npdy	179	9	?	?	.
cord-035016-ipv8npdy	180	1	The	the	DT
cord-035016-ipv8npdy	180	2	equality	equality	NN
cord-035016-ipv8npdy	180	3	vs.	vs.	IN
cord-035016-ipv8npdy	180	4	equity	equity	NN
cord-035016-ipv8npdy	180	5	debate	debate	NN
cord-035016-ipv8npdy	180	6	South	South	NNP
cord-035016-ipv8npdy	180	7	Africa	Africa	NNP
cord-035016-ipv8npdy	180	8	and	and	CC
cord-035016-ipv8npdy	180	9	India	India	NNP
cord-035016-ipv8npdy	180	10	urge	urge	VBP
cord-035016-ipv8npdy	180	11	WTO	WTO	NNP
cord-035016-ipv8npdy	180	12	to	to	TO
cord-035016-ipv8npdy	180	13	waive	waive	VB
cord-035016-ipv8npdy	180	14	IP	ip	NN
cord-035016-ipv8npdy	180	15	rights	right	NNS
cord-035016-ipv8npdy	180	16	,	,	,
cord-035016-ipv8npdy	180	17	widen	widen	VB
cord-035016-ipv8npdy	180	18	access	access	NN
cord-035016-ipv8npdy	180	19	to	to	IN
cord-035016-ipv8npdy	180	20	Covid-19	covid-19	VB
cord-035016-ipv8npdy	180	21	drugs	drug	NNS
cord-035016-ipv8npdy	180	22	and	and	CC
cord-035016-ipv8npdy	180	23	vaccines	vaccine	NNS
cord-035016-ipv8npdy	180	24	Disease	Disease	NNP
cord-035016-ipv8npdy	180	25	X	X	NNP
cord-035016-ipv8npdy	180	26	:	:	:
cord-035016-ipv8npdy	181	1	Accelerating	accelerate	VBG
cord-035016-ipv8npdy	181	2	the	the	DT
cord-035016-ipv8npdy	181	3	development	development	NN
cord-035016-ipv8npdy	181	4	of	of	IN
cord-035016-ipv8npdy	181	5	medical	medical	JJ
cord-035016-ipv8npdy	181	6	countermeasures	countermeasure	NNS
cord-035016-ipv8npdy	181	7	for	for	IN
cord-035016-ipv8npdy	181	8	the	the	DT
cord-035016-ipv8npdy	181	9	next	next	JJ
cord-035016-ipv8npdy	181	10	pandemic	pandemic	NN
cord-035016-ipv8npdy	182	1	The	the	DT
cord-035016-ipv8npdy	182	2	rush	rush	NN
cord-035016-ipv8npdy	182	3	to	to	TO
cord-035016-ipv8npdy	182	4	create	create	VB
cord-035016-ipv8npdy	182	5	a	a	DT
cord-035016-ipv8npdy	182	6	Covid-19	covid-19	JJ
cord-035016-ipv8npdy	182	7	vaccine	vaccine	NN
cord-035016-ipv8npdy	182	8	may	may	MD
cord-035016-ipv8npdy	182	9	do	do	VB
cord-035016-ipv8npdy	182	10	more	more	JJR
cord-035016-ipv8npdy	182	11	harm	harm	NN
cord-035016-ipv8npdy	182	12	than	than	IN
cord-035016-ipv8npdy	182	13	good	good	JJ
cord-035016-ipv8npdy	182	14	Collective	collective	JJ
cord-035016-ipv8npdy	182	15	intelligence	intelligence	NN
cord-035016-ipv8npdy	182	16	,	,	,
cord-035016-ipv8npdy	182	17	not	not	RB
cord-035016-ipv8npdy	182	18	market	market	NN
cord-035016-ipv8npdy	182	19	competition	competition	NN
cord-035016-ipv8npdy	182	20	,	,	,
cord-035016-ipv8npdy	182	21	will	will	MD
cord-035016-ipv8npdy	182	22	deliver	deliver	VB
cord-035016-ipv8npdy	182	23	the	the	DT
cord-035016-ipv8npdy	182	24	best	good	JJS
cord-035016-ipv8npdy	182	25	Covid-19	covid-19	NN
cord-035016-ipv8npdy	182	26	Vaccines	Vaccines	NNPS
cord-035016-ipv8npdy	182	27	As	as	IN
cord-035016-ipv8npdy	182	28	politics	politic	NNS
cord-035016-ipv8npdy	182	29	trumps	trump	VBZ
cord-035016-ipv8npdy	182	30	science	science	NN
cord-035016-ipv8npdy	182	31	in	in	IN
cord-035016-ipv8npdy	182	32	the	the	DT
cord-035016-ipv8npdy	182	33	race	race	NN
cord-035016-ipv8npdy	182	34	for	for	IN
cord-035016-ipv8npdy	182	35	a	a	DT
cord-035016-ipv8npdy	182	36	vaccine	vaccine	NN
cord-035016-ipv8npdy	182	37	,	,	,
cord-035016-ipv8npdy	182	38	who	who	WP
cord-035016-ipv8npdy	182	39	will	will	MD
cord-035016-ipv8npdy	182	40	protect	protect	VB
cord-035016-ipv8npdy	182	41	public	public	JJ
cord-035016-ipv8npdy	182	42	health	health	NN
cord-035016-ipv8npdy	182	43	?	?	.
cord-035016-ipv8npdy	183	1	Ebola	Ebola	NNP
cord-035016-ipv8npdy	183	2	in	in	IN
cord-035016-ipv8npdy	183	3	West	West	NNP
cord-035016-ipv8npdy	183	4	Africa	Africa	NNP
cord-035016-ipv8npdy	183	5	is	be	VBZ
cord-035016-ipv8npdy	183	6	a	a	DT
cord-035016-ipv8npdy	183	7	wakeup	wakeup	JJ
cord-035016-ipv8npdy	183	8	call	call	NN
cord-035016-ipv8npdy	183	9	.	.	.
cord-035016-ipv8npdy	184	1	What	what	WP
cord-035016-ipv8npdy	184	2	the	the	DT
cord-035016-ipv8npdy	184	3	Ebola	Ebola	NNP
cord-035016-ipv8npdy	184	4	crisis	crisis	NN
cord-035016-ipv8npdy	184	5	tells	tell	VBZ
cord-035016-ipv8npdy	184	6	us	-PRON-	PRP
cord-035016-ipv8npdy	184	7	about	about	IN
cord-035016-ipv8npdy	184	8	our	-PRON-	PRP$
cord-035016-ipv8npdy	184	9	failing	fail	VBG
cord-035016-ipv8npdy	184	10	drug	drug	NN
cord-035016-ipv8npdy	184	11	development	development	NN
cord-035016-ipv8npdy	184	12	system	system	NN
cord-035016-ipv8npdy	184	13	Health	Health	NNP
cord-035016-ipv8npdy	184	14	Innovation	Innovation	NNP
cord-035016-ipv8npdy	184	15	as	as	IN
cord-035016-ipv8npdy	184	16	a	a	DT
cord-035016-ipv8npdy	184	17	Public	Public	NNP
cord-035016-ipv8npdy	184	18	Good	Good	NNP
cord-035016-ipv8npdy	184	19	,	,	,
cord-035016-ipv8npdy	184	20	submission	submission	NN
cord-035016-ipv8npdy	184	21	to	to	IN
cord-035016-ipv8npdy	184	22	the	the	DT
cord-035016-ipv8npdy	184	23	UN	UN	NNP
cord-035016-ipv8npdy	184	24	High	High	NNP
cord-035016-ipv8npdy	184	25	Level	Level	NNP
cord-035016-ipv8npdy	184	26	Panel	Panel	NNP
cord-035016-ipv8npdy	184	27	on	on	IN
cord-035016-ipv8npdy	184	28	Access	Access	NNP
cord-035016-ipv8npdy	184	29	to	to	IN
cord-035016-ipv8npdy	184	30	Medicines	medicine	NNS
cord-035016-ipv8npdy	184	31	Conflict	conflict	NN
cord-035016-ipv8npdy	184	32	of	of	IN
cord-035016-ipv8npdy	184	33	interest	interest	NN
cord-035016-ipv8npdy	185	1	The	the	DT
cord-035016-ipv8npdy	185	2	author	author	NN
cord-035016-ipv8npdy	185	3	declares	declare	VBZ
cord-035016-ipv8npdy	185	4	no	no	DT
cord-035016-ipv8npdy	185	5	conflicts	conflict	NNS
cord-035016-ipv8npdy	185	6	of	of	IN
cord-035016-ipv8npdy	185	7	interest	interest	NN
cord-035016-ipv8npdy	185	8	.	.	.